data_2mfl_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mfl _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 23.4 mttm . . . . . 0 N--CA 1.458 -0.072 0 CA-C-O 120.777 0.322 . . . . 74.519999999999996 110.929 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.18 -29.95 65.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 63.450000000000003 111.112 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 32.6 mmtt -58.39 -26.29 63.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 74.340000000000003 110.876 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 6.1 mtt85 -65.44 -25.83 67.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 73.430000000000007 110.894 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 54.0 m170 -51.97 -47.93 64.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 73.450000000000003 110.848 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -80.2 -26.53 39.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 75.409999999999997 110.89 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.2 -21.17 62.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 71.420000000000002 111.089 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 42.1 m0 -58.01 -22.85 51.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.209 -0.451 . . . . 74.319999999999993 110.922 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 74.9 mt -54.59 -26.58 16.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.448 . . . . 72.129999999999995 111.122 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.5 m -77.93 -28.16 49.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 75.129999999999995 111.164 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 18.7 mt -64.1 -27.67 69.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 75.549999999999997 110.907 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -51.56 -49.94 61.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 71.010000000000005 110.9 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -25.07 68.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 74.540000000000006 110.901 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.74 -55.2 8.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 73.430000000000007 111.081 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -57.58 -26.27 61.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 74.040000000000006 110.904 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.71 -40.85 63.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 74.409999999999997 110.869 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -98.48 20.77 12.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 74.239999999999995 110.842 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 61.53 56.4 2.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 75.230000000000004 111.112 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -64.64 143.18 58.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 75.25 110.906 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.3 t -86.72 143.75 27.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.147 -0.479 . . . . 72.549999999999997 111.154 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.6 m -122.07 -179.62 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 74.140000000000001 111.154 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 4.3 t -159.96 119.58 2.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 72.430000000000007 111.14 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -160.2 172.4 36.65 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.716 -0.754 . . . . 62.240000000000002 112.458 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.7 p -116.1 145.35 21.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.775 0.321 . . . . 63.43 111.119 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.6 mt -66.74 117.87 8.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 73.400000000000006 111.109 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -97.65 -43.72 7.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 71.140000000000001 110.887 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -121.67 148.23 17.26 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.725 -0.75 . . . . 74.519999999999996 112.474 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 27.0 pttt -124.21 125.4 44.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.789 0.328 . . . . 75.200000000000003 110.928 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.5 m -114.08 176.96 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 71.400000000000006 111.166 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 28.9 mttp -62.47 94.38 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 72.030000000000001 110.87 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 90.61 -35.76 3.77 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.704 -0.76 . . . . 73.329999999999998 112.508 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -90.38 173.69 39.21 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.749 -0.739 . . . . 73.010000000000005 112.531 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -152.04 118.92 5.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.994 0.426 . . . . 73.129999999999995 110.927 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.11 135.81 33.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.49 . . . . 73.420000000000002 111.152 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 18.1 t -135.39 138.12 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 64.219999999999999 111.089 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -88.85 113.34 24.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.453 . . . . 73.530000000000001 110.881 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 11.1 mt -121.16 96.44 5.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.464 . . . . 74.200000000000003 110.907 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 63.32 25.24 14.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 75.400000000000006 110.919 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 103.96 -23.1 33.24 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.677 -0.773 . . . . 71.510000000000005 112.467 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 21.9 mt -83.05 151.87 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.808 0.337 . . . . 74.420000000000002 111.119 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -99.65 124.3 44.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 75.340000000000003 110.868 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -101.15 171.75 7.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 71.109999999999999 111.097 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -142.82 117.91 10.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 74.439999999999998 110.895 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 7.7 mp -100.28 129.56 27.81 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.653 0.74 . . . . 72.140000000000001 110.918 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 132.5 23.55 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.706 2.27 . . . . 70.400000000000006 112.352 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -74.91 -11.22 83.8 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 72.200000000000003 112.486 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 26.5 t -50.56 -33.94 23.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.934 0.397 . . . . 71.140000000000001 110.888 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 28.0 mt -123.42 39.28 4.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.081 -0.508 . . . . 73.450000000000003 110.906 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 99.4 t -122.77 -59.04 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 73.129999999999995 111.103 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -116.34 117.52 30.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 72.0 110.822 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 7.3 p -173.81 123.9 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 75.200000000000003 111.134 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 53.04 72.61 1.11 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.55 0.69 . . . . 73.319999999999993 110.889 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 132.84 24.09 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.644 2.229 . . . . 72.140000000000001 112.325 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 6.8 p -126.03 -37.93 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.456 . . . . 71.219999999999999 111.102 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -126.92 -176.98 3.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 73.409999999999997 110.872 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -52.09 132.48 33.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.196 -0.456 . . . . 65.310000000000002 110.818 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 9.0 t -123.16 42.6 3.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 70.209999999999994 111.125 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -85.88 -11.46 53.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 72.530000000000001 110.861 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . 0.49 ' HD1' ' N ' ' A' ' 147' ' ' LEU . 0.1 OUTLIER -72.57 -8.38 54.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 72.349999999999994 110.862 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.49 ' N ' ' HD1' ' A' ' 146' ' ' HIS . 64.9 mt -59.51 -31.17 69.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 72.010000000000005 110.892 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -123.53 134.9 53.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 74.439999999999998 110.903 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 92.81 0.95 68.32 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.719 -0.753 . . . . 65.230000000000004 112.482 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.4 127.92 34.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.721 0.295 . . . . 73.219999999999999 110.89 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -109.59 87.0 2.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 74.299999999999997 110.9 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.11 166.34 24.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 72.430000000000007 110.923 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -81.92 173.75 11.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.214 -0.448 . . . . 74.319999999999993 110.9 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -133.47 -179.38 5.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 73.310000000000002 110.852 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 12.1 ttpt -130.84 108.59 9.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 74.340000000000003 110.907 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.9 t -70.42 126.53 30.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 74.349999999999994 111.167 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.9 tp -119.0 -30.47 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 75.519999999999996 111.182 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 20.7 ttmt -171.87 133.21 0.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 75.319999999999993 110.903 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.47 148.17 31.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 73.200000000000003 110.902 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.19 89.37 3.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 74.519999999999996 110.869 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -67.71 -23.16 65.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 74.400000000000006 110.865 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.81 -43.26 63.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 74.310000000000002 110.895 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -99.66 24.74 7.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 65.140000000000001 110.885 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 9.7 p30 41.52 38.59 0.9 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 72.530000000000001 110.917 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -143.07 168.79 18.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 75.129999999999995 110.872 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.8 m -128.67 144.39 38.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 73.129999999999995 111.145 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 18.3 m -116.74 171.8 5.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 72.329999999999998 111.129 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 15.8 t -119.42 152.28 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 74.299999999999997 111.103 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 14.0 t -70.01 154.7 41.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 75.049999999999997 110.873 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 18.4 ttm180 -83.46 -54.56 4.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 71.209999999999994 110.906 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -57.4 -27.01 61.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 73.349999999999994 110.878 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.2 -19.64 55.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 72.340000000000003 111.097 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 11.1 p -52.38 -28.96 12.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 63.229999999999997 111.115 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 30.8 pt -51.26 -30.71 10.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 73.439999999999998 111.085 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -87.98 -46.81 9.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 74.430000000000007 110.89 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 4.2 p -56.51 -40.51 75.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 74.040000000000006 110.83 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -51.92 -49.16 63.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 72.120000000000005 110.911 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -176.94 86.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 70.129999999999995 110.875 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 4.7 p . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 74.5 110.872 -179.834 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.785 0.326 . . . . 74.519999999999996 110.906 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.2 -35.33 79.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 63.450000000000003 111.089 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.68 -27.49 64.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 74.340000000000003 110.963 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.9 tpp180 -60.41 -26.58 66.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 73.430000000000007 110.833 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -52.09 -30.09 24.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 73.450000000000003 110.854 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 -80.04 -34.5 38.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 75.409999999999997 110.872 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.75 -15.96 61.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 71.420000000000002 111.083 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -57.98 -22.68 50.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 74.319999999999993 110.929 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 43.1 mm -55.35 -25.41 17.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.287 -0.415 . . . . 72.129999999999995 111.131 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 71.0 p -85.69 -23.97 27.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.232 -0.44 . . . . 75.129999999999995 111.093 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 63.4 mt -67.54 -49.0 65.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 75.549999999999997 110.922 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -51.9 -43.49 63.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 71.010000000000005 110.876 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.87 -24.39 41.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 74.540000000000006 110.894 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.08 -26.47 56.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 73.430000000000007 111.114 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -56.04 -25.12 43.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 74.040000000000006 110.941 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -54.82 -26.84 37.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 74.409999999999997 110.891 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -92.75 -22.04 19.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.081 -0.509 . . . . 74.239999999999995 110.846 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 63.9 44.91 4.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 75.230000000000004 111.123 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -62.43 -179.81 0.27 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.22 -0.446 . . . . 75.25 110.832 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 32.7 p -106.61 178.82 4.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.1 -0.5 . . . . 72.549999999999997 111.089 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.9 m -152.35 -178.66 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 74.140000000000001 111.181 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 86.5 m -154.22 122.89 6.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 72.430000000000007 111.15 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -158.09 154.97 26.01 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.7 -0.762 . . . . 62.240000000000002 112.422 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.8 p -105.16 137.62 33.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.743 0.306 . . . . 63.43 111.216 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.2 mp -57.98 112.02 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.218 -0.446 . . . . 73.400000000000006 111.134 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 20.4 m-20 -95.17 -30.3 14.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.098 -0.501 . . . . 71.140000000000001 110.892 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -134.14 144.4 16.34 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.708 -0.758 . . . . 74.519999999999996 112.502 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.93 136.84 54.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.861 0.362 . . . . 75.200000000000003 110.917 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.1 m -118.8 176.44 3.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 71.400000000000006 111.044 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.1 tptt -66.0 97.75 0.38 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 72.030000000000001 110.92 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 92.2 -35.02 4.16 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.717 -0.754 . . . . 73.329999999999998 112.46 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -98.18 173.62 27.84 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.747 . . . . 73.010000000000005 112.494 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -146.2 118.91 8.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.911 0.386 . . . . 73.129999999999995 110.918 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.26 149.5 25.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 73.420000000000002 111.14 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.3 t -140.75 142.35 30.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 64.219999999999999 111.103 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -99.61 99.52 10.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 73.530000000000001 110.873 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 16.2 mt -102.02 89.68 3.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 74.200000000000003 110.929 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 51.97 39.31 25.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 75.400000000000006 110.844 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 103.68 -27.15 20.92 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.768 -0.729 . . . . 71.510000000000005 112.464 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 24.4 mm -74.15 150.23 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.787 0.327 . . . . 74.420000000000002 111.154 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.7 ttt180 -110.7 111.87 23.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 75.340000000000003 110.863 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -92.91 171.54 8.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 71.109999999999999 111.147 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -145.58 107.85 4.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 74.439999999999998 110.873 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 6.6 mp -92.35 129.46 40.96 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.512 0.672 . . . . 72.140000000000001 110.959 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 155.18 66.58 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.64 2.226 . . . . 70.400000000000006 112.35 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -67.19 -11.66 59.3 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.707 -0.759 . . . . 72.200000000000003 112.473 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.3 p -79.47 -20.86 46.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.922 0.391 . . . . 71.140000000000001 110.871 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.8 tp -120.34 39.23 3.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.123 -0.49 . . . . 73.450000000000003 110.908 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 85.1 t -62.37 -62.46 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 73.129999999999995 111.106 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -173.76 146.05 1.22 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.095 -0.502 . . . . 72.0 110.873 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.8 m -85.74 151.79 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 75.200000000000003 111.093 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.17 73.47 0.93 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.599 0.714 . . . . 73.319999999999993 110.905 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 139.16 39.72 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.714 2.276 . . . . 72.140000000000001 112.358 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 10.6 p -120.49 151.98 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.301 -0.409 . . . . 71.219999999999999 111.086 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -51.99 -30.15 23.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 73.409999999999997 110.859 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -82.91 129.21 34.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 65.310000000000002 110.834 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 79.6 p -108.57 37.4 2.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 70.209999999999994 111.118 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.3 tp -87.16 -22.15 25.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 72.530000000000001 110.903 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 29.0 p-80 -96.13 18.44 13.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 72.349999999999994 110.823 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 48.4 mt -110.7 39.35 2.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 72.010000000000005 110.878 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -167.48 123.87 1.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 74.439999999999998 110.907 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.19 15.54 71.74 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.673 -0.775 . . . . 65.230000000000004 112.479 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.0 tmmm? -71.2 138.23 49.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.769 0.319 . . . . 73.219999999999999 110.866 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -105.08 118.45 36.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 74.299999999999997 110.832 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.0 tp -139.05 146.92 41.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.108 -0.496 . . . . 72.430000000000007 110.899 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -90.94 129.71 36.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.439 . . . . 74.319999999999993 110.888 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -114.91 -179.43 3.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 73.310000000000002 110.897 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.74 136.05 21.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 74.340000000000003 110.91 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 22.0 t -58.72 112.28 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 74.349999999999994 111.148 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.78 -26.14 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 75.519999999999996 111.183 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -169.17 115.79 0.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 75.319999999999993 110.892 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -150.17 132.95 15.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.225 -0.443 . . . . 73.200000000000003 110.919 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -117.82 109.73 16.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 74.519999999999996 110.804 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -64.71 -30.64 71.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 74.400000000000006 110.926 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 9.3 ttmt -70.29 -29.93 66.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 74.310000000000002 110.895 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 38.7 mtt180 -91.83 -15.37 28.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.427 . . . . 65.140000000000001 110.9 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 60.62 42.89 13.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 72.530000000000001 110.919 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -143.06 140.69 31.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 75.129999999999995 110.864 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 46.7 t -137.23 141.23 40.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 73.129999999999995 111.104 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.5 m -134.78 170.92 18.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 72.329999999999998 111.177 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 20.7 t -120.47 149.19 23.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 74.299999999999997 111.133 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.77 160.89 18.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 75.049999999999997 110.862 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.36 -33.71 13.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 71.209999999999994 110.908 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -76.87 -25.04 52.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 73.349999999999994 110.879 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.8 -9.38 58.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 72.340000000000003 111.131 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 10.5 p -51.35 -30.15 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 63.229999999999997 111.129 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 31.5 pt -52.07 -29.55 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 73.439999999999998 111.081 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -54.73 -65.95 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 74.430000000000007 110.857 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.96 -43.93 63.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 74.040000000000006 110.895 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -55.72 -51.17 68.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.491 . . . . 72.120000000000005 110.863 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -123.15 71.8 1.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 70.129999999999995 110.852 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 63.3 p . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 74.5 110.867 -179.87 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.758 0.313 . . . . 74.519999999999996 110.898 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.62 -26.16 50.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 63.450000000000003 111.112 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.8 pttt -53.88 -27.95 33.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 74.340000000000003 110.846 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -59.69 -25.52 64.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 73.430000000000007 110.793 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -51.99 -37.5 53.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.195 -0.457 . . . . 73.450000000000003 110.874 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -78.56 -37.04 43.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.113 -0.494 . . . . 75.409999999999997 110.911 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.0 -18.14 63.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 71.420000000000002 111.147 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 33.3 m0 -56.6 -24.53 48.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.459 . . . . 74.319999999999993 110.916 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 29.2 pt -55.02 -26.11 17.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 72.129999999999995 111.097 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 57.1 m -78.38 -27.22 46.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 75.129999999999995 111.142 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 17.9 mt -66.61 -24.85 66.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 75.549999999999997 110.95 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -51.85 -34.87 42.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 71.010000000000005 110.881 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 36.5 mttp -83.83 -26.36 29.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.128 -0.487 . . . . 74.540000000000006 110.873 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.33 -58.38 7.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 73.430000000000007 111.089 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -52.32 -29.64 24.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 74.040000000000006 110.961 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.05 -36.19 78.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 74.409999999999997 110.96 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -108.58 20.74 18.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.171 -0.468 . . . . 74.239999999999995 110.896 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 51.59 62.25 2.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 75.230000000000004 111.097 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.33 155.24 40.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 75.25 110.926 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.6 t -104.11 172.65 6.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 72.549999999999997 111.147 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.9 m -146.28 177.37 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.27 -0.423 . . . . 74.140000000000001 111.067 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.8 t -162.2 127.25 3.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 72.430000000000007 111.083 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -165.77 153.95 24.27 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.774 -0.727 . . . . 62.240000000000002 112.506 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 13.1 p -102.64 137.18 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.818 0.342 . . . . 63.43 111.149 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.4 mp -54.09 106.43 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.252 -0.431 . . . . 73.400000000000006 111.067 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -96.02 -39.84 9.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 71.140000000000001 110.885 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -120.99 141.93 15.21 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.783 -0.722 . . . . 74.519999999999996 112.485 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.9 pttp -124.54 147.43 48.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.781 0.325 . . . . 75.200000000000003 110.918 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.2 m -118.1 177.25 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 71.400000000000006 111.142 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.09 95.8 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 72.030000000000001 110.893 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 90.16 -36.71 3.49 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.732 -0.747 . . . . 73.329999999999998 112.461 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -98.27 173.52 27.63 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.761 -0.733 . . . . 73.010000000000005 112.481 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -132.42 164.22 27.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.976 0.417 . . . . 73.129999999999995 110.866 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -135.45 150.82 49.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.108 -0.496 . . . . 73.420000000000002 111.161 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.3 t -136.48 156.57 36.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.255 -0.43 . . . . 64.219999999999999 111.118 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -114.21 108.47 17.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 73.530000000000001 110.927 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 18.9 mt -109.24 84.87 1.99 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 74.200000000000003 110.859 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 51.45 56.39 7.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 75.400000000000006 110.911 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.37 -35.14 4.33 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.769 -0.729 . . . . 71.510000000000005 112.49 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 26.0 mm -70.82 150.42 9.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.866 0.365 . . . . 74.420000000000002 111.103 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -117.25 114.29 23.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.477 . . . . 75.340000000000003 110.881 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -92.64 161.3 14.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.484 . . . . 71.109999999999999 111.129 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -136.11 113.0 10.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 74.439999999999998 110.885 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -86.64 129.98 50.75 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.578 0.704 . . . . 72.140000000000001 110.955 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 127.88 15.19 Favored 'Trans proline' 0 N--CA 1.465 -0.167 0 C-N-CA 122.681 2.254 . . . . 70.400000000000006 112.357 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -51.56 -28.29 21.16 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.753 -0.737 . . . . 72.200000000000003 112.479 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 72.9 m -56.41 -25.09 48.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.958 0.408 . . . . 71.140000000000001 110.852 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.5 mt -88.98 -33.52 17.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.127 -0.488 . . . . 73.450000000000003 110.941 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 87.9 t -53.99 -27.43 16.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 73.129999999999995 111.108 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.45 112.67 20.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.166 -0.47 . . . . 72.0 110.885 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 7.0 p -173.62 123.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 75.200000000000003 111.097 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 62.95 160.6 0.12 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.556 0.693 . . . . 73.319999999999993 110.889 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 149.91 67.75 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.722 2.282 . . . . 72.140000000000001 112.354 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.9 m -150.19 159.47 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 71.219999999999999 111.16 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -110.16 -73.92 0.67 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 73.409999999999997 110.9 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -63.97 145.2 56.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.454 . . . . 65.310000000000002 110.885 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.39 23.61 14.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 70.209999999999994 111.144 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.5 mp -87.34 -22.79 24.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 72.530000000000001 110.909 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 43.9 p-80 -66.68 -25.26 66.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.433 . . . . 72.349999999999994 110.816 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 59.9 mt -63.79 -59.06 5.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 72.010000000000005 110.968 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -119.43 142.18 48.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 74.439999999999998 110.894 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 91.38 -14.55 63.5 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.76 -0.733 . . . . 65.230000000000004 112.472 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -53.87 128.98 32.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.768 0.318 . . . . 73.219999999999999 110.95 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.51 105.06 14.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 74.299999999999997 110.914 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.6 mt -139.04 179.84 6.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 72.430000000000007 110.953 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -115.91 152.94 32.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 74.319999999999993 110.894 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -126.5 178.4 5.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 73.310000000000002 110.853 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 18.1 tttt -131.37 160.39 35.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 74.340000000000003 110.884 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 7.6 p -76.72 127.63 37.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 74.349999999999994 111.146 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.2 tp -127.87 -38.3 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.187 -0.46 . . . . 75.519999999999996 111.095 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -174.66 132.81 0.35 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.484 . . . . 75.319999999999993 110.884 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.7 pp -158.06 135.7 10.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 73.200000000000003 110.902 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -117.12 125.86 51.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.465 . . . . 74.519999999999996 110.85 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -80.47 -26.15 38.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 74.400000000000006 110.922 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -73.29 -41.31 63.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 74.310000000000002 110.973 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -82.97 -15.41 51.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 65.140000000000001 110.897 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.74 42.36 10.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 72.530000000000001 110.894 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -141.71 140.51 33.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 75.129999999999995 110.856 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 5.9 p -146.03 141.09 21.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 73.129999999999995 111.136 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 20.1 m -134.87 167.52 25.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.161 -0.472 . . . . 72.329999999999998 111.095 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 8.5 m -120.45 148.97 23.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 74.299999999999997 111.118 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.73 155.23 21.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.15 -0.477 . . . . 75.049999999999997 110.829 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 30.2 mtt85 -64.08 -38.53 91.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 71.209999999999994 110.946 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -80.1 -23.11 41.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 73.349999999999994 110.888 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -53.72 -41.7 67.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 72.340000000000003 111.113 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 13.0 p -66.02 -21.79 29.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 63.229999999999997 111.101 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 16.3 mm -70.07 -53.98 21.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.451 . . . . 73.439999999999998 111.146 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -55.46 -47.8 75.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 74.430000000000007 110.861 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 68.5 m -56.42 -42.23 77.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 74.040000000000006 110.827 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -64.69 -51.65 61.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.076 -0.511 . . . . 72.120000000000005 110.854 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -92.06 54.18 2.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.504 . . . . 70.129999999999995 110.879 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 4.0 p . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 74.5 110.908 -179.873 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.9 mptt . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.829 0.347 . . . . 74.519999999999996 110.92 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.04 -37.83 33.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.21 -0.45 . . . . 63.450000000000003 111.086 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.4 ttmm -60.1 -20.04 56.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 74.340000000000003 110.854 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 17.2 tpp180 -60.03 -20.12 56.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 73.430000000000007 110.829 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 -51.45 -31.77 24.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 73.450000000000003 110.921 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -80.3 -42.45 23.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.187 -0.46 . . . . 75.409999999999997 110.812 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.57 -19.95 66.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 71.420000000000002 111.092 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 41.7 m0 -57.3 -23.8 50.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 74.319999999999993 110.863 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 49.6 mt -52.43 -28.73 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 72.129999999999995 111.178 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 58.3 p -76.0 -60.75 2.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 75.129999999999995 111.153 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 pp -60.16 -20.39 58.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 75.549999999999997 110.992 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -51.65 -47.81 63.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.103 -0.499 . . . . 71.010000000000005 110.888 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.5 mtpp -54.04 -27.5 32.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 74.540000000000006 110.95 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.7 -43.86 62.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 73.430000000000007 111.092 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -65.38 -31.84 73.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 74.040000000000006 110.924 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -60.31 -26.04 66.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 74.409999999999997 110.895 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -95.85 20.82 9.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.189 -0.459 . . . . 74.239999999999995 110.852 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 51.86 55.46 9.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 75.230000000000004 111.12 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -76.15 163.37 27.16 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.238 -0.437 . . . . 75.25 110.886 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.8 t -91.93 153.76 19.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.476 . . . . 72.549999999999997 111.131 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.2 m -144.53 178.62 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 74.140000000000001 111.179 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.1 t -157.23 123.47 4.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 72.430000000000007 111.171 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -155.87 153.2 24.57 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.73 -0.747 . . . . 62.240000000000002 112.497 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.2 p -101.02 140.21 20.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.839 0.352 . . . . 63.43 111.14 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.4 mp -60.12 120.93 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 73.400000000000006 111.145 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -102.27 -43.02 5.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 71.140000000000001 110.875 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -118.45 142.99 17.36 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.682 -0.77 . . . . 74.519999999999996 112.468 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.6 pttt -124.06 123.71 40.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.837 0.351 . . . . 75.200000000000003 110.945 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 26.6 m -110.09 177.33 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 71.400000000000006 111.122 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -62.16 94.14 0.05 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 72.030000000000001 110.953 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.88 -36.14 3.61 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.765 -0.731 . . . . 73.329999999999998 112.499 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -90.02 173.8 39.94 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.728 -0.749 . . . . 73.010000000000005 112.503 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -151.15 127.48 10.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.992 0.425 . . . . 73.129999999999995 110.872 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 57.8 p -98.19 142.46 29.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 73.420000000000002 111.159 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.3 t -133.74 147.15 30.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 64.219999999999999 111.117 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -97.25 134.87 39.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.1 -0.5 . . . . 73.530000000000001 110.896 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 78.4 mt -139.41 74.55 1.47 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.119 -0.491 . . . . 74.200000000000003 110.972 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 62.98 42.15 7.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.113 -0.494 . . . . 75.400000000000006 110.902 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 103.03 -31.05 9.19 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.695 -0.764 . . . . 71.510000000000005 112.542 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 60.9 mt -78.04 144.07 11.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.869 0.366 . . . . 74.420000000000002 111.101 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.6 mtp180 -109.22 114.02 27.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 75.340000000000003 110.908 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -92.5 171.54 8.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 71.109999999999999 111.109 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -136.44 129.96 31.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.43 . . . . 74.439999999999998 110.842 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.51 130.54 22.66 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.627 0.727 . . . . 72.140000000000001 110.914 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 140.77 43.51 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.707 2.271 . . . . 70.400000000000006 112.334 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.02 -11.88 56.07 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.771 -0.728 . . . . 72.200000000000003 112.554 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.9 t -76.52 -22.52 54.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.906 0.384 . . . . 71.140000000000001 110.873 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.57 39.52 3.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.504 . . . . 73.450000000000003 110.901 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 85.4 t -53.67 -63.09 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 73.129999999999995 111.103 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -179.65 171.21 1.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 72.0 110.901 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 5.9 p -106.06 121.08 58.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 75.200000000000003 111.108 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -177.33 160.79 1.44 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.642 0.734 . . . . 73.319999999999993 110.864 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 166.6 26.93 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.675 2.25 . . . . 72.140000000000001 112.38 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 31.6 m -51.67 -29.63 10.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.233 -0.44 . . . . 71.219999999999999 111.106 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 54.1 mtm180 -51.86 133.04 32.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 73.409999999999997 110.949 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -51.96 169.08 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 65.310000000000002 110.849 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.4 t -169.82 142.41 2.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 70.209999999999994 111.17 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.4 tt -87.9 -8.92 55.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.268 -0.423 . . . . 72.530000000000001 110.883 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -62.25 -15.72 48.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.443 . . . . 72.349999999999994 110.844 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 47.9 mt -68.85 -24.05 64.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 72.010000000000005 110.958 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -118.77 123.97 46.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.169 -0.469 . . . . 74.439999999999998 110.845 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 89.54 26.12 26.1 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.711 -0.757 . . . . 65.230000000000004 112.448 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.78 128.17 34.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.828 0.347 . . . . 73.219999999999999 110.865 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -105.15 108.54 20.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.203 -0.453 . . . . 74.299999999999997 110.932 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.6 mp -139.11 -179.51 5.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 72.430000000000007 110.914 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -114.31 150.89 33.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 74.319999999999993 110.891 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -125.42 168.06 14.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 73.310000000000002 110.884 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -119.76 123.29 43.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 74.340000000000003 110.862 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 91.9 t -67.61 117.02 8.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.244 -0.434 . . . . 74.349999999999994 111.173 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.4 tp -120.79 -33.35 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 75.519999999999996 111.124 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -171.15 119.96 0.5 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 75.319999999999993 110.872 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -125.33 139.14 53.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 73.200000000000003 110.881 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -118.5 88.95 3.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 74.519999999999996 110.908 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -67.7 -20.03 65.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 74.400000000000006 110.934 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.23 -37.73 67.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 74.310000000000002 110.84 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -93.25 16.39 13.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.444 . . . . 65.140000000000001 110.861 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.2 m120 51.74 30.11 6.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 72.530000000000001 110.938 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -143.1 164.18 30.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 75.129999999999995 110.853 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 20.2 t -143.43 144.61 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 73.129999999999995 111.13 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 14.3 p -129.07 152.2 36.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 72.329999999999998 111.13 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 25.2 m -119.42 145.68 25.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 74.299999999999997 111.124 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.36 159.81 33.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 75.049999999999997 110.799 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -93.45 -37.72 11.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.07 -0.513 . . . . 71.209999999999994 110.881 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 -79.59 -26.75 41.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 73.349999999999994 110.895 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.43 -13.94 62.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.124 -0.489 . . . . 72.340000000000003 111.124 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 11.0 p -52.98 -30.7 16.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 63.229999999999997 111.045 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 23.5 pt -61.96 -30.15 47.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 73.439999999999998 111.145 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -71.71 -46.52 58.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.473 . . . . 74.430000000000007 111.027 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 52.6 p -52.01 -47.24 65.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.124 -0.489 . . . . 74.040000000000006 110.81 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -54.9 -52.98 61.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 72.120000000000005 110.945 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -109.1 55.82 0.63 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 70.129999999999995 110.906 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 72.2 p . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 74.5 110.929 -179.906 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt . . . . . 0 C--O 1.23 0.038 0 CA-C-O 120.746 0.307 . . . . 74.519999999999996 110.877 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.56 -40.03 43.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.455 . . . . 63.450000000000003 111.073 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.8 pptp? -60.14 -20.01 56.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 74.340000000000003 110.909 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -59.19 -20.87 57.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.434 . . . . 73.430000000000007 110.898 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -51.38 -31.22 21.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 73.450000000000003 110.838 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -80.43 -46.13 16.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 75.409999999999997 110.861 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.3 -17.18 57.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 71.420000000000002 111.133 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 35.5 m0 -57.85 -22.28 47.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.117 -0.492 . . . . 74.319999999999993 110.92 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 31.0 pt -53.03 -31.24 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 72.129999999999995 111.117 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 12.8 t -72.32 -30.05 64.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 75.129999999999995 111.17 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 18.4 mt -67.38 -21.0 65.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 75.549999999999997 110.865 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -76.23 -36.12 58.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 71.010000000000005 110.87 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -84.03 -22.45 31.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.118 -0.492 . . . . 74.540000000000006 110.823 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.14 -27.73 59.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.416 . . . . 73.430000000000007 111.067 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -55.53 -25.74 39.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.258 -0.428 . . . . 74.040000000000006 110.946 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.74 -27.77 30.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.094 -0.503 . . . . 74.409999999999997 110.906 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -97.1 -19.2 18.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 74.239999999999995 110.846 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 64.03 50.8 2.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 75.230000000000004 111.081 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -64.31 167.14 7.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 75.25 110.867 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.2 t -102.42 165.27 11.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 72.549999999999997 111.244 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.7 m -148.73 177.73 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 74.140000000000001 111.13 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 4.3 t -149.32 118.09 6.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.447 . . . . 72.430000000000007 111.148 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -134.5 164.77 24.59 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.735 -0.745 . . . . 62.240000000000002 112.491 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 13.3 p -105.51 135.79 42.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.777 0.322 . . . . 63.43 111.174 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.2 mp -54.35 101.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 73.400000000000006 111.159 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -74.21 -44.26 53.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 71.140000000000001 110.886 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -134.81 155.06 21.78 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.763 -0.732 . . . . 74.519999999999996 112.469 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -124.32 128.82 49.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.848 0.356 . . . . 75.200000000000003 110.881 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.3 m -114.61 176.79 2.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.201 -0.454 . . . . 71.400000000000006 111.085 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -66.73 98.46 0.53 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 72.030000000000001 110.922 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 91.5 -35.57 3.91 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.753 -0.737 . . . . 73.329999999999998 112.535 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -98.25 173.63 27.76 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.756 -0.735 . . . . 73.010000000000005 112.552 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -146.96 118.75 8.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.925 0.393 . . . . 73.129999999999995 110.882 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.13 150.81 26.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 73.420000000000002 111.145 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 18.7 t -140.64 149.98 21.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 64.219999999999999 111.097 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -105.94 114.64 28.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.451 . . . . 73.530000000000001 110.898 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 77.8 mt -114.53 77.2 1.04 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 74.200000000000003 110.894 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 63.34 52.22 2.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 75.400000000000006 110.933 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 93.96 -34.71 4.51 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.762 -0.732 . . . . 71.510000000000005 112.523 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 27.5 mt -75.18 150.85 6.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.802 0.334 . . . . 74.420000000000002 111.149 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -110.76 132.11 54.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 75.340000000000003 110.822 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -110.12 171.56 7.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 71.109999999999999 111.088 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -138.54 122.38 17.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.24 -0.436 . . . . 74.439999999999998 110.888 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 10.3 mp -95.07 130.11 33.61 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.648 0.737 . . . . 72.140000000000001 110.931 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 132.46 23.38 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.727 2.284 . . . . 70.400000000000006 112.398 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -74.48 -11.14 82.71 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.675 -0.774 . . . . 72.200000000000003 112.445 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 41.8 m -50.4 -32.74 18.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.948 0.404 . . . . 71.140000000000001 110.887 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 28.6 mt -123.12 38.62 4.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.11 -0.496 . . . . 73.450000000000003 110.939 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 89.6 t -122.75 -34.98 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 73.129999999999995 111.113 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -99.2 113.52 25.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 72.0 110.865 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 55.7 t -144.21 108.71 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 75.200000000000003 111.175 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.53 160.94 0.12 Allowed Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.655 0.74 . . . . 73.319999999999993 110.866 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 129.18 17.09 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.725 2.284 . . . . 72.140000000000001 112.353 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 7.7 m -149.04 149.61 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 71.219999999999999 111.136 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 36.3 ptt85 -123.37 36.91 4.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.468 . . . . 73.409999999999997 110.845 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -122.56 104.5 9.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.206 -0.452 . . . . 65.310000000000002 110.876 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 41.3 p -126.47 25.21 6.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.173 -0.467 . . . . 70.209999999999994 111.175 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -86.36 -22.28 26.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.258 -0.428 . . . . 72.530000000000001 110.931 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 50.5 p-80 -90.43 -20.92 22.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 72.349999999999994 110.846 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 89.7 mt -87.89 50.78 2.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.268 -0.424 . . . . 72.010000000000005 110.92 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -165.23 124.07 1.71 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 74.439999999999998 110.873 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 63.46 32.26 83.54 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.693 -0.765 . . . . 65.230000000000004 112.488 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.85 129.25 48.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.747 0.308 . . . . 73.219999999999999 110.913 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -86.07 105.01 16.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 74.299999999999997 110.859 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 10.2 tp -114.62 155.35 26.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 72.430000000000007 110.905 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -97.07 129.99 44.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 74.319999999999993 110.9 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -123.05 -179.4 4.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 73.310000000000002 110.861 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.1 tmmm? -141.45 146.17 36.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.087 -0.506 . . . . 74.340000000000003 110.915 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 47.5 t -94.63 78.96 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.248 -0.433 . . . . 74.349999999999994 111.142 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.5 tt -91.5 -25.33 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 75.519999999999996 111.092 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -152.38 114.53 4.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 75.319999999999993 110.884 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -118.44 149.27 41.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.431 . . . . 73.200000000000003 110.908 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -116.06 57.57 0.75 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.213 -0.449 . . . . 74.519999999999996 110.89 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -58.95 -25.14 63.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.467 . . . . 74.400000000000006 110.906 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 33.0 tttt -55.73 -25.85 42.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 74.310000000000002 110.832 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.12 24.83 12.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.309 -0.405 . . . . 65.140000000000001 110.859 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 9.1 m120 53.66 28.31 7.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.483 . . . . 72.530000000000001 110.902 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -143.08 172.99 11.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 75.129999999999995 110.825 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.8 m -147.88 144.23 19.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 73.129999999999995 111.167 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 19.2 m -128.53 170.46 18.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 72.329999999999998 111.148 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 5.5 m -120.34 155.02 23.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 74.299999999999997 111.169 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.5 m -88.42 156.04 19.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 75.049999999999997 110.902 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.41 -29.0 31.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.134 -0.484 . . . . 71.209999999999994 110.899 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -70.82 -24.05 62.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.488 . . . . 73.349999999999994 110.915 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.57 -14.47 61.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.1 -0.5 . . . . 72.340000000000003 111.171 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 14.4 p -53.26 -28.04 14.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 63.229999999999997 111.081 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 35.4 pt -58.9 -21.49 19.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.24 -0.436 . . . . 73.439999999999998 111.112 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -75.9 -51.46 12.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 74.430000000000007 110.879 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 68.5 p -51.85 -62.01 1.9 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 74.040000000000006 110.836 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -50.15 -53.68 25.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 72.120000000000005 110.928 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 38.9 t30 54.96 29.68 12.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 70.129999999999995 110.909 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 43.2 p . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 74.5 110.85 -179.81 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt . . . . . 0 CA--C 1.526 0.051 0 CA-C-O 120.773 0.321 . . . . 74.519999999999996 110.884 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.36 -41.96 81.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 63.450000000000003 111.084 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 20.6 mmmt -56.47 -25.98 52.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.283 -0.417 . . . . 74.340000000000003 110.917 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.9 tpp180 -74.31 -24.26 59.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.281 -0.418 . . . . 73.430000000000007 110.863 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -51.8 -45.5 63.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 73.450000000000003 110.849 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -76.85 -31.69 57.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 75.409999999999997 110.934 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.44 -17.54 63.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.494 . . . . 71.420000000000002 111.117 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 31.9 m0 -57.19 -23.46 47.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 74.319999999999993 110.882 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 68.1 mt -54.07 -27.59 16.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 72.129999999999995 111.134 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 70.9 p -76.95 -59.11 2.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 75.129999999999995 111.154 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.4 pp -61.66 -18.09 58.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 75.549999999999997 110.842 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -54.15 -61.73 2.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 71.010000000000005 110.93 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? -66.84 -23.97 66.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.091 -0.504 . . . . 74.540000000000006 110.941 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.17 -45.56 68.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 73.430000000000007 111.145 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -53.34 -33.21 52.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 74.040000000000006 110.901 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -57.24 -26.26 60.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 74.409999999999997 110.894 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.28 20.82 11.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 74.239999999999995 110.833 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 53.71 64.14 1.95 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 75.230000000000004 111.075 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -79.25 178.63 7.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 75.25 110.959 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.1 p -120.03 170.71 9.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 72.549999999999997 111.107 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 5.2 m -135.34 -179.3 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 74.140000000000001 111.121 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.6 t -155.69 121.41 4.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 72.430000000000007 111.191 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 176.5 168.09 36.08 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.758 -0.734 . . . . 62.240000000000002 112.502 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 12.5 m -116.01 150.26 18.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.874 0.369 . . . . 63.43 111.132 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.4 mt -60.4 99.2 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 73.400000000000006 111.16 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 64.2 t-20 -87.8 -41.23 13.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 71.140000000000001 110.917 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -114.03 141.08 16.78 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.724 -0.75 . . . . 74.519999999999996 112.446 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -124.4 123.01 39.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.846 0.355 . . . . 75.200000000000003 110.928 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.6 m -108.22 176.67 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.246 -0.434 . . . . 71.400000000000006 111.149 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -66.83 99.18 0.6 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 72.030000000000001 110.953 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 90.85 -35.79 3.79 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.732 -0.747 . . . . 73.329999999999998 112.485 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -98.2 173.49 27.68 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.77 -0.729 . . . . 73.010000000000005 112.472 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -144.09 118.85 9.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.905 0.383 . . . . 73.129999999999995 110.927 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.24 149.68 25.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 73.420000000000002 111.17 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.7 t -143.65 137.42 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 64.219999999999999 111.137 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -90.07 104.94 17.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 73.530000000000001 110.944 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 12.5 mt -97.44 84.82 3.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.088 -0.506 . . . . 74.200000000000003 110.924 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 51.79 44.18 29.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 75.400000000000006 110.879 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 103.87 -33.72 6.35 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.715 -0.755 . . . . 71.510000000000005 112.493 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 21.6 mm -73.53 153.07 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.825 0.345 . . . . 74.420000000000002 111.165 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -105.27 119.39 38.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 75.340000000000003 110.882 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -101.29 171.66 7.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 71.109999999999999 111.075 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -145.89 120.67 9.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 74.439999999999998 110.927 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 9.3 mp -92.92 130.1 37.55 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.619 0.723 . . . . 72.140000000000001 110.946 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.64 135.65 31.28 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.718 2.278 . . . . 70.400000000000006 112.386 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -67.74 -11.44 60.3 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.732 -0.747 . . . . 72.200000000000003 112.476 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 38.2 m -53.49 -35.03 60.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.904 0.383 . . . . 71.140000000000001 110.879 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.41 39.05 4.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 73.450000000000003 110.937 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 83.4 t -118.45 -24.16 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 73.129999999999995 111.129 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -98.53 112.03 24.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 72.0 110.846 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.2 m -154.01 132.07 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 75.200000000000003 111.139 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 19.5 mtm-85 62.62 161.59 0.12 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.612 0.72 . . . . 73.319999999999993 110.867 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.8 164.17 35.56 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.722 2.281 . . . . 72.140000000000001 112.336 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 7.4 p -51.27 139.43 6.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.199 -0.455 . . . . 71.219999999999999 111.105 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -178.4 105.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 73.409999999999997 110.905 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 59.0 97.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 65.310000000000002 110.839 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.17 4.68 33.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.102 -0.499 . . . . 70.209999999999994 111.114 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -87.22 -9.86 54.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.255 -0.429 . . . . 72.530000000000001 110.933 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -75.4 -5.91 47.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 72.349999999999994 110.909 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.7 pp -118.3 31.11 6.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 72.010000000000005 110.906 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -128.68 126.61 40.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 74.439999999999998 110.91 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 63.44 31.71 81.69 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.701 -0.762 . . . . 65.230000000000004 112.531 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.36 131.74 43.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.81 0.338 . . . . 73.219999999999999 110.85 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.84 96.6 7.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.175 -0.466 . . . . 74.299999999999997 110.905 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.9 mt -138.64 141.24 39.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 72.430000000000007 110.934 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -89.92 129.44 36.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 74.319999999999993 110.903 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -110.73 -179.16 3.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 73.310000000000002 110.901 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.99 151.0 39.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 74.340000000000003 110.915 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.2 t -91.45 112.48 25.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 74.349999999999994 111.091 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 15.7 tt -87.57 -33.76 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 75.519999999999996 111.114 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -177.89 126.38 0.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 75.319999999999993 110.873 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.05 119.63 39.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 73.200000000000003 110.949 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -73.5 126.48 30.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 74.519999999999996 110.884 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -78.03 -29.05 49.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 74.400000000000006 110.867 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 12.4 tptm -53.12 -32.17 46.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.248 -0.433 . . . . 74.310000000000002 110.93 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -113.52 -15.27 12.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.1 -0.5 . . . . 65.140000000000001 110.85 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.07 47.94 5.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 72.530000000000001 110.922 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -142.27 154.42 44.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.48 . . . . 75.129999999999995 110.849 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.9 m -102.92 144.33 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 73.129999999999995 111.1 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 29.5 m -132.34 171.25 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 72.329999999999998 111.157 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 26.5 m -119.97 155.25 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 74.299999999999997 111.143 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.77 150.23 30.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 75.049999999999997 110.872 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -82.24 0.11 42.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 71.209999999999994 110.863 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.44 -58.81 2.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 73.349999999999994 110.867 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -83.37 -7.22 59.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 72.340000000000003 111.071 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 7.9 p -50.92 -28.21 6.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 63.229999999999997 111.133 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 28.5 pt -50.32 -30.8 7.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 73.439999999999998 111.118 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -54.7 -45.74 74.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 74.430000000000007 110.925 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 6.2 p -51.22 -44.13 61.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 74.040000000000006 110.913 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -64.42 -51.07 65.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.064 -0.516 . . . . 72.120000000000005 110.901 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -84.81 54.61 3.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 70.129999999999995 110.843 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 74.5 110.806 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.7 ttpp . . . . . 0 C--O 1.23 0.039 0 CA-C-O 120.84 0.353 . . . . 74.519999999999996 110.897 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.27 -28.55 42.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 63.450000000000003 111.137 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -60.03 -20.46 58.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 74.340000000000003 110.851 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -61.9 -19.82 63.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 73.430000000000007 110.875 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -51.76 -30.9 24.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.271 -0.422 . . . . 73.450000000000003 110.907 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -81.31 -45.6 15.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.225 -0.443 . . . . 75.409999999999997 110.854 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.8 -15.89 59.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 71.420000000000002 111.108 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 31.5 m0 -57.72 -22.86 48.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 74.319999999999993 110.866 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 52.1 mt -54.66 -26.33 16.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.304 -0.407 . . . . 72.129999999999995 111.135 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 70.3 p -80.26 -59.2 2.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 75.129999999999995 111.089 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 pp -61.49 -18.48 59.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.235 -0.439 . . . . 75.549999999999997 110.905 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -73.51 -25.7 60.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 71.010000000000005 110.842 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -79.44 -22.9 43.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 74.540000000000006 110.849 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.53 -38.95 91.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 73.430000000000007 111.076 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -69.1 -23.85 64.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.304 -0.407 . . . . 74.040000000000006 110.942 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.27 -25.23 58.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 74.409999999999997 110.906 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -94.82 20.93 8.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 74.239999999999995 110.904 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 60.95 65.34 1.02 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 75.230000000000004 111.158 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -90.19 169.22 11.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 75.25 110.827 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.3 m -120.48 139.24 53.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 72.549999999999997 111.104 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.1 m -125.74 -177.22 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 74.140000000000001 111.072 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.6 t -161.06 123.46 3.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.116 -0.493 . . . . 72.430000000000007 111.184 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -149.24 148.48 19.89 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.731 -0.747 . . . . 62.240000000000002 112.448 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.5 p -90.96 135.61 26.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.804 0.335 . . . . 63.43 111.115 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 mp -63.37 107.14 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.492 . . . . 73.400000000000006 111.101 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -91.51 -34.52 14.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.48 . . . . 71.140000000000001 110.915 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -128.21 143.78 14.69 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.773 -0.727 . . . . 74.519999999999996 112.497 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.5 pttp -123.94 134.77 53.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.822 0.344 . . . . 75.200000000000003 110.907 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.3 m -117.36 176.59 2.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 71.400000000000006 111.095 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -66.37 98.05 0.45 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 72.030000000000001 110.959 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 91.93 -35.26 4.05 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.753 -0.737 . . . . 73.329999999999998 112.485 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -98.17 173.51 27.75 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.761 -0.733 . . . . 73.010000000000005 112.611 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -145.37 118.93 9.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.919 0.39 . . . . 73.129999999999995 110.965 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.79 147.01 26.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 73.420000000000002 111.109 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 32.8 t -138.52 147.68 25.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 64.219999999999999 111.134 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -102.55 105.7 16.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 73.530000000000001 110.828 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 81.8 mt -105.91 74.43 1.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 74.200000000000003 110.962 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 57.72 51.06 9.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 75.400000000000006 111.003 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 99.79 -33.5 6.2 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.757 -0.735 . . . . 71.510000000000005 112.5 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 25.0 mm -76.58 150.25 6.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.793 0.33 . . . . 74.420000000000002 111.157 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 57.9 mtm180 -109.66 117.12 33.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 75.340000000000003 110.859 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -94.55 171.56 8.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 71.109999999999999 111.171 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -146.74 122.03 10.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.28 -0.418 . . . . 74.439999999999998 110.853 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 9.4 mp -110.54 129.43 23.96 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.643 0.735 . . . . 72.140000000000001 110.923 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 152.11 69.01 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.695 2.263 . . . . 70.400000000000006 112.325 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.46 -18.57 61.27 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.724 -0.75 . . . . 72.200000000000003 112.523 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 44.2 t -73.65 -26.21 60.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.849 0.357 . . . . 71.140000000000001 110.8 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 10.1 tt -79.97 -26.92 39.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 73.450000000000003 110.875 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 81.8 t -78.94 -62.76 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 73.129999999999995 111.119 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -166.37 161.92 16.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 72.0 110.908 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 27.0 m -82.04 147.87 5.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 75.200000000000003 111.138 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.01 160.53 0.12 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.605 0.717 . . . . 73.319999999999993 110.884 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.69 145.54 57.89 Favored 'Trans proline' 0 C--O 1.23 0.123 0 C-N-CA 122.745 2.297 . . . . 72.140000000000001 112.289 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.6 p -116.29 149.96 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 71.219999999999999 111.141 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -66.21 -75.22 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 73.409999999999997 110.859 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -179.93 138.57 0.12 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 65.310000000000002 110.896 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.82 157.5 33.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 70.209999999999994 111.122 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.8 mp -87.57 -9.64 53.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 72.530000000000001 110.88 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -60.33 -18.79 52.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.161 -0.472 . . . . 72.349999999999994 110.81 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.4 pp -109.35 36.41 2.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 72.010000000000005 110.931 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -129.66 124.68 34.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 74.439999999999998 110.832 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 66.64 23.51 72.25 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.727 -0.749 . . . . 65.230000000000004 112.489 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.6 ttmm -63.33 130.26 43.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.726 0.298 . . . . 73.219999999999999 110.878 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -104.16 89.71 3.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 74.299999999999997 110.843 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.8 mt -138.34 135.98 35.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.139 -0.482 . . . . 72.430000000000007 110.921 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -85.91 158.03 20.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 74.319999999999993 110.852 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -126.06 -179.23 4.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 73.310000000000002 110.852 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.5 tttp -125.26 108.24 11.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.12 -0.491 . . . . 74.340000000000003 110.899 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.5 t -69.33 128.92 33.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.43 . . . . 74.349999999999994 111.127 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 7.8 tp -118.3 -29.35 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 75.519999999999996 111.164 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.99 166.42 7.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 75.319999999999993 110.918 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.84 165.48 36.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 73.200000000000003 110.917 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -119.18 96.58 5.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 74.519999999999996 110.878 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -77.12 -23.3 51.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.159 -0.473 . . . . 74.400000000000006 110.857 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 22.5 tptt -51.79 -45.75 63.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 74.310000000000002 110.967 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -104.6 16.88 25.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 65.140000000000001 110.893 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 51.51 48.57 22.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 72.530000000000001 110.939 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -121.88 153.81 37.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 75.129999999999995 110.947 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 97.3 t -142.98 128.51 16.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 73.129999999999995 111.151 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.1 m -134.81 171.18 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 72.329999999999998 111.184 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 6.3 m -120.27 145.75 26.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 74.299999999999997 111.084 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.85 157.47 37.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 75.049999999999997 110.871 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.87 -42.13 20.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.121 -0.491 . . . . 71.209999999999994 110.82 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 83.7 mtm-85 -59.7 -20.6 57.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.266 -0.424 . . . . 73.349999999999994 110.847 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.7 -17.45 55.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 72.340000000000003 111.084 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 10.2 p -50.71 -30.5 8.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 63.229999999999997 111.173 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 27.2 pt -51.48 -32.44 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.488 . . . . 73.439999999999998 111.12 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -88.03 -26.4 22.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.463 . . . . 74.430000000000007 110.853 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 5.1 t -91.29 12.79 19.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 74.040000000000006 110.877 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -50.01 -53.43 26.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 72.120000000000005 110.91 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -128.14 -58.48 1.21 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 70.129999999999995 110.886 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 10.9 t . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 74.5 110.873 -179.848 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.5 tptm . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.798 0.332 . . . . 74.519999999999996 110.916 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.75 -30.16 59.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 63.450000000000003 111.079 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -64.67 -27.95 69.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 74.340000000000003 110.939 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -57.07 -27.16 61.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 73.430000000000007 110.866 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -52.04 -37.7 54.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 73.450000000000003 110.904 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -81.77 -29.91 32.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.447 . . . . 75.409999999999997 110.922 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.96 -24.47 61.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 71.420000000000002 111.159 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 53.9 m0 -58.77 -22.57 58.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.197 -0.456 . . . . 74.319999999999993 110.962 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 70.0 mt -51.53 -29.96 10.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.218 -0.446 . . . . 72.129999999999995 111.134 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 73.3 p -64.27 -52.13 60.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 75.129999999999995 111.104 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.88 -21.73 62.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.435 . . . . 75.549999999999997 110.962 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -59.9 -52.29 66.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.164 -0.471 . . . . 71.010000000000005 110.867 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -57.65 -27.45 62.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.471 . . . . 74.540000000000006 110.953 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -51.98 -48.4 64.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.166 -0.47 . . . . 73.430000000000007 111.111 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -55.74 -33.26 64.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 74.040000000000006 110.924 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.57 -26.41 66.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 74.409999999999997 110.899 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -104.46 20.97 17.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 74.239999999999995 110.838 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 57.91 67.41 0.96 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 75.230000000000004 111.043 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -104.06 176.15 5.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 75.25 110.937 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.3 t -121.14 164.95 16.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.166 -0.47 . . . . 72.549999999999997 111.062 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.9 m -135.4 -178.09 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 74.140000000000001 111.096 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 4.9 t -154.13 122.85 6.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.081 -0.508 . . . . 72.430000000000007 111.156 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -156.87 150.97 22.35 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.742 -0.742 . . . . 62.240000000000002 112.503 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.3 p -109.45 141.2 25.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.829 0.347 . . . . 63.43 111.12 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.3 mp -67.36 101.88 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.132 -0.485 . . . . 73.400000000000006 111.066 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -91.26 -27.16 18.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 71.140000000000001 110.912 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -134.18 143.05 14.62 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.736 -0.745 . . . . 74.519999999999996 112.48 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.98 136.66 54.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.788 0.327 . . . . 75.200000000000003 110.937 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.3 m -118.39 176.44 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 71.400000000000006 111.183 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.94 97.73 0.37 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 72.030000000000001 110.928 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 92.24 -35.02 4.16 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.752 -0.737 . . . . 73.329999999999998 112.465 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -98.17 173.55 27.79 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.737 -0.744 . . . . 73.010000000000005 112.48 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -146.03 119.09 8.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.86 0.362 . . . . 73.129999999999995 110.877 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.4 m -86.5 150.6 24.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 73.420000000000002 111.155 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.6 t -138.89 131.93 38.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.287 -0.415 . . . . 64.219999999999999 111.165 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -84.01 99.27 10.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 73.530000000000001 110.897 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 25.4 mt -99.89 77.65 2.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 74.200000000000003 110.907 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 52.14 52.92 13.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 75.400000000000006 110.878 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 93.36 -22.31 35.78 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.764 -0.731 . . . . 71.510000000000005 112.532 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 57.1 mt -83.02 144.43 10.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.8 0.333 . . . . 74.420000000000002 111.141 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -100.52 109.25 21.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 75.340000000000003 110.848 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -92.99 171.59 8.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 71.109999999999999 111.019 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -146.76 129.73 16.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 74.439999999999998 110.856 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.5 mt -120.17 129.52 25.3 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.587 0.708 . . . . 72.140000000000001 110.943 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.88 136.78 33.55 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.677 2.252 . . . . 70.400000000000006 112.29 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -71.54 -16.74 75.95 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.759 -0.734 . . . . 72.200000000000003 112.424 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 2.9 t -55.4 -26.37 41.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.88 0.371 . . . . 71.140000000000001 110.858 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 28.7 mt -120.61 24.64 10.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.47 . . . . 73.450000000000003 110.932 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 88.6 t -113.46 -49.41 5.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 73.129999999999995 111.174 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -99.08 112.64 24.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 72.0 110.85 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 5.8 m -152.89 107.07 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 75.200000000000003 111.14 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 18.7 mmt-85 51.94 69.13 2.63 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.557 0.694 . . . . 73.319999999999993 110.89 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 143.81 52.11 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.618 2.212 . . . . 72.140000000000001 112.362 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 4.1 m -139.77 85.89 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 71.219999999999999 111.196 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.1 ptt-85 39.42 41.74 0.74 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.472 . . . . 73.409999999999997 110.824 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -137.93 97.39 3.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 65.310000000000002 110.925 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.77 -13.67 9.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 70.209999999999994 111.125 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 13.7 mt -62.88 -21.65 66.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 72.530000000000001 110.943 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -93.36 18.21 10.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 72.349999999999994 110.891 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 61.5 mt -110.51 -33.11 6.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 72.010000000000005 110.949 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -128.32 129.5 46.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 74.439999999999998 110.879 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 90.42 -14.84 61.51 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.771 -0.728 . . . . 65.230000000000004 112.45 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.89 129.97 44.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.804 0.335 . . . . 73.219999999999999 110.867 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -111.02 114.28 27.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 74.299999999999997 110.942 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.445 ' C ' ' CD2' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -140.66 165.17 28.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 72.430000000000007 110.922 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -98.38 131.03 45.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.175 -0.466 . . . . 74.319999999999993 110.93 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -97.22 -179.41 4.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 73.310000000000002 110.879 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.6 tttm -137.09 145.98 44.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 74.340000000000003 110.918 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.62 120.18 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.434 . . . . 74.349999999999994 111.145 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.8 tp -130.21 -38.86 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.109 -0.496 . . . . 75.519999999999996 111.146 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -169.28 139.38 2.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 75.319999999999993 110.927 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -153.21 125.76 8.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 73.200000000000003 110.915 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -91.29 63.37 4.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 74.519999999999996 110.873 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -55.39 -26.44 41.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 74.400000000000006 110.923 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 18.5 ttpp -57.3 -43.16 82.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 74.310000000000002 110.915 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -102.94 24.85 10.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.448 . . . . 65.140000000000001 110.937 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 52.71 33.44 13.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.098 -0.501 . . . . 72.530000000000001 110.926 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -108.78 154.67 21.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 75.129999999999995 110.908 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 7.1 p -152.4 123.73 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 73.129999999999995 111.119 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 19.5 m -134.63 148.18 29.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 72.329999999999998 111.192 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 6.1 m -120.44 171.81 8.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 74.299999999999997 111.158 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.9 m -123.88 142.19 51.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 75.049999999999997 110.895 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.92 -34.35 77.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 71.209999999999994 110.899 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -61.93 -20.79 64.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 73.349999999999994 110.883 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -55.89 -24.83 39.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 72.340000000000003 111.069 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 95.6 t -51.88 -37.62 21.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 63.229999999999997 111.102 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 2.0 pp -54.05 -27.31 16.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.186 -0.461 . . . . 73.439999999999998 111.125 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -77.24 -63.63 1.32 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.466 . . . . 74.430000000000007 110.846 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 66.3 p -52.27 -49.24 64.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 74.040000000000006 110.857 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -53.72 -58.58 6.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.489 . . . . 72.120000000000005 110.871 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -59.59 -74.31 0.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 70.129999999999995 110.96 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 6.4 p . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.131 -0.486 . . . . 74.5 110.859 -179.912 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.5 mmtt . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.723 0.296 . . . . 74.519999999999996 110.829 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.95 -55.4 14.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 63.450000000000003 111.11 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.68 -27.28 69.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.27 -0.423 . . . . 74.340000000000003 110.88 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -66.58 -26.84 67.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.426 . . . . 73.430000000000007 110.9 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -51.95 -43.22 63.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 73.450000000000003 110.871 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -79.29 -24.94 42.54 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.198 -0.456 . . . . 75.409999999999997 110.914 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -77.75 -19.72 54.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 71.420000000000002 111.055 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 41.4 m0 -58.1 -22.68 51.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 74.319999999999993 110.897 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 35.7 pt -51.78 -29.35 10.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.285 -0.416 . . . . 72.129999999999995 111.14 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.1 p -75.27 -61.48 1.89 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.146 -0.479 . . . . 75.129999999999995 111.18 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.4 pp -59.05 -21.76 59.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.25 -0.432 . . . . 75.549999999999997 110.874 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -51.92 -47.22 64.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 71.010000000000005 110.85 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -62.65 -28.94 70.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.121 -0.49 . . . . 74.540000000000006 110.893 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.05 -44.09 87.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 73.430000000000007 111.099 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -56.41 -34.08 66.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.158 -0.474 . . . . 74.040000000000006 110.968 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.32 -26.06 60.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.1 -0.5 . . . . 74.409999999999997 110.881 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -94.79 20.7 8.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.143 -0.48 . . . . 74.239999999999995 110.828 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 59.35 36.59 23.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.439 . . . . 75.230000000000004 111.123 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -61.89 152.97 30.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 75.25 110.877 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 35.5 p -93.69 148.52 22.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.066 -0.516 . . . . 72.549999999999997 111.09 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.7 m -123.32 168.85 15.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 74.140000000000001 111.114 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -146.41 118.49 8.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.477 . . . . 72.430000000000007 111.135 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -152.37 151.02 22.94 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.649 -0.786 . . . . 62.240000000000002 112.44 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 12.3 p -101.28 139.6 22.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.722 0.296 . . . . 63.43 111.164 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.0 mp -61.1 116.49 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 73.400000000000006 111.06 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -97.86 -45.2 6.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 71.140000000000001 110.861 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -124.89 153.54 17.9 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.778 -0.725 . . . . 74.519999999999996 112.539 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 9.2 ptmm? -124.05 125.2 44.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.843 0.354 . . . . 75.200000000000003 110.905 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.0 m -104.02 177.31 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 71.400000000000006 111.109 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 53.2 mttt -62.15 94.64 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 72.030000000000001 110.861 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 90.08 -36.25 3.6 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.75 -0.738 . . . . 73.329999999999998 112.534 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -92.59 173.51 35.43 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.713 -0.756 . . . . 73.010000000000005 112.509 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -142.94 118.28 10.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.934 0.397 . . . . 73.129999999999995 110.917 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 33.3 p -84.84 150.97 24.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 73.420000000000002 111.135 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 64.3 t -139.38 138.37 40.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 64.219999999999999 111.168 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -91.44 100.55 13.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 73.530000000000001 110.889 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 10.9 mt -90.72 81.85 5.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 74.200000000000003 110.945 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.3 p30 42.0 52.11 4.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 75.400000000000006 110.905 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 104.01 -34.02 6.11 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.762 -0.732 . . . . 71.510000000000005 112.49 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 25.2 mt -76.45 152.29 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.779 0.323 . . . . 74.420000000000002 111.136 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 53.7 mtm180 -105.09 105.49 15.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 75.340000000000003 110.889 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -92.81 159.12 15.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 71.109999999999999 111.032 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -133.75 125.95 29.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 74.439999999999998 110.871 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 22.6 mt -115.05 131.65 23.42 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.634 0.73 . . . . 72.140000000000001 110.843 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 164.65 33.73 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.665 2.243 . . . . 70.400000000000006 112.399 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -67.13 -11.0 58.02 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.719 -0.753 . . . . 72.200000000000003 112.513 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.5 t -60.24 -32.27 70.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.94 0.4 . . . . 71.140000000000001 110.881 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.09 41.97 3.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 73.450000000000003 110.943 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -50.72 -43.07 23.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 73.129999999999995 111.142 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -179.71 119.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 72.0 110.859 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 12.7 p -76.06 138.79 20.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 75.200000000000003 111.168 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 30.8 mtp180 61.24 75.62 0.44 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.626 0.727 . . . . 73.319999999999993 110.865 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.73 135.31 30.19 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.702 2.268 . . . . 72.140000000000001 112.336 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 5.9 t -127.74 157.94 39.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 71.219999999999999 111.15 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.89 -30.81 15.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 73.409999999999997 110.827 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -84.34 129.57 34.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 65.310000000000002 110.847 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 18.1 p -98.6 27.92 4.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 70.209999999999994 111.131 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.5 tp -87.49 -21.36 25.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 72.530000000000001 110.88 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 33.7 p-80 -89.08 -21.86 23.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 72.349999999999994 110.86 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 59.2 mt -51.84 -57.98 7.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 72.010000000000005 110.973 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -101.7 145.11 29.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 74.439999999999998 110.848 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 95.45 -12.15 68.06 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.756 -0.735 . . . . 65.230000000000004 112.573 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.65 133.56 50.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.682 0.277 . . . . 73.219999999999999 110.95 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -110.26 111.92 23.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.269 -0.423 . . . . 74.299999999999997 110.897 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.4 mt -139.21 159.32 42.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 72.430000000000007 110.894 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -95.0 148.18 22.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 74.319999999999993 110.867 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -123.32 -179.47 4.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 73.310000000000002 110.832 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.14 108.19 7.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 74.340000000000003 110.902 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 89.1 t -60.47 105.98 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.217 -0.447 . . . . 74.349999999999994 111.129 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.6 tt -89.58 -30.29 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 75.519999999999996 111.144 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -176.41 169.67 2.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 75.319999999999993 110.894 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.1 160.96 39.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 73.200000000000003 110.889 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.78 101.8 10.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.187 -0.461 . . . . 74.519999999999996 110.931 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -81.15 -36.08 30.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 74.400000000000006 110.929 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 29.9 tttp -69.45 -46.14 67.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 74.310000000000002 110.888 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -73.62 -15.31 61.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 65.140000000000001 110.922 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.4 m120 63.34 41.06 8.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 72.530000000000001 110.945 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -139.09 128.94 24.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 75.129999999999995 110.897 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.98 130.59 48.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 73.129999999999995 111.066 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 18.9 m -134.79 171.17 18.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 72.329999999999998 111.118 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 1.8 m -120.34 153.16 23.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.468 . . . . 74.299999999999997 111.112 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.28 160.64 31.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 75.049999999999997 110.875 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -121.74 -33.94 3.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.167 -0.47 . . . . 71.209999999999994 110.893 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -81.75 -34.35 30.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 73.349999999999994 110.86 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -83.62 -26.4 29.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 72.340000000000003 111.12 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 5.7 p -58.07 -20.29 14.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 63.229999999999997 111.128 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 27.3 pt -53.11 -27.96 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.485 . . . . 73.439999999999998 111.117 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -87.21 -31.81 20.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 74.430000000000007 110.895 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 3.7 t -76.8 -25.03 52.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 74.040000000000006 110.827 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -60.81 -33.7 73.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.122 -0.49 . . . . 72.120000000000005 110.889 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -123.88 49.04 1.79 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.491 . . . . 70.129999999999995 110.886 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 41.8 t . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 74.5 110.825 -179.829 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.854 0.359 . . . . 74.519999999999996 110.957 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.41 -51.44 68.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 63.450000000000003 111.08 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.1 mtmm -55.87 -26.01 45.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 74.340000000000003 110.892 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.87 -26.46 36.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 73.430000000000007 110.865 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 14.7 t60 -51.61 -30.27 20.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.153 -0.476 . . . . 73.450000000000003 110.911 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -79.29 -34.98 41.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.165 -0.47 . . . . 75.409999999999997 110.872 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.32 -15.52 62.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 71.420000000000002 111.096 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -57.76 -22.48 47.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 74.319999999999993 110.951 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 27.2 pt -52.31 -32.7 16.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.288 -0.414 . . . . 72.129999999999995 111.154 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.6 p -86.07 -23.65 26.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 75.129999999999995 111.13 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.6 tp -67.8 -28.55 67.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.21 -0.45 . . . . 75.549999999999997 110.889 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -60.35 -48.17 82.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 71.010000000000005 110.898 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -67.41 -24.65 65.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 74.540000000000006 110.888 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.1 -36.92 85.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 73.430000000000007 111.095 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -52.81 -28.96 25.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 74.040000000000006 110.977 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.49 -25.05 50.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.078 -0.51 . . . . 74.409999999999997 110.902 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -94.3 -22.21 18.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.139 -0.482 . . . . 74.239999999999995 110.874 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 62.16 44.49 7.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.443 . . . . 75.230000000000004 111.066 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.77 165.27 15.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 75.25 110.936 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.8 t -94.56 168.07 11.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 72.549999999999997 111.163 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.2 m -152.96 -178.62 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 74.140000000000001 111.128 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 4.1 t -141.43 116.67 10.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 72.430000000000007 111.215 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -134.46 151.98 20.5 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.721 -0.752 . . . . 62.240000000000002 112.449 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 85.5 t -115.56 134.2 59.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.751 0.31 . . . . 63.43 111.132 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.5 mp -54.66 115.34 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 73.400000000000006 111.136 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -100.16 -41.64 7.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 71.140000000000001 110.926 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -120.87 145.84 17.37 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.799 -0.715 . . . . 74.519999999999996 112.512 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.2 pttt -124.03 128.42 49.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.788 0.328 . . . . 75.200000000000003 110.927 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.6 m -119.82 176.5 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 71.400000000000006 111.167 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -68.15 99.06 0.85 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 72.030000000000001 110.927 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 92.02 -35.13 4.1 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.763 -0.732 . . . . 73.329999999999998 112.452 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -98.26 173.6 27.71 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.774 -0.727 . . . . 73.010000000000005 112.494 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -152.56 119.06 5.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.989 0.423 . . . . 73.129999999999995 110.905 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.29 150.89 24.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.159 -0.473 . . . . 73.420000000000002 111.116 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 19.9 t -140.69 139.83 34.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.494 . . . . 64.219999999999999 111.121 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -95.02 107.28 19.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 73.530000000000001 110.871 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 26.9 mt -103.18 72.67 1.18 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.157 -0.474 . . . . 74.200000000000003 110.955 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 54.38 50.89 15.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 75.400000000000006 110.927 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 103.9 -33.38 6.62 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.714 -0.755 . . . . 71.510000000000005 112.461 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.6 mm -80.06 156.18 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.842 0.354 . . . . 74.420000000000002 111.114 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 47.7 mtt180 -114.84 121.67 43.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 75.340000000000003 110.956 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -102.25 168.45 9.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.25 -0.432 . . . . 71.109999999999999 111.123 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -147.87 124.41 11.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 74.439999999999998 110.844 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.89 130.16 24.72 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.68 0.753 . . . . 72.140000000000001 110.887 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 146.21 59.77 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.652 2.235 . . . . 70.400000000000006 112.373 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -67.63 -11.35 59.88 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.772 -0.727 . . . . 72.200000000000003 112.482 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.6 m -51.33 -30.63 19.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.89 0.376 . . . . 71.140000000000001 110.838 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.0 tp -116.16 29.09 8.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 73.450000000000003 110.886 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 94.4 t -120.01 -32.74 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.251 -0.431 . . . . 73.129999999999995 111.113 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -108.11 116.0 31.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 72.0 110.843 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.4 t -129.18 166.95 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 75.200000000000003 111.092 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.47 ' N ' ' HD2' ' A' ' 140' ' ' PRO . 0.9 OUTLIER -50.86 -60.68 5.05 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.602 0.715 . . . . 73.319999999999993 110.893 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 139' ' ' ARG . 54.5 Cg_endo -69.74 133.36 25.42 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.746 2.297 . . . . 72.140000000000001 112.361 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.7 m -128.83 148.7 33.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 71.219999999999999 111.103 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 81.9 mtt180 -124.73 -60.72 1.36 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.48 . . . . 73.409999999999997 110.88 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -153.01 162.75 40.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 65.310000000000002 110.87 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.8 p -106.5 19.72 20.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.205 -0.452 . . . . 70.209999999999994 111.184 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -87.36 -24.56 24.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.494 . . . . 72.530000000000001 110.968 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.4 -8.59 59.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.146 -0.479 . . . . 72.349999999999994 110.88 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 78.7 mt -58.92 -49.42 77.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.171 -0.468 . . . . 72.010000000000005 110.918 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -130.26 137.44 50.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 74.439999999999998 110.855 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 92.11 -16.44 59.62 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.799 -0.715 . . . . 65.230000000000004 112.505 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.62 127.17 19.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.717 0.294 . . . . 73.219999999999999 110.914 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -89.29 111.1 21.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.252 -0.431 . . . . 74.299999999999997 110.852 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.5 tp -139.25 -175.46 4.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 72.430000000000007 110.941 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -133.78 135.7 44.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 74.319999999999993 110.884 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -119.25 -179.34 3.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.477 . . . . 73.310000000000002 110.834 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -128.47 160.77 31.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 74.340000000000003 110.948 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.6 t -84.07 82.06 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.276 -0.42 . . . . 74.349999999999994 111.096 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.1 mp -77.99 -40.49 26.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 75.519999999999996 111.089 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.41 154.74 7.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 75.319999999999993 110.857 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.03 112.73 7.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 73.200000000000003 110.869 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -67.61 91.45 0.29 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.172 -0.467 . . . . 74.519999999999996 110.885 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -60.58 -19.93 59.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 74.400000000000006 110.923 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -51.6 -37.79 51.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 74.310000000000002 110.905 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 24.2 ttt85 -123.06 19.79 9.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 65.140000000000001 110.894 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 51.82 29.89 6.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 72.530000000000001 110.874 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -112.85 157.98 20.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.202 -0.454 . . . . 75.129999999999995 110.928 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 10.2 p -125.96 144.23 36.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 73.129999999999995 111.137 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 19.7 m -127.81 169.54 19.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 72.329999999999998 111.171 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 15.5 m -120.28 162.01 19.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.451 . . . . 74.299999999999997 111.087 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 28.4 t -103.36 161.17 14.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 75.049999999999997 110.852 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 25.8 mtm180 -79.93 -58.16 3.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 71.209999999999994 110.918 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -56.35 -26.02 51.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 73.349999999999994 110.871 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.26 -14.03 61.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 72.340000000000003 111.04 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 13.5 p -51.6 -29.59 10.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 63.229999999999997 111.168 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 32.7 pt -51.62 -30.32 11.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.135 -0.484 . . . . 73.439999999999998 111.106 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -69.7 -38.54 77.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 74.430000000000007 110.945 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 26.0 t -51.78 -58.57 6.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.07 -0.514 . . . . 74.040000000000006 110.916 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -72.72 -61.61 1.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 72.120000000000005 110.874 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 16.0 t30 57.19 47.58 16.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 70.129999999999995 110.833 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 74.5 110.889 -179.928 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.915 0.388 . . . . 75.230000000000004 110.868 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -89.06 -46.78 8.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 74.519999999999996 110.929 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.18 -29.95 65.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 63.450000000000003 111.112 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 32.6 mmtt -58.39 -26.29 63.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 74.340000000000003 110.876 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 6.1 mtt85 -65.44 -25.83 67.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 73.430000000000007 110.894 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 54.0 m170 -51.97 -47.93 64.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 73.450000000000003 110.848 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -80.2 -26.53 39.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 75.409999999999997 110.89 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.2 -21.17 62.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 71.420000000000002 111.089 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 42.1 m0 -58.01 -22.85 51.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.209 -0.451 . . . . 74.319999999999993 110.922 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 74.9 mt -54.59 -26.58 16.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.448 . . . . 72.129999999999995 111.122 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.5 m -77.93 -28.16 49.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 75.129999999999995 111.164 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 18.7 mt -64.1 -27.67 69.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 75.549999999999997 110.907 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -51.56 -49.94 61.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 71.010000000000005 110.9 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -25.07 68.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 74.540000000000006 110.901 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.74 -55.2 8.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 73.430000000000007 111.081 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -57.58 -26.27 61.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 74.040000000000006 110.904 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.71 -40.85 63.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 74.409999999999997 110.869 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -98.48 20.77 12.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 74.239999999999995 110.842 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 61.53 56.4 2.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 75.230000000000004 111.112 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -64.64 143.18 58.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 75.25 110.906 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.3 t -86.72 143.75 27.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.147 -0.479 . . . . 72.549999999999997 111.154 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.6 m -122.07 -179.62 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 74.140000000000001 111.154 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 4.3 t -159.96 119.58 2.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 72.430000000000007 111.14 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -160.2 172.4 36.65 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.716 -0.754 . . . . 62.240000000000002 112.458 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.7 p -116.1 145.35 21.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.775 0.321 . . . . 63.43 111.119 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.6 mt -66.74 117.87 8.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 73.400000000000006 111.109 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -97.65 -43.72 7.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 71.140000000000001 110.887 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -121.67 148.23 17.26 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.725 -0.75 . . . . 74.519999999999996 112.474 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 27.0 pttt -124.21 125.4 44.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.789 0.328 . . . . 75.200000000000003 110.928 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.5 m -114.08 176.96 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 71.400000000000006 111.166 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 28.9 mttp -62.47 94.38 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 72.030000000000001 110.87 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 90.61 -35.76 3.77 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.704 -0.76 . . . . 73.329999999999998 112.508 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -90.38 173.69 39.21 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.749 -0.739 . . . . 73.010000000000005 112.531 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -152.04 118.92 5.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.994 0.426 . . . . 73.129999999999995 110.927 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.11 135.81 33.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.49 . . . . 73.420000000000002 111.152 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 18.1 t -135.39 138.12 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 64.219999999999999 111.089 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -88.85 113.34 24.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.453 . . . . 73.530000000000001 110.881 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 11.1 mt -121.16 96.44 5.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.464 . . . . 74.200000000000003 110.907 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 63.32 25.24 14.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 75.400000000000006 110.919 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 103.96 -23.1 33.24 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.677 -0.773 . . . . 71.510000000000005 112.467 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 21.9 mt -83.05 151.87 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.808 0.337 . . . . 74.420000000000002 111.119 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -99.65 124.3 44.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 75.340000000000003 110.868 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -101.15 171.75 7.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 71.109999999999999 111.097 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -142.82 117.91 10.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 74.439999999999998 110.895 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 7.7 mp -100.28 129.56 27.81 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.653 0.74 . . . . 72.140000000000001 110.918 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 132.5 23.55 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.706 2.27 . . . . 70.400000000000006 112.352 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -74.91 -11.22 83.8 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 72.200000000000003 112.486 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 26.5 t -50.56 -33.94 23.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.934 0.397 . . . . 71.140000000000001 110.888 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 28.0 mt -123.42 39.28 4.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.081 -0.508 . . . . 73.450000000000003 110.906 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 99.4 t -122.77 -59.04 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 73.129999999999995 111.103 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -116.34 117.52 30.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 72.0 110.822 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 7.3 p -173.81 123.9 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 75.200000000000003 111.134 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 53.04 72.61 1.11 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.55 0.69 . . . . 73.319999999999993 110.889 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 132.84 24.09 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.644 2.229 . . . . 72.140000000000001 112.325 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 6.8 p -126.03 -37.93 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.456 . . . . 71.219999999999999 111.102 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -126.92 -176.98 3.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 73.409999999999997 110.872 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -52.09 132.48 33.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.196 -0.456 . . . . 65.310000000000002 110.818 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 9.0 t -123.16 42.6 3.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 70.209999999999994 111.125 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -85.88 -11.46 53.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 72.530000000000001 110.861 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.49 ' HD1' ' N ' ' A' ' 147' ' ' LEU . 0.1 OUTLIER -72.57 -8.38 54.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 72.349999999999994 110.862 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.49 ' N ' ' HD1' ' A' ' 146' ' ' HIS . 64.9 mt -59.51 -31.17 69.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 72.010000000000005 110.892 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -123.53 134.9 53.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 74.439999999999998 110.903 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 92.81 0.95 68.32 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.719 -0.753 . . . . 65.230000000000004 112.482 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.4 127.92 34.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.721 0.295 . . . . 73.219999999999999 110.89 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -109.59 87.0 2.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 74.299999999999997 110.9 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.11 166.34 24.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 72.430000000000007 110.923 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -81.92 173.75 11.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.214 -0.448 . . . . 74.319999999999993 110.9 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -133.47 -179.38 5.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 73.310000000000002 110.852 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 12.1 ttpt -130.84 108.59 9.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 74.340000000000003 110.907 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.9 t -70.42 126.53 30.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 74.349999999999994 111.167 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.9 tp -119.0 -30.47 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 75.519999999999996 111.182 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 20.7 ttmt -171.87 133.21 0.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 75.319999999999993 110.903 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.47 148.17 31.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 73.200000000000003 110.902 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.19 89.37 3.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 74.519999999999996 110.869 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -67.71 -23.16 65.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 74.400000000000006 110.865 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.81 -43.26 63.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 74.310000000000002 110.895 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -99.66 24.74 7.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 65.140000000000001 110.885 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 9.7 p30 41.52 38.59 0.9 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 72.530000000000001 110.917 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -143.07 168.79 18.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 75.129999999999995 110.872 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.8 m -128.67 144.39 38.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 73.129999999999995 111.145 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 18.3 m -116.74 171.8 5.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 72.329999999999998 111.129 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 15.8 t -119.42 152.28 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 74.299999999999997 111.103 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 14.0 t -70.01 154.7 41.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 75.049999999999997 110.873 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 18.4 ttm180 -83.46 -54.56 4.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 71.209999999999994 110.906 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -57.4 -27.01 61.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 73.349999999999994 110.878 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.2 -19.64 55.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 72.340000000000003 111.097 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 11.1 p -52.38 -28.96 12.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 63.229999999999997 111.115 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 30.8 pt -51.26 -30.71 10.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 73.439999999999998 111.085 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -87.98 -46.81 9.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 74.430000000000007 110.89 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 4.2 p -56.51 -40.51 75.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 74.040000000000006 110.83 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -51.92 -49.16 63.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 72.120000000000005 110.911 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -176.94 86.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 70.129999999999995 110.875 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 4.7 p . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 74.5 110.872 -179.834 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.871 0.367 . . . . 75.230000000000004 110.873 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? -105.14 -34.25 8.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 74.519999999999996 110.906 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.2 -35.33 79.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 63.450000000000003 111.089 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.68 -27.49 64.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 74.340000000000003 110.963 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.9 tpp180 -60.41 -26.58 66.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 73.430000000000007 110.833 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -52.09 -30.09 24.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 73.450000000000003 110.854 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 -80.04 -34.5 38.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 75.409999999999997 110.872 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.75 -15.96 61.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 71.420000000000002 111.083 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -57.98 -22.68 50.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 74.319999999999993 110.929 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 43.1 mm -55.35 -25.41 17.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.287 -0.415 . . . . 72.129999999999995 111.131 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 71.0 p -85.69 -23.97 27.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.232 -0.44 . . . . 75.129999999999995 111.093 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 63.4 mt -67.54 -49.0 65.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 75.549999999999997 110.922 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -51.9 -43.49 63.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 71.010000000000005 110.876 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.87 -24.39 41.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 74.540000000000006 110.894 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.08 -26.47 56.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 73.430000000000007 111.114 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -56.04 -25.12 43.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 74.040000000000006 110.941 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -54.82 -26.84 37.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 74.409999999999997 110.891 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -92.75 -22.04 19.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.081 -0.509 . . . . 74.239999999999995 110.846 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 63.9 44.91 4.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 75.230000000000004 111.123 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -62.43 -179.81 0.27 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.22 -0.446 . . . . 75.25 110.832 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 32.7 p -106.61 178.82 4.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.1 -0.5 . . . . 72.549999999999997 111.089 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.9 m -152.35 -178.66 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 74.140000000000001 111.181 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 86.5 m -154.22 122.89 6.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 72.430000000000007 111.15 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -158.09 154.97 26.01 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.7 -0.762 . . . . 62.240000000000002 112.422 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.8 p -105.16 137.62 33.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.743 0.306 . . . . 63.43 111.216 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.2 mp -57.98 112.02 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.218 -0.446 . . . . 73.400000000000006 111.134 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 20.4 m-20 -95.17 -30.3 14.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.098 -0.501 . . . . 71.140000000000001 110.892 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -134.14 144.4 16.34 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.708 -0.758 . . . . 74.519999999999996 112.502 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.93 136.84 54.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.861 0.362 . . . . 75.200000000000003 110.917 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.1 m -118.8 176.44 3.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 71.400000000000006 111.044 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.1 tptt -66.0 97.75 0.38 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 72.030000000000001 110.92 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 92.2 -35.02 4.16 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.717 -0.754 . . . . 73.329999999999998 112.46 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -98.18 173.62 27.84 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.747 . . . . 73.010000000000005 112.494 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -146.2 118.91 8.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.911 0.386 . . . . 73.129999999999995 110.918 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.26 149.5 25.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 73.420000000000002 111.14 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.3 t -140.75 142.35 30.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 64.219999999999999 111.103 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -99.61 99.52 10.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 73.530000000000001 110.873 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 16.2 mt -102.02 89.68 3.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 74.200000000000003 110.929 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 51.97 39.31 25.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 75.400000000000006 110.844 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 103.68 -27.15 20.92 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.768 -0.729 . . . . 71.510000000000005 112.464 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 24.4 mm -74.15 150.23 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.787 0.327 . . . . 74.420000000000002 111.154 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.7 ttt180 -110.7 111.87 23.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 75.340000000000003 110.863 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -92.91 171.54 8.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 71.109999999999999 111.147 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -145.58 107.85 4.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 74.439999999999998 110.873 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 6.6 mp -92.35 129.46 40.96 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.512 0.672 . . . . 72.140000000000001 110.959 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 155.18 66.58 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.64 2.226 . . . . 70.400000000000006 112.35 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -67.19 -11.66 59.3 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.707 -0.759 . . . . 72.200000000000003 112.473 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.3 p -79.47 -20.86 46.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.922 0.391 . . . . 71.140000000000001 110.871 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.8 tp -120.34 39.23 3.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.123 -0.49 . . . . 73.450000000000003 110.908 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 85.1 t -62.37 -62.46 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 73.129999999999995 111.106 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -173.76 146.05 1.22 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.095 -0.502 . . . . 72.0 110.873 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.8 m -85.74 151.79 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 75.200000000000003 111.093 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.17 73.47 0.93 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.599 0.714 . . . . 73.319999999999993 110.905 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 139.16 39.72 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.714 2.276 . . . . 72.140000000000001 112.358 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 10.6 p -120.49 151.98 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.301 -0.409 . . . . 71.219999999999999 111.086 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -51.99 -30.15 23.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 73.409999999999997 110.859 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -82.91 129.21 34.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 65.310000000000002 110.834 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 79.6 p -108.57 37.4 2.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 70.209999999999994 111.118 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.3 tp -87.16 -22.15 25.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 72.530000000000001 110.903 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 29.0 p-80 -96.13 18.44 13.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 72.349999999999994 110.823 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 48.4 mt -110.7 39.35 2.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 72.010000000000005 110.878 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -167.48 123.87 1.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 74.439999999999998 110.907 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.19 15.54 71.74 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.673 -0.775 . . . . 65.230000000000004 112.479 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.0 tmmm? -71.2 138.23 49.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.769 0.319 . . . . 73.219999999999999 110.866 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -105.08 118.45 36.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 74.299999999999997 110.832 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.0 tp -139.05 146.92 41.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.108 -0.496 . . . . 72.430000000000007 110.899 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -90.94 129.71 36.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.439 . . . . 74.319999999999993 110.888 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -114.91 -179.43 3.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 73.310000000000002 110.897 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.74 136.05 21.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 74.340000000000003 110.91 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 22.0 t -58.72 112.28 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 74.349999999999994 111.148 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.78 -26.14 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 75.519999999999996 111.183 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -169.17 115.79 0.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 75.319999999999993 110.892 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -150.17 132.95 15.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.225 -0.443 . . . . 73.200000000000003 110.919 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -117.82 109.73 16.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 74.519999999999996 110.804 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -64.71 -30.64 71.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 74.400000000000006 110.926 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 9.3 ttmt -70.29 -29.93 66.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 74.310000000000002 110.895 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 38.7 mtt180 -91.83 -15.37 28.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.427 . . . . 65.140000000000001 110.9 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 60.62 42.89 13.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 72.530000000000001 110.919 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -143.06 140.69 31.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 75.129999999999995 110.864 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 46.7 t -137.23 141.23 40.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 73.129999999999995 111.104 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.5 m -134.78 170.92 18.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 72.329999999999998 111.177 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 20.7 t -120.47 149.19 23.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 74.299999999999997 111.133 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.77 160.89 18.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 75.049999999999997 110.862 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.36 -33.71 13.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 71.209999999999994 110.908 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -76.87 -25.04 52.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 73.349999999999994 110.879 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.8 -9.38 58.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 72.340000000000003 111.131 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 10.5 p -51.35 -30.15 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 63.229999999999997 111.129 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 31.5 pt -52.07 -29.55 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 73.439999999999998 111.081 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -54.73 -65.95 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 74.430000000000007 110.857 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.96 -43.93 63.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 74.040000000000006 110.895 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -55.72 -51.17 68.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.491 . . . . 72.120000000000005 110.863 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -123.15 71.8 1.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 70.129999999999995 110.852 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 63.3 p . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 74.5 110.867 -179.87 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.898 0.38 . . . . 75.230000000000004 110.889 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -89.49 93.64 9.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.465 . . . . 74.519999999999996 110.898 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.62 -26.16 50.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 63.450000000000003 111.112 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.8 pttt -53.88 -27.95 33.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 74.340000000000003 110.846 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -59.69 -25.52 64.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 73.430000000000007 110.793 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -51.99 -37.5 53.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.195 -0.457 . . . . 73.450000000000003 110.874 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -78.56 -37.04 43.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.113 -0.494 . . . . 75.409999999999997 110.911 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.0 -18.14 63.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 71.420000000000002 111.147 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 33.3 m0 -56.6 -24.53 48.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.459 . . . . 74.319999999999993 110.916 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 29.2 pt -55.02 -26.11 17.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 72.129999999999995 111.097 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 57.1 m -78.38 -27.22 46.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 75.129999999999995 111.142 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 17.9 mt -66.61 -24.85 66.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 75.549999999999997 110.95 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -51.85 -34.87 42.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 71.010000000000005 110.881 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 36.5 mttp -83.83 -26.36 29.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.128 -0.487 . . . . 74.540000000000006 110.873 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.33 -58.38 7.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 73.430000000000007 111.089 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -52.32 -29.64 24.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 74.040000000000006 110.961 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.05 -36.19 78.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 74.409999999999997 110.96 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -108.58 20.74 18.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.171 -0.468 . . . . 74.239999999999995 110.896 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 51.59 62.25 2.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 75.230000000000004 111.097 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.33 155.24 40.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 75.25 110.926 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.6 t -104.11 172.65 6.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 72.549999999999997 111.147 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.9 m -146.28 177.37 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.27 -0.423 . . . . 74.140000000000001 111.067 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.8 t -162.2 127.25 3.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 72.430000000000007 111.083 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -165.77 153.95 24.27 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.774 -0.727 . . . . 62.240000000000002 112.506 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 13.1 p -102.64 137.18 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.818 0.342 . . . . 63.43 111.149 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.4 mp -54.09 106.43 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.252 -0.431 . . . . 73.400000000000006 111.067 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -96.02 -39.84 9.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 71.140000000000001 110.885 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -120.99 141.93 15.21 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.783 -0.722 . . . . 74.519999999999996 112.485 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.9 pttp -124.54 147.43 48.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.781 0.325 . . . . 75.200000000000003 110.918 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.2 m -118.1 177.25 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 71.400000000000006 111.142 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.09 95.8 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 72.030000000000001 110.893 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 90.16 -36.71 3.49 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.732 -0.747 . . . . 73.329999999999998 112.461 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -98.27 173.52 27.63 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.761 -0.733 . . . . 73.010000000000005 112.481 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -132.42 164.22 27.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.976 0.417 . . . . 73.129999999999995 110.866 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -135.45 150.82 49.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.108 -0.496 . . . . 73.420000000000002 111.161 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.3 t -136.48 156.57 36.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.255 -0.43 . . . . 64.219999999999999 111.118 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -114.21 108.47 17.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 73.530000000000001 110.927 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 18.9 mt -109.24 84.87 1.99 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 74.200000000000003 110.859 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 51.45 56.39 7.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 75.400000000000006 110.911 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.37 -35.14 4.33 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.769 -0.729 . . . . 71.510000000000005 112.49 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 26.0 mm -70.82 150.42 9.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.866 0.365 . . . . 74.420000000000002 111.103 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -117.25 114.29 23.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.477 . . . . 75.340000000000003 110.881 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -92.64 161.3 14.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.484 . . . . 71.109999999999999 111.129 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -136.11 113.0 10.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 74.439999999999998 110.885 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -86.64 129.98 50.75 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.578 0.704 . . . . 72.140000000000001 110.955 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 127.88 15.19 Favored 'Trans proline' 0 N--CA 1.465 -0.167 0 C-N-CA 122.681 2.254 . . . . 70.400000000000006 112.357 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -51.56 -28.29 21.16 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.753 -0.737 . . . . 72.200000000000003 112.479 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 72.9 m -56.41 -25.09 48.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.958 0.408 . . . . 71.140000000000001 110.852 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.5 mt -88.98 -33.52 17.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.127 -0.488 . . . . 73.450000000000003 110.941 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 87.9 t -53.99 -27.43 16.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 73.129999999999995 111.108 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.45 112.67 20.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.166 -0.47 . . . . 72.0 110.885 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 7.0 p -173.62 123.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 75.200000000000003 111.097 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 62.95 160.6 0.12 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.556 0.693 . . . . 73.319999999999993 110.889 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 149.91 67.75 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.722 2.282 . . . . 72.140000000000001 112.354 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.9 m -150.19 159.47 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 71.219999999999999 111.16 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -110.16 -73.92 0.67 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 73.409999999999997 110.9 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -63.97 145.2 56.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.454 . . . . 65.310000000000002 110.885 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.39 23.61 14.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 70.209999999999994 111.144 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.5 mp -87.34 -22.79 24.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 72.530000000000001 110.909 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 43.9 p-80 -66.68 -25.26 66.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.433 . . . . 72.349999999999994 110.816 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 59.9 mt -63.79 -59.06 5.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 72.010000000000005 110.968 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -119.43 142.18 48.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 74.439999999999998 110.894 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 91.38 -14.55 63.5 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.76 -0.733 . . . . 65.230000000000004 112.472 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -53.87 128.98 32.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.768 0.318 . . . . 73.219999999999999 110.95 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.51 105.06 14.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 74.299999999999997 110.914 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.6 mt -139.04 179.84 6.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 72.430000000000007 110.953 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -115.91 152.94 32.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 74.319999999999993 110.894 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -126.5 178.4 5.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 73.310000000000002 110.853 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 18.1 tttt -131.37 160.39 35.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 74.340000000000003 110.884 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 7.6 p -76.72 127.63 37.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 74.349999999999994 111.146 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.2 tp -127.87 -38.3 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.187 -0.46 . . . . 75.519999999999996 111.095 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -174.66 132.81 0.35 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.484 . . . . 75.319999999999993 110.884 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.7 pp -158.06 135.7 10.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 73.200000000000003 110.902 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -117.12 125.86 51.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.465 . . . . 74.519999999999996 110.85 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -80.47 -26.15 38.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 74.400000000000006 110.922 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -73.29 -41.31 63.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 74.310000000000002 110.973 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -82.97 -15.41 51.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 65.140000000000001 110.897 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.74 42.36 10.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 72.530000000000001 110.894 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -141.71 140.51 33.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 75.129999999999995 110.856 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 5.9 p -146.03 141.09 21.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 73.129999999999995 111.136 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 20.1 m -134.87 167.52 25.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.161 -0.472 . . . . 72.329999999999998 111.095 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 8.5 m -120.45 148.97 23.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 74.299999999999997 111.118 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.73 155.23 21.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.15 -0.477 . . . . 75.049999999999997 110.829 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 30.2 mtt85 -64.08 -38.53 91.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 71.209999999999994 110.946 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -80.1 -23.11 41.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 73.349999999999994 110.888 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -53.72 -41.7 67.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 72.340000000000003 111.113 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 13.0 p -66.02 -21.79 29.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 63.229999999999997 111.101 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 16.3 mm -70.07 -53.98 21.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.451 . . . . 73.439999999999998 111.146 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -55.46 -47.8 75.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 74.430000000000007 110.861 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 68.5 m -56.42 -42.23 77.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 74.040000000000006 110.827 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -64.69 -51.65 61.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.076 -0.511 . . . . 72.120000000000005 110.854 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -92.06 54.18 2.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.504 . . . . 70.129999999999995 110.879 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 4.0 p . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 74.5 110.908 -179.873 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.886 0.374 . . . . 75.230000000000004 110.88 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -120.24 140.33 51.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 74.519999999999996 110.92 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.04 -37.83 33.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.21 -0.45 . . . . 63.450000000000003 111.086 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.4 ttmm -60.1 -20.04 56.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 74.340000000000003 110.854 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 17.2 tpp180 -60.03 -20.12 56.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 73.430000000000007 110.829 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 -51.45 -31.77 24.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 73.450000000000003 110.921 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -80.3 -42.45 23.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.187 -0.46 . . . . 75.409999999999997 110.812 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.57 -19.95 66.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 71.420000000000002 111.092 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 41.7 m0 -57.3 -23.8 50.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 74.319999999999993 110.863 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 49.6 mt -52.43 -28.73 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 72.129999999999995 111.178 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 58.3 p -76.0 -60.75 2.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 75.129999999999995 111.153 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 pp -60.16 -20.39 58.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 75.549999999999997 110.992 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -51.65 -47.81 63.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.103 -0.499 . . . . 71.010000000000005 110.888 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.5 mtpp -54.04 -27.5 32.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 74.540000000000006 110.95 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.7 -43.86 62.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 73.430000000000007 111.092 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -65.38 -31.84 73.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 74.040000000000006 110.924 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -60.31 -26.04 66.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 74.409999999999997 110.895 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -95.85 20.82 9.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.189 -0.459 . . . . 74.239999999999995 110.852 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 51.86 55.46 9.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 75.230000000000004 111.12 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -76.15 163.37 27.16 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.238 -0.437 . . . . 75.25 110.886 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.8 t -91.93 153.76 19.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.476 . . . . 72.549999999999997 111.131 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.2 m -144.53 178.62 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 74.140000000000001 111.179 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.1 t -157.23 123.47 4.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 72.430000000000007 111.171 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -155.87 153.2 24.57 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.73 -0.747 . . . . 62.240000000000002 112.497 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.2 p -101.02 140.21 20.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.839 0.352 . . . . 63.43 111.14 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.4 mp -60.12 120.93 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 73.400000000000006 111.145 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -102.27 -43.02 5.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 71.140000000000001 110.875 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -118.45 142.99 17.36 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.682 -0.77 . . . . 74.519999999999996 112.468 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.6 pttt -124.06 123.71 40.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.837 0.351 . . . . 75.200000000000003 110.945 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 26.6 m -110.09 177.33 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 71.400000000000006 111.122 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -62.16 94.14 0.05 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 72.030000000000001 110.953 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.88 -36.14 3.61 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.765 -0.731 . . . . 73.329999999999998 112.499 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -90.02 173.8 39.94 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.728 -0.749 . . . . 73.010000000000005 112.503 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -151.15 127.48 10.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.992 0.425 . . . . 73.129999999999995 110.872 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 57.8 p -98.19 142.46 29.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 73.420000000000002 111.159 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.3 t -133.74 147.15 30.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 64.219999999999999 111.117 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -97.25 134.87 39.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.1 -0.5 . . . . 73.530000000000001 110.896 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 78.4 mt -139.41 74.55 1.47 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.119 -0.491 . . . . 74.200000000000003 110.972 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 62.98 42.15 7.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.113 -0.494 . . . . 75.400000000000006 110.902 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 103.03 -31.05 9.19 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.695 -0.764 . . . . 71.510000000000005 112.542 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 60.9 mt -78.04 144.07 11.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.869 0.366 . . . . 74.420000000000002 111.101 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.6 mtp180 -109.22 114.02 27.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 75.340000000000003 110.908 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -92.5 171.54 8.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 71.109999999999999 111.109 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -136.44 129.96 31.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.43 . . . . 74.439999999999998 110.842 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.51 130.54 22.66 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.627 0.727 . . . . 72.140000000000001 110.914 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 140.77 43.51 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.707 2.271 . . . . 70.400000000000006 112.334 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.02 -11.88 56.07 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.771 -0.728 . . . . 72.200000000000003 112.554 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.9 t -76.52 -22.52 54.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.906 0.384 . . . . 71.140000000000001 110.873 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.57 39.52 3.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.504 . . . . 73.450000000000003 110.901 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 85.4 t -53.67 -63.09 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 73.129999999999995 111.103 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -179.65 171.21 1.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 72.0 110.901 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 5.9 p -106.06 121.08 58.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 75.200000000000003 111.108 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -177.33 160.79 1.44 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.642 0.734 . . . . 73.319999999999993 110.864 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 166.6 26.93 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.675 2.25 . . . . 72.140000000000001 112.38 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 31.6 m -51.67 -29.63 10.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.233 -0.44 . . . . 71.219999999999999 111.106 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 54.1 mtm180 -51.86 133.04 32.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 73.409999999999997 110.949 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -51.96 169.08 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 65.310000000000002 110.849 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.4 t -169.82 142.41 2.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 70.209999999999994 111.17 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.4 tt -87.9 -8.92 55.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.268 -0.423 . . . . 72.530000000000001 110.883 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -62.25 -15.72 48.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.443 . . . . 72.349999999999994 110.844 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 47.9 mt -68.85 -24.05 64.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 72.010000000000005 110.958 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -118.77 123.97 46.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.169 -0.469 . . . . 74.439999999999998 110.845 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 89.54 26.12 26.1 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.711 -0.757 . . . . 65.230000000000004 112.448 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.78 128.17 34.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.828 0.347 . . . . 73.219999999999999 110.865 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -105.15 108.54 20.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.203 -0.453 . . . . 74.299999999999997 110.932 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.6 mp -139.11 -179.51 5.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 72.430000000000007 110.914 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -114.31 150.89 33.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 74.319999999999993 110.891 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -125.42 168.06 14.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 73.310000000000002 110.884 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -119.76 123.29 43.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 74.340000000000003 110.862 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 91.9 t -67.61 117.02 8.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.244 -0.434 . . . . 74.349999999999994 111.173 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.4 tp -120.79 -33.35 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 75.519999999999996 111.124 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -171.15 119.96 0.5 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 75.319999999999993 110.872 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -125.33 139.14 53.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 73.200000000000003 110.881 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -118.5 88.95 3.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 74.519999999999996 110.908 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -67.7 -20.03 65.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 74.400000000000006 110.934 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.23 -37.73 67.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 74.310000000000002 110.84 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -93.25 16.39 13.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.444 . . . . 65.140000000000001 110.861 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.2 m120 51.74 30.11 6.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 72.530000000000001 110.938 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -143.1 164.18 30.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 75.129999999999995 110.853 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 20.2 t -143.43 144.61 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 73.129999999999995 111.13 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 14.3 p -129.07 152.2 36.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 72.329999999999998 111.13 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 25.2 m -119.42 145.68 25.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 74.299999999999997 111.124 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.36 159.81 33.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 75.049999999999997 110.799 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -93.45 -37.72 11.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.07 -0.513 . . . . 71.209999999999994 110.881 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 -79.59 -26.75 41.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 73.349999999999994 110.895 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.43 -13.94 62.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.124 -0.489 . . . . 72.340000000000003 111.124 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 11.0 p -52.98 -30.7 16.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 63.229999999999997 111.045 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 23.5 pt -61.96 -30.15 47.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 73.439999999999998 111.145 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -71.71 -46.52 58.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.473 . . . . 74.430000000000007 111.027 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 52.6 p -52.01 -47.24 65.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.124 -0.489 . . . . 74.040000000000006 110.81 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -54.9 -52.98 61.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 72.120000000000005 110.945 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -109.1 55.82 0.63 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 70.129999999999995 110.906 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 72.2 p . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 74.5 110.929 -179.906 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.926 0.393 . . . . 75.230000000000004 110.874 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -98.95 -178.24 3.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 74.519999999999996 110.877 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.56 -40.03 43.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.455 . . . . 63.450000000000003 111.073 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.8 pptp? -60.14 -20.01 56.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 74.340000000000003 110.909 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -59.19 -20.87 57.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.434 . . . . 73.430000000000007 110.898 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -51.38 -31.22 21.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 73.450000000000003 110.838 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -80.43 -46.13 16.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 75.409999999999997 110.861 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.3 -17.18 57.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 71.420000000000002 111.133 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 35.5 m0 -57.85 -22.28 47.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.117 -0.492 . . . . 74.319999999999993 110.92 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 31.0 pt -53.03 -31.24 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 72.129999999999995 111.117 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 12.8 t -72.32 -30.05 64.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 75.129999999999995 111.17 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 18.4 mt -67.38 -21.0 65.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 75.549999999999997 110.865 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -76.23 -36.12 58.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 71.010000000000005 110.87 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -84.03 -22.45 31.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.118 -0.492 . . . . 74.540000000000006 110.823 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.14 -27.73 59.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.416 . . . . 73.430000000000007 111.067 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -55.53 -25.74 39.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.258 -0.428 . . . . 74.040000000000006 110.946 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.74 -27.77 30.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.094 -0.503 . . . . 74.409999999999997 110.906 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -97.1 -19.2 18.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 74.239999999999995 110.846 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 64.03 50.8 2.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 75.230000000000004 111.081 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -64.31 167.14 7.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 75.25 110.867 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.2 t -102.42 165.27 11.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 72.549999999999997 111.244 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.7 m -148.73 177.73 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 74.140000000000001 111.13 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 4.3 t -149.32 118.09 6.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.447 . . . . 72.430000000000007 111.148 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -134.5 164.77 24.59 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.735 -0.745 . . . . 62.240000000000002 112.491 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 13.3 p -105.51 135.79 42.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.777 0.322 . . . . 63.43 111.174 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.2 mp -54.35 101.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 73.400000000000006 111.159 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -74.21 -44.26 53.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 71.140000000000001 110.886 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -134.81 155.06 21.78 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.763 -0.732 . . . . 74.519999999999996 112.469 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -124.32 128.82 49.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.848 0.356 . . . . 75.200000000000003 110.881 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.3 m -114.61 176.79 2.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.201 -0.454 . . . . 71.400000000000006 111.085 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -66.73 98.46 0.53 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 72.030000000000001 110.922 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 91.5 -35.57 3.91 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.753 -0.737 . . . . 73.329999999999998 112.535 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -98.25 173.63 27.76 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.756 -0.735 . . . . 73.010000000000005 112.552 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -146.96 118.75 8.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.925 0.393 . . . . 73.129999999999995 110.882 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.13 150.81 26.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 73.420000000000002 111.145 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 18.7 t -140.64 149.98 21.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 64.219999999999999 111.097 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -105.94 114.64 28.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.451 . . . . 73.530000000000001 110.898 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 77.8 mt -114.53 77.2 1.04 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 74.200000000000003 110.894 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 63.34 52.22 2.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 75.400000000000006 110.933 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 93.96 -34.71 4.51 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.762 -0.732 . . . . 71.510000000000005 112.523 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 27.5 mt -75.18 150.85 6.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.802 0.334 . . . . 74.420000000000002 111.149 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -110.76 132.11 54.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 75.340000000000003 110.822 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -110.12 171.56 7.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 71.109999999999999 111.088 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -138.54 122.38 17.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.24 -0.436 . . . . 74.439999999999998 110.888 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 10.3 mp -95.07 130.11 33.61 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.648 0.737 . . . . 72.140000000000001 110.931 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 132.46 23.38 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.727 2.284 . . . . 70.400000000000006 112.398 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -74.48 -11.14 82.71 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.675 -0.774 . . . . 72.200000000000003 112.445 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 41.8 m -50.4 -32.74 18.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.948 0.404 . . . . 71.140000000000001 110.887 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 28.6 mt -123.12 38.62 4.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.11 -0.496 . . . . 73.450000000000003 110.939 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 89.6 t -122.75 -34.98 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 73.129999999999995 111.113 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -99.2 113.52 25.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 72.0 110.865 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 55.7 t -144.21 108.71 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 75.200000000000003 111.175 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.53 160.94 0.12 Allowed Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.655 0.74 . . . . 73.319999999999993 110.866 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 129.18 17.09 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.725 2.284 . . . . 72.140000000000001 112.353 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 7.7 m -149.04 149.61 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 71.219999999999999 111.136 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 36.3 ptt85 -123.37 36.91 4.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.468 . . . . 73.409999999999997 110.845 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -122.56 104.5 9.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.206 -0.452 . . . . 65.310000000000002 110.876 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 41.3 p -126.47 25.21 6.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.173 -0.467 . . . . 70.209999999999994 111.175 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -86.36 -22.28 26.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.258 -0.428 . . . . 72.530000000000001 110.931 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 50.5 p-80 -90.43 -20.92 22.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 72.349999999999994 110.846 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 89.7 mt -87.89 50.78 2.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.268 -0.424 . . . . 72.010000000000005 110.92 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -165.23 124.07 1.71 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 74.439999999999998 110.873 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 63.46 32.26 83.54 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.693 -0.765 . . . . 65.230000000000004 112.488 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.85 129.25 48.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.747 0.308 . . . . 73.219999999999999 110.913 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -86.07 105.01 16.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 74.299999999999997 110.859 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 10.2 tp -114.62 155.35 26.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 72.430000000000007 110.905 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -97.07 129.99 44.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 74.319999999999993 110.9 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -123.05 -179.4 4.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 73.310000000000002 110.861 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.1 tmmm? -141.45 146.17 36.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.087 -0.506 . . . . 74.340000000000003 110.915 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 47.5 t -94.63 78.96 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.248 -0.433 . . . . 74.349999999999994 111.142 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.5 tt -91.5 -25.33 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 75.519999999999996 111.092 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -152.38 114.53 4.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 75.319999999999993 110.884 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -118.44 149.27 41.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.431 . . . . 73.200000000000003 110.908 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -116.06 57.57 0.75 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.213 -0.449 . . . . 74.519999999999996 110.89 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -58.95 -25.14 63.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.467 . . . . 74.400000000000006 110.906 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 33.0 tttt -55.73 -25.85 42.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 74.310000000000002 110.832 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.12 24.83 12.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.309 -0.405 . . . . 65.140000000000001 110.859 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 9.1 m120 53.66 28.31 7.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.483 . . . . 72.530000000000001 110.902 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -143.08 172.99 11.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 75.129999999999995 110.825 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.8 m -147.88 144.23 19.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 73.129999999999995 111.167 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 19.2 m -128.53 170.46 18.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 72.329999999999998 111.148 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 5.5 m -120.34 155.02 23.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 74.299999999999997 111.169 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.5 m -88.42 156.04 19.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 75.049999999999997 110.902 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.41 -29.0 31.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.134 -0.484 . . . . 71.209999999999994 110.899 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -70.82 -24.05 62.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.488 . . . . 73.349999999999994 110.915 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.57 -14.47 61.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.1 -0.5 . . . . 72.340000000000003 111.171 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 14.4 p -53.26 -28.04 14.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 63.229999999999997 111.081 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 35.4 pt -58.9 -21.49 19.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.24 -0.436 . . . . 73.439999999999998 111.112 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -75.9 -51.46 12.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 74.430000000000007 110.879 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 68.5 p -51.85 -62.01 1.9 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 74.040000000000006 110.836 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -50.15 -53.68 25.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 72.120000000000005 110.928 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 38.9 t30 54.96 29.68 12.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 70.129999999999995 110.909 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 43.2 p . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 74.5 110.85 -179.81 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.939 0.399 . . . . 75.230000000000004 110.836 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -126.84 -70.09 0.73 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.1 -0.5 . . . . 74.519999999999996 110.884 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.36 -41.96 81.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 63.450000000000003 111.084 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 20.6 mmmt -56.47 -25.98 52.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.283 -0.417 . . . . 74.340000000000003 110.917 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.9 tpp180 -74.31 -24.26 59.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.281 -0.418 . . . . 73.430000000000007 110.863 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -51.8 -45.5 63.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 73.450000000000003 110.849 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -76.85 -31.69 57.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 75.409999999999997 110.934 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.44 -17.54 63.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.494 . . . . 71.420000000000002 111.117 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 31.9 m0 -57.19 -23.46 47.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 74.319999999999993 110.882 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 68.1 mt -54.07 -27.59 16.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 72.129999999999995 111.134 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 70.9 p -76.95 -59.11 2.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 75.129999999999995 111.154 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.4 pp -61.66 -18.09 58.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 75.549999999999997 110.842 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -54.15 -61.73 2.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 71.010000000000005 110.93 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? -66.84 -23.97 66.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.091 -0.504 . . . . 74.540000000000006 110.941 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.17 -45.56 68.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 73.430000000000007 111.145 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -53.34 -33.21 52.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 74.040000000000006 110.901 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -57.24 -26.26 60.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 74.409999999999997 110.894 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.28 20.82 11.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 74.239999999999995 110.833 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 53.71 64.14 1.95 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 75.230000000000004 111.075 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -79.25 178.63 7.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 75.25 110.959 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.1 p -120.03 170.71 9.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 72.549999999999997 111.107 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 5.2 m -135.34 -179.3 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 74.140000000000001 111.121 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.6 t -155.69 121.41 4.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 72.430000000000007 111.191 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 176.5 168.09 36.08 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.758 -0.734 . . . . 62.240000000000002 112.502 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 12.5 m -116.01 150.26 18.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.874 0.369 . . . . 63.43 111.132 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.4 mt -60.4 99.2 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 73.400000000000006 111.16 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 64.2 t-20 -87.8 -41.23 13.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 71.140000000000001 110.917 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -114.03 141.08 16.78 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.724 -0.75 . . . . 74.519999999999996 112.446 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -124.4 123.01 39.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.846 0.355 . . . . 75.200000000000003 110.928 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.6 m -108.22 176.67 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.246 -0.434 . . . . 71.400000000000006 111.149 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -66.83 99.18 0.6 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 72.030000000000001 110.953 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 90.85 -35.79 3.79 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.732 -0.747 . . . . 73.329999999999998 112.485 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -98.2 173.49 27.68 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.77 -0.729 . . . . 73.010000000000005 112.472 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -144.09 118.85 9.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.905 0.383 . . . . 73.129999999999995 110.927 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.24 149.68 25.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 73.420000000000002 111.17 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.7 t -143.65 137.42 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 64.219999999999999 111.137 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -90.07 104.94 17.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 73.530000000000001 110.944 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 12.5 mt -97.44 84.82 3.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.088 -0.506 . . . . 74.200000000000003 110.924 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 51.79 44.18 29.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 75.400000000000006 110.879 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 103.87 -33.72 6.35 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.715 -0.755 . . . . 71.510000000000005 112.493 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 21.6 mm -73.53 153.07 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.825 0.345 . . . . 74.420000000000002 111.165 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -105.27 119.39 38.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 75.340000000000003 110.882 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -101.29 171.66 7.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 71.109999999999999 111.075 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -145.89 120.67 9.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 74.439999999999998 110.927 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 9.3 mp -92.92 130.1 37.55 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.619 0.723 . . . . 72.140000000000001 110.946 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.64 135.65 31.28 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.718 2.278 . . . . 70.400000000000006 112.386 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -67.74 -11.44 60.3 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.732 -0.747 . . . . 72.200000000000003 112.476 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 38.2 m -53.49 -35.03 60.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.904 0.383 . . . . 71.140000000000001 110.879 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.41 39.05 4.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 73.450000000000003 110.937 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 83.4 t -118.45 -24.16 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 73.129999999999995 111.129 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -98.53 112.03 24.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 72.0 110.846 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.2 m -154.01 132.07 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 75.200000000000003 111.139 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 19.5 mtm-85 62.62 161.59 0.12 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.612 0.72 . . . . 73.319999999999993 110.867 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.8 164.17 35.56 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.722 2.281 . . . . 72.140000000000001 112.336 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 7.4 p -51.27 139.43 6.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.199 -0.455 . . . . 71.219999999999999 111.105 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -178.4 105.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 73.409999999999997 110.905 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 59.0 97.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 65.310000000000002 110.839 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.17 4.68 33.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.102 -0.499 . . . . 70.209999999999994 111.114 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -87.22 -9.86 54.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.255 -0.429 . . . . 72.530000000000001 110.933 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -75.4 -5.91 47.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 72.349999999999994 110.909 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.7 pp -118.3 31.11 6.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 72.010000000000005 110.906 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -128.68 126.61 40.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 74.439999999999998 110.91 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 63.44 31.71 81.69 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.701 -0.762 . . . . 65.230000000000004 112.531 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.36 131.74 43.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.81 0.338 . . . . 73.219999999999999 110.85 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.84 96.6 7.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.175 -0.466 . . . . 74.299999999999997 110.905 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.9 mt -138.64 141.24 39.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 72.430000000000007 110.934 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -89.92 129.44 36.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 74.319999999999993 110.903 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -110.73 -179.16 3.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 73.310000000000002 110.901 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.99 151.0 39.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 74.340000000000003 110.915 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.2 t -91.45 112.48 25.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 74.349999999999994 111.091 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 15.7 tt -87.57 -33.76 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 75.519999999999996 111.114 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -177.89 126.38 0.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 75.319999999999993 110.873 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.05 119.63 39.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 73.200000000000003 110.949 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -73.5 126.48 30.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 74.519999999999996 110.884 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -78.03 -29.05 49.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 74.400000000000006 110.867 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 12.4 tptm -53.12 -32.17 46.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.248 -0.433 . . . . 74.310000000000002 110.93 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -113.52 -15.27 12.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.1 -0.5 . . . . 65.140000000000001 110.85 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.07 47.94 5.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 72.530000000000001 110.922 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -142.27 154.42 44.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.48 . . . . 75.129999999999995 110.849 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.9 m -102.92 144.33 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 73.129999999999995 111.1 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 29.5 m -132.34 171.25 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 72.329999999999998 111.157 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 26.5 m -119.97 155.25 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 74.299999999999997 111.143 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.77 150.23 30.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 75.049999999999997 110.872 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -82.24 0.11 42.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 71.209999999999994 110.863 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.44 -58.81 2.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 73.349999999999994 110.867 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -83.37 -7.22 59.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 72.340000000000003 111.071 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 7.9 p -50.92 -28.21 6.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 63.229999999999997 111.133 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 28.5 pt -50.32 -30.8 7.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 73.439999999999998 111.118 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -54.7 -45.74 74.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 74.430000000000007 110.925 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 6.2 p -51.22 -44.13 61.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 74.040000000000006 110.913 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -64.42 -51.07 65.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.064 -0.516 . . . . 72.120000000000005 110.901 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -84.81 54.61 3.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 70.129999999999995 110.843 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 74.5 110.806 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.949 0.404 . . . . 75.230000000000004 110.832 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.7 ttpp -144.96 163.44 34.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 74.519999999999996 110.897 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.27 -28.55 42.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 63.450000000000003 111.137 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -60.03 -20.46 58.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 74.340000000000003 110.851 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -61.9 -19.82 63.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 73.430000000000007 110.875 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -51.76 -30.9 24.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.271 -0.422 . . . . 73.450000000000003 110.907 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -81.31 -45.6 15.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.225 -0.443 . . . . 75.409999999999997 110.854 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.8 -15.89 59.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 71.420000000000002 111.108 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 31.5 m0 -57.72 -22.86 48.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 74.319999999999993 110.866 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 52.1 mt -54.66 -26.33 16.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.304 -0.407 . . . . 72.129999999999995 111.135 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 70.3 p -80.26 -59.2 2.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 75.129999999999995 111.089 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 pp -61.49 -18.48 59.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.235 -0.439 . . . . 75.549999999999997 110.905 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -73.51 -25.7 60.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 71.010000000000005 110.842 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -79.44 -22.9 43.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 74.540000000000006 110.849 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.53 -38.95 91.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 73.430000000000007 111.076 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -69.1 -23.85 64.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.304 -0.407 . . . . 74.040000000000006 110.942 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.27 -25.23 58.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 74.409999999999997 110.906 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -94.82 20.93 8.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 74.239999999999995 110.904 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 60.95 65.34 1.02 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 75.230000000000004 111.158 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -90.19 169.22 11.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 75.25 110.827 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.3 m -120.48 139.24 53.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 72.549999999999997 111.104 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.1 m -125.74 -177.22 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 74.140000000000001 111.072 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.6 t -161.06 123.46 3.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.116 -0.493 . . . . 72.430000000000007 111.184 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -149.24 148.48 19.89 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.731 -0.747 . . . . 62.240000000000002 112.448 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.5 p -90.96 135.61 26.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.804 0.335 . . . . 63.43 111.115 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 mp -63.37 107.14 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.492 . . . . 73.400000000000006 111.101 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -91.51 -34.52 14.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.48 . . . . 71.140000000000001 110.915 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -128.21 143.78 14.69 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.773 -0.727 . . . . 74.519999999999996 112.497 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.5 pttp -123.94 134.77 53.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.822 0.344 . . . . 75.200000000000003 110.907 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.3 m -117.36 176.59 2.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 71.400000000000006 111.095 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -66.37 98.05 0.45 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 72.030000000000001 110.959 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 91.93 -35.26 4.05 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.753 -0.737 . . . . 73.329999999999998 112.485 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -98.17 173.51 27.75 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.761 -0.733 . . . . 73.010000000000005 112.611 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -145.37 118.93 9.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.919 0.39 . . . . 73.129999999999995 110.965 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.79 147.01 26.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 73.420000000000002 111.109 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 32.8 t -138.52 147.68 25.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 64.219999999999999 111.134 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -102.55 105.7 16.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 73.530000000000001 110.828 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 81.8 mt -105.91 74.43 1.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 74.200000000000003 110.962 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 57.72 51.06 9.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 75.400000000000006 111.003 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 99.79 -33.5 6.2 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.757 -0.735 . . . . 71.510000000000005 112.5 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 25.0 mm -76.58 150.25 6.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.793 0.33 . . . . 74.420000000000002 111.157 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 57.9 mtm180 -109.66 117.12 33.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 75.340000000000003 110.859 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -94.55 171.56 8.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 71.109999999999999 111.171 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -146.74 122.03 10.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.28 -0.418 . . . . 74.439999999999998 110.853 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 9.4 mp -110.54 129.43 23.96 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.643 0.735 . . . . 72.140000000000001 110.923 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 152.11 69.01 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.695 2.263 . . . . 70.400000000000006 112.325 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.46 -18.57 61.27 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.724 -0.75 . . . . 72.200000000000003 112.523 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 44.2 t -73.65 -26.21 60.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.849 0.357 . . . . 71.140000000000001 110.8 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 10.1 tt -79.97 -26.92 39.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 73.450000000000003 110.875 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 81.8 t -78.94 -62.76 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 73.129999999999995 111.119 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -166.37 161.92 16.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 72.0 110.908 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 27.0 m -82.04 147.87 5.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 75.200000000000003 111.138 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.01 160.53 0.12 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.605 0.717 . . . . 73.319999999999993 110.884 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.69 145.54 57.89 Favored 'Trans proline' 0 C--O 1.23 0.123 0 C-N-CA 122.745 2.297 . . . . 72.140000000000001 112.289 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.6 p -116.29 149.96 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 71.219999999999999 111.141 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -66.21 -75.22 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 73.409999999999997 110.859 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -179.93 138.57 0.12 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 65.310000000000002 110.896 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.82 157.5 33.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 70.209999999999994 111.122 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.8 mp -87.57 -9.64 53.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 72.530000000000001 110.88 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -60.33 -18.79 52.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.161 -0.472 . . . . 72.349999999999994 110.81 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.4 pp -109.35 36.41 2.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 72.010000000000005 110.931 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -129.66 124.68 34.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 74.439999999999998 110.832 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 66.64 23.51 72.25 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.727 -0.749 . . . . 65.230000000000004 112.489 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.6 ttmm -63.33 130.26 43.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.726 0.298 . . . . 73.219999999999999 110.878 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -104.16 89.71 3.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 74.299999999999997 110.843 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.8 mt -138.34 135.98 35.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.139 -0.482 . . . . 72.430000000000007 110.921 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -85.91 158.03 20.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 74.319999999999993 110.852 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -126.06 -179.23 4.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 73.310000000000002 110.852 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.5 tttp -125.26 108.24 11.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.12 -0.491 . . . . 74.340000000000003 110.899 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.5 t -69.33 128.92 33.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.43 . . . . 74.349999999999994 111.127 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 7.8 tp -118.3 -29.35 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 75.519999999999996 111.164 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.99 166.42 7.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 75.319999999999993 110.918 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.84 165.48 36.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 73.200000000000003 110.917 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -119.18 96.58 5.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 74.519999999999996 110.878 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -77.12 -23.3 51.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.159 -0.473 . . . . 74.400000000000006 110.857 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 22.5 tptt -51.79 -45.75 63.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 74.310000000000002 110.967 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -104.6 16.88 25.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 65.140000000000001 110.893 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 51.51 48.57 22.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 72.530000000000001 110.939 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -121.88 153.81 37.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 75.129999999999995 110.947 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 97.3 t -142.98 128.51 16.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 73.129999999999995 111.151 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.1 m -134.81 171.18 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 72.329999999999998 111.184 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 6.3 m -120.27 145.75 26.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 74.299999999999997 111.084 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.85 157.47 37.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 75.049999999999997 110.871 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.87 -42.13 20.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.121 -0.491 . . . . 71.209999999999994 110.82 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 83.7 mtm-85 -59.7 -20.6 57.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.266 -0.424 . . . . 73.349999999999994 110.847 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.7 -17.45 55.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 72.340000000000003 111.084 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 10.2 p -50.71 -30.5 8.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 63.229999999999997 111.173 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 27.2 pt -51.48 -32.44 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.488 . . . . 73.439999999999998 111.12 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -88.03 -26.4 22.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.463 . . . . 74.430000000000007 110.853 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 5.1 t -91.29 12.79 19.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 74.040000000000006 110.877 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -50.01 -53.43 26.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 72.120000000000005 110.91 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -128.14 -58.48 1.21 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 70.129999999999995 110.886 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 10.9 t . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 74.5 110.873 -179.848 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.3 mp0 . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.966 0.412 . . . . 75.230000000000004 110.867 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -114.93 117.66 31.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 74.519999999999996 110.916 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.75 -30.16 59.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 63.450000000000003 111.079 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -64.67 -27.95 69.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 74.340000000000003 110.939 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -57.07 -27.16 61.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 73.430000000000007 110.866 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -52.04 -37.7 54.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 73.450000000000003 110.904 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -81.77 -29.91 32.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.447 . . . . 75.409999999999997 110.922 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.96 -24.47 61.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 71.420000000000002 111.159 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 53.9 m0 -58.77 -22.57 58.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.197 -0.456 . . . . 74.319999999999993 110.962 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 70.0 mt -51.53 -29.96 10.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.218 -0.446 . . . . 72.129999999999995 111.134 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 73.3 p -64.27 -52.13 60.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 75.129999999999995 111.104 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.88 -21.73 62.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.435 . . . . 75.549999999999997 110.962 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -59.9 -52.29 66.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.164 -0.471 . . . . 71.010000000000005 110.867 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -57.65 -27.45 62.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.471 . . . . 74.540000000000006 110.953 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -51.98 -48.4 64.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.166 -0.47 . . . . 73.430000000000007 111.111 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -55.74 -33.26 64.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 74.040000000000006 110.924 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.57 -26.41 66.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 74.409999999999997 110.899 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -104.46 20.97 17.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 74.239999999999995 110.838 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 57.91 67.41 0.96 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 75.230000000000004 111.043 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -104.06 176.15 5.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 75.25 110.937 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.3 t -121.14 164.95 16.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.166 -0.47 . . . . 72.549999999999997 111.062 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.9 m -135.4 -178.09 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 74.140000000000001 111.096 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 4.9 t -154.13 122.85 6.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.081 -0.508 . . . . 72.430000000000007 111.156 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -156.87 150.97 22.35 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.742 -0.742 . . . . 62.240000000000002 112.503 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.3 p -109.45 141.2 25.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.829 0.347 . . . . 63.43 111.12 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.3 mp -67.36 101.88 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.132 -0.485 . . . . 73.400000000000006 111.066 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -91.26 -27.16 18.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 71.140000000000001 110.912 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -134.18 143.05 14.62 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.736 -0.745 . . . . 74.519999999999996 112.48 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.98 136.66 54.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.788 0.327 . . . . 75.200000000000003 110.937 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.3 m -118.39 176.44 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 71.400000000000006 111.183 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.94 97.73 0.37 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 72.030000000000001 110.928 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 92.24 -35.02 4.16 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.752 -0.737 . . . . 73.329999999999998 112.465 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -98.17 173.55 27.79 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.737 -0.744 . . . . 73.010000000000005 112.48 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -146.03 119.09 8.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.86 0.362 . . . . 73.129999999999995 110.877 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.4 m -86.5 150.6 24.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 73.420000000000002 111.155 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.6 t -138.89 131.93 38.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.287 -0.415 . . . . 64.219999999999999 111.165 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -84.01 99.27 10.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 73.530000000000001 110.897 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 25.4 mt -99.89 77.65 2.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 74.200000000000003 110.907 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 52.14 52.92 13.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 75.400000000000006 110.878 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 93.36 -22.31 35.78 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.764 -0.731 . . . . 71.510000000000005 112.532 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 57.1 mt -83.02 144.43 10.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.8 0.333 . . . . 74.420000000000002 111.141 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -100.52 109.25 21.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 75.340000000000003 110.848 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -92.99 171.59 8.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 71.109999999999999 111.019 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -146.76 129.73 16.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 74.439999999999998 110.856 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.5 mt -120.17 129.52 25.3 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.587 0.708 . . . . 72.140000000000001 110.943 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.88 136.78 33.55 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.677 2.252 . . . . 70.400000000000006 112.29 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -71.54 -16.74 75.95 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.759 -0.734 . . . . 72.200000000000003 112.424 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 2.9 t -55.4 -26.37 41.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.88 0.371 . . . . 71.140000000000001 110.858 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 28.7 mt -120.61 24.64 10.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.47 . . . . 73.450000000000003 110.932 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 88.6 t -113.46 -49.41 5.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 73.129999999999995 111.174 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -99.08 112.64 24.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 72.0 110.85 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 5.8 m -152.89 107.07 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 75.200000000000003 111.14 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 18.7 mmt-85 51.94 69.13 2.63 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.557 0.694 . . . . 73.319999999999993 110.89 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 143.81 52.11 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.618 2.212 . . . . 72.140000000000001 112.362 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 4.1 m -139.77 85.89 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 71.219999999999999 111.196 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.1 ptt-85 39.42 41.74 0.74 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.472 . . . . 73.409999999999997 110.824 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -137.93 97.39 3.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 65.310000000000002 110.925 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.77 -13.67 9.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 70.209999999999994 111.125 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 13.7 mt -62.88 -21.65 66.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 72.530000000000001 110.943 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -93.36 18.21 10.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 72.349999999999994 110.891 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 61.5 mt -110.51 -33.11 6.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 72.010000000000005 110.949 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -128.32 129.5 46.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 74.439999999999998 110.879 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 90.42 -14.84 61.51 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.771 -0.728 . . . . 65.230000000000004 112.45 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.89 129.97 44.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.804 0.335 . . . . 73.219999999999999 110.867 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -111.02 114.28 27.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 74.299999999999997 110.942 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.445 ' C ' ' CD2' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -140.66 165.17 28.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 72.430000000000007 110.922 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -98.38 131.03 45.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.175 -0.466 . . . . 74.319999999999993 110.93 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -97.22 -179.41 4.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 73.310000000000002 110.879 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.6 tttm -137.09 145.98 44.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 74.340000000000003 110.918 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.62 120.18 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.434 . . . . 74.349999999999994 111.145 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.8 tp -130.21 -38.86 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.109 -0.496 . . . . 75.519999999999996 111.146 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -169.28 139.38 2.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 75.319999999999993 110.927 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -153.21 125.76 8.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 73.200000000000003 110.915 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -91.29 63.37 4.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 74.519999999999996 110.873 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -55.39 -26.44 41.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 74.400000000000006 110.923 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 18.5 ttpp -57.3 -43.16 82.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 74.310000000000002 110.915 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -102.94 24.85 10.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.448 . . . . 65.140000000000001 110.937 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 52.71 33.44 13.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.098 -0.501 . . . . 72.530000000000001 110.926 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -108.78 154.67 21.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 75.129999999999995 110.908 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 7.1 p -152.4 123.73 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 73.129999999999995 111.119 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 19.5 m -134.63 148.18 29.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 72.329999999999998 111.192 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 6.1 m -120.44 171.81 8.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 74.299999999999997 111.158 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.9 m -123.88 142.19 51.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 75.049999999999997 110.895 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.92 -34.35 77.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 71.209999999999994 110.899 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -61.93 -20.79 64.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 73.349999999999994 110.883 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -55.89 -24.83 39.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 72.340000000000003 111.069 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 95.6 t -51.88 -37.62 21.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 63.229999999999997 111.102 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 2.0 pp -54.05 -27.31 16.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.186 -0.461 . . . . 73.439999999999998 111.125 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -77.24 -63.63 1.32 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.466 . . . . 74.430000000000007 110.846 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 66.3 p -52.27 -49.24 64.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 74.040000000000006 110.857 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -53.72 -58.58 6.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.489 . . . . 72.120000000000005 110.871 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -59.59 -74.31 0.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 70.129999999999995 110.96 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 6.4 p . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.131 -0.486 . . . . 74.5 110.859 -179.912 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.943 0.401 . . . . 75.230000000000004 110.895 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.5 mmtt 59.6 40.11 20.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.145 -0.479 . . . . 74.519999999999996 110.829 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.95 -55.4 14.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 63.450000000000003 111.11 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.68 -27.28 69.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.27 -0.423 . . . . 74.340000000000003 110.88 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -66.58 -26.84 67.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.426 . . . . 73.430000000000007 110.9 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -51.95 -43.22 63.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 73.450000000000003 110.871 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -79.29 -24.94 42.54 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.198 -0.456 . . . . 75.409999999999997 110.914 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -77.75 -19.72 54.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 71.420000000000002 111.055 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 41.4 m0 -58.1 -22.68 51.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 74.319999999999993 110.897 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 35.7 pt -51.78 -29.35 10.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.285 -0.416 . . . . 72.129999999999995 111.14 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.1 p -75.27 -61.48 1.89 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.146 -0.479 . . . . 75.129999999999995 111.18 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.4 pp -59.05 -21.76 59.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.25 -0.432 . . . . 75.549999999999997 110.874 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -51.92 -47.22 64.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 71.010000000000005 110.85 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -62.65 -28.94 70.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.121 -0.49 . . . . 74.540000000000006 110.893 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.05 -44.09 87.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 73.430000000000007 111.099 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -56.41 -34.08 66.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.158 -0.474 . . . . 74.040000000000006 110.968 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.32 -26.06 60.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.1 -0.5 . . . . 74.409999999999997 110.881 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -94.79 20.7 8.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.143 -0.48 . . . . 74.239999999999995 110.828 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 59.35 36.59 23.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.439 . . . . 75.230000000000004 111.123 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -61.89 152.97 30.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 75.25 110.877 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 35.5 p -93.69 148.52 22.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.066 -0.516 . . . . 72.549999999999997 111.09 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.7 m -123.32 168.85 15.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 74.140000000000001 111.114 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -146.41 118.49 8.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.477 . . . . 72.430000000000007 111.135 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -152.37 151.02 22.94 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.649 -0.786 . . . . 62.240000000000002 112.44 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 12.3 p -101.28 139.6 22.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.722 0.296 . . . . 63.43 111.164 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.0 mp -61.1 116.49 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 73.400000000000006 111.06 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -97.86 -45.2 6.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 71.140000000000001 110.861 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -124.89 153.54 17.9 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.778 -0.725 . . . . 74.519999999999996 112.539 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 9.2 ptmm? -124.05 125.2 44.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.843 0.354 . . . . 75.200000000000003 110.905 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.0 m -104.02 177.31 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 71.400000000000006 111.109 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 53.2 mttt -62.15 94.64 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 72.030000000000001 110.861 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 90.08 -36.25 3.6 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.75 -0.738 . . . . 73.329999999999998 112.534 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -92.59 173.51 35.43 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.713 -0.756 . . . . 73.010000000000005 112.509 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -142.94 118.28 10.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.934 0.397 . . . . 73.129999999999995 110.917 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 33.3 p -84.84 150.97 24.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 73.420000000000002 111.135 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 64.3 t -139.38 138.37 40.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 64.219999999999999 111.168 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -91.44 100.55 13.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 73.530000000000001 110.889 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 10.9 mt -90.72 81.85 5.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 74.200000000000003 110.945 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.3 p30 42.0 52.11 4.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 75.400000000000006 110.905 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 104.01 -34.02 6.11 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.762 -0.732 . . . . 71.510000000000005 112.49 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 25.2 mt -76.45 152.29 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.779 0.323 . . . . 74.420000000000002 111.136 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 53.7 mtm180 -105.09 105.49 15.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 75.340000000000003 110.889 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -92.81 159.12 15.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 71.109999999999999 111.032 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -133.75 125.95 29.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 74.439999999999998 110.871 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 22.6 mt -115.05 131.65 23.42 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.634 0.73 . . . . 72.140000000000001 110.843 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 164.65 33.73 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.665 2.243 . . . . 70.400000000000006 112.399 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -67.13 -11.0 58.02 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.719 -0.753 . . . . 72.200000000000003 112.513 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.5 t -60.24 -32.27 70.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.94 0.4 . . . . 71.140000000000001 110.881 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.09 41.97 3.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 73.450000000000003 110.943 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -50.72 -43.07 23.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 73.129999999999995 111.142 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -179.71 119.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 72.0 110.859 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 12.7 p -76.06 138.79 20.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 75.200000000000003 111.168 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 30.8 mtp180 61.24 75.62 0.44 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.626 0.727 . . . . 73.319999999999993 110.865 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.73 135.31 30.19 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.702 2.268 . . . . 72.140000000000001 112.336 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 5.9 t -127.74 157.94 39.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 71.219999999999999 111.15 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.89 -30.81 15.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 73.409999999999997 110.827 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -84.34 129.57 34.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 65.310000000000002 110.847 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 18.1 p -98.6 27.92 4.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 70.209999999999994 111.131 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.5 tp -87.49 -21.36 25.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 72.530000000000001 110.88 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 33.7 p-80 -89.08 -21.86 23.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 72.349999999999994 110.86 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 59.2 mt -51.84 -57.98 7.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 72.010000000000005 110.973 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -101.7 145.11 29.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 74.439999999999998 110.848 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 95.45 -12.15 68.06 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.756 -0.735 . . . . 65.230000000000004 112.573 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.65 133.56 50.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.682 0.277 . . . . 73.219999999999999 110.95 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -110.26 111.92 23.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.269 -0.423 . . . . 74.299999999999997 110.897 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.4 mt -139.21 159.32 42.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 72.430000000000007 110.894 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -95.0 148.18 22.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 74.319999999999993 110.867 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -123.32 -179.47 4.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 73.310000000000002 110.832 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.14 108.19 7.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 74.340000000000003 110.902 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 89.1 t -60.47 105.98 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.217 -0.447 . . . . 74.349999999999994 111.129 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.6 tt -89.58 -30.29 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 75.519999999999996 111.144 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -176.41 169.67 2.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 75.319999999999993 110.894 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.1 160.96 39.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 73.200000000000003 110.889 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.78 101.8 10.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.187 -0.461 . . . . 74.519999999999996 110.931 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -81.15 -36.08 30.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 74.400000000000006 110.929 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 29.9 tttp -69.45 -46.14 67.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 74.310000000000002 110.888 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -73.62 -15.31 61.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 65.140000000000001 110.922 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.4 m120 63.34 41.06 8.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 72.530000000000001 110.945 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -139.09 128.94 24.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 75.129999999999995 110.897 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.98 130.59 48.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 73.129999999999995 111.066 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 18.9 m -134.79 171.17 18.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 72.329999999999998 111.118 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 1.8 m -120.34 153.16 23.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.468 . . . . 74.299999999999997 111.112 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.28 160.64 31.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 75.049999999999997 110.875 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -121.74 -33.94 3.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.167 -0.47 . . . . 71.209999999999994 110.893 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -81.75 -34.35 30.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 73.349999999999994 110.86 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -83.62 -26.4 29.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 72.340000000000003 111.12 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 5.7 p -58.07 -20.29 14.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 63.229999999999997 111.128 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 27.3 pt -53.11 -27.96 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.485 . . . . 73.439999999999998 111.117 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -87.21 -31.81 20.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 74.430000000000007 110.895 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 3.7 t -76.8 -25.03 52.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 74.040000000000006 110.827 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -60.81 -33.7 73.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.122 -0.49 . . . . 72.120000000000005 110.889 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -123.88 49.04 1.79 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.491 . . . . 70.129999999999995 110.886 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 41.8 t . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 74.5 110.825 -179.829 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.903 0.382 . . . . 75.230000000000004 110.892 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -81.71 -27.78 33.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.11 -0.495 . . . . 74.519999999999996 110.957 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.41 -51.44 68.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 63.450000000000003 111.08 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.1 mtmm -55.87 -26.01 45.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 74.340000000000003 110.892 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.87 -26.46 36.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 73.430000000000007 110.865 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 14.7 t60 -51.61 -30.27 20.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.153 -0.476 . . . . 73.450000000000003 110.911 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -79.29 -34.98 41.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.165 -0.47 . . . . 75.409999999999997 110.872 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.32 -15.52 62.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 71.420000000000002 111.096 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -57.76 -22.48 47.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 74.319999999999993 110.951 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 27.2 pt -52.31 -32.7 16.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.288 -0.414 . . . . 72.129999999999995 111.154 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.6 p -86.07 -23.65 26.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 75.129999999999995 111.13 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.6 tp -67.8 -28.55 67.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.21 -0.45 . . . . 75.549999999999997 110.889 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -60.35 -48.17 82.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 71.010000000000005 110.898 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -67.41 -24.65 65.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 74.540000000000006 110.888 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.1 -36.92 85.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 73.430000000000007 111.095 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -52.81 -28.96 25.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 74.040000000000006 110.977 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.49 -25.05 50.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.078 -0.51 . . . . 74.409999999999997 110.902 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -94.3 -22.21 18.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.139 -0.482 . . . . 74.239999999999995 110.874 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 62.16 44.49 7.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.443 . . . . 75.230000000000004 111.066 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.77 165.27 15.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 75.25 110.936 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.8 t -94.56 168.07 11.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 72.549999999999997 111.163 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.2 m -152.96 -178.62 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 74.140000000000001 111.128 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 4.1 t -141.43 116.67 10.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 72.430000000000007 111.215 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -134.46 151.98 20.5 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.721 -0.752 . . . . 62.240000000000002 112.449 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 85.5 t -115.56 134.2 59.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.751 0.31 . . . . 63.43 111.132 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.5 mp -54.66 115.34 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 73.400000000000006 111.136 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -100.16 -41.64 7.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 71.140000000000001 110.926 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -120.87 145.84 17.37 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.799 -0.715 . . . . 74.519999999999996 112.512 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.2 pttt -124.03 128.42 49.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.788 0.328 . . . . 75.200000000000003 110.927 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.6 m -119.82 176.5 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 71.400000000000006 111.167 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -68.15 99.06 0.85 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 72.030000000000001 110.927 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 92.02 -35.13 4.1 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.763 -0.732 . . . . 73.329999999999998 112.452 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -98.26 173.6 27.71 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.774 -0.727 . . . . 73.010000000000005 112.494 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -152.56 119.06 5.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.989 0.423 . . . . 73.129999999999995 110.905 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.29 150.89 24.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.159 -0.473 . . . . 73.420000000000002 111.116 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 19.9 t -140.69 139.83 34.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.494 . . . . 64.219999999999999 111.121 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -95.02 107.28 19.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 73.530000000000001 110.871 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 26.9 mt -103.18 72.67 1.18 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.157 -0.474 . . . . 74.200000000000003 110.955 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 54.38 50.89 15.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 75.400000000000006 110.927 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 103.9 -33.38 6.62 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.714 -0.755 . . . . 71.510000000000005 112.461 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.6 mm -80.06 156.18 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.842 0.354 . . . . 74.420000000000002 111.114 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 47.7 mtt180 -114.84 121.67 43.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 75.340000000000003 110.956 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -102.25 168.45 9.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.25 -0.432 . . . . 71.109999999999999 111.123 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -147.87 124.41 11.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 74.439999999999998 110.844 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.89 130.16 24.72 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.68 0.753 . . . . 72.140000000000001 110.887 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 146.21 59.77 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.652 2.235 . . . . 70.400000000000006 112.373 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -67.63 -11.35 59.88 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.772 -0.727 . . . . 72.200000000000003 112.482 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.6 m -51.33 -30.63 19.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.89 0.376 . . . . 71.140000000000001 110.838 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.0 tp -116.16 29.09 8.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 73.450000000000003 110.886 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 94.4 t -120.01 -32.74 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.251 -0.431 . . . . 73.129999999999995 111.113 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -108.11 116.0 31.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 72.0 110.843 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.4 t -129.18 166.95 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 75.200000000000003 111.092 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.47 ' N ' ' HD2' ' A' ' 140' ' ' PRO . 0.9 OUTLIER -50.86 -60.68 5.05 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.602 0.715 . . . . 73.319999999999993 110.893 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 139' ' ' ARG . 54.5 Cg_endo -69.74 133.36 25.42 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.746 2.297 . . . . 72.140000000000001 112.361 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.7 m -128.83 148.7 33.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 71.219999999999999 111.103 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 81.9 mtt180 -124.73 -60.72 1.36 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.48 . . . . 73.409999999999997 110.88 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -153.01 162.75 40.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 65.310000000000002 110.87 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.8 p -106.5 19.72 20.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.205 -0.452 . . . . 70.209999999999994 111.184 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -87.36 -24.56 24.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.494 . . . . 72.530000000000001 110.968 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.4 -8.59 59.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.146 -0.479 . . . . 72.349999999999994 110.88 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 78.7 mt -58.92 -49.42 77.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.171 -0.468 . . . . 72.010000000000005 110.918 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -130.26 137.44 50.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 74.439999999999998 110.855 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 92.11 -16.44 59.62 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.799 -0.715 . . . . 65.230000000000004 112.505 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.62 127.17 19.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.717 0.294 . . . . 73.219999999999999 110.914 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -89.29 111.1 21.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.252 -0.431 . . . . 74.299999999999997 110.852 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.5 tp -139.25 -175.46 4.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 72.430000000000007 110.941 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -133.78 135.7 44.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 74.319999999999993 110.884 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -119.25 -179.34 3.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.477 . . . . 73.310000000000002 110.834 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -128.47 160.77 31.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 74.340000000000003 110.948 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.6 t -84.07 82.06 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.276 -0.42 . . . . 74.349999999999994 111.096 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.1 mp -77.99 -40.49 26.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 75.519999999999996 111.089 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.41 154.74 7.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 75.319999999999993 110.857 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.03 112.73 7.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 73.200000000000003 110.869 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -67.61 91.45 0.29 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.172 -0.467 . . . . 74.519999999999996 110.885 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -60.58 -19.93 59.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 74.400000000000006 110.923 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -51.6 -37.79 51.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 74.310000000000002 110.905 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 24.2 ttt85 -123.06 19.79 9.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 65.140000000000001 110.894 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 51.82 29.89 6.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 72.530000000000001 110.874 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -112.85 157.98 20.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.202 -0.454 . . . . 75.129999999999995 110.928 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 10.2 p -125.96 144.23 36.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 73.129999999999995 111.137 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 19.7 m -127.81 169.54 19.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 72.329999999999998 111.171 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 15.5 m -120.28 162.01 19.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.451 . . . . 74.299999999999997 111.087 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 28.4 t -103.36 161.17 14.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 75.049999999999997 110.852 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 25.8 mtm180 -79.93 -58.16 3.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 71.209999999999994 110.918 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -56.35 -26.02 51.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 73.349999999999994 110.871 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.26 -14.03 61.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 72.340000000000003 111.04 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 13.5 p -51.6 -29.59 10.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 63.229999999999997 111.168 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 32.7 pt -51.62 -30.32 11.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.135 -0.484 . . . . 73.439999999999998 111.106 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -69.7 -38.54 77.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 74.430000000000007 110.945 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 26.0 t -51.78 -58.57 6.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.07 -0.514 . . . . 74.040000000000006 110.916 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -72.72 -61.61 1.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 72.120000000000005 110.874 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 16.0 t30 57.19 47.58 16.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 70.129999999999995 110.833 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 74.5 110.889 -179.928 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 23.4 mttm . . . . . 0 N--CA 1.458 -0.072 0 CA-C-O 120.777 0.322 . . . . 73.430000000000007 110.929 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.18 -29.95 65.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 63.450000000000003 111.112 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 32.6 mmtt -58.39 -26.29 63.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 73.340000000000003 110.876 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 6.1 mtt85 -65.44 -25.83 67.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 73.430000000000007 110.894 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 54.0 m170 -51.97 -47.93 64.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 73.450000000000003 110.848 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -80.2 -26.53 39.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 71.430000000000007 110.89 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.2 -21.17 62.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 71.420000000000002 111.089 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.435 ' CD1' HD11 ' A' ' 98' ' ' LEU . 42.1 m0 -58.01 -22.85 51.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.209 -0.451 . . . . 74.319999999999993 110.922 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 74.9 mt -54.59 -26.58 16.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.448 . . . . 70.150000000000006 111.122 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.5 m -77.93 -28.16 49.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 60.329999999999998 111.164 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.595 ' CD1' HD11 ' A' ' 127' ' ' ILE . 18.7 mt -64.1 -27.67 69.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 75.549999999999997 110.907 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -51.56 -49.94 61.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 35.399999999999999 110.9 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -25.07 68.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 74.540000000000006 110.901 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.74 -55.2 8.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 73.430000000000007 111.081 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.493 ' CB ' HD22 ' A' ' 159' ' ' LEU . 33.3 m-85 -57.58 -26.27 61.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 64.120000000000005 110.904 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.71 -40.85 63.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 65.010000000000005 110.869 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -98.48 20.77 12.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 74.239999999999995 110.842 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 61.53 56.4 2.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 75.230000000000004 111.112 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -64.64 143.18 58.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 75.25 110.906 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.3 t -86.72 143.75 27.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.147 -0.479 . . . . 72.549999999999997 111.154 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.418 HG21 HD13 ' A' ' 124' ' ' LEU . 23.6 m -122.07 -179.62 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 71.209999999999994 111.154 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 4.3 t -159.96 119.58 2.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 72.430000000000007 111.14 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.687 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -160.2 172.4 36.65 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.716 -0.754 . . . . 43.329999999999998 112.458 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.627 ' C ' HG13 ' A' ' 122' ' ' VAL . 11.7 p -116.1 145.35 21.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.775 0.321 . . . . 54.299999999999997 111.119 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.431 ' CG1' HG22 ' A' ' 122' ' ' VAL . 5.6 mt -66.74 117.87 8.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 73.400000000000006 111.109 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -97.65 -43.72 7.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 70.019999999999996 110.887 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -121.67 148.23 17.26 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.725 -0.75 . . . . 74.519999999999996 112.474 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 27.0 pttt -124.21 125.4 44.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.789 0.328 . . . . 75.200000000000003 110.928 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.5 m -114.08 176.96 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 71.400000000000006 111.166 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 28.9 mttp -62.47 94.38 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 72.030000000000001 110.87 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 90.61 -35.76 3.77 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.704 -0.76 . . . . 73.329999999999998 112.508 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -90.38 173.69 39.21 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.749 -0.739 . . . . 73.010000000000005 112.531 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.489 ' HE2' HG11 ' A' ' 136' ' ' VAL . 15.3 m-85 -152.04 118.92 5.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.994 0.426 . . . . 73.129999999999995 110.927 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.11 135.81 33.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.49 . . . . 71.299999999999997 111.152 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.725 HG11 ' CZ ' ' A' ' 154' ' ' PHE . 18.1 t -135.39 138.12 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 62.520000000000003 111.089 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -88.85 113.34 24.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.453 . . . . 63.43 110.881 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.687 HD23 ' HA3' ' A' ' 110' ' ' GLY . 11.1 mt -121.16 96.44 5.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.464 . . . . 74.200000000000003 110.907 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 63.32 25.24 14.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 75.400000000000006 110.919 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 103.96 -23.1 33.24 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.677 -0.773 . . . . 71.510000000000005 112.467 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.595 HD11 ' CD1' ' A' ' 98' ' ' LEU . 21.9 mt -83.05 151.87 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.808 0.337 . . . . 73.319999999999993 111.119 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -99.65 124.3 44.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 73.510000000000005 110.868 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.628 ' HB1' ' CG2' ' A' ' 168' ' ' VAL . . . -101.15 171.75 7.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 63.520000000000003 111.097 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -142.82 117.91 10.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 74.439999999999998 110.895 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.575 HD11 ' CE2' ' A' ' 154' ' ' PHE . 7.7 mp -100.28 129.56 27.81 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.653 0.74 . . . . 72.140000000000001 110.918 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.518 ' O ' HG23 ' A' ' 136' ' ' VAL . 53.7 Cg_endo -69.71 132.5 23.55 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.706 2.27 . . . . 70.400000000000006 112.352 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -74.91 -11.22 83.8 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 72.200000000000003 112.486 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 26.5 t -50.56 -33.94 23.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.934 0.397 . . . . 71.140000000000001 110.888 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.622 HD12 ' HG2' ' A' ' 170' ' ' ARG . 28.0 mt -123.42 39.28 4.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.081 -0.508 . . . . 71.019999999999996 110.906 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 132' ' ' PRO . 99.4 t -122.77 -59.04 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 72.439999999999998 111.103 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -116.34 117.52 30.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 72.0 110.822 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 7.3 p -173.81 123.9 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 53.409999999999997 111.134 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 53.04 72.61 1.11 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.55 0.69 . . . . 72.019999999999996 110.889 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 132.84 24.09 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.644 2.229 . . . . 72.140000000000001 112.325 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 6.8 p -126.03 -37.93 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.456 . . . . 61.409999999999997 111.102 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -126.92 -176.98 3.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 73.120000000000005 110.872 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -52.09 132.48 33.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.196 -0.456 . . . . 65.310000000000002 110.818 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 9.0 t -123.16 42.6 3.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 34.450000000000003 111.125 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -85.88 -11.46 53.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 72.530000000000001 110.861 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.57 -8.38 54.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 72.349999999999994 110.862 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 64.9 mt -59.51 -31.17 69.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 63.329999999999998 110.892 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -123.53 134.9 53.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 74.439999999999998 110.903 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 92.81 0.95 68.32 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.719 -0.753 . . . . 65.230000000000004 112.482 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.4 127.92 34.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.721 0.295 . . . . 70.040000000000006 110.89 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.479 ' O ' HD22 ' A' ' 152' ' ' LEU . 34.1 mt-10 -109.59 87.0 2.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 74.299999999999997 110.9 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.479 HD22 ' O ' ' A' ' 151' ' ' GLU . 0.4 OUTLIER -139.11 166.34 24.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 72.430000000000007 110.923 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -81.92 173.75 11.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.214 -0.448 . . . . 74.319999999999993 110.9 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.725 ' CZ ' HG11 ' A' ' 122' ' ' VAL . 37.3 m-85 -133.47 -179.38 5.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 73.310000000000002 110.852 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 12.1 ttpt -130.84 108.59 9.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 74.340000000000003 110.907 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.457 HG11 ' CD1' ' A' ' 102' ' ' TYR . 21.9 t -70.42 126.53 30.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 74.319999999999993 111.167 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.9 tp -119.0 -30.47 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 71.040000000000006 111.182 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 20.7 ttmt -171.87 133.21 0.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 75.319999999999993 110.903 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.494 HD23 ' H ' ' A' ' 159' ' ' LEU . 0.9 OUTLIER -109.47 148.17 31.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 65.040000000000006 110.902 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.19 89.37 3.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 74.519999999999996 110.869 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -67.71 -23.16 65.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 71.329999999999998 110.865 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.81 -43.26 63.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 74.310000000000002 110.895 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -99.66 24.74 7.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 65.140000000000001 110.885 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 41.52 38.59 0.9 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 72.530000000000001 110.917 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -143.07 168.79 18.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 75.129999999999995 110.872 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.48 HG22 HG22 ' A' ' 127' ' ' ILE . 15.8 m -128.67 144.39 38.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 71.019999999999996 111.145 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 18.3 m -116.74 171.8 5.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 72.329999999999998 111.129 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.628 ' CG2' ' HB1' ' A' ' 129' ' ' ALA . 15.8 t -119.42 152.28 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 74.299999999999997 111.103 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 14.0 t -70.01 154.7 41.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 62.549999999999997 110.873 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.622 ' HG2' HD12 ' A' ' 135' ' ' LEU . 18.4 ttm180 -83.46 -54.56 4.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 71.209999999999994 110.906 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.417 ' O ' HG23 ' A' ' 174' ' ' ILE . 12.5 ptp180 -57.4 -27.01 61.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 64.340000000000003 110.878 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.2 -19.64 55.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 63.399999999999999 111.097 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.554 HG22 ' HG3' ' A' ' 177' ' ' GLU . 11.1 p -52.38 -28.96 12.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 63.229999999999997 111.115 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 171' ' ' ARG . 30.8 pt -51.26 -30.71 10.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 73.439999999999998 111.085 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -87.98 -46.81 9.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 72.129999999999995 110.89 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 4.2 p -56.51 -40.51 75.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 74.040000000000006 110.83 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.554 ' HG3' HG22 ' A' ' 173' ' ' VAL . 8.2 mt-10 -51.92 -49.16 63.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 62.409999999999997 110.911 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -176.94 86.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 61.140000000000001 110.875 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 4.7 p . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 74.5 110.872 -179.834 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.785 0.326 . . . . 73.430000000000007 110.906 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.2 -35.33 79.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 63.450000000000003 111.089 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.68 -27.49 64.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 73.340000000000003 110.963 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.9 tpp180 -60.41 -26.58 66.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 73.430000000000007 110.833 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -52.09 -30.09 24.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 73.450000000000003 110.854 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 -80.04 -34.5 38.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 71.430000000000007 110.872 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.75 -15.96 61.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 71.420000000000002 111.083 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -57.98 -22.68 50.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 74.319999999999993 110.929 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 43.1 mm -55.35 -25.41 17.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.287 -0.415 . . . . 70.150000000000006 111.131 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 71.0 p -85.69 -23.97 27.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.232 -0.44 . . . . 60.329999999999998 111.093 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.463 ' CD1' HD11 ' A' ' 127' ' ' ILE . 63.4 mt -67.54 -49.0 65.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 75.549999999999997 110.922 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -51.9 -43.49 63.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 35.399999999999999 110.876 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.87 -24.39 41.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 74.540000000000006 110.894 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.08 -26.47 56.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 73.430000000000007 111.114 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.454 ' HB2' HD21 ' A' ' 159' ' ' LEU . 16.1 t80 -56.04 -25.12 43.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 64.120000000000005 110.941 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -54.82 -26.84 37.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 65.010000000000005 110.891 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -92.75 -22.04 19.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.081 -0.509 . . . . 74.239999999999995 110.846 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 63.9 44.91 4.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 75.230000000000004 111.123 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -62.43 -179.81 0.27 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.22 -0.446 . . . . 75.25 110.832 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 32.7 p -106.61 178.82 4.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.1 -0.5 . . . . 72.549999999999997 111.089 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.9 m -152.35 -178.66 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 71.209999999999994 111.181 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 86.5 m -154.22 122.89 6.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 72.430000000000007 111.15 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.406 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -158.09 154.97 26.01 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.7 -0.762 . . . . 43.329999999999998 112.422 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 150' ' ' LYS . 10.8 p -105.16 137.62 33.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.743 0.306 . . . . 54.299999999999997 111.216 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.735 HG13 HG22 ' A' ' 122' ' ' VAL . 4.2 mp -57.98 112.02 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.218 -0.446 . . . . 73.400000000000006 111.134 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 20.4 m-20 -95.17 -30.3 14.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.098 -0.501 . . . . 70.019999999999996 110.892 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -134.14 144.4 16.34 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.708 -0.758 . . . . 74.519999999999996 112.502 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.93 136.84 54.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.861 0.362 . . . . 75.200000000000003 110.917 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.1 m -118.8 176.44 3.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 71.400000000000006 111.044 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.1 tptt -66.0 97.75 0.38 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 72.030000000000001 110.92 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 92.2 -35.02 4.16 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.717 -0.754 . . . . 73.329999999999998 112.46 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -98.18 173.62 27.84 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.747 . . . . 73.010000000000005 112.494 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.416 ' HE2' HG13 ' A' ' 136' ' ' VAL . 8.4 m-85 -146.2 118.91 8.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.911 0.386 . . . . 73.129999999999995 110.918 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.631 ' O ' HG23 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -86.26 149.5 25.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 71.299999999999997 111.14 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.735 HG22 HG13 ' A' ' 112' ' ' ILE . 21.3 t -140.75 142.35 30.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 62.520000000000003 111.103 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -99.61 99.52 10.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 63.43 110.873 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.606 HD21 ' HD2' ' A' ' 154' ' ' PHE . 16.2 mt -102.02 89.68 3.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 74.200000000000003 110.929 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 51.97 39.31 25.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 75.400000000000006 110.844 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 103.68 -27.15 20.92 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.768 -0.729 . . . . 71.510000000000005 112.464 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.463 HD11 ' CD1' ' A' ' 98' ' ' LEU . 24.4 mm -74.15 150.23 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.787 0.327 . . . . 73.319999999999993 111.154 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.7 ttt180 -110.7 111.87 23.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 73.510000000000005 110.863 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.711 ' HB1' ' CG2' ' A' ' 168' ' ' VAL . . . -92.91 171.54 8.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 63.520000000000003 111.147 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -145.58 107.85 4.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 74.439999999999998 110.873 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.653 HD11 ' CE1' ' A' ' 154' ' ' PHE . 6.6 mp -92.35 129.46 40.96 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.512 0.672 . . . . 72.140000000000001 110.959 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 155.18 66.58 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.64 2.226 . . . . 70.400000000000006 112.35 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.64 ' O ' HG23 ' A' ' 136' ' ' VAL . . . -67.19 -11.66 59.3 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.707 -0.759 . . . . 72.200000000000003 112.473 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.3 p -79.47 -20.86 46.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.922 0.391 . . . . 71.140000000000001 110.871 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.724 HD22 ' HA ' ' A' ' 170' ' ' ARG . 4.8 tp -120.34 39.23 3.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.123 -0.49 . . . . 71.019999999999996 110.908 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 133' ' ' GLY . 85.1 t -62.37 -62.46 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 72.439999999999998 111.106 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -173.76 146.05 1.22 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.095 -0.502 . . . . 72.0 110.873 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.8 m -85.74 151.79 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 53.409999999999997 111.093 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.17 73.47 0.93 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.599 0.714 . . . . 72.019999999999996 110.905 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 139.16 39.72 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.714 2.276 . . . . 72.140000000000001 112.358 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.514 HG12 ' HE1' ' A' ' 146' ' ' HIS . 10.6 p -120.49 151.98 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.301 -0.409 . . . . 61.409999999999997 111.086 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -51.99 -30.15 23.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 73.120000000000005 110.859 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.477 ' O ' HG13 ' A' ' 141' ' ' VAL . 2.7 m-20 -82.91 129.21 34.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 65.310000000000002 110.834 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 79.6 p -108.57 37.4 2.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 34.450000000000003 111.118 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.3 tp -87.16 -22.15 25.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 72.530000000000001 110.903 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' HIS . . . . . 0.514 ' HE1' HG12 ' A' ' 141' ' ' VAL . 29.0 p-80 -96.13 18.44 13.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 72.349999999999994 110.823 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 48.4 mt -110.7 39.35 2.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 63.329999999999998 110.878 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -167.48 123.87 1.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 74.439999999999998 110.907 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.19 15.54 71.74 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.673 -0.775 . . . . 65.230000000000004 112.479 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.607 ' O ' HD12 ' A' ' 112' ' ' ILE . 2.0 tmmm? -71.2 138.23 49.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.769 0.319 . . . . 70.040000000000006 110.866 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -105.08 118.45 36.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 74.299999999999997 110.832 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.0 tp -139.05 146.92 41.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.108 -0.496 . . . . 72.430000000000007 110.899 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -90.94 129.71 36.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.439 . . . . 74.319999999999993 110.888 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.693 ' CE2' HG11 ' A' ' 122' ' ' VAL . 17.9 m-85 -114.91 -179.43 3.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 73.310000000000002 110.897 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.74 136.05 21.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 74.340000000000003 110.91 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.675 ' CG1' HD22 ' A' ' 159' ' ' LEU . 22.0 t -58.72 112.28 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 74.319999999999993 111.148 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.462 ' O ' HD13 ' A' ' 157' ' ' ILE . 0.0 OUTLIER -114.78 -26.14 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 71.040000000000006 111.183 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -169.17 115.79 0.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 75.319999999999993 110.892 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.675 HD22 ' CG1' ' A' ' 156' ' ' VAL . 2.2 pt? -150.17 132.95 15.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.225 -0.443 . . . . 65.040000000000006 110.919 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -117.82 109.73 16.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 74.519999999999996 110.804 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -64.71 -30.64 71.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 71.329999999999998 110.926 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 9.3 ttmt -70.29 -29.93 66.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 74.310000000000002 110.895 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 38.7 mtt180 -91.83 -15.37 28.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.427 . . . . 65.140000000000001 110.9 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 60.62 42.89 13.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 72.530000000000001 110.919 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -143.06 140.69 31.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 75.129999999999995 110.864 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.553 HG22 ' HB2' ' A' ' 159' ' ' LEU . 46.7 t -137.23 141.23 40.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 71.019999999999996 111.104 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.5 m -134.78 170.92 18.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 72.329999999999998 111.177 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.711 ' CG2' ' HB1' ' A' ' 129' ' ' ALA . 20.7 t -120.47 149.19 23.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 74.299999999999997 111.133 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.77 160.89 18.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 62.549999999999997 110.862 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.724 ' HA ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -94.36 -33.71 13.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 71.209999999999994 110.908 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -76.87 -25.04 52.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 64.340000000000003 110.879 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.8 -9.38 58.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 63.399999999999999 111.131 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 10.5 p -51.35 -30.15 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 63.229999999999997 111.129 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 31.5 pt -52.07 -29.55 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 73.439999999999998 111.081 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -54.73 -65.95 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 72.129999999999995 110.857 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.96 -43.93 63.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 74.040000000000006 110.895 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -55.72 -51.17 68.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.491 . . . . 62.409999999999997 110.863 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -123.15 71.8 1.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 61.140000000000001 110.852 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 63.3 p . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 74.5 110.867 -179.87 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.758 0.313 . . . . 73.430000000000007 110.898 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.62 -26.16 50.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 63.450000000000003 111.112 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.8 pttt -53.88 -27.95 33.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 73.340000000000003 110.846 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -59.69 -25.52 64.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 73.430000000000007 110.793 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -51.99 -37.5 53.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.195 -0.457 . . . . 73.450000000000003 110.874 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.41 ' O ' HG23 ' A' ' 96' ' ' ILE . 41.9 tt0 -78.56 -37.04 43.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.113 -0.494 . . . . 71.430000000000007 110.911 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.0 -18.14 63.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 71.420000000000002 111.147 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.419 ' CD1' HD11 ' A' ' 98' ' ' LEU . 33.3 m0 -56.6 -24.53 48.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.459 . . . . 74.319999999999993 110.916 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 93' ' ' GLU . 29.2 pt -55.02 -26.11 17.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 70.150000000000006 111.097 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 57.1 m -78.38 -27.22 46.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 60.329999999999998 111.142 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.452 ' CD1' HD11 ' A' ' 127' ' ' ILE . 17.9 mt -66.61 -24.85 66.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 75.549999999999997 110.95 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -51.85 -34.87 42.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 35.399999999999999 110.881 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 36.5 mttp -83.83 -26.36 29.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.128 -0.487 . . . . 74.540000000000006 110.873 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.565 ' HB1' ' CB ' ' A' ' 106' ' ' GLU . . . -53.33 -58.38 7.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 73.430000000000007 111.089 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -52.32 -29.64 24.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 64.120000000000005 110.961 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.05 -36.19 78.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 65.010000000000005 110.96 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -108.58 20.74 18.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.171 -0.468 . . . . 74.239999999999995 110.896 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 51.59 62.25 2.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 75.230000000000004 111.097 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.565 ' CB ' ' HB1' ' A' ' 101' ' ' ALA . 0.6 OUTLIER -71.33 155.24 40.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 75.25 110.926 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.6 t -104.11 172.65 6.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 72.549999999999997 111.147 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.746 HG21 HD13 ' A' ' 124' ' ' LEU . 16.9 m -146.28 177.37 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.27 -0.423 . . . . 71.209999999999994 111.067 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.8 t -162.2 127.25 3.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 72.430000000000007 111.083 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.665 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -165.77 153.95 24.27 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.774 -0.727 . . . . 43.329999999999998 112.506 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 150' ' ' LYS . 13.1 p -102.64 137.18 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.818 0.342 . . . . 54.299999999999997 111.149 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.733 HG13 HG22 ' A' ' 122' ' ' VAL . 4.4 mp -54.09 106.43 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.252 -0.431 . . . . 73.400000000000006 111.067 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -96.02 -39.84 9.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 70.019999999999996 110.885 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -120.99 141.93 15.21 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.783 -0.722 . . . . 74.519999999999996 112.485 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.9 pttp -124.54 147.43 48.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.781 0.325 . . . . 75.200000000000003 110.918 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.2 m -118.1 177.25 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 71.400000000000006 111.142 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.09 95.8 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 72.030000000000001 110.893 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 90.16 -36.71 3.49 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.732 -0.747 . . . . 73.329999999999998 112.461 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -98.27 173.52 27.63 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.761 -0.733 . . . . 73.010000000000005 112.481 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.582 ' HB3' HD23 ' A' ' 131' ' ' LEU . 8.3 m-85 -132.42 164.22 27.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.976 0.417 . . . . 73.129999999999995 110.866 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.47 ' O ' HG23 ' A' ' 112' ' ' ILE . 0.3 OUTLIER -135.45 150.82 49.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.108 -0.496 . . . . 71.299999999999997 111.161 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.733 HG22 HG13 ' A' ' 112' ' ' ILE . 5.3 t -136.48 156.57 36.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.255 -0.43 . . . . 62.520000000000003 111.118 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -114.21 108.47 17.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 63.43 110.927 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.746 HD13 HG21 ' A' ' 108' ' ' VAL . 18.9 mt -109.24 84.87 1.99 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 74.200000000000003 110.859 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 51.45 56.39 7.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 75.400000000000006 110.911 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.37 -35.14 4.33 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.769 -0.729 . . . . 71.510000000000005 112.49 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.694 ' CG2' HG11 ' A' ' 166' ' ' VAL . 26.0 mm -70.82 150.42 9.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.866 0.365 . . . . 73.319999999999993 111.103 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.557 ' O ' HG13 ' A' ' 166' ' ' VAL . 1.9 mpt_? -117.25 114.29 23.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.477 . . . . 73.510000000000005 110.881 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.45 ' HB3' ' HB ' ' A' ' 122' ' ' VAL . . . -92.64 161.3 14.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.484 . . . . 63.520000000000003 111.129 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -136.11 113.0 10.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 74.439999999999998 110.885 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.677 HD21 HG23 ' A' ' 122' ' ' VAL . 1.2 mm? -86.64 129.98 50.75 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.578 0.704 . . . . 72.140000000000001 110.955 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 127.88 15.19 Favored 'Trans proline' 0 N--CA 1.465 -0.167 0 C-N-CA 122.681 2.254 . . . . 70.400000000000006 112.357 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -51.56 -28.29 21.16 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.753 -0.737 . . . . 72.200000000000003 112.479 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 72.9 m -56.41 -25.09 48.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.958 0.408 . . . . 71.140000000000001 110.852 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.5 mt -88.98 -33.52 17.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.127 -0.488 . . . . 71.019999999999996 110.941 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.401 HG13 HD22 ' A' ' 147' ' ' LEU . 87.9 t -53.99 -27.43 16.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 72.439999999999998 111.108 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.45 112.67 20.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.166 -0.47 . . . . 72.0 110.885 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.401 ' O ' HG13 ' A' ' 138' ' ' VAL . 7.0 p -173.62 123.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 53.409999999999997 111.097 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 62.95 160.6 0.12 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.556 0.693 . . . . 72.019999999999996 110.889 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 149.91 67.75 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.722 2.282 . . . . 72.140000000000001 112.354 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.9 m -150.19 159.47 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 61.409999999999997 111.16 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -110.16 -73.92 0.67 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 73.120000000000005 110.9 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -63.97 145.2 56.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.454 . . . . 65.310000000000002 110.885 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.798 HG22 HD12 ' A' ' 147' ' ' LEU . 0.2 OUTLIER -108.39 23.61 14.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 34.450000000000003 111.144 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.5 mp -87.34 -22.79 24.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 72.530000000000001 110.909 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 43.9 p-80 -66.68 -25.26 66.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.433 . . . . 72.349999999999994 110.816 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.798 HD12 HG22 ' A' ' 144' ' ' THR . 59.9 mt -63.79 -59.06 5.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 63.329999999999998 110.968 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -119.43 142.18 48.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 74.439999999999998 110.894 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 91.38 -14.55 63.5 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.76 -0.733 . . . . 65.230000000000004 112.472 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.585 ' O ' HD12 ' A' ' 112' ' ' ILE . 1.6 tmmm? -53.87 128.98 32.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.768 0.318 . . . . 70.040000000000006 110.95 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.51 105.06 14.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 74.299999999999997 110.914 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.574 HD12 ' HD3' ' A' ' 150' ' ' LYS . 4.6 mt -139.04 179.84 6.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 72.430000000000007 110.953 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -115.91 152.94 32.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 74.319999999999993 110.894 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.479 ' CZ ' HG21 ' A' ' 122' ' ' VAL . 11.9 m-85 -126.5 178.4 5.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 73.310000000000002 110.853 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 18.1 tttt -131.37 160.39 35.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 74.340000000000003 110.884 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 106' ' ' GLU . 7.6 p -76.72 127.63 37.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 74.319999999999993 111.146 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.2 tp -127.87 -38.3 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.187 -0.46 . . . . 71.040000000000006 111.095 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -174.66 132.81 0.35 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.484 . . . . 75.319999999999993 110.884 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.604 ' HB3' HG23 ' A' ' 166' ' ' VAL . 3.7 pp -158.06 135.7 10.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 65.040000000000006 110.902 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -117.12 125.86 51.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.465 . . . . 74.519999999999996 110.85 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -80.47 -26.15 38.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 71.329999999999998 110.922 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -73.29 -41.31 63.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 74.310000000000002 110.973 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -82.97 -15.41 51.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 65.140000000000001 110.897 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.74 42.36 10.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 72.530000000000001 110.894 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -141.71 140.51 33.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 75.129999999999995 110.856 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.694 HG11 ' CG2' ' A' ' 127' ' ' ILE . 5.9 p -146.03 141.09 21.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 71.019999999999996 111.136 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 20.1 m -134.87 167.52 25.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.161 -0.472 . . . . 72.329999999999998 111.095 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 8.5 m -120.45 148.97 23.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 74.299999999999997 111.118 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.652 ' OG ' ' HB2' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -84.73 155.23 21.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.15 -0.477 . . . . 62.549999999999997 110.829 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.621 ' O ' HG12 ' A' ' 173' ' ' VAL . 30.2 mtt85 -64.08 -38.53 91.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 71.209999999999994 110.946 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -80.1 -23.11 41.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 64.340000000000003 110.888 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.652 ' HB2' ' OG ' ' A' ' 169' ' ' SER . . . -53.72 -41.7 67.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 63.399999999999999 111.113 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.621 HG12 ' O ' ' A' ' 170' ' ' ARG . 13.0 p -66.02 -21.79 29.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 63.229999999999997 111.101 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 16.3 mm -70.07 -53.98 21.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.451 . . . . 73.439999999999998 111.146 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -55.46 -47.8 75.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 72.129999999999995 110.861 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 68.5 m -56.42 -42.23 77.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 74.040000000000006 110.827 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -64.69 -51.65 61.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.076 -0.511 . . . . 62.409999999999997 110.854 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -92.06 54.18 2.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.504 . . . . 61.140000000000001 110.879 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 4.0 p . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 74.5 110.908 -179.873 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.9 mptt . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.829 0.347 . . . . 73.430000000000007 110.92 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.04 -37.83 33.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.21 -0.45 . . . . 63.450000000000003 111.086 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.4 ttmm -60.1 -20.04 56.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 73.340000000000003 110.854 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 17.2 tpp180 -60.03 -20.12 56.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 73.430000000000007 110.829 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 -51.45 -31.77 24.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 73.450000000000003 110.921 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -80.3 -42.45 23.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.187 -0.46 . . . . 71.430000000000007 110.812 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.57 -19.95 66.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 71.420000000000002 111.092 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.445 ' CD1' HD21 ' A' ' 98' ' ' LEU . 41.7 m0 -57.3 -23.8 50.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 74.319999999999993 110.863 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 49.6 mt -52.43 -28.73 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 70.150000000000006 111.178 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 58.3 p -76.0 -60.75 2.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 60.329999999999998 111.153 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.445 HD21 ' CD1' ' A' ' 95' ' ' TRP . 4.5 pp -60.16 -20.39 58.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 75.549999999999997 110.992 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.43 ' N ' HD12 ' A' ' 98' ' ' LEU . 5.7 mm-40 -51.65 -47.81 63.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.103 -0.499 . . . . 35.399999999999999 110.888 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.5 mtpp -54.04 -27.5 32.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 74.540000000000006 110.95 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 98' ' ' LEU . . . -72.7 -43.86 62.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 73.430000000000007 111.092 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.569 ' CD2' HD13 ' A' ' 159' ' ' LEU . 12.5 m-85 -65.38 -31.84 73.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 64.120000000000005 110.924 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -60.31 -26.04 66.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 65.010000000000005 110.895 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -95.85 20.82 9.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.189 -0.459 . . . . 74.239999999999995 110.852 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 51.86 55.46 9.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 75.230000000000004 111.12 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -76.15 163.37 27.16 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.238 -0.437 . . . . 75.25 110.886 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.8 t -91.93 153.76 19.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.476 . . . . 72.549999999999997 111.131 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.2 m -144.53 178.62 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 71.209999999999994 111.179 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.1 t -157.23 123.47 4.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 72.430000000000007 111.171 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -155.87 153.2 24.57 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.73 -0.747 . . . . 43.329999999999998 112.497 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 150' ' ' LYS . 10.2 p -101.02 140.21 20.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.839 0.352 . . . . 54.299999999999997 111.14 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.685 HG13 HG22 ' A' ' 122' ' ' VAL . 4.4 mp -60.12 120.93 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 73.400000000000006 111.145 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -102.27 -43.02 5.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 70.019999999999996 110.875 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -118.45 142.99 17.36 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.682 -0.77 . . . . 74.519999999999996 112.468 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.6 pttt -124.06 123.71 40.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.837 0.351 . . . . 75.200000000000003 110.945 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 26.6 m -110.09 177.33 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 71.400000000000006 111.122 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -62.16 94.14 0.05 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 72.030000000000001 110.953 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.88 -36.14 3.61 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.765 -0.731 . . . . 73.329999999999998 112.499 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -90.02 173.8 39.94 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.728 -0.749 . . . . 73.010000000000005 112.503 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -151.15 127.48 10.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.992 0.425 . . . . 73.129999999999995 110.872 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 57.8 p -98.19 142.46 29.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 71.299999999999997 111.159 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.685 HG22 HG13 ' A' ' 112' ' ' ILE . 21.3 t -133.74 147.15 30.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 62.520000000000003 111.117 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -97.25 134.87 39.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.1 -0.5 . . . . 63.43 110.896 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 78.4 mt -139.41 74.55 1.47 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.119 -0.491 . . . . 74.200000000000003 110.972 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 62.98 42.15 7.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.113 -0.494 . . . . 75.400000000000006 110.902 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 103.03 -31.05 9.19 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.695 -0.764 . . . . 71.510000000000005 112.542 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.573 ' CG2' HG21 ' A' ' 166' ' ' VAL . 60.9 mt -78.04 144.07 11.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.869 0.366 . . . . 73.319999999999993 111.101 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.6 mtp180 -109.22 114.02 27.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 73.510000000000005 110.908 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -92.5 171.54 8.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 63.520000000000003 111.109 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.494 ' HB3' HG23 ' A' ' 167' ' ' VAL . 2.3 t80 -136.44 129.96 31.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.43 . . . . 74.439999999999998 110.842 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.414 HD22 ' CE2' ' A' ' 154' ' ' PHE . 1.0 OUTLIER -109.51 130.54 22.66 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.627 0.727 . . . . 72.140000000000001 110.914 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 140.77 43.51 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.707 2.271 . . . . 70.400000000000006 112.334 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.668 ' O ' HG23 ' A' ' 136' ' ' VAL . . . -66.02 -11.88 56.07 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.771 -0.728 . . . . 72.200000000000003 112.554 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.9 t -76.52 -22.52 54.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.906 0.384 . . . . 71.140000000000001 110.873 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.57 39.52 3.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.504 . . . . 71.019999999999996 110.901 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 133' ' ' GLY . 85.4 t -53.67 -63.09 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 72.439999999999998 111.103 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.544 ' HB3' ' HE2' ' A' ' 146' ' ' HIS . 1.0 OUTLIER -179.65 171.21 1.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 72.0 110.901 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 138' ' ' VAL . 5.9 p -106.06 121.08 58.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 53.409999999999997 111.108 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -177.33 160.79 1.44 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.642 0.734 . . . . 72.019999999999996 110.864 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 166.6 26.93 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.675 2.25 . . . . 72.140000000000001 112.38 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 31.6 m -51.67 -29.63 10.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.233 -0.44 . . . . 61.409999999999997 111.106 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 54.1 mtm180 -51.86 133.04 32.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 73.120000000000005 110.949 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -51.96 169.08 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 65.310000000000002 110.849 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.4 t -169.82 142.41 2.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 34.450000000000003 111.17 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.4 tt -87.9 -8.92 55.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.268 -0.423 . . . . 72.530000000000001 110.883 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' HIS . . . . . 0.544 ' HE2' ' HB3' ' A' ' 137' ' ' ASP . 0.9 OUTLIER -62.25 -15.72 48.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.443 . . . . 72.349999999999994 110.844 179.909 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 47.9 mt -68.85 -24.05 64.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 63.329999999999998 110.958 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -118.77 123.97 46.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.169 -0.469 . . . . 74.439999999999998 110.845 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 89.54 26.12 26.1 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.711 -0.757 . . . . 65.230000000000004 112.448 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.615 ' HD3' HD13 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -82.78 128.17 34.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.828 0.347 . . . . 70.040000000000006 110.865 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.657 ' O ' HD12 ' A' ' 152' ' ' LEU . 16.4 pt-20 -105.15 108.54 20.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.203 -0.453 . . . . 74.299999999999997 110.932 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.657 HD12 ' O ' ' A' ' 151' ' ' GLU . 2.6 mp -139.11 -179.51 5.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 72.430000000000007 110.914 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -114.31 150.89 33.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 74.319999999999993 110.891 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.414 ' CE2' HD22 ' A' ' 131' ' ' LEU . 19.3 m-85 -125.42 168.06 14.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 73.310000000000002 110.884 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -119.76 123.29 43.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 74.340000000000003 110.862 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 91.9 t -67.61 117.02 8.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.244 -0.434 . . . . 74.319999999999993 111.173 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.4 tp -120.79 -33.35 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 71.040000000000006 111.124 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -171.15 119.96 0.5 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 75.319999999999993 110.872 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.619 HD23 ' H ' ' A' ' 159' ' ' LEU . 2.6 pt? -125.33 139.14 53.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 65.040000000000006 110.881 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -118.5 88.95 3.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 74.519999999999996 110.908 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -67.7 -20.03 65.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 71.329999999999998 110.934 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.23 -37.73 67.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 74.310000000000002 110.84 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -93.25 16.39 13.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.444 . . . . 65.140000000000001 110.861 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.2 m120 51.74 30.11 6.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 72.530000000000001 110.938 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -143.1 164.18 30.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 75.129999999999995 110.853 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.573 HG21 ' CG2' ' A' ' 127' ' ' ILE . 20.2 t -143.43 144.61 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 71.019999999999996 111.13 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.494 HG23 ' HB3' ' A' ' 130' ' ' PHE . 14.3 p -129.07 152.2 36.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 72.329999999999998 111.13 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 130' ' ' PHE . 25.2 m -119.42 145.68 25.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 74.299999999999997 111.124 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.36 159.81 33.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 62.549999999999997 110.799 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.4 ' O ' HG12 ' A' ' 173' ' ' VAL . 11.0 ptm180 -93.45 -37.72 11.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.07 -0.513 . . . . 71.209999999999994 110.881 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 -79.59 -26.75 41.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 64.340000000000003 110.895 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.43 -13.94 62.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.124 -0.489 . . . . 63.399999999999999 111.124 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 170' ' ' ARG . 11.0 p -52.98 -30.7 16.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 63.229999999999997 111.045 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 23.5 pt -61.96 -30.15 47.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 73.439999999999998 111.145 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -71.71 -46.52 58.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.473 . . . . 72.129999999999995 111.027 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 52.6 p -52.01 -47.24 65.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.124 -0.489 . . . . 74.040000000000006 110.81 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -54.9 -52.98 61.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 62.409999999999997 110.945 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -109.1 55.82 0.63 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 61.140000000000001 110.906 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 72.2 p . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 74.5 110.929 -179.906 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt . . . . . 0 C--O 1.23 0.038 0 CA-C-O 120.746 0.307 . . . . 73.430000000000007 110.877 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.56 -40.03 43.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.455 . . . . 63.450000000000003 111.073 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.8 pptp? -60.14 -20.01 56.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 73.340000000000003 110.909 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -59.19 -20.87 57.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.434 . . . . 73.430000000000007 110.898 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -51.38 -31.22 21.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 73.450000000000003 110.838 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.501 ' O ' HG23 ' A' ' 96' ' ' ILE . 16.9 tt0 -80.43 -46.13 16.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 71.430000000000007 110.861 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.703 ' O ' HG22 ' A' ' 97' ' ' THR . . . -62.3 -17.18 57.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 71.420000000000002 111.133 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 35.5 m0 -57.85 -22.28 47.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.117 -0.492 . . . . 74.319999999999993 110.92 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.501 HG23 ' O ' ' A' ' 93' ' ' GLU . 31.0 pt -53.03 -31.24 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 70.150000000000006 111.117 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.703 HG22 ' O ' ' A' ' 94' ' ' ALA . 12.8 t -72.32 -30.05 64.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 60.329999999999998 111.17 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.611 ' CD1' HD11 ' A' ' 127' ' ' ILE . 18.4 mt -67.38 -21.0 65.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 75.549999999999997 110.865 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -76.23 -36.12 58.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 35.399999999999999 110.87 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -84.03 -22.45 31.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.118 -0.492 . . . . 74.540000000000006 110.823 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.14 -27.73 59.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.416 . . . . 73.430000000000007 111.067 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.621 ' CG ' HD21 ' A' ' 159' ' ' LEU . 50.9 t80 -55.53 -25.74 39.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.258 -0.428 . . . . 64.120000000000005 110.946 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.74 -27.77 30.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.094 -0.503 . . . . 65.010000000000005 110.906 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -97.1 -19.2 18.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 74.239999999999995 110.846 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 64.03 50.8 2.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 75.230000000000004 111.081 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -64.31 167.14 7.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 75.25 110.867 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.2 t -102.42 165.27 11.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 72.549999999999997 111.244 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.7 m -148.73 177.73 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 71.209999999999994 111.13 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 109' ' ' THR . 4.3 t -149.32 118.09 6.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.447 . . . . 72.430000000000007 111.148 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -134.5 164.77 24.59 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.735 -0.745 . . . . 43.329999999999998 112.491 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.707 HG23 ' C ' ' A' ' 150' ' ' LYS . 13.3 p -105.51 135.79 42.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.777 0.322 . . . . 54.299999999999997 111.174 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.539 HD12 ' O ' ' A' ' 150' ' ' LYS . 4.2 mp -54.35 101.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 73.400000000000006 111.159 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -74.21 -44.26 53.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 70.019999999999996 110.886 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -134.81 155.06 21.78 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.763 -0.732 . . . . 74.519999999999996 112.469 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -124.32 128.82 49.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.848 0.356 . . . . 75.200000000000003 110.881 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.3 m -114.61 176.79 2.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.201 -0.454 . . . . 71.400000000000006 111.085 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -66.73 98.46 0.53 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 72.030000000000001 110.922 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 91.5 -35.57 3.91 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.753 -0.737 . . . . 73.329999999999998 112.535 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -98.25 173.63 27.76 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.756 -0.735 . . . . 73.010000000000005 112.552 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -146.96 118.75 8.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.925 0.393 . . . . 73.129999999999995 110.882 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.13 150.81 26.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 71.299999999999997 111.145 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.418 ' HB ' ' HB3' ' A' ' 129' ' ' ALA . 18.7 t -140.64 149.98 21.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 62.520000000000003 111.097 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -105.94 114.64 28.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.451 . . . . 63.43 110.898 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 77.8 mt -114.53 77.2 1.04 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 74.200000000000003 110.894 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 63.34 52.22 2.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 75.400000000000006 110.933 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 93.96 -34.71 4.51 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.762 -0.732 . . . . 71.510000000000005 112.523 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.611 HD11 ' CD1' ' A' ' 98' ' ' LEU . 27.5 mt -75.18 150.85 6.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.802 0.334 . . . . 73.319999999999993 111.149 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -110.76 132.11 54.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 73.510000000000005 110.822 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.418 ' HB3' ' HB ' ' A' ' 122' ' ' VAL . . . -110.12 171.56 7.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 63.520000000000003 111.088 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -138.54 122.38 17.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.24 -0.436 . . . . 74.439999999999998 110.888 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.507 HD21 ' HE2' ' A' ' 154' ' ' PHE . 10.3 mp -95.07 130.11 33.61 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.648 0.737 . . . . 72.140000000000001 110.931 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.413 ' O ' HG23 ' A' ' 136' ' ' VAL . 54.1 Cg_endo -69.76 132.46 23.38 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.727 2.284 . . . . 70.400000000000006 112.398 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -74.48 -11.14 82.71 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.675 -0.774 . . . . 72.200000000000003 112.445 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 41.8 m -50.4 -32.74 18.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.948 0.404 . . . . 71.140000000000001 110.887 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.783 HD12 ' HB2' ' A' ' 170' ' ' ARG . 28.6 mt -123.12 38.62 4.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.11 -0.496 . . . . 71.019999999999996 110.939 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 132' ' ' PRO . 89.6 t -122.75 -34.98 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 72.439999999999998 111.113 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -99.2 113.52 25.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 72.0 110.865 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 55.7 t -144.21 108.71 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 53.409999999999997 111.175 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.53 160.94 0.12 Allowed Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.655 0.74 . . . . 72.019999999999996 110.866 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 129.18 17.09 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.725 2.284 . . . . 72.140000000000001 112.353 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 7.7 m -149.04 149.61 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 61.409999999999997 111.136 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 36.3 ptt85 -123.37 36.91 4.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.468 . . . . 73.120000000000005 110.845 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -122.56 104.5 9.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.206 -0.452 . . . . 65.310000000000002 110.876 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 41.3 p -126.47 25.21 6.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.173 -0.467 . . . . 34.450000000000003 111.175 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -86.36 -22.28 26.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.258 -0.428 . . . . 72.530000000000001 110.931 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 50.5 p-80 -90.43 -20.92 22.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 72.349999999999994 110.846 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 89.7 mt -87.89 50.78 2.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.268 -0.424 . . . . 63.329999999999998 110.92 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -165.23 124.07 1.71 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 74.439999999999998 110.873 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 63.46 32.26 83.54 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.693 -0.765 . . . . 65.230000000000004 112.488 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.707 ' C ' HG23 ' A' ' 111' ' ' VAL . 0.3 OUTLIER -101.85 129.25 48.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.747 0.308 . . . . 70.040000000000006 110.913 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -86.07 105.01 16.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 74.299999999999997 110.859 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.474 HD22 ' HE3' ' A' ' 150' ' ' LYS . 10.2 tp -114.62 155.35 26.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 72.430000000000007 110.905 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -97.07 129.99 44.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 74.319999999999993 110.9 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.507 ' HE2' HD21 ' A' ' 131' ' ' LEU . 46.3 m-85 -123.05 -179.4 4.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 73.310000000000002 110.861 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.1 tmmm? -141.45 146.17 36.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.087 -0.506 . . . . 74.340000000000003 110.915 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 47.5 t -94.63 78.96 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.248 -0.433 . . . . 74.319999999999993 111.142 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.5 tt -91.5 -25.33 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 71.040000000000006 111.092 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -152.38 114.53 4.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 75.319999999999993 110.884 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.621 HD21 ' CG ' ' A' ' 102' ' ' TYR . 0.9 OUTLIER -118.44 149.27 41.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.431 . . . . 65.040000000000006 110.908 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -116.06 57.57 0.75 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.213 -0.449 . . . . 74.519999999999996 110.89 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -58.95 -25.14 63.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.467 . . . . 71.329999999999998 110.906 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 33.0 tttt -55.73 -25.85 42.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 74.310000000000002 110.832 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.12 24.83 12.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.309 -0.405 . . . . 65.140000000000001 110.859 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 9.1 m120 53.66 28.31 7.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.483 . . . . 72.530000000000001 110.902 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -143.08 172.99 11.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 75.129999999999995 110.825 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.8 m -147.88 144.23 19.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 71.019999999999996 111.167 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 19.2 m -128.53 170.46 18.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 72.329999999999998 111.148 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.444 HG21 HD12 ' A' ' 131' ' ' LEU . 5.5 m -120.34 155.02 23.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 74.299999999999997 111.169 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.5 m -88.42 156.04 19.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 62.549999999999997 110.902 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.783 ' HB2' HD12 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -82.41 -29.0 31.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.134 -0.484 . . . . 71.209999999999994 110.899 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -70.82 -24.05 62.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.488 . . . . 64.340000000000003 110.915 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.57 -14.47 61.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.1 -0.5 . . . . 63.399999999999999 111.171 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 170' ' ' ARG . 14.4 p -53.26 -28.04 14.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 63.229999999999997 111.081 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 35.4 pt -58.9 -21.49 19.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.24 -0.436 . . . . 73.439999999999998 111.112 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -75.9 -51.46 12.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 72.129999999999995 110.879 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 68.5 p -51.85 -62.01 1.9 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 74.040000000000006 110.836 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -50.15 -53.68 25.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 62.409999999999997 110.928 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 38.9 t30 54.96 29.68 12.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 61.140000000000001 110.909 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 43.2 p . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 74.5 110.85 -179.81 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt . . . . . 0 CA--C 1.526 0.051 0 CA-C-O 120.773 0.321 . . . . 73.430000000000007 110.884 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.36 -41.96 81.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 63.450000000000003 111.084 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 20.6 mmmt -56.47 -25.98 52.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.283 -0.417 . . . . 73.340000000000003 110.917 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.9 tpp180 -74.31 -24.26 59.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.281 -0.418 . . . . 73.430000000000007 110.863 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -51.8 -45.5 63.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 73.450000000000003 110.849 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -76.85 -31.69 57.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 71.430000000000007 110.934 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.44 -17.54 63.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.494 . . . . 71.420000000000002 111.117 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.655 ' CD1' HD21 ' A' ' 98' ' ' LEU . 31.9 m0 -57.19 -23.46 47.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 74.319999999999993 110.882 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 68.1 mt -54.07 -27.59 16.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 70.150000000000006 111.134 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 70.9 p -76.95 -59.11 2.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 60.329999999999998 111.154 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.655 HD21 ' CD1' ' A' ' 95' ' ' TRP . 3.4 pp -61.66 -18.09 58.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 75.549999999999997 110.842 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -54.15 -61.73 2.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 35.399999999999999 110.93 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? -66.84 -23.97 66.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.091 -0.504 . . . . 74.540000000000006 110.941 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.524 ' HB1' ' HG3' ' A' ' 106' ' ' GLU . . . -53.17 -45.56 68.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 73.430000000000007 111.145 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.652 ' CE1' HG21 ' A' ' 156' ' ' VAL . 38.1 m-85 -53.34 -33.21 52.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 64.120000000000005 110.901 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -57.24 -26.26 60.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 65.010000000000005 110.894 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.28 20.82 11.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 74.239999999999995 110.833 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 53.71 64.14 1.95 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 75.230000000000004 111.075 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.524 ' HG3' ' HB1' ' A' ' 101' ' ' ALA . 16.2 mm-40 -79.25 178.63 7.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 75.25 110.959 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.1 p -120.03 170.71 9.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 72.549999999999997 111.107 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.705 HG11 HD13 ' A' ' 124' ' ' LEU . 5.2 m -135.34 -179.3 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 71.209999999999994 111.121 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.6 t -155.69 121.41 4.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 72.430000000000007 111.191 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 176.5 168.09 36.08 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.758 -0.734 . . . . 43.329999999999998 112.502 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 151' ' ' GLU . 12.5 m -116.01 150.26 18.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.874 0.369 . . . . 54.299999999999997 111.132 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.793 HD12 ' HB3' ' A' ' 150' ' ' LYS . 5.4 mt -60.4 99.2 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 73.400000000000006 111.16 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 64.2 t-20 -87.8 -41.23 13.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 70.019999999999996 110.917 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -114.03 141.08 16.78 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.724 -0.75 . . . . 74.519999999999996 112.446 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -124.4 123.01 39.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.846 0.355 . . . . 75.200000000000003 110.928 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.6 m -108.22 176.67 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.246 -0.434 . . . . 71.400000000000006 111.149 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -66.83 99.18 0.6 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 72.030000000000001 110.953 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 90.85 -35.79 3.79 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.732 -0.747 . . . . 73.329999999999998 112.485 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -98.2 173.49 27.68 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.77 -0.729 . . . . 73.010000000000005 112.472 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.574 ' HZ ' HD22 ' A' ' 147' ' ' LEU . 6.6 m-85 -144.09 118.85 9.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.905 0.383 . . . . 73.129999999999995 110.927 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.24 149.68 25.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 71.299999999999997 111.17 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.7 t -143.65 137.42 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 62.520000000000003 111.137 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -90.07 104.94 17.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 63.43 110.944 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.705 HD13 HG11 ' A' ' 108' ' ' VAL . 12.5 mt -97.44 84.82 3.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.088 -0.506 . . . . 74.200000000000003 110.924 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 51.79 44.18 29.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 75.400000000000006 110.879 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 103.87 -33.72 6.35 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.715 -0.755 . . . . 71.510000000000005 112.493 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 21.6 mm -73.53 153.07 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.825 0.345 . . . . 73.319999999999993 111.165 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -105.27 119.39 38.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 73.510000000000005 110.882 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.636 ' HB2' HD11 ' A' ' 124' ' ' LEU . . . -101.29 171.66 7.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 63.520000000000003 111.075 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.513 ' O ' HG22 ' A' ' 168' ' ' VAL . 6.4 t80 -145.89 120.67 9.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 74.439999999999998 110.927 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.518 HD12 HG21 ' A' ' 168' ' ' VAL . 9.3 mp -92.92 130.1 37.55 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.619 0.723 . . . . 72.140000000000001 110.946 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.591 ' O ' HG23 ' A' ' 136' ' ' VAL . 55.1 Cg_endo -69.64 135.65 31.28 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.718 2.278 . . . . 70.400000000000006 112.386 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -67.74 -11.44 60.3 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.732 -0.747 . . . . 72.200000000000003 112.476 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 38.2 m -53.49 -35.03 60.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.904 0.383 . . . . 71.140000000000001 110.879 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.489 HD12 ' HB2' ' A' ' 170' ' ' ARG . 0.6 OUTLIER -123.41 39.05 4.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 71.019999999999996 110.937 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 132' ' ' PRO . 83.4 t -118.45 -24.16 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 72.439999999999998 111.129 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -98.53 112.03 24.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 72.0 110.846 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.2 m -154.01 132.07 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 53.409999999999997 111.139 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 19.5 mtm-85 62.62 161.59 0.12 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.612 0.72 . . . . 72.019999999999996 110.867 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.8 164.17 35.56 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.722 2.281 . . . . 72.140000000000001 112.336 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 7.4 p -51.27 139.43 6.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.199 -0.455 . . . . 61.409999999999997 111.105 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -178.4 105.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 73.120000000000005 110.905 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 59.0 97.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 65.310000000000002 110.839 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.17 4.68 33.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.102 -0.499 . . . . 34.450000000000003 111.114 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -87.22 -9.86 54.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.255 -0.429 . . . . 72.530000000000001 110.933 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' HIS . . . . . 0.469 ' CE1' HD23 ' A' ' 147' ' ' LEU . 0.7 OUTLIER -75.4 -5.91 47.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 72.349999999999994 110.909 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.574 HD22 ' HZ ' ' A' ' 120' ' ' PHE . 2.7 pp -118.3 31.11 6.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 63.329999999999998 110.906 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.421 ' OE1' HD12 ' A' ' 147' ' ' LEU . 5.7 mm-40 -128.68 126.61 40.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 74.439999999999998 110.91 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 63.44 31.71 81.69 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.701 -0.762 . . . . 65.230000000000004 112.531 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.793 ' HB3' HD12 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -72.36 131.74 43.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.81 0.338 . . . . 70.040000000000006 110.85 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.568 ' HA ' HG12 ' A' ' 111' ' ' VAL . 0.2 OUTLIER -99.84 96.6 7.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.175 -0.466 . . . . 74.299999999999997 110.905 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.747 HD22 ' CB ' ' A' ' 176' ' ' SER . 6.9 mt -138.64 141.24 39.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 72.430000000000007 110.934 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -89.92 129.44 36.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 74.319999999999993 110.903 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.451 ' HE2' HD21 ' A' ' 131' ' ' LEU . 34.8 m-85 -110.73 -179.16 3.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 73.310000000000002 110.901 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.667 ' CE ' ' HB3' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -143.99 151.0 39.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 74.340000000000003 110.915 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.652 HG21 ' CE1' ' A' ' 102' ' ' TYR . 61.2 t -91.45 112.48 25.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 74.319999999999993 111.091 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 15.7 tt -87.57 -33.76 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 71.040000000000006 111.114 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -177.89 126.38 0.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 75.319999999999993 110.873 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.481 ' HB3' HG12 ' A' ' 166' ' ' VAL . 0.2 OUTLIER -102.05 119.63 39.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 65.040000000000006 110.949 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -73.5 126.48 30.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 74.519999999999996 110.884 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -78.03 -29.05 49.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 71.329999999999998 110.867 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 12.4 tptm -53.12 -32.17 46.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.248 -0.433 . . . . 74.310000000000002 110.93 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -113.52 -15.27 12.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.1 -0.5 . . . . 65.140000000000001 110.85 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.07 47.94 5.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 72.530000000000001 110.922 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -142.27 154.42 44.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.48 . . . . 75.129999999999995 110.849 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.481 HG12 ' HB3' ' A' ' 159' ' ' LEU . 16.9 m -102.92 144.33 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 71.019999999999996 111.1 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 29.5 m -132.34 171.25 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 72.329999999999998 111.157 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.518 HG21 HD12 ' A' ' 131' ' ' LEU . 26.5 m -119.97 155.25 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 74.299999999999997 111.143 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.77 150.23 30.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 62.549999999999997 110.872 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.558 ' O ' HG12 ' A' ' 173' ' ' VAL . 10.8 ptt180 -82.24 0.11 42.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 71.209999999999994 110.863 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.44 -58.81 2.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 64.340000000000003 110.867 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.667 ' HB3' ' CE ' ' A' ' 155' ' ' LYS . . . -83.37 -7.22 59.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 63.399999999999999 111.071 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.558 HG12 ' O ' ' A' ' 170' ' ' ARG . 7.9 p -50.92 -28.21 6.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 63.229999999999997 111.133 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 28.5 pt -50.32 -30.8 7.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 73.439999999999998 111.118 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -54.7 -45.74 74.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 72.129999999999995 110.925 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' SER . . . . . 0.747 ' CB ' HD22 ' A' ' 152' ' ' LEU . 6.2 p -51.22 -44.13 61.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 74.040000000000006 110.913 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -64.42 -51.07 65.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.064 -0.516 . . . . 62.409999999999997 110.901 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -84.81 54.61 3.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 61.140000000000001 110.843 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 74.5 110.806 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.7 ttpp . . . . . 0 C--O 1.23 0.039 0 CA-C-O 120.84 0.353 . . . . 73.430000000000007 110.897 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.27 -28.55 42.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 63.450000000000003 111.137 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -60.03 -20.46 58.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 73.340000000000003 110.851 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -61.9 -19.82 63.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 73.430000000000007 110.875 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 -51.76 -30.9 24.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.271 -0.422 . . . . 73.450000000000003 110.907 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -81.31 -45.6 15.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.225 -0.443 . . . . 71.430000000000007 110.854 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.8 -15.89 59.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 71.420000000000002 111.108 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.716 ' CD1' HD21 ' A' ' 98' ' ' LEU . 31.5 m0 -57.72 -22.86 48.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 74.319999999999993 110.866 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 52.1 mt -54.66 -26.33 16.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.304 -0.407 . . . . 70.150000000000006 111.135 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 70.3 p -80.26 -59.2 2.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 60.329999999999998 111.089 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.716 HD21 ' CD1' ' A' ' 95' ' ' TRP . 4.2 pp -61.49 -18.48 59.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.235 -0.439 . . . . 75.549999999999997 110.905 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -73.51 -25.7 60.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 35.399999999999999 110.842 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -79.44 -22.9 43.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 74.540000000000006 110.849 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.684 ' HB1' ' OE2' ' A' ' 106' ' ' GLU . . . -65.53 -38.95 91.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 73.430000000000007 111.076 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.451 ' CD1' HG11 ' A' ' 156' ' ' VAL . 37.9 m-85 -69.1 -23.85 64.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.304 -0.407 . . . . 64.120000000000005 110.942 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.27 -25.23 58.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 65.010000000000005 110.906 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -94.82 20.93 8.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 74.239999999999995 110.904 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 60.95 65.34 1.02 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 75.230000000000004 111.158 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.684 ' OE2' ' HB1' ' A' ' 101' ' ' ALA . 27.4 mt-10 -90.19 169.22 11.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 75.25 110.827 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.3 m -120.48 139.24 53.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 72.549999999999997 111.104 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.506 HG22 HG23 ' A' ' 156' ' ' VAL . 30.1 m -125.74 -177.22 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 71.209999999999994 111.072 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.6 t -161.06 123.46 3.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.116 -0.493 . . . . 72.430000000000007 111.184 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.497 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -149.24 148.48 19.89 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.731 -0.747 . . . . 43.329999999999998 112.448 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 150' ' ' LYS . 10.5 p -90.96 135.61 26.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.804 0.335 . . . . 54.299999999999997 111.115 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.736 HG13 HG22 ' A' ' 122' ' ' VAL . 4.8 mp -63.37 107.14 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.492 . . . . 73.400000000000006 111.101 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -91.51 -34.52 14.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.48 . . . . 70.019999999999996 110.915 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -128.21 143.78 14.69 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.773 -0.727 . . . . 74.519999999999996 112.497 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.5 pttp -123.94 134.77 53.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.822 0.344 . . . . 75.200000000000003 110.907 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.3 m -117.36 176.59 2.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 71.400000000000006 111.095 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -66.37 98.05 0.45 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 72.030000000000001 110.959 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 91.93 -35.26 4.05 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.753 -0.737 . . . . 73.329999999999998 112.485 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -98.17 173.51 27.75 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.761 -0.733 . . . . 73.010000000000005 112.611 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.578 ' HZ ' HD22 ' A' ' 147' ' ' LEU . 7.1 m-85 -145.37 118.93 9.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.919 0.39 . . . . 73.129999999999995 110.965 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.434 ' O ' HG23 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -85.79 147.01 26.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 71.299999999999997 111.109 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.765 ' HB ' ' HB3' ' A' ' 129' ' ' ALA . 32.8 t -138.52 147.68 25.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 62.520000000000003 111.134 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -102.55 105.7 16.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 63.43 110.828 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.499 HD13 HG21 ' A' ' 108' ' ' VAL . 81.8 mt -105.91 74.43 1.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 74.200000000000003 110.962 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 57.72 51.06 9.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 75.400000000000006 111.003 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 99.79 -33.5 6.2 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.757 -0.735 . . . . 71.510000000000005 112.5 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.55 ' CG2' HG21 ' A' ' 166' ' ' VAL . 25.0 mm -76.58 150.25 6.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.793 0.33 . . . . 73.319999999999993 111.157 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 57.9 mtm180 -109.66 117.12 33.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 73.510000000000005 110.859 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.765 ' HB3' ' HB ' ' A' ' 122' ' ' VAL . . . -94.55 171.56 8.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 63.520000000000003 111.171 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.405 ' HB3' HG12 ' A' ' 167' ' ' VAL . 3.0 t80 -146.74 122.03 10.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.28 -0.418 . . . . 74.439999999999998 110.853 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 9.4 mp -110.54 129.43 23.96 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.643 0.735 . . . . 72.140000000000001 110.923 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 152.11 69.01 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.695 2.263 . . . . 70.400000000000006 112.325 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.46 -18.57 61.27 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.724 -0.75 . . . . 72.200000000000003 112.523 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 44.2 t -73.65 -26.21 60.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.849 0.357 . . . . 71.140000000000001 110.8 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.771 HD12 ' HA ' ' A' ' 170' ' ' ARG . 10.1 tt -79.97 -26.92 39.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 71.019999999999996 110.875 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.537 HG21 ' CD2' ' A' ' 120' ' ' PHE . 81.8 t -78.94 -62.76 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 72.439999999999998 111.119 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -166.37 161.92 16.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 72.0 110.908 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 27.0 m -82.04 147.87 5.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 53.409999999999997 111.138 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.01 160.53 0.12 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.605 0.717 . . . . 72.019999999999996 110.884 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.69 145.54 57.89 Favored 'Trans proline' 0 C--O 1.23 0.123 0 C-N-CA 122.745 2.297 . . . . 72.140000000000001 112.289 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.6 p -116.29 149.96 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 61.409999999999997 111.141 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -66.21 -75.22 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 73.120000000000005 110.859 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -179.93 138.57 0.12 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 65.310000000000002 110.896 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.82 157.5 33.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 34.450000000000003 111.122 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.8 mp -87.57 -9.64 53.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 72.530000000000001 110.88 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -60.33 -18.79 52.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.161 -0.472 . . . . 72.349999999999994 110.81 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.578 HD22 ' HZ ' ' A' ' 120' ' ' PHE . 1.4 pp -109.35 36.41 2.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 63.329999999999998 110.931 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -129.66 124.68 34.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 74.439999999999998 110.832 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 66.64 23.51 72.25 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.727 -0.749 . . . . 65.230000000000004 112.489 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.666 ' HD3' HD12 ' A' ' 152' ' ' LEU . 1.6 ttmm -63.33 130.26 43.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.726 0.298 . . . . 70.040000000000006 110.878 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -104.16 89.71 3.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 74.299999999999997 110.843 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.666 HD12 ' HD3' ' A' ' 150' ' ' LYS . 5.8 mt -138.34 135.98 35.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.139 -0.482 . . . . 72.430000000000007 110.921 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -85.91 158.03 20.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 74.319999999999993 110.852 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.427 ' CE2' HG21 ' A' ' 122' ' ' VAL . 4.2 m-85 -126.06 -179.23 4.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 73.310000000000002 110.852 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.435 ' CB ' ' HB1' ' A' ' 172' ' ' ALA . 6.5 tttp -125.26 108.24 11.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.12 -0.491 . . . . 74.340000000000003 110.899 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.506 HG23 HG22 ' A' ' 108' ' ' VAL . 21.5 t -69.33 128.92 33.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.43 . . . . 74.319999999999993 111.127 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 7.8 tp -118.3 -29.35 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 71.040000000000006 111.164 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.614 ' C ' HD13 ' A' ' 159' ' ' LEU . 0.0 OUTLIER -170.99 166.42 7.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 75.319999999999993 110.918 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.614 HD13 ' C ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -155.84 165.48 36.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 65.040000000000006 110.917 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -119.18 96.58 5.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 74.519999999999996 110.878 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -77.12 -23.3 51.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.159 -0.473 . . . . 71.329999999999998 110.857 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 22.5 tptt -51.79 -45.75 63.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 74.310000000000002 110.967 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -104.6 16.88 25.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 65.140000000000001 110.893 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 51.51 48.57 22.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 72.530000000000001 110.939 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -121.88 153.81 37.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 75.129999999999995 110.947 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.55 HG21 ' CG2' ' A' ' 127' ' ' ILE . 97.3 t -142.98 128.51 16.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 71.019999999999996 111.151 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.405 HG12 ' HB3' ' A' ' 130' ' ' PHE . 34.1 m -134.81 171.18 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 72.329999999999998 111.184 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 6.3 m -120.27 145.75 26.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 74.299999999999997 111.084 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.85 157.47 37.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 62.549999999999997 110.871 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.771 ' HA ' HD12 ' A' ' 135' ' ' LEU . 0.3 OUTLIER -81.87 -42.13 20.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.121 -0.491 . . . . 71.209999999999994 110.82 -179.912 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 83.7 mtm-85 -59.7 -20.6 57.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.266 -0.424 . . . . 64.340000000000003 110.847 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.435 ' HB1' ' CB ' ' A' ' 155' ' ' LYS . . . -61.7 -17.45 55.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 63.399999999999999 111.084 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 10.2 p -50.71 -30.5 8.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 63.229999999999997 111.173 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 27.2 pt -51.48 -32.44 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.488 . . . . 73.439999999999998 111.12 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -88.03 -26.4 22.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.463 . . . . 72.129999999999995 110.853 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' SER . . . . . 0.467 ' OG ' HD22 ' A' ' 152' ' ' LEU . 5.1 t -91.29 12.79 19.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 74.040000000000006 110.877 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -50.01 -53.43 26.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 62.409999999999997 110.91 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -128.14 -58.48 1.21 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 61.140000000000001 110.886 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 10.9 t . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 74.5 110.873 -179.848 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.5 tptm . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.798 0.332 . . . . 73.430000000000007 110.916 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.75 -30.16 59.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 63.450000000000003 111.079 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -64.67 -27.95 69.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 73.340000000000003 110.939 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -57.07 -27.16 61.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 73.430000000000007 110.866 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -52.04 -37.7 54.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 73.450000000000003 110.904 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -81.77 -29.91 32.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.447 . . . . 71.430000000000007 110.922 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.96 -24.47 61.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 71.420000000000002 111.159 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.561 ' HA ' HD23 ' A' ' 98' ' ' LEU . 53.9 m0 -58.77 -22.57 58.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.197 -0.456 . . . . 74.319999999999993 110.962 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 70.0 mt -51.53 -29.96 10.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.218 -0.446 . . . . 70.150000000000006 111.134 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 73.3 p -64.27 -52.13 60.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 60.329999999999998 111.104 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.629 HD21 HD11 ' A' ' 127' ' ' ILE . 0.6 OUTLIER -70.88 -21.73 62.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.435 . . . . 75.549999999999997 110.962 179.961 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -59.9 -52.29 66.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.164 -0.471 . . . . 35.399999999999999 110.867 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -57.65 -27.45 62.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.471 . . . . 74.540000000000006 110.953 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 98' ' ' LEU . . . -51.98 -48.4 64.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.166 -0.47 . . . . 73.430000000000007 111.111 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.426 ' OH ' HG11 ' A' ' 108' ' ' VAL . 92.8 m-85 -55.74 -33.26 64.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 64.120000000000005 110.924 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.57 -26.41 66.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 65.010000000000005 110.899 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -104.46 20.97 17.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 74.239999999999995 110.838 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 57.91 67.41 0.96 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 75.230000000000004 111.043 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -104.06 176.15 5.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 75.25 110.937 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.3 t -121.14 164.95 16.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.166 -0.47 . . . . 72.549999999999997 111.062 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.426 HG11 ' OH ' ' A' ' 102' ' ' TYR . 34.9 m -135.4 -178.09 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 71.209999999999994 111.096 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.438 ' O ' HD23 ' A' ' 124' ' ' LEU . 4.9 t -154.13 122.85 6.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.081 -0.508 . . . . 72.430000000000007 111.156 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -156.87 150.97 22.35 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.742 -0.742 . . . . 43.329999999999998 112.503 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.467 ' C ' HG13 ' A' ' 122' ' ' VAL . 7.3 p -109.45 141.2 25.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.829 0.347 . . . . 54.299999999999997 111.12 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.768 HG13 HG22 ' A' ' 122' ' ' VAL . 4.3 mp -67.36 101.88 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.132 -0.485 . . . . 73.400000000000006 111.066 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -91.26 -27.16 18.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 70.019999999999996 110.912 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -134.18 143.05 14.62 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.736 -0.745 . . . . 74.519999999999996 112.48 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.98 136.66 54.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.788 0.327 . . . . 75.200000000000003 110.937 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.3 m -118.39 176.44 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 71.400000000000006 111.183 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.94 97.73 0.37 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 72.030000000000001 110.928 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 92.24 -35.02 4.16 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.752 -0.737 . . . . 73.329999999999998 112.465 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -98.17 173.55 27.79 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.737 -0.744 . . . . 73.010000000000005 112.48 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.742 ' CE2' HG11 ' A' ' 136' ' ' VAL . 9.0 m-85 -146.03 119.09 8.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.86 0.362 . . . . 73.129999999999995 110.877 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.486 ' O ' HG23 ' A' ' 112' ' ' ILE . 1.4 m -86.5 150.6 24.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 71.299999999999997 111.155 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.768 HG22 HG13 ' A' ' 112' ' ' ILE . 21.6 t -138.89 131.93 38.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.287 -0.415 . . . . 62.520000000000003 111.165 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -84.01 99.27 10.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 63.43 110.897 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.719 HD12 ' HB2' ' A' ' 129' ' ' ALA . 25.4 mt -99.89 77.65 2.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 74.200000000000003 110.907 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 52.14 52.92 13.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 75.400000000000006 110.878 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 93.36 -22.31 35.78 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.764 -0.731 . . . . 71.510000000000005 112.532 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.629 HD11 HD21 ' A' ' 98' ' ' LEU . 57.1 mt -83.02 144.43 10.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.8 0.333 . . . . 73.319999999999993 111.141 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -100.52 109.25 21.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 73.510000000000005 110.848 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.765 ' HB3' ' HB ' ' A' ' 122' ' ' VAL . . . -92.99 171.59 8.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 63.520000000000003 111.019 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -146.76 129.73 16.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 74.439999999999998 110.856 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.591 ' CD2' HG23 ' A' ' 168' ' ' VAL . 5.5 mt -120.17 129.52 25.3 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.587 0.708 . . . . 72.140000000000001 110.943 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.615 ' O ' HG23 ' A' ' 136' ' ' VAL . 53.7 Cg_endo -69.88 136.78 33.55 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.677 2.252 . . . . 70.400000000000006 112.29 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -71.54 -16.74 75.95 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.759 -0.734 . . . . 72.200000000000003 112.424 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 2.9 t -55.4 -26.37 41.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.88 0.371 . . . . 71.140000000000001 110.858 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.503 HD13 ' HB2' ' A' ' 171' ' ' ARG . 28.7 mt -120.61 24.64 10.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.47 . . . . 71.019999999999996 110.932 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.742 HG11 ' CE2' ' A' ' 120' ' ' PHE . 88.6 t -113.46 -49.41 5.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 72.439999999999998 111.174 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -99.08 112.64 24.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 72.0 110.85 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 138' ' ' VAL . 5.8 m -152.89 107.07 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 53.409999999999997 111.14 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 18.7 mmt-85 51.94 69.13 2.63 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.557 0.694 . . . . 72.019999999999996 110.89 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 143.81 52.11 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.618 2.212 . . . . 72.140000000000001 112.362 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 4.1 m -139.77 85.89 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 61.409999999999997 111.196 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.1 ptt-85 39.42 41.74 0.74 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.472 . . . . 73.120000000000005 110.824 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -137.93 97.39 3.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 65.310000000000002 110.925 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.721 ' CG2' HD12 ' A' ' 147' ' ' LEU . 0.2 OUTLIER -118.77 -13.67 9.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 34.450000000000003 111.125 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 13.7 mt -62.88 -21.65 66.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 72.530000000000001 110.943 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -93.36 18.21 10.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 72.349999999999994 110.891 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.721 HD12 ' CG2' ' A' ' 144' ' ' THR . 61.5 mt -110.51 -33.11 6.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 63.329999999999998 110.949 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -128.32 129.5 46.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 74.439999999999998 110.879 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 90.42 -14.84 61.51 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.771 -0.728 . . . . 65.230000000000004 112.45 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.548 ' O ' HD12 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -59.89 129.97 44.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.804 0.335 . . . . 70.040000000000006 110.867 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -111.02 114.28 27.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 74.299999999999997 110.942 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.712 ' C ' HD22 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -140.66 165.17 28.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 72.430000000000007 110.922 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.57 ' N ' HD22 ' A' ' 152' ' ' LEU . 1.3 tt0 -98.38 131.03 45.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.175 -0.466 . . . . 74.319999999999993 110.93 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.476 ' CZ ' HD11 ' A' ' 152' ' ' LEU . 16.2 m-85 -97.22 -179.41 4.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 73.310000000000002 110.879 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.45 ' H ' ' HB1' ' A' ' 172' ' ' ALA . 13.6 tttm -137.09 145.98 44.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 74.340000000000003 110.918 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 156' ' ' VAL . 5.5 p -56.62 120.18 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.434 . . . . 74.319999999999993 111.145 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.8 tp -130.21 -38.86 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.109 -0.496 . . . . 71.040000000000006 111.146 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -169.28 139.38 2.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 75.319999999999993 110.927 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -153.21 125.76 8.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 65.040000000000006 110.915 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -91.29 63.37 4.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 74.519999999999996 110.873 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -55.39 -26.44 41.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 71.329999999999998 110.923 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 18.5 ttpp -57.3 -43.16 82.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 74.310000000000002 110.915 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -102.94 24.85 10.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.448 . . . . 65.140000000000001 110.937 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 52.71 33.44 13.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.098 -0.501 . . . . 72.530000000000001 110.926 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -108.78 154.67 21.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 75.129999999999995 110.908 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 7.1 p -152.4 123.73 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 71.019999999999996 111.119 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 19.5 m -134.63 148.18 29.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 72.329999999999998 111.192 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.591 HG23 ' CD2' ' A' ' 131' ' ' LEU . 6.1 m -120.44 171.81 8.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 74.299999999999997 111.158 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.9 m -123.88 142.19 51.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 62.549999999999997 110.895 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.591 ' O ' HG23 ' A' ' 173' ' ' VAL . 0.2 OUTLIER -65.92 -34.35 77.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 71.209999999999994 110.899 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.503 ' HB2' HD13 ' A' ' 135' ' ' LEU . 29.5 ttm180 -61.93 -20.79 64.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 64.340000000000003 110.883 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.45 ' HB1' ' H ' ' A' ' 155' ' ' LYS . . . -55.89 -24.83 39.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 63.399999999999999 111.069 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 170' ' ' ARG . 95.6 t -51.88 -37.62 21.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 63.229999999999997 111.102 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 2.0 pp -54.05 -27.31 16.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.186 -0.461 . . . . 73.439999999999998 111.125 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -77.24 -63.63 1.32 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.466 . . . . 72.129999999999995 110.846 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 66.3 p -52.27 -49.24 64.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 74.040000000000006 110.857 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -53.72 -58.58 6.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.489 . . . . 62.409999999999997 110.871 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -59.59 -74.31 0.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 61.140000000000001 110.96 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 6.4 p . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.131 -0.486 . . . . 74.5 110.859 -179.912 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.5 mmtt . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.723 0.296 . . . . 73.430000000000007 110.829 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.95 -55.4 14.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 63.450000000000003 111.11 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.68 -27.28 69.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.27 -0.423 . . . . 73.340000000000003 110.88 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -66.58 -26.84 67.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.426 . . . . 73.430000000000007 110.9 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -51.95 -43.22 63.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 73.450000000000003 110.871 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -79.29 -24.94 42.54 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.198 -0.456 . . . . 71.430000000000007 110.914 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -77.75 -19.72 54.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 71.420000000000002 111.055 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.573 ' CD1' HD21 ' A' ' 98' ' ' LEU . 41.4 m0 -58.1 -22.68 51.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 74.319999999999993 110.897 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 35.7 pt -51.78 -29.35 10.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.285 -0.416 . . . . 70.150000000000006 111.14 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.1 p -75.27 -61.48 1.89 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.146 -0.479 . . . . 60.329999999999998 111.18 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.573 HD21 ' CD1' ' A' ' 95' ' ' TRP . 3.4 pp -59.05 -21.76 59.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.25 -0.432 . . . . 75.549999999999997 110.874 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -51.92 -47.22 64.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 35.399999999999999 110.85 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -62.65 -28.94 70.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.121 -0.49 . . . . 74.540000000000006 110.893 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 98' ' ' LEU . . . -58.05 -44.09 87.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 73.430000000000007 111.099 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.798 ' HB3' HD11 ' A' ' 159' ' ' LEU . 42.6 m-85 -56.41 -34.08 66.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.158 -0.474 . . . . 64.120000000000005 110.968 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.32 -26.06 60.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.1 -0.5 . . . . 65.010000000000005 110.881 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -94.79 20.7 8.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.143 -0.48 . . . . 74.239999999999995 110.828 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 59.35 36.59 23.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.439 . . . . 75.230000000000004 111.123 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -61.89 152.97 30.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 75.25 110.877 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.636 HG22 ' HG2' ' A' ' 155' ' ' LYS . 35.5 p -93.69 148.52 22.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.066 -0.516 . . . . 72.549999999999997 111.09 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.7 m -123.32 168.85 15.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 71.209999999999994 111.114 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.518 HG22 ' HG2' ' A' ' 153' ' ' GLU . 0.5 OUTLIER -146.41 118.49 8.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.477 . . . . 72.430000000000007 111.135 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -152.37 151.02 22.94 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.649 -0.786 . . . . 43.329999999999998 112.44 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 150' ' ' LYS . 12.3 p -101.28 139.6 22.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.722 0.296 . . . . 54.299999999999997 111.164 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.622 HD12 ' O ' ' A' ' 150' ' ' LYS . 4.0 mp -61.1 116.49 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 73.400000000000006 111.06 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -97.86 -45.2 6.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 70.019999999999996 110.861 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -124.89 153.54 17.9 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.778 -0.725 . . . . 74.519999999999996 112.539 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 9.2 ptmm? -124.05 125.2 44.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.843 0.354 . . . . 75.200000000000003 110.905 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.0 m -104.02 177.31 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 71.400000000000006 111.109 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 53.2 mttt -62.15 94.64 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 72.030000000000001 110.861 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 90.08 -36.25 3.6 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.75 -0.738 . . . . 73.329999999999998 112.534 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -92.59 173.51 35.43 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.713 -0.756 . . . . 73.010000000000005 112.509 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -142.94 118.28 10.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.934 0.397 . . . . 73.129999999999995 110.917 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 33.3 p -84.84 150.97 24.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 71.299999999999997 111.135 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.611 HG22 HG13 ' A' ' 112' ' ' ILE . 64.3 t -139.38 138.37 40.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 62.520000000000003 111.168 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -91.44 100.55 13.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 63.43 110.889 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 10.9 mt -90.72 81.85 5.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 74.200000000000003 110.945 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 42.0 52.11 4.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 75.400000000000006 110.905 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 104.01 -34.02 6.11 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.762 -0.732 . . . . 71.510000000000005 112.49 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.662 ' CG2' HG11 ' A' ' 166' ' ' VAL . 25.2 mt -76.45 152.29 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.779 0.323 . . . . 73.319999999999993 111.136 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.555 ' O ' HG13 ' A' ' 166' ' ' VAL . 53.7 mtm180 -105.09 105.49 15.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 73.510000000000005 110.889 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.573 ' HB3' ' HB ' ' A' ' 122' ' ' VAL . . . -92.81 159.12 15.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 63.520000000000003 111.032 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -133.75 125.95 29.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 74.439999999999998 110.871 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.809 HD22 HD11 ' A' ' 135' ' ' LEU . 22.6 mt -115.05 131.65 23.42 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.634 0.73 . . . . 72.140000000000001 110.843 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.614 ' HD2' HD21 ' A' ' 135' ' ' LEU . 53.8 Cg_endo -69.74 164.65 33.73 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.665 2.243 . . . . 70.400000000000006 112.399 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.729 ' HA2' HG13 ' A' ' 136' ' ' VAL . . . -67.13 -11.0 58.02 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.719 -0.753 . . . . 72.200000000000003 112.513 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.5 t -60.24 -32.27 70.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.94 0.4 . . . . 71.140000000000001 110.881 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.809 HD11 HD22 ' A' ' 131' ' ' LEU . 0.8 OUTLIER -124.09 41.97 3.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 71.019999999999996 110.943 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.729 HG13 ' HA2' ' A' ' 133' ' ' GLY . 0.3 OUTLIER -50.72 -43.07 23.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 72.439999999999998 111.142 179.814 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -179.71 119.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 72.0 110.859 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 12.7 p -76.06 138.79 20.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 53.409999999999997 111.168 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 30.8 mtp180 61.24 75.62 0.44 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.626 0.727 . . . . 72.019999999999996 110.865 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.73 135.31 30.19 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.702 2.268 . . . . 72.140000000000001 112.336 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.412 HG12 ' N ' ' A' ' 142' ' ' ARG . 5.9 t -127.74 157.94 39.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 61.409999999999997 111.15 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.412 ' N ' HG12 ' A' ' 141' ' ' VAL . 0.0 OUTLIER -50.89 -30.81 15.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 73.120000000000005 110.827 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -84.34 129.57 34.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 65.310000000000002 110.847 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.615 HG22 HD11 ' A' ' 147' ' ' LEU . 18.1 p -98.6 27.92 4.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 34.450000000000003 111.131 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.5 tp -87.49 -21.36 25.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 72.530000000000001 110.88 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 33.7 p-80 -89.08 -21.86 23.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 72.349999999999994 110.86 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.615 HD11 HG22 ' A' ' 144' ' ' THR . 59.2 mt -51.84 -57.98 7.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 63.329999999999998 110.973 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -101.7 145.11 29.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 74.439999999999998 110.848 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 95.45 -12.15 68.06 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.756 -0.735 . . . . 65.230000000000004 112.573 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.622 ' O ' HD12 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -55.65 133.56 50.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.682 0.277 . . . . 70.040000000000006 110.95 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -110.26 111.92 23.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.269 -0.423 . . . . 74.299999999999997 110.897 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.514 HD12 ' HD3' ' A' ' 150' ' ' LYS . 5.4 mt -139.21 159.32 42.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 72.430000000000007 110.894 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.518 ' HG2' HG22 ' A' ' 109' ' ' THR . 12.9 mt-10 -95.0 148.18 22.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 74.319999999999993 110.867 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.724 ' HA ' HG23 ' A' ' 173' ' ' VAL . 3.6 m-85 -123.32 -179.47 4.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 73.310000000000002 110.832 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.636 ' HG2' HG22 ' A' ' 107' ' ' THR . 0.2 OUTLIER -135.14 108.19 7.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 74.340000000000003 110.902 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.602 HG21 ' CD1' ' A' ' 102' ' ' TYR . 89.1 t -60.47 105.98 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.217 -0.447 . . . . 74.319999999999993 111.129 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.6 tt -89.58 -30.29 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 71.040000000000006 111.144 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -176.41 169.67 2.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 75.319999999999993 110.894 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.798 HD11 ' HB3' ' A' ' 102' ' ' TYR . 0.4 OUTLIER -143.1 160.96 39.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 65.040000000000006 110.889 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.78 101.8 10.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.187 -0.461 . . . . 74.519999999999996 110.931 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -81.15 -36.08 30.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 71.329999999999998 110.929 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 29.9 tttp -69.45 -46.14 67.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 74.310000000000002 110.888 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -73.62 -15.31 61.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 65.140000000000001 110.922 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.4 m120 63.34 41.06 8.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 72.530000000000001 110.945 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -139.09 128.94 24.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 75.129999999999995 110.897 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.662 HG11 ' CG2' ' A' ' 127' ' ' ILE . 7.2 p -99.98 130.59 48.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 71.019999999999996 111.066 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 18.9 m -134.79 171.17 18.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 72.329999999999998 111.118 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.433 HG23 HD23 ' A' ' 131' ' ' LEU . 1.8 m -120.34 153.16 23.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.468 . . . . 74.299999999999997 111.112 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.28 160.64 31.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 62.549999999999997 110.875 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.701 ' O ' HG12 ' A' ' 173' ' ' VAL . 17.6 ptt180 -121.74 -33.94 3.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.167 -0.47 . . . . 71.209999999999994 110.893 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -81.75 -34.35 30.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 64.340000000000003 110.86 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -83.62 -26.4 29.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 63.399999999999999 111.12 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.724 HG23 ' HA ' ' A' ' 154' ' ' PHE . 5.7 p -58.07 -20.29 14.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 63.229999999999997 111.128 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 27.3 pt -53.11 -27.96 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.485 . . . . 73.439999999999998 111.117 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -87.21 -31.81 20.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 72.129999999999995 110.895 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 3.7 t -76.8 -25.03 52.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 74.040000000000006 110.827 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.481 ' HA ' HD22 ' A' ' 152' ' ' LEU . 36.6 mt-10 -60.81 -33.7 73.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.122 -0.49 . . . . 62.409999999999997 110.889 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -123.88 49.04 1.79 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.491 . . . . 61.140000000000001 110.886 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 41.8 t . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 74.5 110.825 -179.829 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.854 0.359 . . . . 73.430000000000007 110.957 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.41 -51.44 68.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 63.450000000000003 111.08 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.1 mtmm -55.87 -26.01 45.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 73.340000000000003 110.892 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.87 -26.46 36.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 73.430000000000007 110.865 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 14.7 t60 -51.61 -30.27 20.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.153 -0.476 . . . . 73.450000000000003 110.911 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -79.29 -34.98 41.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.165 -0.47 . . . . 71.430000000000007 110.872 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.32 -15.52 62.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 71.420000000000002 111.096 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -57.76 -22.48 47.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 74.319999999999993 110.951 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 27.2 pt -52.31 -32.7 16.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.288 -0.414 . . . . 70.150000000000006 111.154 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.6 p -86.07 -23.65 26.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 60.329999999999998 111.13 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.497 ' O ' HD12 ' A' ' 98' ' ' LEU . 7.6 tp -67.8 -28.55 67.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.21 -0.45 . . . . 75.549999999999997 110.889 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -60.35 -48.17 82.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 35.399999999999999 110.898 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -67.41 -24.65 65.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 74.540000000000006 110.888 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.1 -36.92 85.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 73.430000000000007 111.095 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.73 ' CG ' HD21 ' A' ' 159' ' ' LEU . 12.6 t80 -52.81 -28.96 25.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 64.120000000000005 110.977 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.49 -25.05 50.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.078 -0.51 . . . . 65.010000000000005 110.902 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -94.3 -22.21 18.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.139 -0.482 . . . . 74.239999999999995 110.874 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 62.16 44.49 7.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.443 . . . . 75.230000000000004 111.066 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.77 165.27 15.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 75.25 110.936 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.8 t -94.56 168.07 11.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 72.549999999999997 111.163 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.2 m -152.96 -178.62 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 71.209999999999994 111.128 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 109' ' ' THR . 4.1 t -141.43 116.67 10.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 72.430000000000007 111.215 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.403 ' CA ' HD23 ' A' ' 124' ' ' LEU . . . -134.46 151.98 20.5 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.721 -0.752 . . . . 43.329999999999998 112.449 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.689 HG22 ' HA ' ' A' ' 151' ' ' GLU . 85.5 t -115.56 134.2 59.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.751 0.31 . . . . 54.299999999999997 111.132 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.494 HD12 ' O ' ' A' ' 150' ' ' LYS . 3.5 mp -54.66 115.34 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 73.400000000000006 111.136 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -100.16 -41.64 7.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 70.019999999999996 110.926 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -120.87 145.84 17.37 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.799 -0.715 . . . . 74.519999999999996 112.512 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.2 pttt -124.03 128.42 49.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.788 0.328 . . . . 75.200000000000003 110.927 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.6 m -119.82 176.5 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 71.400000000000006 111.167 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -68.15 99.06 0.85 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 72.030000000000001 110.927 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 92.02 -35.13 4.1 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.763 -0.732 . . . . 73.329999999999998 112.452 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -98.26 173.6 27.71 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.774 -0.727 . . . . 73.010000000000005 112.494 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -152.56 119.06 5.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.989 0.423 . . . . 73.129999999999995 110.905 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.418 ' O ' HG23 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -86.29 150.89 24.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.159 -0.473 . . . . 71.299999999999997 111.116 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.653 ' HB ' ' HB3' ' A' ' 129' ' ' ALA . 19.9 t -140.69 139.83 34.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.494 . . . . 62.520000000000003 111.121 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -95.02 107.28 19.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 63.43 110.871 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.403 HD23 ' CA ' ' A' ' 110' ' ' GLY . 26.9 mt -103.18 72.67 1.18 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.157 -0.474 . . . . 74.200000000000003 110.955 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 54.38 50.89 15.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 75.400000000000006 110.927 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 103.9 -33.38 6.62 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.714 -0.755 . . . . 71.510000000000005 112.461 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.6 mm -80.06 156.18 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.842 0.354 . . . . 73.319999999999993 111.114 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 47.7 mtt180 -114.84 121.67 43.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 73.510000000000005 110.956 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.653 ' HB3' ' HB ' ' A' ' 122' ' ' VAL . . . -102.25 168.45 9.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.25 -0.432 . . . . 63.520000000000003 111.123 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -147.87 124.41 11.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 74.439999999999998 110.844 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.584 HD21 ' CG2' ' A' ' 122' ' ' VAL . 0.1 OUTLIER -122.89 130.16 24.72 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.68 0.753 . . . . 72.140000000000001 110.887 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 146.21 59.77 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.652 2.235 . . . . 70.400000000000006 112.373 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -67.63 -11.35 59.88 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.772 -0.727 . . . . 72.200000000000003 112.482 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.6 m -51.33 -30.63 19.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.89 0.376 . . . . 71.140000000000001 110.838 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.539 HD22 ' CA ' ' A' ' 170' ' ' ARG . 5.0 tp -116.16 29.09 8.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 71.019999999999996 110.886 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 94.4 t -120.01 -32.74 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.251 -0.431 . . . . 72.439999999999998 111.113 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -108.11 116.0 31.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 72.0 110.843 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.439 HG12 ' H ' ' A' ' 139' ' ' ARG . 1.4 t -129.18 166.95 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 53.409999999999997 111.092 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.484 ' N ' ' HD2' ' A' ' 140' ' ' PRO . 0.9 OUTLIER -50.86 -60.68 5.05 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.602 0.715 . . . . 72.019999999999996 110.893 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 139' ' ' ARG . 54.5 Cg_endo -69.74 133.36 25.42 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.746 2.297 . . . . 72.140000000000001 112.361 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.7 m -128.83 148.7 33.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 61.409999999999997 111.103 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 81.9 mtt180 -124.73 -60.72 1.36 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.48 . . . . 73.120000000000005 110.88 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -153.01 162.75 40.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 65.310000000000002 110.87 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.526 HG22 HD11 ' A' ' 147' ' ' LEU . 5.8 p -106.5 19.72 20.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.205 -0.452 . . . . 34.450000000000003 111.184 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 145' ' ' LEU . 4.2 mm? -87.36 -24.56 24.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.494 . . . . 72.530000000000001 110.968 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.4 -8.59 59.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.146 -0.479 . . . . 72.349999999999994 110.88 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.526 HD11 HG22 ' A' ' 144' ' ' THR . 78.7 mt -58.92 -49.42 77.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.171 -0.468 . . . . 63.329999999999998 110.918 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -130.26 137.44 50.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 74.439999999999998 110.855 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 92.11 -16.44 59.62 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.799 -0.715 . . . . 65.230000000000004 112.505 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.593 ' HD3' HD13 ' A' ' 152' ' ' LEU . 0.4 OUTLIER -51.62 127.17 19.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.717 0.294 . . . . 70.040000000000006 110.914 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.689 ' HA ' HG22 ' A' ' 111' ' ' VAL . 2.9 pm0 -89.29 111.1 21.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.252 -0.431 . . . . 74.299999999999997 110.852 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.593 HD13 ' HD3' ' A' ' 150' ' ' LYS . 1.5 tp -139.25 -175.46 4.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 72.430000000000007 110.941 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -133.78 135.7 44.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 74.319999999999993 110.884 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.578 ' CE1' HG11 ' A' ' 122' ' ' VAL . 13.4 m-85 -119.25 -179.34 3.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.477 . . . . 73.310000000000002 110.834 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.666 ' O ' HD12 ' A' ' 157' ' ' ILE . 4.2 mttm -128.47 160.77 31.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 74.340000000000003 110.948 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.422 HG12 ' CD1' ' A' ' 102' ' ' TYR . 21.6 t -84.07 82.06 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.276 -0.42 . . . . 74.319999999999993 111.096 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.666 HD12 ' O ' ' A' ' 155' ' ' LYS . 5.1 mp -77.99 -40.49 26.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 71.040000000000006 111.089 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.41 154.74 7.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 75.319999999999993 110.857 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.73 HD21 ' CG ' ' A' ' 102' ' ' TYR . 0.2 OUTLIER -140.03 112.73 7.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 65.040000000000006 110.869 179.904 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -67.61 91.45 0.29 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.172 -0.467 . . . . 74.519999999999996 110.885 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -60.58 -19.93 59.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 71.329999999999998 110.923 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -51.6 -37.79 51.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 74.310000000000002 110.905 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 24.2 ttt85 -123.06 19.79 9.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 65.140000000000001 110.894 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 51.82 29.89 6.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 72.530000000000001 110.874 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -112.85 157.98 20.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.202 -0.454 . . . . 75.129999999999995 110.928 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.623 HG23 ' HB3' ' A' ' 159' ' ' LEU . 10.2 p -125.96 144.23 36.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 71.019999999999996 111.137 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 19.7 m -127.81 169.54 19.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 72.329999999999998 111.171 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 15.5 m -120.28 162.01 19.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.451 . . . . 74.299999999999997 111.087 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.638 ' H ' HD13 ' A' ' 157' ' ' ILE . 28.4 t -103.36 161.17 14.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 62.549999999999997 110.852 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.539 ' CA ' HD22 ' A' ' 135' ' ' LEU . 25.8 mtm180 -79.93 -58.16 3.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 71.209999999999994 110.918 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -56.35 -26.02 51.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 64.340000000000003 110.871 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.26 -14.03 61.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 63.399999999999999 111.04 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 13.5 p -51.6 -29.59 10.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 63.229999999999997 111.168 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 32.7 pt -51.62 -30.32 11.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.135 -0.484 . . . . 73.439999999999998 111.106 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -69.7 -38.54 77.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 72.129999999999995 110.945 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 26.0 t -51.78 -58.57 6.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.07 -0.514 . . . . 74.040000000000006 110.916 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -72.72 -61.61 1.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 62.409999999999997 110.874 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 16.0 t30 57.19 47.58 16.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 61.140000000000001 110.833 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 74.5 110.889 -179.928 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.915 0.388 . . . . 75.230000000000004 110.868 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -89.06 -46.78 8.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 73.430000000000007 110.929 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.18 -29.95 65.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 63.450000000000003 111.112 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 32.6 mmtt -58.39 -26.29 63.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 73.340000000000003 110.876 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 6.1 mtt85 -65.44 -25.83 67.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 73.430000000000007 110.894 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 54.0 m170 -51.97 -47.93 64.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 73.450000000000003 110.848 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -80.2 -26.53 39.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 71.430000000000007 110.89 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.2 -21.17 62.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 71.420000000000002 111.089 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.435 ' CD1' HD11 ' A' ' 98' ' ' LEU . 42.1 m0 -58.01 -22.85 51.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.209 -0.451 . . . . 74.319999999999993 110.922 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 74.9 mt -54.59 -26.58 16.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.448 . . . . 70.150000000000006 111.122 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.5 m -77.93 -28.16 49.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 60.329999999999998 111.164 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.595 ' CD1' HD11 ' A' ' 127' ' ' ILE . 18.7 mt -64.1 -27.67 69.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 75.549999999999997 110.907 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -51.56 -49.94 61.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 35.399999999999999 110.9 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -25.07 68.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 74.540000000000006 110.901 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.74 -55.2 8.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 73.430000000000007 111.081 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.493 ' CB ' HD22 ' A' ' 159' ' ' LEU . 33.3 m-85 -57.58 -26.27 61.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 64.120000000000005 110.904 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.71 -40.85 63.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 65.010000000000005 110.869 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -98.48 20.77 12.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 74.239999999999995 110.842 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 61.53 56.4 2.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 75.230000000000004 111.112 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -64.64 143.18 58.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 75.25 110.906 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.3 t -86.72 143.75 27.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.147 -0.479 . . . . 72.549999999999997 111.154 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.418 HG21 HD13 ' A' ' 124' ' ' LEU . 23.6 m -122.07 -179.62 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 71.209999999999994 111.154 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 4.3 t -159.96 119.58 2.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 72.430000000000007 111.14 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.687 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -160.2 172.4 36.65 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.716 -0.754 . . . . 43.329999999999998 112.458 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.627 ' C ' HG13 ' A' ' 122' ' ' VAL . 11.7 p -116.1 145.35 21.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.775 0.321 . . . . 54.299999999999997 111.119 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.431 ' CG1' HG22 ' A' ' 122' ' ' VAL . 5.6 mt -66.74 117.87 8.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 73.400000000000006 111.109 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -97.65 -43.72 7.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 70.019999999999996 110.887 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -121.67 148.23 17.26 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.725 -0.75 . . . . 74.519999999999996 112.474 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 27.0 pttt -124.21 125.4 44.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.789 0.328 . . . . 75.200000000000003 110.928 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.5 m -114.08 176.96 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 71.400000000000006 111.166 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 28.9 mttp -62.47 94.38 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 72.030000000000001 110.87 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 90.61 -35.76 3.77 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.704 -0.76 . . . . 73.329999999999998 112.508 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -90.38 173.69 39.21 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.749 -0.739 . . . . 73.010000000000005 112.531 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.489 ' HE2' HG11 ' A' ' 136' ' ' VAL . 15.3 m-85 -152.04 118.92 5.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.994 0.426 . . . . 73.129999999999995 110.927 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.11 135.81 33.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.49 . . . . 71.299999999999997 111.152 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.725 HG11 ' CZ ' ' A' ' 154' ' ' PHE . 18.1 t -135.39 138.12 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 62.520000000000003 111.089 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -88.85 113.34 24.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.453 . . . . 63.43 110.881 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.687 HD23 ' HA3' ' A' ' 110' ' ' GLY . 11.1 mt -121.16 96.44 5.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.464 . . . . 74.200000000000003 110.907 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 63.32 25.24 14.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 75.400000000000006 110.919 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 103.96 -23.1 33.24 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.677 -0.773 . . . . 71.510000000000005 112.467 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.595 HD11 ' CD1' ' A' ' 98' ' ' LEU . 21.9 mt -83.05 151.87 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.808 0.337 . . . . 73.319999999999993 111.119 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -99.65 124.3 44.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 73.510000000000005 110.868 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.628 ' HB1' ' CG2' ' A' ' 168' ' ' VAL . . . -101.15 171.75 7.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 63.520000000000003 111.097 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -142.82 117.91 10.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 74.439999999999998 110.895 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.575 HD11 ' CE2' ' A' ' 154' ' ' PHE . 7.7 mp -100.28 129.56 27.81 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.653 0.74 . . . . 72.140000000000001 110.918 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.518 ' O ' HG23 ' A' ' 136' ' ' VAL . 53.7 Cg_endo -69.71 132.5 23.55 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.706 2.27 . . . . 70.400000000000006 112.352 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -74.91 -11.22 83.8 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 72.200000000000003 112.486 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 26.5 t -50.56 -33.94 23.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.934 0.397 . . . . 71.140000000000001 110.888 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.622 HD12 ' HG2' ' A' ' 170' ' ' ARG . 28.0 mt -123.42 39.28 4.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.081 -0.508 . . . . 71.019999999999996 110.906 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 132' ' ' PRO . 99.4 t -122.77 -59.04 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 72.439999999999998 111.103 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -116.34 117.52 30.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 72.0 110.822 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 7.3 p -173.81 123.9 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 53.409999999999997 111.134 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 53.04 72.61 1.11 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.55 0.69 . . . . 72.019999999999996 110.889 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 132.84 24.09 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.644 2.229 . . . . 72.140000000000001 112.325 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 6.8 p -126.03 -37.93 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.456 . . . . 61.409999999999997 111.102 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -126.92 -176.98 3.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 73.120000000000005 110.872 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -52.09 132.48 33.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.196 -0.456 . . . . 65.310000000000002 110.818 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 9.0 t -123.16 42.6 3.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 34.450000000000003 111.125 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -85.88 -11.46 53.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 72.530000000000001 110.861 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.57 -8.38 54.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 72.349999999999994 110.862 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 64.9 mt -59.51 -31.17 69.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 63.329999999999998 110.892 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -123.53 134.9 53.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 74.439999999999998 110.903 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 92.81 0.95 68.32 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.719 -0.753 . . . . 65.230000000000004 112.482 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.4 127.92 34.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.721 0.295 . . . . 70.040000000000006 110.89 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.479 ' O ' HD22 ' A' ' 152' ' ' LEU . 34.1 mt-10 -109.59 87.0 2.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 74.299999999999997 110.9 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.479 HD22 ' O ' ' A' ' 151' ' ' GLU . 0.4 OUTLIER -139.11 166.34 24.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 72.430000000000007 110.923 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -81.92 173.75 11.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.214 -0.448 . . . . 74.319999999999993 110.9 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.725 ' CZ ' HG11 ' A' ' 122' ' ' VAL . 37.3 m-85 -133.47 -179.38 5.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 73.310000000000002 110.852 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 12.1 ttpt -130.84 108.59 9.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 74.340000000000003 110.907 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.457 HG11 ' CD1' ' A' ' 102' ' ' TYR . 21.9 t -70.42 126.53 30.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 74.319999999999993 111.167 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.9 tp -119.0 -30.47 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 71.040000000000006 111.182 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 20.7 ttmt -171.87 133.21 0.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 75.319999999999993 110.903 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.494 HD23 ' H ' ' A' ' 159' ' ' LEU . 0.9 OUTLIER -109.47 148.17 31.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 65.040000000000006 110.902 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.19 89.37 3.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 74.519999999999996 110.869 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -67.71 -23.16 65.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 71.329999999999998 110.865 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.81 -43.26 63.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 74.310000000000002 110.895 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -99.66 24.74 7.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 65.140000000000001 110.885 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 41.52 38.59 0.9 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 72.530000000000001 110.917 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -143.07 168.79 18.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 75.129999999999995 110.872 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.48 HG22 HG22 ' A' ' 127' ' ' ILE . 15.8 m -128.67 144.39 38.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 71.019999999999996 111.145 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 18.3 m -116.74 171.8 5.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 72.329999999999998 111.129 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.628 ' CG2' ' HB1' ' A' ' 129' ' ' ALA . 15.8 t -119.42 152.28 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 74.299999999999997 111.103 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 14.0 t -70.01 154.7 41.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 62.549999999999997 110.873 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.622 ' HG2' HD12 ' A' ' 135' ' ' LEU . 18.4 ttm180 -83.46 -54.56 4.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 71.209999999999994 110.906 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.417 ' O ' HG23 ' A' ' 174' ' ' ILE . 12.5 ptp180 -57.4 -27.01 61.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 64.340000000000003 110.878 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.2 -19.64 55.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 63.399999999999999 111.097 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.554 HG22 ' HG3' ' A' ' 177' ' ' GLU . 11.1 p -52.38 -28.96 12.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 63.229999999999997 111.115 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 171' ' ' ARG . 30.8 pt -51.26 -30.71 10.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 73.439999999999998 111.085 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -87.98 -46.81 9.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 72.129999999999995 110.89 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 4.2 p -56.51 -40.51 75.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 74.040000000000006 110.83 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.554 ' HG3' HG22 ' A' ' 173' ' ' VAL . 8.2 mt-10 -51.92 -49.16 63.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 62.409999999999997 110.911 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -176.94 86.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 61.140000000000001 110.875 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 4.7 p . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 74.5 110.872 -179.834 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.871 0.367 . . . . 75.230000000000004 110.873 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? -105.14 -34.25 8.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 73.430000000000007 110.906 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.2 -35.33 79.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 63.450000000000003 111.089 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.68 -27.49 64.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 73.340000000000003 110.963 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.9 tpp180 -60.41 -26.58 66.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 73.430000000000007 110.833 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -52.09 -30.09 24.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 73.450000000000003 110.854 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 -80.04 -34.5 38.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 71.430000000000007 110.872 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.75 -15.96 61.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 71.420000000000002 111.083 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -57.98 -22.68 50.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 74.319999999999993 110.929 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 43.1 mm -55.35 -25.41 17.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.287 -0.415 . . . . 70.150000000000006 111.131 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 71.0 p -85.69 -23.97 27.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.232 -0.44 . . . . 60.329999999999998 111.093 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.463 ' CD1' HD11 ' A' ' 127' ' ' ILE . 63.4 mt -67.54 -49.0 65.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 75.549999999999997 110.922 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -51.9 -43.49 63.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 35.399999999999999 110.876 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.87 -24.39 41.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 74.540000000000006 110.894 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.08 -26.47 56.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 73.430000000000007 111.114 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.454 ' HB2' HD21 ' A' ' 159' ' ' LEU . 16.1 t80 -56.04 -25.12 43.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 64.120000000000005 110.941 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -54.82 -26.84 37.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 65.010000000000005 110.891 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -92.75 -22.04 19.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.081 -0.509 . . . . 74.239999999999995 110.846 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 63.9 44.91 4.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 75.230000000000004 111.123 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -62.43 -179.81 0.27 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.22 -0.446 . . . . 75.25 110.832 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 32.7 p -106.61 178.82 4.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.1 -0.5 . . . . 72.549999999999997 111.089 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.9 m -152.35 -178.66 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 71.209999999999994 111.181 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 86.5 m -154.22 122.89 6.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 72.430000000000007 111.15 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.406 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -158.09 154.97 26.01 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.7 -0.762 . . . . 43.329999999999998 112.422 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 150' ' ' LYS . 10.8 p -105.16 137.62 33.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.743 0.306 . . . . 54.299999999999997 111.216 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.735 HG13 HG22 ' A' ' 122' ' ' VAL . 4.2 mp -57.98 112.02 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.218 -0.446 . . . . 73.400000000000006 111.134 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 20.4 m-20 -95.17 -30.3 14.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.098 -0.501 . . . . 70.019999999999996 110.892 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -134.14 144.4 16.34 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.708 -0.758 . . . . 74.519999999999996 112.502 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.93 136.84 54.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.861 0.362 . . . . 75.200000000000003 110.917 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.1 m -118.8 176.44 3.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 71.400000000000006 111.044 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.1 tptt -66.0 97.75 0.38 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 72.030000000000001 110.92 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 92.2 -35.02 4.16 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.717 -0.754 . . . . 73.329999999999998 112.46 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -98.18 173.62 27.84 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.747 . . . . 73.010000000000005 112.494 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.416 ' HE2' HG13 ' A' ' 136' ' ' VAL . 8.4 m-85 -146.2 118.91 8.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.911 0.386 . . . . 73.129999999999995 110.918 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.631 ' O ' HG23 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -86.26 149.5 25.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 71.299999999999997 111.14 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.735 HG22 HG13 ' A' ' 112' ' ' ILE . 21.3 t -140.75 142.35 30.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 62.520000000000003 111.103 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -99.61 99.52 10.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 63.43 110.873 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.606 HD21 ' HD2' ' A' ' 154' ' ' PHE . 16.2 mt -102.02 89.68 3.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 74.200000000000003 110.929 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 51.97 39.31 25.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 75.400000000000006 110.844 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 103.68 -27.15 20.92 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.768 -0.729 . . . . 71.510000000000005 112.464 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.463 HD11 ' CD1' ' A' ' 98' ' ' LEU . 24.4 mm -74.15 150.23 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.787 0.327 . . . . 73.319999999999993 111.154 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.7 ttt180 -110.7 111.87 23.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 73.510000000000005 110.863 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.711 ' HB1' ' CG2' ' A' ' 168' ' ' VAL . . . -92.91 171.54 8.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 63.520000000000003 111.147 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -145.58 107.85 4.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 74.439999999999998 110.873 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.653 HD11 ' CE1' ' A' ' 154' ' ' PHE . 6.6 mp -92.35 129.46 40.96 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.512 0.672 . . . . 72.140000000000001 110.959 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 155.18 66.58 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.64 2.226 . . . . 70.400000000000006 112.35 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.64 ' O ' HG23 ' A' ' 136' ' ' VAL . . . -67.19 -11.66 59.3 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.707 -0.759 . . . . 72.200000000000003 112.473 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.3 p -79.47 -20.86 46.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.922 0.391 . . . . 71.140000000000001 110.871 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.724 HD22 ' HA ' ' A' ' 170' ' ' ARG . 4.8 tp -120.34 39.23 3.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.123 -0.49 . . . . 71.019999999999996 110.908 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 133' ' ' GLY . 85.1 t -62.37 -62.46 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 72.439999999999998 111.106 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -173.76 146.05 1.22 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.095 -0.502 . . . . 72.0 110.873 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.8 m -85.74 151.79 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 53.409999999999997 111.093 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.17 73.47 0.93 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.599 0.714 . . . . 72.019999999999996 110.905 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 139.16 39.72 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.714 2.276 . . . . 72.140000000000001 112.358 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.514 HG12 ' HE1' ' A' ' 146' ' ' HIS . 10.6 p -120.49 151.98 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.301 -0.409 . . . . 61.409999999999997 111.086 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -51.99 -30.15 23.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 73.120000000000005 110.859 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.477 ' O ' HG13 ' A' ' 141' ' ' VAL . 2.7 m-20 -82.91 129.21 34.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 65.310000000000002 110.834 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 79.6 p -108.57 37.4 2.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 34.450000000000003 111.118 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.3 tp -87.16 -22.15 25.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 72.530000000000001 110.903 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.514 ' HE1' HG12 ' A' ' 141' ' ' VAL . 29.0 p-80 -96.13 18.44 13.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 72.349999999999994 110.823 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 48.4 mt -110.7 39.35 2.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 63.329999999999998 110.878 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -167.48 123.87 1.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 74.439999999999998 110.907 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.19 15.54 71.74 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.673 -0.775 . . . . 65.230000000000004 112.479 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.607 ' O ' HD12 ' A' ' 112' ' ' ILE . 2.0 tmmm? -71.2 138.23 49.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.769 0.319 . . . . 70.040000000000006 110.866 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -105.08 118.45 36.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 74.299999999999997 110.832 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.0 tp -139.05 146.92 41.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.108 -0.496 . . . . 72.430000000000007 110.899 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -90.94 129.71 36.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.439 . . . . 74.319999999999993 110.888 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.693 ' CE2' HG11 ' A' ' 122' ' ' VAL . 17.9 m-85 -114.91 -179.43 3.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 73.310000000000002 110.897 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.74 136.05 21.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 74.340000000000003 110.91 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.675 ' CG1' HD22 ' A' ' 159' ' ' LEU . 22.0 t -58.72 112.28 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 74.319999999999993 111.148 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.462 ' O ' HD13 ' A' ' 157' ' ' ILE . 0.0 OUTLIER -114.78 -26.14 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 71.040000000000006 111.183 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -169.17 115.79 0.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 75.319999999999993 110.892 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.675 HD22 ' CG1' ' A' ' 156' ' ' VAL . 2.2 pt? -150.17 132.95 15.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.225 -0.443 . . . . 65.040000000000006 110.919 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -117.82 109.73 16.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 74.519999999999996 110.804 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -64.71 -30.64 71.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 71.329999999999998 110.926 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 9.3 ttmt -70.29 -29.93 66.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 74.310000000000002 110.895 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 38.7 mtt180 -91.83 -15.37 28.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.427 . . . . 65.140000000000001 110.9 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 60.62 42.89 13.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 72.530000000000001 110.919 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -143.06 140.69 31.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 75.129999999999995 110.864 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.553 HG22 ' HB2' ' A' ' 159' ' ' LEU . 46.7 t -137.23 141.23 40.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 71.019999999999996 111.104 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.5 m -134.78 170.92 18.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 72.329999999999998 111.177 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.711 ' CG2' ' HB1' ' A' ' 129' ' ' ALA . 20.7 t -120.47 149.19 23.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 74.299999999999997 111.133 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.77 160.89 18.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 62.549999999999997 110.862 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.724 ' HA ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -94.36 -33.71 13.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 71.209999999999994 110.908 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -76.87 -25.04 52.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 64.340000000000003 110.879 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.8 -9.38 58.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 63.399999999999999 111.131 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 10.5 p -51.35 -30.15 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 63.229999999999997 111.129 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 31.5 pt -52.07 -29.55 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 73.439999999999998 111.081 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -54.73 -65.95 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 72.129999999999995 110.857 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.96 -43.93 63.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 74.040000000000006 110.895 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -55.72 -51.17 68.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.491 . . . . 62.409999999999997 110.863 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -123.15 71.8 1.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 61.140000000000001 110.852 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 63.3 p . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 74.5 110.867 -179.87 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.898 0.38 . . . . 75.230000000000004 110.889 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -89.49 93.64 9.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.465 . . . . 73.430000000000007 110.898 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.62 -26.16 50.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 63.450000000000003 111.112 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.8 pttt -53.88 -27.95 33.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 73.340000000000003 110.846 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -59.69 -25.52 64.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 73.430000000000007 110.793 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -51.99 -37.5 53.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.195 -0.457 . . . . 73.450000000000003 110.874 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.41 ' O ' HG23 ' A' ' 96' ' ' ILE . 41.9 tt0 -78.56 -37.04 43.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.113 -0.494 . . . . 71.430000000000007 110.911 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.0 -18.14 63.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 71.420000000000002 111.147 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.419 ' CD1' HD11 ' A' ' 98' ' ' LEU . 33.3 m0 -56.6 -24.53 48.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.459 . . . . 74.319999999999993 110.916 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 93' ' ' GLU . 29.2 pt -55.02 -26.11 17.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 70.150000000000006 111.097 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 57.1 m -78.38 -27.22 46.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 60.329999999999998 111.142 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.452 ' CD1' HD11 ' A' ' 127' ' ' ILE . 17.9 mt -66.61 -24.85 66.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 75.549999999999997 110.95 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -51.85 -34.87 42.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 35.399999999999999 110.881 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 36.5 mttp -83.83 -26.36 29.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.128 -0.487 . . . . 74.540000000000006 110.873 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.565 ' HB1' ' CB ' ' A' ' 106' ' ' GLU . . . -53.33 -58.38 7.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 73.430000000000007 111.089 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -52.32 -29.64 24.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 64.120000000000005 110.961 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.05 -36.19 78.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 65.010000000000005 110.96 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -108.58 20.74 18.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.171 -0.468 . . . . 74.239999999999995 110.896 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 51.59 62.25 2.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 75.230000000000004 111.097 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.565 ' CB ' ' HB1' ' A' ' 101' ' ' ALA . 0.6 OUTLIER -71.33 155.24 40.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 75.25 110.926 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.6 t -104.11 172.65 6.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 72.549999999999997 111.147 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.746 HG21 HD13 ' A' ' 124' ' ' LEU . 16.9 m -146.28 177.37 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.27 -0.423 . . . . 71.209999999999994 111.067 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.8 t -162.2 127.25 3.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 72.430000000000007 111.083 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.665 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -165.77 153.95 24.27 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.774 -0.727 . . . . 43.329999999999998 112.506 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 150' ' ' LYS . 13.1 p -102.64 137.18 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.818 0.342 . . . . 54.299999999999997 111.149 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.733 HG13 HG22 ' A' ' 122' ' ' VAL . 4.4 mp -54.09 106.43 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.252 -0.431 . . . . 73.400000000000006 111.067 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -96.02 -39.84 9.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 70.019999999999996 110.885 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -120.99 141.93 15.21 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.783 -0.722 . . . . 74.519999999999996 112.485 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.9 pttp -124.54 147.43 48.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.781 0.325 . . . . 75.200000000000003 110.918 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.2 m -118.1 177.25 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 71.400000000000006 111.142 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.09 95.8 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 72.030000000000001 110.893 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 90.16 -36.71 3.49 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.732 -0.747 . . . . 73.329999999999998 112.461 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -98.27 173.52 27.63 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.761 -0.733 . . . . 73.010000000000005 112.481 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.582 ' HB3' HD23 ' A' ' 131' ' ' LEU . 8.3 m-85 -132.42 164.22 27.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.976 0.417 . . . . 73.129999999999995 110.866 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.47 ' O ' HG23 ' A' ' 112' ' ' ILE . 0.3 OUTLIER -135.45 150.82 49.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.108 -0.496 . . . . 71.299999999999997 111.161 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.733 HG22 HG13 ' A' ' 112' ' ' ILE . 5.3 t -136.48 156.57 36.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.255 -0.43 . . . . 62.520000000000003 111.118 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -114.21 108.47 17.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 63.43 110.927 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.746 HD13 HG21 ' A' ' 108' ' ' VAL . 18.9 mt -109.24 84.87 1.99 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 74.200000000000003 110.859 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 51.45 56.39 7.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 75.400000000000006 110.911 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.37 -35.14 4.33 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.769 -0.729 . . . . 71.510000000000005 112.49 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.694 ' CG2' HG11 ' A' ' 166' ' ' VAL . 26.0 mm -70.82 150.42 9.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.866 0.365 . . . . 73.319999999999993 111.103 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.557 ' O ' HG13 ' A' ' 166' ' ' VAL . 1.9 mpt_? -117.25 114.29 23.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.477 . . . . 73.510000000000005 110.881 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.45 ' HB3' ' HB ' ' A' ' 122' ' ' VAL . . . -92.64 161.3 14.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.484 . . . . 63.520000000000003 111.129 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -136.11 113.0 10.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 74.439999999999998 110.885 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.677 HD21 HG23 ' A' ' 122' ' ' VAL . 1.2 mm? -86.64 129.98 50.75 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.578 0.704 . . . . 72.140000000000001 110.955 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 127.88 15.19 Favored 'Trans proline' 0 N--CA 1.465 -0.167 0 C-N-CA 122.681 2.254 . . . . 70.400000000000006 112.357 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -51.56 -28.29 21.16 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.753 -0.737 . . . . 72.200000000000003 112.479 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 72.9 m -56.41 -25.09 48.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.958 0.408 . . . . 71.140000000000001 110.852 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.5 mt -88.98 -33.52 17.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.127 -0.488 . . . . 71.019999999999996 110.941 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.401 HG13 HD22 ' A' ' 147' ' ' LEU . 87.9 t -53.99 -27.43 16.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 72.439999999999998 111.108 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.45 112.67 20.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.166 -0.47 . . . . 72.0 110.885 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.401 ' O ' HG13 ' A' ' 138' ' ' VAL . 7.0 p -173.62 123.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 53.409999999999997 111.097 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 62.95 160.6 0.12 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.556 0.693 . . . . 72.019999999999996 110.889 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 149.91 67.75 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.722 2.282 . . . . 72.140000000000001 112.354 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.9 m -150.19 159.47 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 61.409999999999997 111.16 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -110.16 -73.92 0.67 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 73.120000000000005 110.9 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -63.97 145.2 56.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.454 . . . . 65.310000000000002 110.885 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.798 HG22 HD12 ' A' ' 147' ' ' LEU . 0.2 OUTLIER -108.39 23.61 14.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 34.450000000000003 111.144 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.5 mp -87.34 -22.79 24.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 72.530000000000001 110.909 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 43.9 p-80 -66.68 -25.26 66.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.433 . . . . 72.349999999999994 110.816 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.798 HD12 HG22 ' A' ' 144' ' ' THR . 59.9 mt -63.79 -59.06 5.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 63.329999999999998 110.968 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -119.43 142.18 48.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 74.439999999999998 110.894 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 91.38 -14.55 63.5 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.76 -0.733 . . . . 65.230000000000004 112.472 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.585 ' O ' HD12 ' A' ' 112' ' ' ILE . 1.6 tmmm? -53.87 128.98 32.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.768 0.318 . . . . 70.040000000000006 110.95 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.51 105.06 14.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 74.299999999999997 110.914 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.574 HD12 ' HD3' ' A' ' 150' ' ' LYS . 4.6 mt -139.04 179.84 6.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 72.430000000000007 110.953 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -115.91 152.94 32.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 74.319999999999993 110.894 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.479 ' CZ ' HG21 ' A' ' 122' ' ' VAL . 11.9 m-85 -126.5 178.4 5.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 73.310000000000002 110.853 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 18.1 tttt -131.37 160.39 35.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 74.340000000000003 110.884 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 106' ' ' GLU . 7.6 p -76.72 127.63 37.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 74.319999999999993 111.146 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.2 tp -127.87 -38.3 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.187 -0.46 . . . . 71.040000000000006 111.095 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -174.66 132.81 0.35 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.484 . . . . 75.319999999999993 110.884 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.604 ' HB3' HG23 ' A' ' 166' ' ' VAL . 3.7 pp -158.06 135.7 10.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 65.040000000000006 110.902 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -117.12 125.86 51.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.465 . . . . 74.519999999999996 110.85 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -80.47 -26.15 38.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 71.329999999999998 110.922 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -73.29 -41.31 63.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 74.310000000000002 110.973 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -82.97 -15.41 51.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 65.140000000000001 110.897 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.74 42.36 10.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 72.530000000000001 110.894 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -141.71 140.51 33.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 75.129999999999995 110.856 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.694 HG11 ' CG2' ' A' ' 127' ' ' ILE . 5.9 p -146.03 141.09 21.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 71.019999999999996 111.136 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 20.1 m -134.87 167.52 25.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.161 -0.472 . . . . 72.329999999999998 111.095 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 8.5 m -120.45 148.97 23.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 74.299999999999997 111.118 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.652 ' OG ' ' HB2' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -84.73 155.23 21.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.15 -0.477 . . . . 62.549999999999997 110.829 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.621 ' O ' HG12 ' A' ' 173' ' ' VAL . 30.2 mtt85 -64.08 -38.53 91.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 71.209999999999994 110.946 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -80.1 -23.11 41.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 64.340000000000003 110.888 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.652 ' HB2' ' OG ' ' A' ' 169' ' ' SER . . . -53.72 -41.7 67.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 63.399999999999999 111.113 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.621 HG12 ' O ' ' A' ' 170' ' ' ARG . 13.0 p -66.02 -21.79 29.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 63.229999999999997 111.101 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 16.3 mm -70.07 -53.98 21.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.451 . . . . 73.439999999999998 111.146 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -55.46 -47.8 75.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 72.129999999999995 110.861 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 68.5 m -56.42 -42.23 77.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 74.040000000000006 110.827 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -64.69 -51.65 61.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.076 -0.511 . . . . 62.409999999999997 110.854 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -92.06 54.18 2.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.504 . . . . 61.140000000000001 110.879 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 4.0 p . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 74.5 110.908 -179.873 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.886 0.374 . . . . 75.230000000000004 110.88 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -120.24 140.33 51.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 73.430000000000007 110.92 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.04 -37.83 33.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.21 -0.45 . . . . 63.450000000000003 111.086 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.4 ttmm -60.1 -20.04 56.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 73.340000000000003 110.854 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 17.2 tpp180 -60.03 -20.12 56.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 73.430000000000007 110.829 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 -51.45 -31.77 24.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 73.450000000000003 110.921 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -80.3 -42.45 23.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.187 -0.46 . . . . 71.430000000000007 110.812 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.57 -19.95 66.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 71.420000000000002 111.092 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.445 ' CD1' HD21 ' A' ' 98' ' ' LEU . 41.7 m0 -57.3 -23.8 50.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 74.319999999999993 110.863 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 49.6 mt -52.43 -28.73 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 70.150000000000006 111.178 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 58.3 p -76.0 -60.75 2.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 60.329999999999998 111.153 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.445 HD21 ' CD1' ' A' ' 95' ' ' TRP . 4.5 pp -60.16 -20.39 58.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 75.549999999999997 110.992 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.43 ' N ' HD12 ' A' ' 98' ' ' LEU . 5.7 mm-40 -51.65 -47.81 63.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.103 -0.499 . . . . 35.399999999999999 110.888 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.5 mtpp -54.04 -27.5 32.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 74.540000000000006 110.95 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 98' ' ' LEU . . . -72.7 -43.86 62.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 73.430000000000007 111.092 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.569 ' CD2' HD13 ' A' ' 159' ' ' LEU . 12.5 m-85 -65.38 -31.84 73.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 64.120000000000005 110.924 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -60.31 -26.04 66.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 65.010000000000005 110.895 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -95.85 20.82 9.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.189 -0.459 . . . . 74.239999999999995 110.852 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 51.86 55.46 9.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 75.230000000000004 111.12 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -76.15 163.37 27.16 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.238 -0.437 . . . . 75.25 110.886 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.8 t -91.93 153.76 19.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.476 . . . . 72.549999999999997 111.131 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.2 m -144.53 178.62 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 71.209999999999994 111.179 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.1 t -157.23 123.47 4.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 72.430000000000007 111.171 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -155.87 153.2 24.57 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.73 -0.747 . . . . 43.329999999999998 112.497 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 150' ' ' LYS . 10.2 p -101.02 140.21 20.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.839 0.352 . . . . 54.299999999999997 111.14 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.685 HG13 HG22 ' A' ' 122' ' ' VAL . 4.4 mp -60.12 120.93 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 73.400000000000006 111.145 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -102.27 -43.02 5.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 70.019999999999996 110.875 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -118.45 142.99 17.36 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.682 -0.77 . . . . 74.519999999999996 112.468 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.6 pttt -124.06 123.71 40.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.837 0.351 . . . . 75.200000000000003 110.945 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 26.6 m -110.09 177.33 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 71.400000000000006 111.122 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -62.16 94.14 0.05 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 72.030000000000001 110.953 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.88 -36.14 3.61 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.765 -0.731 . . . . 73.329999999999998 112.499 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -90.02 173.8 39.94 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.728 -0.749 . . . . 73.010000000000005 112.503 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -151.15 127.48 10.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.992 0.425 . . . . 73.129999999999995 110.872 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 57.8 p -98.19 142.46 29.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 71.299999999999997 111.159 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.685 HG22 HG13 ' A' ' 112' ' ' ILE . 21.3 t -133.74 147.15 30.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 62.520000000000003 111.117 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -97.25 134.87 39.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.1 -0.5 . . . . 63.43 110.896 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 78.4 mt -139.41 74.55 1.47 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.119 -0.491 . . . . 74.200000000000003 110.972 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 62.98 42.15 7.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.113 -0.494 . . . . 75.400000000000006 110.902 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 103.03 -31.05 9.19 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.695 -0.764 . . . . 71.510000000000005 112.542 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.573 ' CG2' HG21 ' A' ' 166' ' ' VAL . 60.9 mt -78.04 144.07 11.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.869 0.366 . . . . 73.319999999999993 111.101 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.6 mtp180 -109.22 114.02 27.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 73.510000000000005 110.908 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -92.5 171.54 8.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 63.520000000000003 111.109 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.494 ' HB3' HG23 ' A' ' 167' ' ' VAL . 2.3 t80 -136.44 129.96 31.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.43 . . . . 74.439999999999998 110.842 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.414 HD22 ' CE2' ' A' ' 154' ' ' PHE . 1.0 OUTLIER -109.51 130.54 22.66 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.627 0.727 . . . . 72.140000000000001 110.914 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 140.77 43.51 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.707 2.271 . . . . 70.400000000000006 112.334 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.668 ' O ' HG23 ' A' ' 136' ' ' VAL . . . -66.02 -11.88 56.07 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.771 -0.728 . . . . 72.200000000000003 112.554 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.9 t -76.52 -22.52 54.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.906 0.384 . . . . 71.140000000000001 110.873 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.57 39.52 3.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.504 . . . . 71.019999999999996 110.901 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 133' ' ' GLY . 85.4 t -53.67 -63.09 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 72.439999999999998 111.103 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.544 ' HB3' ' HE2' ' A' ' 146' ' ' HIS . 1.0 OUTLIER -179.65 171.21 1.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 72.0 110.901 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 138' ' ' VAL . 5.9 p -106.06 121.08 58.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 53.409999999999997 111.108 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -177.33 160.79 1.44 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.642 0.734 . . . . 72.019999999999996 110.864 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 166.6 26.93 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.675 2.25 . . . . 72.140000000000001 112.38 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 31.6 m -51.67 -29.63 10.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.233 -0.44 . . . . 61.409999999999997 111.106 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 54.1 mtm180 -51.86 133.04 32.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 73.120000000000005 110.949 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -51.96 169.08 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 65.310000000000002 110.849 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.4 t -169.82 142.41 2.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 34.450000000000003 111.17 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.4 tt -87.9 -8.92 55.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.268 -0.423 . . . . 72.530000000000001 110.883 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.544 ' HE2' ' HB3' ' A' ' 137' ' ' ASP . 0.9 OUTLIER -62.25 -15.72 48.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.443 . . . . 72.349999999999994 110.844 179.909 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 47.9 mt -68.85 -24.05 64.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 63.329999999999998 110.958 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -118.77 123.97 46.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.169 -0.469 . . . . 74.439999999999998 110.845 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 89.54 26.12 26.1 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.711 -0.757 . . . . 65.230000000000004 112.448 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.615 ' HD3' HD13 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -82.78 128.17 34.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.828 0.347 . . . . 70.040000000000006 110.865 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.657 ' O ' HD12 ' A' ' 152' ' ' LEU . 16.4 pt-20 -105.15 108.54 20.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.203 -0.453 . . . . 74.299999999999997 110.932 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.657 HD12 ' O ' ' A' ' 151' ' ' GLU . 2.6 mp -139.11 -179.51 5.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 72.430000000000007 110.914 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -114.31 150.89 33.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 74.319999999999993 110.891 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.414 ' CE2' HD22 ' A' ' 131' ' ' LEU . 19.3 m-85 -125.42 168.06 14.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 73.310000000000002 110.884 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -119.76 123.29 43.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 74.340000000000003 110.862 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 91.9 t -67.61 117.02 8.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.244 -0.434 . . . . 74.319999999999993 111.173 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.4 tp -120.79 -33.35 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 71.040000000000006 111.124 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -171.15 119.96 0.5 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 75.319999999999993 110.872 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.619 HD23 ' H ' ' A' ' 159' ' ' LEU . 2.6 pt? -125.33 139.14 53.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 65.040000000000006 110.881 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -118.5 88.95 3.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 74.519999999999996 110.908 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -67.7 -20.03 65.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 71.329999999999998 110.934 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.23 -37.73 67.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 74.310000000000002 110.84 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -93.25 16.39 13.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.444 . . . . 65.140000000000001 110.861 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.2 m120 51.74 30.11 6.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 72.530000000000001 110.938 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -143.1 164.18 30.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 75.129999999999995 110.853 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.573 HG21 ' CG2' ' A' ' 127' ' ' ILE . 20.2 t -143.43 144.61 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 71.019999999999996 111.13 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.494 HG23 ' HB3' ' A' ' 130' ' ' PHE . 14.3 p -129.07 152.2 36.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 72.329999999999998 111.13 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 130' ' ' PHE . 25.2 m -119.42 145.68 25.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 74.299999999999997 111.124 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.36 159.81 33.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 62.549999999999997 110.799 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.4 ' O ' HG12 ' A' ' 173' ' ' VAL . 11.0 ptm180 -93.45 -37.72 11.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.07 -0.513 . . . . 71.209999999999994 110.881 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 -79.59 -26.75 41.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 64.340000000000003 110.895 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.43 -13.94 62.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.124 -0.489 . . . . 63.399999999999999 111.124 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 170' ' ' ARG . 11.0 p -52.98 -30.7 16.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 63.229999999999997 111.045 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 23.5 pt -61.96 -30.15 47.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 73.439999999999998 111.145 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -71.71 -46.52 58.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.473 . . . . 72.129999999999995 111.027 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 52.6 p -52.01 -47.24 65.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.124 -0.489 . . . . 74.040000000000006 110.81 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -54.9 -52.98 61.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 62.409999999999997 110.945 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -109.1 55.82 0.63 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 61.140000000000001 110.906 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 72.2 p . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 74.5 110.929 -179.906 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.926 0.393 . . . . 75.230000000000004 110.874 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -98.95 -178.24 3.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 73.430000000000007 110.877 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.56 -40.03 43.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.455 . . . . 63.450000000000003 111.073 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.8 pptp? -60.14 -20.01 56.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 73.340000000000003 110.909 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -59.19 -20.87 57.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.434 . . . . 73.430000000000007 110.898 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -51.38 -31.22 21.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 73.450000000000003 110.838 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.501 ' O ' HG23 ' A' ' 96' ' ' ILE . 16.9 tt0 -80.43 -46.13 16.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 71.430000000000007 110.861 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.703 ' O ' HG22 ' A' ' 97' ' ' THR . . . -62.3 -17.18 57.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 71.420000000000002 111.133 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 35.5 m0 -57.85 -22.28 47.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.117 -0.492 . . . . 74.319999999999993 110.92 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.501 HG23 ' O ' ' A' ' 93' ' ' GLU . 31.0 pt -53.03 -31.24 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 70.150000000000006 111.117 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.703 HG22 ' O ' ' A' ' 94' ' ' ALA . 12.8 t -72.32 -30.05 64.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 60.329999999999998 111.17 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.611 ' CD1' HD11 ' A' ' 127' ' ' ILE . 18.4 mt -67.38 -21.0 65.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 75.549999999999997 110.865 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -76.23 -36.12 58.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 35.399999999999999 110.87 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -84.03 -22.45 31.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.118 -0.492 . . . . 74.540000000000006 110.823 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.14 -27.73 59.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.416 . . . . 73.430000000000007 111.067 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.621 ' CG ' HD21 ' A' ' 159' ' ' LEU . 50.9 t80 -55.53 -25.74 39.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.258 -0.428 . . . . 64.120000000000005 110.946 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.74 -27.77 30.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.094 -0.503 . . . . 65.010000000000005 110.906 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -97.1 -19.2 18.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 74.239999999999995 110.846 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 64.03 50.8 2.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 75.230000000000004 111.081 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -64.31 167.14 7.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 75.25 110.867 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.2 t -102.42 165.27 11.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 72.549999999999997 111.244 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.7 m -148.73 177.73 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 71.209999999999994 111.13 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 109' ' ' THR . 4.3 t -149.32 118.09 6.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.447 . . . . 72.430000000000007 111.148 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -134.5 164.77 24.59 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.735 -0.745 . . . . 43.329999999999998 112.491 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.707 HG23 ' C ' ' A' ' 150' ' ' LYS . 13.3 p -105.51 135.79 42.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.777 0.322 . . . . 54.299999999999997 111.174 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.539 HD12 ' O ' ' A' ' 150' ' ' LYS . 4.2 mp -54.35 101.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 73.400000000000006 111.159 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -74.21 -44.26 53.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 70.019999999999996 110.886 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -134.81 155.06 21.78 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.763 -0.732 . . . . 74.519999999999996 112.469 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -124.32 128.82 49.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.848 0.356 . . . . 75.200000000000003 110.881 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.3 m -114.61 176.79 2.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.201 -0.454 . . . . 71.400000000000006 111.085 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -66.73 98.46 0.53 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 72.030000000000001 110.922 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 91.5 -35.57 3.91 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.753 -0.737 . . . . 73.329999999999998 112.535 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -98.25 173.63 27.76 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.756 -0.735 . . . . 73.010000000000005 112.552 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -146.96 118.75 8.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.925 0.393 . . . . 73.129999999999995 110.882 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.13 150.81 26.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 71.299999999999997 111.145 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.418 ' HB ' ' HB3' ' A' ' 129' ' ' ALA . 18.7 t -140.64 149.98 21.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 62.520000000000003 111.097 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -105.94 114.64 28.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.451 . . . . 63.43 110.898 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 77.8 mt -114.53 77.2 1.04 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 74.200000000000003 110.894 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 63.34 52.22 2.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 75.400000000000006 110.933 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 93.96 -34.71 4.51 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.762 -0.732 . . . . 71.510000000000005 112.523 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.611 HD11 ' CD1' ' A' ' 98' ' ' LEU . 27.5 mt -75.18 150.85 6.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.802 0.334 . . . . 73.319999999999993 111.149 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -110.76 132.11 54.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 73.510000000000005 110.822 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.418 ' HB3' ' HB ' ' A' ' 122' ' ' VAL . . . -110.12 171.56 7.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 63.520000000000003 111.088 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -138.54 122.38 17.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.24 -0.436 . . . . 74.439999999999998 110.888 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.507 HD21 ' HE2' ' A' ' 154' ' ' PHE . 10.3 mp -95.07 130.11 33.61 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.648 0.737 . . . . 72.140000000000001 110.931 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.413 ' O ' HG23 ' A' ' 136' ' ' VAL . 54.1 Cg_endo -69.76 132.46 23.38 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.727 2.284 . . . . 70.400000000000006 112.398 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -74.48 -11.14 82.71 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.675 -0.774 . . . . 72.200000000000003 112.445 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 41.8 m -50.4 -32.74 18.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.948 0.404 . . . . 71.140000000000001 110.887 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.783 HD12 ' HB2' ' A' ' 170' ' ' ARG . 28.6 mt -123.12 38.62 4.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.11 -0.496 . . . . 71.019999999999996 110.939 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 132' ' ' PRO . 89.6 t -122.75 -34.98 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 72.439999999999998 111.113 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -99.2 113.52 25.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 72.0 110.865 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 55.7 t -144.21 108.71 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 53.409999999999997 111.175 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.53 160.94 0.12 Allowed Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.655 0.74 . . . . 72.019999999999996 110.866 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 129.18 17.09 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.725 2.284 . . . . 72.140000000000001 112.353 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 7.7 m -149.04 149.61 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 61.409999999999997 111.136 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 36.3 ptt85 -123.37 36.91 4.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.468 . . . . 73.120000000000005 110.845 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -122.56 104.5 9.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.206 -0.452 . . . . 65.310000000000002 110.876 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 41.3 p -126.47 25.21 6.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.173 -0.467 . . . . 34.450000000000003 111.175 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -86.36 -22.28 26.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.258 -0.428 . . . . 72.530000000000001 110.931 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 50.5 p-80 -90.43 -20.92 22.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 72.349999999999994 110.846 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 89.7 mt -87.89 50.78 2.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.268 -0.424 . . . . 63.329999999999998 110.92 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -165.23 124.07 1.71 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 74.439999999999998 110.873 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 63.46 32.26 83.54 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.693 -0.765 . . . . 65.230000000000004 112.488 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.707 ' C ' HG23 ' A' ' 111' ' ' VAL . 0.3 OUTLIER -101.85 129.25 48.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.747 0.308 . . . . 70.040000000000006 110.913 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -86.07 105.01 16.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 74.299999999999997 110.859 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.474 HD22 ' HE3' ' A' ' 150' ' ' LYS . 10.2 tp -114.62 155.35 26.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 72.430000000000007 110.905 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -97.07 129.99 44.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 74.319999999999993 110.9 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.507 ' HE2' HD21 ' A' ' 131' ' ' LEU . 46.3 m-85 -123.05 -179.4 4.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 73.310000000000002 110.861 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.1 tmmm? -141.45 146.17 36.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.087 -0.506 . . . . 74.340000000000003 110.915 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 47.5 t -94.63 78.96 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.248 -0.433 . . . . 74.319999999999993 111.142 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.5 tt -91.5 -25.33 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 71.040000000000006 111.092 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -152.38 114.53 4.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 75.319999999999993 110.884 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.621 HD21 ' CG ' ' A' ' 102' ' ' TYR . 0.9 OUTLIER -118.44 149.27 41.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.431 . . . . 65.040000000000006 110.908 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -116.06 57.57 0.75 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.213 -0.449 . . . . 74.519999999999996 110.89 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -58.95 -25.14 63.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.467 . . . . 71.329999999999998 110.906 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 33.0 tttt -55.73 -25.85 42.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 74.310000000000002 110.832 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.12 24.83 12.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.309 -0.405 . . . . 65.140000000000001 110.859 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 9.1 m120 53.66 28.31 7.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.483 . . . . 72.530000000000001 110.902 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -143.08 172.99 11.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 75.129999999999995 110.825 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.8 m -147.88 144.23 19.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 71.019999999999996 111.167 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 19.2 m -128.53 170.46 18.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 72.329999999999998 111.148 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.444 HG21 HD12 ' A' ' 131' ' ' LEU . 5.5 m -120.34 155.02 23.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 74.299999999999997 111.169 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.5 m -88.42 156.04 19.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 62.549999999999997 110.902 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.783 ' HB2' HD12 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -82.41 -29.0 31.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.134 -0.484 . . . . 71.209999999999994 110.899 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -70.82 -24.05 62.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.488 . . . . 64.340000000000003 110.915 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.57 -14.47 61.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.1 -0.5 . . . . 63.399999999999999 111.171 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 170' ' ' ARG . 14.4 p -53.26 -28.04 14.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 63.229999999999997 111.081 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 35.4 pt -58.9 -21.49 19.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.24 -0.436 . . . . 73.439999999999998 111.112 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -75.9 -51.46 12.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 72.129999999999995 110.879 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 68.5 p -51.85 -62.01 1.9 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 74.040000000000006 110.836 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -50.15 -53.68 25.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 62.409999999999997 110.928 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 38.9 t30 54.96 29.68 12.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 61.140000000000001 110.909 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 43.2 p . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 74.5 110.85 -179.81 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.939 0.399 . . . . 75.230000000000004 110.836 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -126.84 -70.09 0.73 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.1 -0.5 . . . . 73.430000000000007 110.884 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.36 -41.96 81.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 63.450000000000003 111.084 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 20.6 mmmt -56.47 -25.98 52.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.283 -0.417 . . . . 73.340000000000003 110.917 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.9 tpp180 -74.31 -24.26 59.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.281 -0.418 . . . . 73.430000000000007 110.863 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -51.8 -45.5 63.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 73.450000000000003 110.849 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -76.85 -31.69 57.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 71.430000000000007 110.934 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.44 -17.54 63.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.494 . . . . 71.420000000000002 111.117 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.655 ' CD1' HD21 ' A' ' 98' ' ' LEU . 31.9 m0 -57.19 -23.46 47.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 74.319999999999993 110.882 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 68.1 mt -54.07 -27.59 16.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 70.150000000000006 111.134 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 70.9 p -76.95 -59.11 2.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 60.329999999999998 111.154 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.655 HD21 ' CD1' ' A' ' 95' ' ' TRP . 3.4 pp -61.66 -18.09 58.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 75.549999999999997 110.842 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -54.15 -61.73 2.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 35.399999999999999 110.93 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? -66.84 -23.97 66.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.091 -0.504 . . . . 74.540000000000006 110.941 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.524 ' HB1' ' HG3' ' A' ' 106' ' ' GLU . . . -53.17 -45.56 68.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 73.430000000000007 111.145 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.652 ' CE1' HG21 ' A' ' 156' ' ' VAL . 38.1 m-85 -53.34 -33.21 52.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 64.120000000000005 110.901 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -57.24 -26.26 60.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 65.010000000000005 110.894 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.28 20.82 11.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 74.239999999999995 110.833 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 53.71 64.14 1.95 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 75.230000000000004 111.075 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.524 ' HG3' ' HB1' ' A' ' 101' ' ' ALA . 16.2 mm-40 -79.25 178.63 7.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 75.25 110.959 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.1 p -120.03 170.71 9.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 72.549999999999997 111.107 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.705 HG11 HD13 ' A' ' 124' ' ' LEU . 5.2 m -135.34 -179.3 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 71.209999999999994 111.121 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.6 t -155.69 121.41 4.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 72.430000000000007 111.191 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 176.5 168.09 36.08 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.758 -0.734 . . . . 43.329999999999998 112.502 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 151' ' ' GLU . 12.5 m -116.01 150.26 18.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.874 0.369 . . . . 54.299999999999997 111.132 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.793 HD12 ' HB3' ' A' ' 150' ' ' LYS . 5.4 mt -60.4 99.2 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 73.400000000000006 111.16 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 64.2 t-20 -87.8 -41.23 13.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 70.019999999999996 110.917 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -114.03 141.08 16.78 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.724 -0.75 . . . . 74.519999999999996 112.446 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -124.4 123.01 39.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.846 0.355 . . . . 75.200000000000003 110.928 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.6 m -108.22 176.67 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.246 -0.434 . . . . 71.400000000000006 111.149 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -66.83 99.18 0.6 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 72.030000000000001 110.953 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 90.85 -35.79 3.79 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.732 -0.747 . . . . 73.329999999999998 112.485 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -98.2 173.49 27.68 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.77 -0.729 . . . . 73.010000000000005 112.472 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.574 ' HZ ' HD22 ' A' ' 147' ' ' LEU . 6.6 m-85 -144.09 118.85 9.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.905 0.383 . . . . 73.129999999999995 110.927 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.24 149.68 25.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 71.299999999999997 111.17 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.7 t -143.65 137.42 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 62.520000000000003 111.137 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -90.07 104.94 17.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 63.43 110.944 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.705 HD13 HG11 ' A' ' 108' ' ' VAL . 12.5 mt -97.44 84.82 3.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.088 -0.506 . . . . 74.200000000000003 110.924 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 51.79 44.18 29.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 75.400000000000006 110.879 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 103.87 -33.72 6.35 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.715 -0.755 . . . . 71.510000000000005 112.493 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 21.6 mm -73.53 153.07 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.825 0.345 . . . . 73.319999999999993 111.165 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -105.27 119.39 38.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 73.510000000000005 110.882 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.636 ' HB2' HD11 ' A' ' 124' ' ' LEU . . . -101.29 171.66 7.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 63.520000000000003 111.075 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.513 ' O ' HG22 ' A' ' 168' ' ' VAL . 6.4 t80 -145.89 120.67 9.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 74.439999999999998 110.927 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.518 HD12 HG21 ' A' ' 168' ' ' VAL . 9.3 mp -92.92 130.1 37.55 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.619 0.723 . . . . 72.140000000000001 110.946 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.591 ' O ' HG23 ' A' ' 136' ' ' VAL . 55.1 Cg_endo -69.64 135.65 31.28 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.718 2.278 . . . . 70.400000000000006 112.386 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -67.74 -11.44 60.3 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.732 -0.747 . . . . 72.200000000000003 112.476 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 38.2 m -53.49 -35.03 60.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.904 0.383 . . . . 71.140000000000001 110.879 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.489 HD12 ' HB2' ' A' ' 170' ' ' ARG . 0.6 OUTLIER -123.41 39.05 4.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 71.019999999999996 110.937 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 132' ' ' PRO . 83.4 t -118.45 -24.16 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 72.439999999999998 111.129 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -98.53 112.03 24.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 72.0 110.846 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.2 m -154.01 132.07 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 53.409999999999997 111.139 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 19.5 mtm-85 62.62 161.59 0.12 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.612 0.72 . . . . 72.019999999999996 110.867 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.8 164.17 35.56 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.722 2.281 . . . . 72.140000000000001 112.336 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 7.4 p -51.27 139.43 6.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.199 -0.455 . . . . 61.409999999999997 111.105 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -178.4 105.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 73.120000000000005 110.905 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 59.0 97.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 65.310000000000002 110.839 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.17 4.68 33.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.102 -0.499 . . . . 34.450000000000003 111.114 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -87.22 -9.86 54.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.255 -0.429 . . . . 72.530000000000001 110.933 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.469 ' CE1' HD23 ' A' ' 147' ' ' LEU . 0.7 OUTLIER -75.4 -5.91 47.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 72.349999999999994 110.909 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.574 HD22 ' HZ ' ' A' ' 120' ' ' PHE . 2.7 pp -118.3 31.11 6.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 63.329999999999998 110.906 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.421 ' OE1' HD12 ' A' ' 147' ' ' LEU . 5.7 mm-40 -128.68 126.61 40.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 74.439999999999998 110.91 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 63.44 31.71 81.69 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.701 -0.762 . . . . 65.230000000000004 112.531 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.793 ' HB3' HD12 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -72.36 131.74 43.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.81 0.338 . . . . 70.040000000000006 110.85 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.568 ' HA ' HG12 ' A' ' 111' ' ' VAL . 0.2 OUTLIER -99.84 96.6 7.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.175 -0.466 . . . . 74.299999999999997 110.905 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.747 HD22 ' CB ' ' A' ' 176' ' ' SER . 6.9 mt -138.64 141.24 39.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 72.430000000000007 110.934 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -89.92 129.44 36.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 74.319999999999993 110.903 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.451 ' HE2' HD21 ' A' ' 131' ' ' LEU . 34.8 m-85 -110.73 -179.16 3.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 73.310000000000002 110.901 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.667 ' CE ' ' HB3' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -143.99 151.0 39.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 74.340000000000003 110.915 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.652 HG21 ' CE1' ' A' ' 102' ' ' TYR . 61.2 t -91.45 112.48 25.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 74.319999999999993 111.091 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 15.7 tt -87.57 -33.76 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 71.040000000000006 111.114 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -177.89 126.38 0.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 75.319999999999993 110.873 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.481 ' HB3' HG12 ' A' ' 166' ' ' VAL . 0.2 OUTLIER -102.05 119.63 39.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 65.040000000000006 110.949 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -73.5 126.48 30.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 74.519999999999996 110.884 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -78.03 -29.05 49.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 71.329999999999998 110.867 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 12.4 tptm -53.12 -32.17 46.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.248 -0.433 . . . . 74.310000000000002 110.93 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -113.52 -15.27 12.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.1 -0.5 . . . . 65.140000000000001 110.85 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.07 47.94 5.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 72.530000000000001 110.922 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -142.27 154.42 44.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.48 . . . . 75.129999999999995 110.849 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.481 HG12 ' HB3' ' A' ' 159' ' ' LEU . 16.9 m -102.92 144.33 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 71.019999999999996 111.1 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 29.5 m -132.34 171.25 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 72.329999999999998 111.157 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.518 HG21 HD12 ' A' ' 131' ' ' LEU . 26.5 m -119.97 155.25 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 74.299999999999997 111.143 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.77 150.23 30.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 62.549999999999997 110.872 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.558 ' O ' HG12 ' A' ' 173' ' ' VAL . 10.8 ptt180 -82.24 0.11 42.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 71.209999999999994 110.863 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.44 -58.81 2.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 64.340000000000003 110.867 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.667 ' HB3' ' CE ' ' A' ' 155' ' ' LYS . . . -83.37 -7.22 59.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 63.399999999999999 111.071 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.558 HG12 ' O ' ' A' ' 170' ' ' ARG . 7.9 p -50.92 -28.21 6.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 63.229999999999997 111.133 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 28.5 pt -50.32 -30.8 7.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 73.439999999999998 111.118 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -54.7 -45.74 74.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 72.129999999999995 110.925 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.747 ' CB ' HD22 ' A' ' 152' ' ' LEU . 6.2 p -51.22 -44.13 61.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 74.040000000000006 110.913 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -64.42 -51.07 65.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.064 -0.516 . . . . 62.409999999999997 110.901 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -84.81 54.61 3.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 61.140000000000001 110.843 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 74.5 110.806 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.949 0.404 . . . . 75.230000000000004 110.832 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.7 ttpp -144.96 163.44 34.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 73.430000000000007 110.897 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.27 -28.55 42.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 63.450000000000003 111.137 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -60.03 -20.46 58.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 73.340000000000003 110.851 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -61.9 -19.82 63.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 73.430000000000007 110.875 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 -51.76 -30.9 24.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.271 -0.422 . . . . 73.450000000000003 110.907 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -81.31 -45.6 15.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.225 -0.443 . . . . 71.430000000000007 110.854 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.8 -15.89 59.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 71.420000000000002 111.108 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.716 ' CD1' HD21 ' A' ' 98' ' ' LEU . 31.5 m0 -57.72 -22.86 48.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 74.319999999999993 110.866 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 52.1 mt -54.66 -26.33 16.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.304 -0.407 . . . . 70.150000000000006 111.135 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 70.3 p -80.26 -59.2 2.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 60.329999999999998 111.089 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.716 HD21 ' CD1' ' A' ' 95' ' ' TRP . 4.2 pp -61.49 -18.48 59.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.235 -0.439 . . . . 75.549999999999997 110.905 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -73.51 -25.7 60.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 35.399999999999999 110.842 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -79.44 -22.9 43.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 74.540000000000006 110.849 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.684 ' HB1' ' OE2' ' A' ' 106' ' ' GLU . . . -65.53 -38.95 91.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 73.430000000000007 111.076 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.451 ' CD1' HG11 ' A' ' 156' ' ' VAL . 37.9 m-85 -69.1 -23.85 64.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.304 -0.407 . . . . 64.120000000000005 110.942 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.27 -25.23 58.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 65.010000000000005 110.906 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -94.82 20.93 8.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 74.239999999999995 110.904 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 60.95 65.34 1.02 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 75.230000000000004 111.158 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.684 ' OE2' ' HB1' ' A' ' 101' ' ' ALA . 27.4 mt-10 -90.19 169.22 11.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 75.25 110.827 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.3 m -120.48 139.24 53.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 72.549999999999997 111.104 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.506 HG22 HG23 ' A' ' 156' ' ' VAL . 30.1 m -125.74 -177.22 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 71.209999999999994 111.072 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.6 t -161.06 123.46 3.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.116 -0.493 . . . . 72.430000000000007 111.184 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.497 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -149.24 148.48 19.89 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.731 -0.747 . . . . 43.329999999999998 112.448 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 150' ' ' LYS . 10.5 p -90.96 135.61 26.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.804 0.335 . . . . 54.299999999999997 111.115 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.736 HG13 HG22 ' A' ' 122' ' ' VAL . 4.8 mp -63.37 107.14 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.492 . . . . 73.400000000000006 111.101 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -91.51 -34.52 14.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.48 . . . . 70.019999999999996 110.915 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -128.21 143.78 14.69 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.773 -0.727 . . . . 74.519999999999996 112.497 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.5 pttp -123.94 134.77 53.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.822 0.344 . . . . 75.200000000000003 110.907 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.3 m -117.36 176.59 2.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 71.400000000000006 111.095 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -66.37 98.05 0.45 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 72.030000000000001 110.959 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 91.93 -35.26 4.05 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.753 -0.737 . . . . 73.329999999999998 112.485 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -98.17 173.51 27.75 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.761 -0.733 . . . . 73.010000000000005 112.611 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.578 ' HZ ' HD22 ' A' ' 147' ' ' LEU . 7.1 m-85 -145.37 118.93 9.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.919 0.39 . . . . 73.129999999999995 110.965 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.434 ' O ' HG23 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -85.79 147.01 26.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 71.299999999999997 111.109 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.765 ' HB ' ' HB3' ' A' ' 129' ' ' ALA . 32.8 t -138.52 147.68 25.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 62.520000000000003 111.134 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -102.55 105.7 16.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 63.43 110.828 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.499 HD13 HG21 ' A' ' 108' ' ' VAL . 81.8 mt -105.91 74.43 1.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 74.200000000000003 110.962 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 57.72 51.06 9.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 75.400000000000006 111.003 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 99.79 -33.5 6.2 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.757 -0.735 . . . . 71.510000000000005 112.5 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.55 ' CG2' HG21 ' A' ' 166' ' ' VAL . 25.0 mm -76.58 150.25 6.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.793 0.33 . . . . 73.319999999999993 111.157 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 57.9 mtm180 -109.66 117.12 33.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 73.510000000000005 110.859 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.765 ' HB3' ' HB ' ' A' ' 122' ' ' VAL . . . -94.55 171.56 8.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 63.520000000000003 111.171 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.405 ' HB3' HG12 ' A' ' 167' ' ' VAL . 3.0 t80 -146.74 122.03 10.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.28 -0.418 . . . . 74.439999999999998 110.853 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 9.4 mp -110.54 129.43 23.96 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.643 0.735 . . . . 72.140000000000001 110.923 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 152.11 69.01 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.695 2.263 . . . . 70.400000000000006 112.325 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.46 -18.57 61.27 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.724 -0.75 . . . . 72.200000000000003 112.523 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 44.2 t -73.65 -26.21 60.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.849 0.357 . . . . 71.140000000000001 110.8 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.771 HD12 ' HA ' ' A' ' 170' ' ' ARG . 10.1 tt -79.97 -26.92 39.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 71.019999999999996 110.875 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.537 HG21 ' CD2' ' A' ' 120' ' ' PHE . 81.8 t -78.94 -62.76 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 72.439999999999998 111.119 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -166.37 161.92 16.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 72.0 110.908 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 27.0 m -82.04 147.87 5.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 53.409999999999997 111.138 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.01 160.53 0.12 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.605 0.717 . . . . 72.019999999999996 110.884 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.69 145.54 57.89 Favored 'Trans proline' 0 C--O 1.23 0.123 0 C-N-CA 122.745 2.297 . . . . 72.140000000000001 112.289 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.6 p -116.29 149.96 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 61.409999999999997 111.141 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -66.21 -75.22 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 73.120000000000005 110.859 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -179.93 138.57 0.12 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 65.310000000000002 110.896 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.82 157.5 33.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 34.450000000000003 111.122 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.8 mp -87.57 -9.64 53.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 72.530000000000001 110.88 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -60.33 -18.79 52.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.161 -0.472 . . . . 72.349999999999994 110.81 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.578 HD22 ' HZ ' ' A' ' 120' ' ' PHE . 1.4 pp -109.35 36.41 2.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 63.329999999999998 110.931 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -129.66 124.68 34.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 74.439999999999998 110.832 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 66.64 23.51 72.25 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.727 -0.749 . . . . 65.230000000000004 112.489 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.666 ' HD3' HD12 ' A' ' 152' ' ' LEU . 1.6 ttmm -63.33 130.26 43.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.726 0.298 . . . . 70.040000000000006 110.878 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -104.16 89.71 3.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 74.299999999999997 110.843 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.666 HD12 ' HD3' ' A' ' 150' ' ' LYS . 5.8 mt -138.34 135.98 35.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.139 -0.482 . . . . 72.430000000000007 110.921 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -85.91 158.03 20.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 74.319999999999993 110.852 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.427 ' CE2' HG21 ' A' ' 122' ' ' VAL . 4.2 m-85 -126.06 -179.23 4.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 73.310000000000002 110.852 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.435 ' CB ' ' HB1' ' A' ' 172' ' ' ALA . 6.5 tttp -125.26 108.24 11.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.12 -0.491 . . . . 74.340000000000003 110.899 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.506 HG23 HG22 ' A' ' 108' ' ' VAL . 21.5 t -69.33 128.92 33.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.43 . . . . 74.319999999999993 111.127 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 7.8 tp -118.3 -29.35 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 71.040000000000006 111.164 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.614 ' C ' HD13 ' A' ' 159' ' ' LEU . 0.0 OUTLIER -170.99 166.42 7.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 75.319999999999993 110.918 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.614 HD13 ' C ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -155.84 165.48 36.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 65.040000000000006 110.917 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -119.18 96.58 5.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 74.519999999999996 110.878 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -77.12 -23.3 51.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.159 -0.473 . . . . 71.329999999999998 110.857 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 22.5 tptt -51.79 -45.75 63.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 74.310000000000002 110.967 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -104.6 16.88 25.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 65.140000000000001 110.893 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 51.51 48.57 22.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 72.530000000000001 110.939 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -121.88 153.81 37.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 75.129999999999995 110.947 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.55 HG21 ' CG2' ' A' ' 127' ' ' ILE . 97.3 t -142.98 128.51 16.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 71.019999999999996 111.151 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.405 HG12 ' HB3' ' A' ' 130' ' ' PHE . 34.1 m -134.81 171.18 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 72.329999999999998 111.184 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 6.3 m -120.27 145.75 26.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 74.299999999999997 111.084 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.85 157.47 37.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 62.549999999999997 110.871 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.771 ' HA ' HD12 ' A' ' 135' ' ' LEU . 0.3 OUTLIER -81.87 -42.13 20.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.121 -0.491 . . . . 71.209999999999994 110.82 -179.912 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 83.7 mtm-85 -59.7 -20.6 57.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.266 -0.424 . . . . 64.340000000000003 110.847 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.435 ' HB1' ' CB ' ' A' ' 155' ' ' LYS . . . -61.7 -17.45 55.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 63.399999999999999 111.084 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 10.2 p -50.71 -30.5 8.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 63.229999999999997 111.173 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 27.2 pt -51.48 -32.44 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.488 . . . . 73.439999999999998 111.12 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -88.03 -26.4 22.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.463 . . . . 72.129999999999995 110.853 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.467 ' OG ' HD22 ' A' ' 152' ' ' LEU . 5.1 t -91.29 12.79 19.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 74.040000000000006 110.877 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -50.01 -53.43 26.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 62.409999999999997 110.91 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -128.14 -58.48 1.21 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 61.140000000000001 110.886 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 10.9 t . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 74.5 110.873 -179.848 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.3 mp0 . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.966 0.412 . . . . 75.230000000000004 110.867 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -114.93 117.66 31.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 73.430000000000007 110.916 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.75 -30.16 59.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 63.450000000000003 111.079 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -64.67 -27.95 69.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 73.340000000000003 110.939 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -57.07 -27.16 61.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 73.430000000000007 110.866 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -52.04 -37.7 54.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 73.450000000000003 110.904 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -81.77 -29.91 32.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.447 . . . . 71.430000000000007 110.922 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.96 -24.47 61.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 71.420000000000002 111.159 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.561 ' HA ' HD23 ' A' ' 98' ' ' LEU . 53.9 m0 -58.77 -22.57 58.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.197 -0.456 . . . . 74.319999999999993 110.962 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 70.0 mt -51.53 -29.96 10.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.218 -0.446 . . . . 70.150000000000006 111.134 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 73.3 p -64.27 -52.13 60.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 60.329999999999998 111.104 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.629 HD21 HD11 ' A' ' 127' ' ' ILE . 0.6 OUTLIER -70.88 -21.73 62.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.435 . . . . 75.549999999999997 110.962 179.961 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -59.9 -52.29 66.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.164 -0.471 . . . . 35.399999999999999 110.867 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -57.65 -27.45 62.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.471 . . . . 74.540000000000006 110.953 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 98' ' ' LEU . . . -51.98 -48.4 64.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.166 -0.47 . . . . 73.430000000000007 111.111 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.426 ' OH ' HG11 ' A' ' 108' ' ' VAL . 92.8 m-85 -55.74 -33.26 64.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 64.120000000000005 110.924 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.57 -26.41 66.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 65.010000000000005 110.899 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -104.46 20.97 17.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 74.239999999999995 110.838 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 57.91 67.41 0.96 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 75.230000000000004 111.043 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -104.06 176.15 5.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 75.25 110.937 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.3 t -121.14 164.95 16.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.166 -0.47 . . . . 72.549999999999997 111.062 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.426 HG11 ' OH ' ' A' ' 102' ' ' TYR . 34.9 m -135.4 -178.09 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 71.209999999999994 111.096 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.438 ' O ' HD23 ' A' ' 124' ' ' LEU . 4.9 t -154.13 122.85 6.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.081 -0.508 . . . . 72.430000000000007 111.156 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -156.87 150.97 22.35 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.742 -0.742 . . . . 43.329999999999998 112.503 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.467 ' C ' HG13 ' A' ' 122' ' ' VAL . 7.3 p -109.45 141.2 25.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.829 0.347 . . . . 54.299999999999997 111.12 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.768 HG13 HG22 ' A' ' 122' ' ' VAL . 4.3 mp -67.36 101.88 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.132 -0.485 . . . . 73.400000000000006 111.066 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -91.26 -27.16 18.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 70.019999999999996 110.912 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -134.18 143.05 14.62 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.736 -0.745 . . . . 74.519999999999996 112.48 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.98 136.66 54.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.788 0.327 . . . . 75.200000000000003 110.937 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.3 m -118.39 176.44 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 71.400000000000006 111.183 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.94 97.73 0.37 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 72.030000000000001 110.928 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 92.24 -35.02 4.16 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.752 -0.737 . . . . 73.329999999999998 112.465 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -98.17 173.55 27.79 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.737 -0.744 . . . . 73.010000000000005 112.48 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.742 ' CE2' HG11 ' A' ' 136' ' ' VAL . 9.0 m-85 -146.03 119.09 8.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.86 0.362 . . . . 73.129999999999995 110.877 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.486 ' O ' HG23 ' A' ' 112' ' ' ILE . 1.4 m -86.5 150.6 24.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 71.299999999999997 111.155 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.768 HG22 HG13 ' A' ' 112' ' ' ILE . 21.6 t -138.89 131.93 38.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.287 -0.415 . . . . 62.520000000000003 111.165 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -84.01 99.27 10.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 63.43 110.897 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.719 HD12 ' HB2' ' A' ' 129' ' ' ALA . 25.4 mt -99.89 77.65 2.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 74.200000000000003 110.907 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 52.14 52.92 13.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 75.400000000000006 110.878 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 93.36 -22.31 35.78 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.764 -0.731 . . . . 71.510000000000005 112.532 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.629 HD11 HD21 ' A' ' 98' ' ' LEU . 57.1 mt -83.02 144.43 10.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.8 0.333 . . . . 73.319999999999993 111.141 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -100.52 109.25 21.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 73.510000000000005 110.848 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.765 ' HB3' ' HB ' ' A' ' 122' ' ' VAL . . . -92.99 171.59 8.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 63.520000000000003 111.019 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -146.76 129.73 16.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 74.439999999999998 110.856 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.591 ' CD2' HG23 ' A' ' 168' ' ' VAL . 5.5 mt -120.17 129.52 25.3 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.587 0.708 . . . . 72.140000000000001 110.943 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.615 ' O ' HG23 ' A' ' 136' ' ' VAL . 53.7 Cg_endo -69.88 136.78 33.55 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.677 2.252 . . . . 70.400000000000006 112.29 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -71.54 -16.74 75.95 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.759 -0.734 . . . . 72.200000000000003 112.424 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 2.9 t -55.4 -26.37 41.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.88 0.371 . . . . 71.140000000000001 110.858 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.503 HD13 ' HB2' ' A' ' 171' ' ' ARG . 28.7 mt -120.61 24.64 10.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.47 . . . . 71.019999999999996 110.932 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.742 HG11 ' CE2' ' A' ' 120' ' ' PHE . 88.6 t -113.46 -49.41 5.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 72.439999999999998 111.174 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -99.08 112.64 24.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 72.0 110.85 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 138' ' ' VAL . 5.8 m -152.89 107.07 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 53.409999999999997 111.14 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 18.7 mmt-85 51.94 69.13 2.63 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.557 0.694 . . . . 72.019999999999996 110.89 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 143.81 52.11 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.618 2.212 . . . . 72.140000000000001 112.362 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 4.1 m -139.77 85.89 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 61.409999999999997 111.196 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.1 ptt-85 39.42 41.74 0.74 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.472 . . . . 73.120000000000005 110.824 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -137.93 97.39 3.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 65.310000000000002 110.925 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.721 ' CG2' HD12 ' A' ' 147' ' ' LEU . 0.2 OUTLIER -118.77 -13.67 9.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 34.450000000000003 111.125 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 13.7 mt -62.88 -21.65 66.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 72.530000000000001 110.943 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -93.36 18.21 10.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 72.349999999999994 110.891 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.721 HD12 ' CG2' ' A' ' 144' ' ' THR . 61.5 mt -110.51 -33.11 6.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 63.329999999999998 110.949 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -128.32 129.5 46.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 74.439999999999998 110.879 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 90.42 -14.84 61.51 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.771 -0.728 . . . . 65.230000000000004 112.45 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.548 ' O ' HD12 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -59.89 129.97 44.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.804 0.335 . . . . 70.040000000000006 110.867 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -111.02 114.28 27.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 74.299999999999997 110.942 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.712 ' C ' HD22 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -140.66 165.17 28.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 72.430000000000007 110.922 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.57 ' N ' HD22 ' A' ' 152' ' ' LEU . 1.3 tt0 -98.38 131.03 45.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.175 -0.466 . . . . 74.319999999999993 110.93 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.476 ' CZ ' HD11 ' A' ' 152' ' ' LEU . 16.2 m-85 -97.22 -179.41 4.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 73.310000000000002 110.879 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.45 ' H ' ' HB1' ' A' ' 172' ' ' ALA . 13.6 tttm -137.09 145.98 44.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 74.340000000000003 110.918 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 156' ' ' VAL . 5.5 p -56.62 120.18 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.434 . . . . 74.319999999999993 111.145 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.8 tp -130.21 -38.86 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.109 -0.496 . . . . 71.040000000000006 111.146 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -169.28 139.38 2.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 75.319999999999993 110.927 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -153.21 125.76 8.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 65.040000000000006 110.915 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -91.29 63.37 4.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 74.519999999999996 110.873 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -55.39 -26.44 41.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 71.329999999999998 110.923 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 18.5 ttpp -57.3 -43.16 82.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 74.310000000000002 110.915 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -102.94 24.85 10.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.448 . . . . 65.140000000000001 110.937 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 52.71 33.44 13.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.098 -0.501 . . . . 72.530000000000001 110.926 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -108.78 154.67 21.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 75.129999999999995 110.908 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 7.1 p -152.4 123.73 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 71.019999999999996 111.119 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 19.5 m -134.63 148.18 29.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 72.329999999999998 111.192 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.591 HG23 ' CD2' ' A' ' 131' ' ' LEU . 6.1 m -120.44 171.81 8.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 74.299999999999997 111.158 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.9 m -123.88 142.19 51.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 62.549999999999997 110.895 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.591 ' O ' HG23 ' A' ' 173' ' ' VAL . 0.2 OUTLIER -65.92 -34.35 77.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 71.209999999999994 110.899 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.503 ' HB2' HD13 ' A' ' 135' ' ' LEU . 29.5 ttm180 -61.93 -20.79 64.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 64.340000000000003 110.883 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.45 ' HB1' ' H ' ' A' ' 155' ' ' LYS . . . -55.89 -24.83 39.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 63.399999999999999 111.069 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 170' ' ' ARG . 95.6 t -51.88 -37.62 21.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 63.229999999999997 111.102 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 2.0 pp -54.05 -27.31 16.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.186 -0.461 . . . . 73.439999999999998 111.125 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -77.24 -63.63 1.32 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.466 . . . . 72.129999999999995 110.846 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 66.3 p -52.27 -49.24 64.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 74.040000000000006 110.857 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -53.72 -58.58 6.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.489 . . . . 62.409999999999997 110.871 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -59.59 -74.31 0.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 61.140000000000001 110.96 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 6.4 p . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.131 -0.486 . . . . 74.5 110.859 -179.912 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.943 0.401 . . . . 75.230000000000004 110.895 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.5 mmtt 59.6 40.11 20.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.145 -0.479 . . . . 73.430000000000007 110.829 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.95 -55.4 14.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 63.450000000000003 111.11 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.68 -27.28 69.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.27 -0.423 . . . . 73.340000000000003 110.88 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -66.58 -26.84 67.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.426 . . . . 73.430000000000007 110.9 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -51.95 -43.22 63.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 73.450000000000003 110.871 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -79.29 -24.94 42.54 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.198 -0.456 . . . . 71.430000000000007 110.914 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -77.75 -19.72 54.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 71.420000000000002 111.055 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.573 ' CD1' HD21 ' A' ' 98' ' ' LEU . 41.4 m0 -58.1 -22.68 51.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 74.319999999999993 110.897 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 35.7 pt -51.78 -29.35 10.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.285 -0.416 . . . . 70.150000000000006 111.14 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.1 p -75.27 -61.48 1.89 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.146 -0.479 . . . . 60.329999999999998 111.18 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.573 HD21 ' CD1' ' A' ' 95' ' ' TRP . 3.4 pp -59.05 -21.76 59.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.25 -0.432 . . . . 75.549999999999997 110.874 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -51.92 -47.22 64.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 35.399999999999999 110.85 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -62.65 -28.94 70.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.121 -0.49 . . . . 74.540000000000006 110.893 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 98' ' ' LEU . . . -58.05 -44.09 87.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 73.430000000000007 111.099 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.798 ' HB3' HD11 ' A' ' 159' ' ' LEU . 42.6 m-85 -56.41 -34.08 66.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.158 -0.474 . . . . 64.120000000000005 110.968 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.32 -26.06 60.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.1 -0.5 . . . . 65.010000000000005 110.881 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -94.79 20.7 8.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.143 -0.48 . . . . 74.239999999999995 110.828 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 59.35 36.59 23.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.439 . . . . 75.230000000000004 111.123 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -61.89 152.97 30.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 75.25 110.877 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.636 HG22 ' HG2' ' A' ' 155' ' ' LYS . 35.5 p -93.69 148.52 22.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.066 -0.516 . . . . 72.549999999999997 111.09 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.7 m -123.32 168.85 15.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 71.209999999999994 111.114 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.518 HG22 ' HG2' ' A' ' 153' ' ' GLU . 0.5 OUTLIER -146.41 118.49 8.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.477 . . . . 72.430000000000007 111.135 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -152.37 151.02 22.94 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.649 -0.786 . . . . 43.329999999999998 112.44 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 150' ' ' LYS . 12.3 p -101.28 139.6 22.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.722 0.296 . . . . 54.299999999999997 111.164 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.622 HD12 ' O ' ' A' ' 150' ' ' LYS . 4.0 mp -61.1 116.49 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 73.400000000000006 111.06 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -97.86 -45.2 6.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 70.019999999999996 110.861 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -124.89 153.54 17.9 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.778 -0.725 . . . . 74.519999999999996 112.539 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 9.2 ptmm? -124.05 125.2 44.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.843 0.354 . . . . 75.200000000000003 110.905 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.0 m -104.02 177.31 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 71.400000000000006 111.109 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 53.2 mttt -62.15 94.64 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 72.030000000000001 110.861 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 90.08 -36.25 3.6 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.75 -0.738 . . . . 73.329999999999998 112.534 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -92.59 173.51 35.43 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.713 -0.756 . . . . 73.010000000000005 112.509 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -142.94 118.28 10.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.934 0.397 . . . . 73.129999999999995 110.917 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 33.3 p -84.84 150.97 24.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 71.299999999999997 111.135 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.611 HG22 HG13 ' A' ' 112' ' ' ILE . 64.3 t -139.38 138.37 40.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 62.520000000000003 111.168 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -91.44 100.55 13.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 63.43 110.889 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 10.9 mt -90.72 81.85 5.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 74.200000000000003 110.945 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 42.0 52.11 4.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 75.400000000000006 110.905 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 104.01 -34.02 6.11 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.762 -0.732 . . . . 71.510000000000005 112.49 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.662 ' CG2' HG11 ' A' ' 166' ' ' VAL . 25.2 mt -76.45 152.29 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.779 0.323 . . . . 73.319999999999993 111.136 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.555 ' O ' HG13 ' A' ' 166' ' ' VAL . 53.7 mtm180 -105.09 105.49 15.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 73.510000000000005 110.889 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.573 ' HB3' ' HB ' ' A' ' 122' ' ' VAL . . . -92.81 159.12 15.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 63.520000000000003 111.032 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -133.75 125.95 29.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 74.439999999999998 110.871 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.809 HD22 HD11 ' A' ' 135' ' ' LEU . 22.6 mt -115.05 131.65 23.42 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.634 0.73 . . . . 72.140000000000001 110.843 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.614 ' HD2' HD21 ' A' ' 135' ' ' LEU . 53.8 Cg_endo -69.74 164.65 33.73 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.665 2.243 . . . . 70.400000000000006 112.399 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.729 ' HA2' HG13 ' A' ' 136' ' ' VAL . . . -67.13 -11.0 58.02 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.719 -0.753 . . . . 72.200000000000003 112.513 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.5 t -60.24 -32.27 70.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.94 0.4 . . . . 71.140000000000001 110.881 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.809 HD11 HD22 ' A' ' 131' ' ' LEU . 0.8 OUTLIER -124.09 41.97 3.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 71.019999999999996 110.943 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.729 HG13 ' HA2' ' A' ' 133' ' ' GLY . 0.3 OUTLIER -50.72 -43.07 23.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 72.439999999999998 111.142 179.814 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -179.71 119.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 72.0 110.859 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 12.7 p -76.06 138.79 20.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 53.409999999999997 111.168 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 30.8 mtp180 61.24 75.62 0.44 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.626 0.727 . . . . 72.019999999999996 110.865 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.73 135.31 30.19 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.702 2.268 . . . . 72.140000000000001 112.336 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.412 HG12 ' N ' ' A' ' 142' ' ' ARG . 5.9 t -127.74 157.94 39.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 61.409999999999997 111.15 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.412 ' N ' HG12 ' A' ' 141' ' ' VAL . 0.0 OUTLIER -50.89 -30.81 15.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 73.120000000000005 110.827 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -84.34 129.57 34.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 65.310000000000002 110.847 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.615 HG22 HD11 ' A' ' 147' ' ' LEU . 18.1 p -98.6 27.92 4.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 34.450000000000003 111.131 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.5 tp -87.49 -21.36 25.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 72.530000000000001 110.88 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 33.7 p-80 -89.08 -21.86 23.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 72.349999999999994 110.86 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.615 HD11 HG22 ' A' ' 144' ' ' THR . 59.2 mt -51.84 -57.98 7.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 63.329999999999998 110.973 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -101.7 145.11 29.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 74.439999999999998 110.848 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 95.45 -12.15 68.06 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.756 -0.735 . . . . 65.230000000000004 112.573 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.622 ' O ' HD12 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -55.65 133.56 50.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.682 0.277 . . . . 70.040000000000006 110.95 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -110.26 111.92 23.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.269 -0.423 . . . . 74.299999999999997 110.897 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.514 HD12 ' HD3' ' A' ' 150' ' ' LYS . 5.4 mt -139.21 159.32 42.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 72.430000000000007 110.894 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.518 ' HG2' HG22 ' A' ' 109' ' ' THR . 12.9 mt-10 -95.0 148.18 22.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 74.319999999999993 110.867 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.724 ' HA ' HG23 ' A' ' 173' ' ' VAL . 3.6 m-85 -123.32 -179.47 4.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 73.310000000000002 110.832 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.636 ' HG2' HG22 ' A' ' 107' ' ' THR . 0.2 OUTLIER -135.14 108.19 7.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 74.340000000000003 110.902 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.602 HG21 ' CD1' ' A' ' 102' ' ' TYR . 89.1 t -60.47 105.98 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.217 -0.447 . . . . 74.319999999999993 111.129 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.6 tt -89.58 -30.29 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 71.040000000000006 111.144 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -176.41 169.67 2.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 75.319999999999993 110.894 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.798 HD11 ' HB3' ' A' ' 102' ' ' TYR . 0.4 OUTLIER -143.1 160.96 39.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 65.040000000000006 110.889 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.78 101.8 10.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.187 -0.461 . . . . 74.519999999999996 110.931 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -81.15 -36.08 30.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 71.329999999999998 110.929 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 29.9 tttp -69.45 -46.14 67.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 74.310000000000002 110.888 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -73.62 -15.31 61.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 65.140000000000001 110.922 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.4 m120 63.34 41.06 8.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 72.530000000000001 110.945 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -139.09 128.94 24.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 75.129999999999995 110.897 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.662 HG11 ' CG2' ' A' ' 127' ' ' ILE . 7.2 p -99.98 130.59 48.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 71.019999999999996 111.066 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 18.9 m -134.79 171.17 18.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 72.329999999999998 111.118 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.433 HG23 HD23 ' A' ' 131' ' ' LEU . 1.8 m -120.34 153.16 23.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.468 . . . . 74.299999999999997 111.112 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.28 160.64 31.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 62.549999999999997 110.875 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.701 ' O ' HG12 ' A' ' 173' ' ' VAL . 17.6 ptt180 -121.74 -33.94 3.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.167 -0.47 . . . . 71.209999999999994 110.893 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -81.75 -34.35 30.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 64.340000000000003 110.86 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -83.62 -26.4 29.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 63.399999999999999 111.12 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.724 HG23 ' HA ' ' A' ' 154' ' ' PHE . 5.7 p -58.07 -20.29 14.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 63.229999999999997 111.128 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 27.3 pt -53.11 -27.96 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.485 . . . . 73.439999999999998 111.117 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -87.21 -31.81 20.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 72.129999999999995 110.895 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 3.7 t -76.8 -25.03 52.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 74.040000000000006 110.827 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.481 ' HA ' HD22 ' A' ' 152' ' ' LEU . 36.6 mt-10 -60.81 -33.7 73.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.122 -0.49 . . . . 62.409999999999997 110.889 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -123.88 49.04 1.79 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.491 . . . . 61.140000000000001 110.886 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 41.8 t . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 74.5 110.825 -179.829 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.903 0.382 . . . . 75.230000000000004 110.892 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -81.71 -27.78 33.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.11 -0.495 . . . . 73.430000000000007 110.957 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.41 -51.44 68.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 63.450000000000003 111.08 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.1 mtmm -55.87 -26.01 45.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 73.340000000000003 110.892 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.87 -26.46 36.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 73.430000000000007 110.865 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 14.7 t60 -51.61 -30.27 20.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.153 -0.476 . . . . 73.450000000000003 110.911 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -79.29 -34.98 41.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.165 -0.47 . . . . 71.430000000000007 110.872 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.32 -15.52 62.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 71.420000000000002 111.096 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -57.76 -22.48 47.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 74.319999999999993 110.951 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 27.2 pt -52.31 -32.7 16.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.288 -0.414 . . . . 70.150000000000006 111.154 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.6 p -86.07 -23.65 26.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 60.329999999999998 111.13 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.497 ' O ' HD12 ' A' ' 98' ' ' LEU . 7.6 tp -67.8 -28.55 67.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.21 -0.45 . . . . 75.549999999999997 110.889 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -60.35 -48.17 82.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 35.399999999999999 110.898 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -67.41 -24.65 65.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 74.540000000000006 110.888 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.1 -36.92 85.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 73.430000000000007 111.095 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.73 ' CG ' HD21 ' A' ' 159' ' ' LEU . 12.6 t80 -52.81 -28.96 25.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 64.120000000000005 110.977 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.49 -25.05 50.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.078 -0.51 . . . . 65.010000000000005 110.902 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -94.3 -22.21 18.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.139 -0.482 . . . . 74.239999999999995 110.874 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 62.16 44.49 7.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.443 . . . . 75.230000000000004 111.066 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.77 165.27 15.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 75.25 110.936 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.8 t -94.56 168.07 11.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 72.549999999999997 111.163 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.2 m -152.96 -178.62 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 71.209999999999994 111.128 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 109' ' ' THR . 4.1 t -141.43 116.67 10.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 72.430000000000007 111.215 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.403 ' CA ' HD23 ' A' ' 124' ' ' LEU . . . -134.46 151.98 20.5 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.721 -0.752 . . . . 43.329999999999998 112.449 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.689 HG22 ' HA ' ' A' ' 151' ' ' GLU . 85.5 t -115.56 134.2 59.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.751 0.31 . . . . 54.299999999999997 111.132 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.494 HD12 ' O ' ' A' ' 150' ' ' LYS . 3.5 mp -54.66 115.34 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 73.400000000000006 111.136 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -100.16 -41.64 7.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 70.019999999999996 110.926 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -120.87 145.84 17.37 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.799 -0.715 . . . . 74.519999999999996 112.512 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.2 pttt -124.03 128.42 49.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.788 0.328 . . . . 75.200000000000003 110.927 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.6 m -119.82 176.5 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 71.400000000000006 111.167 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -68.15 99.06 0.85 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 72.030000000000001 110.927 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 92.02 -35.13 4.1 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.763 -0.732 . . . . 73.329999999999998 112.452 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -98.26 173.6 27.71 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.774 -0.727 . . . . 73.010000000000005 112.494 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -152.56 119.06 5.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.989 0.423 . . . . 73.129999999999995 110.905 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.418 ' O ' HG23 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -86.29 150.89 24.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.159 -0.473 . . . . 71.299999999999997 111.116 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.653 ' HB ' ' HB3' ' A' ' 129' ' ' ALA . 19.9 t -140.69 139.83 34.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.494 . . . . 62.520000000000003 111.121 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -95.02 107.28 19.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 63.43 110.871 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.403 HD23 ' CA ' ' A' ' 110' ' ' GLY . 26.9 mt -103.18 72.67 1.18 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.157 -0.474 . . . . 74.200000000000003 110.955 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 54.38 50.89 15.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 75.400000000000006 110.927 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 103.9 -33.38 6.62 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.714 -0.755 . . . . 71.510000000000005 112.461 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.6 mm -80.06 156.18 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.842 0.354 . . . . 73.319999999999993 111.114 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 47.7 mtt180 -114.84 121.67 43.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 73.510000000000005 110.956 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.653 ' HB3' ' HB ' ' A' ' 122' ' ' VAL . . . -102.25 168.45 9.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.25 -0.432 . . . . 63.520000000000003 111.123 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -147.87 124.41 11.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 74.439999999999998 110.844 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.584 HD21 ' CG2' ' A' ' 122' ' ' VAL . 0.1 OUTLIER -122.89 130.16 24.72 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.68 0.753 . . . . 72.140000000000001 110.887 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 146.21 59.77 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.652 2.235 . . . . 70.400000000000006 112.373 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -67.63 -11.35 59.88 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.772 -0.727 . . . . 72.200000000000003 112.482 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.6 m -51.33 -30.63 19.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.89 0.376 . . . . 71.140000000000001 110.838 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.539 HD22 ' CA ' ' A' ' 170' ' ' ARG . 5.0 tp -116.16 29.09 8.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 71.019999999999996 110.886 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 94.4 t -120.01 -32.74 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.251 -0.431 . . . . 72.439999999999998 111.113 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -108.11 116.0 31.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 72.0 110.843 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.439 HG12 ' H ' ' A' ' 139' ' ' ARG . 1.4 t -129.18 166.95 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 53.409999999999997 111.092 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.484 ' N ' ' HD2' ' A' ' 140' ' ' PRO . 0.9 OUTLIER -50.86 -60.68 5.05 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.602 0.715 . . . . 72.019999999999996 110.893 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 139' ' ' ARG . 54.5 Cg_endo -69.74 133.36 25.42 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.746 2.297 . . . . 72.140000000000001 112.361 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.7 m -128.83 148.7 33.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 61.409999999999997 111.103 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 81.9 mtt180 -124.73 -60.72 1.36 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.48 . . . . 73.120000000000005 110.88 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -153.01 162.75 40.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 65.310000000000002 110.87 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.526 HG22 HD11 ' A' ' 147' ' ' LEU . 5.8 p -106.5 19.72 20.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.205 -0.452 . . . . 34.450000000000003 111.184 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 145' ' ' LEU . 4.2 mm? -87.36 -24.56 24.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.494 . . . . 72.530000000000001 110.968 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.4 -8.59 59.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.146 -0.479 . . . . 72.349999999999994 110.88 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.526 HD11 HG22 ' A' ' 144' ' ' THR . 78.7 mt -58.92 -49.42 77.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.171 -0.468 . . . . 63.329999999999998 110.918 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -130.26 137.44 50.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 74.439999999999998 110.855 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 92.11 -16.44 59.62 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.799 -0.715 . . . . 65.230000000000004 112.505 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.593 ' HD3' HD13 ' A' ' 152' ' ' LEU . 0.4 OUTLIER -51.62 127.17 19.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.717 0.294 . . . . 70.040000000000006 110.914 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.689 ' HA ' HG22 ' A' ' 111' ' ' VAL . 2.9 pm0 -89.29 111.1 21.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.252 -0.431 . . . . 74.299999999999997 110.852 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.593 HD13 ' HD3' ' A' ' 150' ' ' LYS . 1.5 tp -139.25 -175.46 4.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 72.430000000000007 110.941 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -133.78 135.7 44.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 74.319999999999993 110.884 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.578 ' CE1' HG11 ' A' ' 122' ' ' VAL . 13.4 m-85 -119.25 -179.34 3.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.477 . . . . 73.310000000000002 110.834 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.666 ' O ' HD12 ' A' ' 157' ' ' ILE . 4.2 mttm -128.47 160.77 31.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 74.340000000000003 110.948 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.422 HG12 ' CD1' ' A' ' 102' ' ' TYR . 21.6 t -84.07 82.06 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.276 -0.42 . . . . 74.319999999999993 111.096 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.666 HD12 ' O ' ' A' ' 155' ' ' LYS . 5.1 mp -77.99 -40.49 26.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 71.040000000000006 111.089 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.41 154.74 7.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 75.319999999999993 110.857 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.73 HD21 ' CG ' ' A' ' 102' ' ' TYR . 0.2 OUTLIER -140.03 112.73 7.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 65.040000000000006 110.869 179.904 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -67.61 91.45 0.29 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.172 -0.467 . . . . 74.519999999999996 110.885 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -60.58 -19.93 59.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 71.329999999999998 110.923 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -51.6 -37.79 51.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 74.310000000000002 110.905 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 24.2 ttt85 -123.06 19.79 9.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 65.140000000000001 110.894 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 51.82 29.89 6.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 72.530000000000001 110.874 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -112.85 157.98 20.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.202 -0.454 . . . . 75.129999999999995 110.928 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.623 HG23 ' HB3' ' A' ' 159' ' ' LEU . 10.2 p -125.96 144.23 36.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 71.019999999999996 111.137 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 19.7 m -127.81 169.54 19.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 72.329999999999998 111.171 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 15.5 m -120.28 162.01 19.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.451 . . . . 74.299999999999997 111.087 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.638 ' H ' HD13 ' A' ' 157' ' ' ILE . 28.4 t -103.36 161.17 14.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 62.549999999999997 110.852 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.539 ' CA ' HD22 ' A' ' 135' ' ' LEU . 25.8 mtm180 -79.93 -58.16 3.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 71.209999999999994 110.918 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -56.35 -26.02 51.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 64.340000000000003 110.871 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.26 -14.03 61.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 63.399999999999999 111.04 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 13.5 p -51.6 -29.59 10.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 63.229999999999997 111.168 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 32.7 pt -51.62 -30.32 11.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.135 -0.484 . . . . 73.439999999999998 111.106 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -69.7 -38.54 77.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 72.129999999999995 110.945 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 26.0 t -51.78 -58.57 6.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.07 -0.514 . . . . 74.040000000000006 110.916 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -72.72 -61.61 1.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 62.409999999999997 110.874 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 16.0 t30 57.19 47.58 16.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 61.140000000000001 110.833 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 74.5 110.889 -179.928 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 23.4 mttm . . . . . 0 N--CA 1.458 -0.072 0 CA-C-O 120.777 0.322 . . . . 73.43 110.929 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.18 -29.95 65.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 63.45 111.112 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 32.6 mmtt -58.39 -26.29 63.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 73.34 110.876 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 6.1 mtt85 -65.44 -25.83 67.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 73.43 110.894 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 54.0 m170 -51.97 -47.93 64.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 73.45 110.848 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -80.2 -26.53 39.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 71.43 110.89 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.2 -21.17 62.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 71.42 111.089 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.435 ' CD1' HD11 ' A' ' 98' ' ' LEU . 42.1 m0 -58.01 -22.85 51.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.209 -0.451 . . . . 74.32 110.922 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 74.9 mt -54.59 -26.58 16.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.448 . . . . 70.15 111.122 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.5 m -77.93 -28.16 49.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 60.33 111.164 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.595 ' CD1' HD11 ' A' ' 127' ' ' ILE . 18.7 mt -64.1 -27.67 69.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 75.55 110.907 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -51.56 -49.94 61.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 35.4 110.9 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -25.07 68.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 74.54 110.901 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.74 -55.2 8.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 73.43 111.081 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.493 ' CB ' HD22 ' A' ' 159' ' ' LEU . 33.3 m-85 -57.58 -26.27 61.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 64.12 110.904 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.71 -40.85 63.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 65.01 110.869 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -98.48 20.77 12.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 74.24 110.842 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 61.53 56.4 2.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 75.23 111.112 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -64.64 143.18 58.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 75.25 110.906 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.3 t -86.72 143.75 27.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.147 -0.479 . . . . 72.55 111.154 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.418 HG21 HD13 ' A' ' 124' ' ' LEU . 23.6 m -122.07 -179.62 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 71.21 111.154 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 4.3 t -159.96 119.58 2.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 72.43 111.14 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.687 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -160.2 172.4 36.65 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.716 -0.754 . . . . 43.33 112.458 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.627 ' C ' HG13 ' A' ' 122' ' ' VAL . 11.7 p -116.1 145.35 21.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.775 0.321 . . . . 54.3 111.119 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.431 ' CG1' HG22 ' A' ' 122' ' ' VAL . 5.6 mt -66.74 117.87 8.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 73.4 111.109 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -97.65 -43.72 7.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 70.02 110.887 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -121.67 148.23 17.26 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.725 -0.75 . . . . 74.52 112.474 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 27.0 pttt -124.21 125.4 44.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.789 0.328 . . . . 75.2 110.928 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.5 m -114.08 176.96 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 71.4 111.166 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 28.9 mttp -62.47 94.38 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 72.03 110.87 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 90.61 -35.76 3.77 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.704 -0.76 . . . . 73.33 112.508 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -90.38 173.69 39.21 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.749 -0.739 . . . . 73.01 112.531 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.489 ' HE2' HG11 ' A' ' 136' ' ' VAL . 15.3 m-85 -152.04 118.92 5.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.994 0.426 . . . . 73.13 110.927 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.11 135.81 33.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.49 . . . . 71.3 111.152 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.725 HG11 ' CZ ' ' A' ' 154' ' ' PHE . 18.1 t -135.39 138.12 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 62.52 111.089 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -88.85 113.34 24.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.453 . . . . 63.43 110.881 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.687 HD23 ' HA3' ' A' ' 110' ' ' GLY . 11.1 mt -121.16 96.44 5.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.464 . . . . 74.2 110.907 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 63.32 25.24 14.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 75.4 110.919 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 103.96 -23.1 33.24 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.677 -0.773 . . . . 71.51 112.467 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.595 HD11 ' CD1' ' A' ' 98' ' ' LEU . 21.9 mt -83.05 151.87 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.808 0.337 . . . . 73.32 111.119 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -99.65 124.3 44.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 73.51 110.868 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.628 ' HB1' ' CG2' ' A' ' 168' ' ' VAL . . . -101.15 171.75 7.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 63.52 111.097 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -142.82 117.91 10.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 74.44 110.895 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.575 HD11 ' CE2' ' A' ' 154' ' ' PHE . 7.7 mp -100.28 129.56 27.81 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.653 0.74 . . . . 72.14 110.918 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.518 ' O ' HG23 ' A' ' 136' ' ' VAL . 53.7 Cg_endo -69.71 132.5 23.55 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.706 2.27 . . . . 70.4 112.352 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -74.91 -11.22 83.8 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 72.2 112.486 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 26.5 t -50.56 -33.94 23.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.934 0.397 . . . . 71.14 110.888 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.622 HD12 ' HG2' ' A' ' 170' ' ' ARG . 28.0 mt -123.42 39.28 4.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.081 -0.508 . . . . 71.02 110.906 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 132' ' ' PRO . 99.4 t -122.77 -59.04 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 72.44 111.103 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -116.34 117.52 30.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 72.0 110.822 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 7.3 p -173.81 123.9 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 53.41 111.134 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 53.04 72.61 1.11 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.55 0.69 . . . . 72.02 110.889 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 132.84 24.09 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.644 2.229 . . . . 72.14 112.325 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 6.8 p -126.03 -37.93 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.456 . . . . 61.41 111.102 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -126.92 -176.98 3.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 73.12 110.872 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -52.09 132.48 33.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.196 -0.456 . . . . 65.31 110.818 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 9.0 t -123.16 42.6 3.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 34.45 111.125 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -85.88 -11.46 53.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 72.53 110.861 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.57 -8.38 54.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 72.35 110.862 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 64.9 mt -59.51 -31.17 69.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 63.33 110.892 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -123.53 134.9 53.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 74.44 110.903 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 92.81 0.95 68.32 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.719 -0.753 . . . . 65.23 112.482 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.4 127.92 34.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.721 0.295 . . . . 70.04 110.89 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.479 ' O ' HD22 ' A' ' 152' ' ' LEU . 34.1 mt-10 -109.59 87.0 2.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 74.3 110.9 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.479 HD22 ' O ' ' A' ' 151' ' ' GLU . 0.4 OUTLIER -139.11 166.34 24.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 72.43 110.923 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -81.92 173.75 11.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.214 -0.448 . . . . 74.32 110.9 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.725 ' CZ ' HG11 ' A' ' 122' ' ' VAL . 37.3 m-85 -133.47 -179.38 5.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 73.31 110.852 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 12.1 ttpt -130.84 108.59 9.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 74.34 110.907 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.457 HG11 ' CD1' ' A' ' 102' ' ' TYR . 21.9 t -70.42 126.53 30.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 74.32 111.167 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.9 tp -119.0 -30.47 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 71.04 111.182 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 20.7 ttmt -171.87 133.21 0.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 75.32 110.903 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.494 ' H ' HD23 ' A' ' 159' ' ' LEU . 0.9 OUTLIER -109.47 148.17 31.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 65.04 110.902 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.19 89.37 3.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 74.52 110.869 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -67.71 -23.16 65.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 71.33 110.865 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.81 -43.26 63.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 74.31 110.895 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -99.66 24.74 7.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 65.14 110.885 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 9.7 p30 41.52 38.59 0.9 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 72.53 110.917 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -143.07 168.79 18.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 75.13 110.872 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.48 HG22 HG22 ' A' ' 127' ' ' ILE . 15.8 m -128.67 144.39 38.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 71.02 111.145 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 18.3 m -116.74 171.8 5.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 72.33 111.129 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.628 ' CG2' ' HB1' ' A' ' 129' ' ' ALA . 15.8 t -119.42 152.28 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 74.3 111.103 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 14.0 t -70.01 154.7 41.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 62.55 110.873 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.622 ' HG2' HD12 ' A' ' 135' ' ' LEU . 18.4 ttm180 -83.46 -54.56 4.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 71.21 110.906 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.417 ' O ' HG23 ' A' ' 174' ' ' ILE . 12.5 ptp180 -57.4 -27.01 61.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 64.34 110.878 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.2 -19.64 55.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 63.4 111.097 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.554 HG22 ' HG3' ' A' ' 177' ' ' GLU . 11.1 p -52.38 -28.96 12.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 63.23 111.115 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 171' ' ' ARG . 30.8 pt -51.26 -30.71 10.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 73.44 111.085 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -87.98 -46.81 9.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 72.13 110.89 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 4.2 p -56.51 -40.51 75.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 74.04 110.83 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.554 ' HG3' HG22 ' A' ' 173' ' ' VAL . 8.2 mt-10 -51.92 -49.16 63.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 62.41 110.911 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -176.94 86.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 61.14 110.875 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 4.7 p . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 74.5 110.872 -179.834 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.785 0.326 . . . . 73.43 110.906 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.2 -35.33 79.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 63.45 111.089 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.68 -27.49 64.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 73.34 110.963 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.9 tpp180 -60.41 -26.58 66.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 73.43 110.833 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -52.09 -30.09 24.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 73.45 110.854 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 -80.04 -34.5 38.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 71.43 110.872 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.75 -15.96 61.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 71.42 111.083 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -57.98 -22.68 50.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 74.32 110.929 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 43.1 mm -55.35 -25.41 17.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.287 -0.415 . . . . 70.15 111.131 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 71.0 p -85.69 -23.97 27.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.232 -0.44 . . . . 60.33 111.093 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.463 ' CD1' HD11 ' A' ' 127' ' ' ILE . 63.4 mt -67.54 -49.0 65.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 75.55 110.922 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -51.9 -43.49 63.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 35.4 110.876 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.87 -24.39 41.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 74.54 110.894 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.08 -26.47 56.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 73.43 111.114 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.454 ' HB2' HD21 ' A' ' 159' ' ' LEU . 16.1 t80 -56.04 -25.12 43.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 64.12 110.941 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -54.82 -26.84 37.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 65.01 110.891 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -92.75 -22.04 19.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.081 -0.509 . . . . 74.24 110.846 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 63.9 44.91 4.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 75.23 111.123 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -62.43 -179.81 0.27 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.22 -0.446 . . . . 75.25 110.832 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 32.7 p -106.61 178.82 4.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.1 -0.5 . . . . 72.55 111.089 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.9 m -152.35 -178.66 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 71.21 111.181 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 86.5 m -154.22 122.89 6.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 72.43 111.15 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.406 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -158.09 154.97 26.01 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.7 -0.762 . . . . 43.33 112.422 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 150' ' ' LYS . 10.8 p -105.16 137.62 33.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.743 0.306 . . . . 54.3 111.216 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.735 HG13 HG22 ' A' ' 122' ' ' VAL . 4.2 mp -57.98 112.02 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.218 -0.446 . . . . 73.4 111.134 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 20.4 m-20 -95.17 -30.3 14.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.098 -0.501 . . . . 70.02 110.892 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -134.14 144.4 16.34 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.708 -0.758 . . . . 74.52 112.502 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.93 136.84 54.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.861 0.362 . . . . 75.2 110.917 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.1 m -118.8 176.44 3.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 71.4 111.044 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.1 tptt -66.0 97.75 0.38 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 72.03 110.92 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 92.2 -35.02 4.16 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.717 -0.754 . . . . 73.33 112.46 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -98.18 173.62 27.84 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.747 . . . . 73.01 112.494 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.416 ' HE2' HG13 ' A' ' 136' ' ' VAL . 8.4 m-85 -146.2 118.91 8.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.911 0.386 . . . . 73.13 110.918 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.631 ' O ' HG23 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -86.26 149.5 25.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 71.3 111.14 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.735 HG22 HG13 ' A' ' 112' ' ' ILE . 21.3 t -140.75 142.35 30.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 62.52 111.103 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -99.61 99.52 10.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 63.43 110.873 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.606 HD21 ' HD2' ' A' ' 154' ' ' PHE . 16.2 mt -102.02 89.68 3.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 74.2 110.929 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 51.97 39.31 25.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 75.4 110.844 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 103.68 -27.15 20.92 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.768 -0.729 . . . . 71.51 112.464 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.463 HD11 ' CD1' ' A' ' 98' ' ' LEU . 24.4 mm -74.15 150.23 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.787 0.327 . . . . 73.32 111.154 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.7 ttt180 -110.7 111.87 23.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 73.51 110.863 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.711 ' HB1' ' CG2' ' A' ' 168' ' ' VAL . . . -92.91 171.54 8.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 63.52 111.147 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -145.58 107.85 4.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 74.44 110.873 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.653 HD11 ' CE1' ' A' ' 154' ' ' PHE . 6.6 mp -92.35 129.46 40.96 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.512 0.672 . . . . 72.14 110.959 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 155.18 66.58 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.64 2.226 . . . . 70.4 112.35 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.64 ' O ' HG23 ' A' ' 136' ' ' VAL . . . -67.19 -11.66 59.3 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.707 -0.759 . . . . 72.2 112.473 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.3 p -79.47 -20.86 46.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.922 0.391 . . . . 71.14 110.871 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.724 HD22 ' HA ' ' A' ' 170' ' ' ARG . 4.8 tp -120.34 39.23 3.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.123 -0.49 . . . . 71.02 110.908 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 133' ' ' GLY . 85.1 t -62.37 -62.46 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 72.44 111.106 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -173.76 146.05 1.22 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.095 -0.502 . . . . 72.0 110.873 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.8 m -85.74 151.79 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 53.41 111.093 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.17 73.47 0.93 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.599 0.714 . . . . 72.02 110.905 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 139.16 39.72 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.714 2.276 . . . . 72.14 112.358 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.514 HG12 ' HE1' ' A' ' 146' ' ' HIS . 10.6 p -120.49 151.98 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.301 -0.409 . . . . 61.41 111.086 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -51.99 -30.15 23.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 73.12 110.859 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.477 ' O ' HG13 ' A' ' 141' ' ' VAL . 2.7 m-20 -82.91 129.21 34.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 65.31 110.834 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 79.6 p -108.57 37.4 2.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 34.45 111.118 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.3 tp -87.16 -22.15 25.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 72.53 110.903 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . 0.514 ' HE1' HG12 ' A' ' 141' ' ' VAL . 29.0 p-80 -96.13 18.44 13.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 72.35 110.823 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 48.4 mt -110.7 39.35 2.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 63.33 110.878 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -167.48 123.87 1.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 74.44 110.907 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.19 15.54 71.74 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.673 -0.775 . . . . 65.23 112.479 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.607 ' O ' HD12 ' A' ' 112' ' ' ILE . 2.0 tmmm? -71.2 138.23 49.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.769 0.319 . . . . 70.04 110.866 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -105.08 118.45 36.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 74.3 110.832 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.0 tp -139.05 146.92 41.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.108 -0.496 . . . . 72.43 110.899 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -90.94 129.71 36.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.439 . . . . 74.32 110.888 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.693 ' CE2' HG11 ' A' ' 122' ' ' VAL . 17.9 m-85 -114.91 -179.43 3.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 73.31 110.897 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.74 136.05 21.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 74.34 110.91 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.675 ' CG1' HD22 ' A' ' 159' ' ' LEU . 22.0 t -58.72 112.28 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 74.32 111.148 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.462 HD13 ' O ' ' A' ' 157' ' ' ILE . 0.0 OUTLIER -114.78 -26.14 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 71.04 111.183 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -169.17 115.79 0.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 75.32 110.892 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.675 HD22 ' CG1' ' A' ' 156' ' ' VAL . 2.2 pt? -150.17 132.95 15.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.225 -0.443 . . . . 65.04 110.919 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -117.82 109.73 16.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 74.52 110.804 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -64.71 -30.64 71.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 71.33 110.926 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 9.3 ttmt -70.29 -29.93 66.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 74.31 110.895 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 38.7 mtt180 -91.83 -15.37 28.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.427 . . . . 65.14 110.9 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 60.62 42.89 13.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 72.53 110.919 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -143.06 140.69 31.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 75.13 110.864 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.553 HG22 ' HB2' ' A' ' 159' ' ' LEU . 46.7 t -137.23 141.23 40.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 71.02 111.104 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.5 m -134.78 170.92 18.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 72.33 111.177 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.711 ' CG2' ' HB1' ' A' ' 129' ' ' ALA . 20.7 t -120.47 149.19 23.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 74.3 111.133 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.77 160.89 18.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 62.55 110.862 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.724 ' HA ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -94.36 -33.71 13.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 71.21 110.908 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -76.87 -25.04 52.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 64.34 110.879 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.8 -9.38 58.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 63.4 111.131 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 10.5 p -51.35 -30.15 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 63.23 111.129 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 31.5 pt -52.07 -29.55 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 73.44 111.081 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -54.73 -65.95 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 72.13 110.857 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.96 -43.93 63.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 74.04 110.895 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -55.72 -51.17 68.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.491 . . . . 62.41 110.863 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -123.15 71.8 1.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 61.14 110.852 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 63.3 p . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 74.5 110.867 -179.87 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.758 0.313 . . . . 73.43 110.898 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.62 -26.16 50.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 63.45 111.112 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.8 pttt -53.88 -27.95 33.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 73.34 110.846 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -59.69 -25.52 64.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 73.43 110.793 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -51.99 -37.5 53.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.195 -0.457 . . . . 73.45 110.874 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.41 ' O ' HG23 ' A' ' 96' ' ' ILE . 41.9 tt0 -78.56 -37.04 43.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.113 -0.494 . . . . 71.43 110.911 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.0 -18.14 63.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 71.42 111.147 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.419 ' CD1' HD11 ' A' ' 98' ' ' LEU . 33.3 m0 -56.6 -24.53 48.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.459 . . . . 74.32 110.916 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 93' ' ' GLU . 29.2 pt -55.02 -26.11 17.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 70.15 111.097 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 57.1 m -78.38 -27.22 46.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 60.33 111.142 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.452 ' CD1' HD11 ' A' ' 127' ' ' ILE . 17.9 mt -66.61 -24.85 66.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 75.55 110.95 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -51.85 -34.87 42.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 35.4 110.881 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 36.5 mttp -83.83 -26.36 29.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.128 -0.487 . . . . 74.54 110.873 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.565 ' HB1' ' CB ' ' A' ' 106' ' ' GLU . . . -53.33 -58.38 7.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 73.43 111.089 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -52.32 -29.64 24.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 64.12 110.961 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.05 -36.19 78.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 65.01 110.96 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -108.58 20.74 18.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.171 -0.468 . . . . 74.24 110.896 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 51.59 62.25 2.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 75.23 111.097 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.565 ' CB ' ' HB1' ' A' ' 101' ' ' ALA . 0.6 OUTLIER -71.33 155.24 40.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 75.25 110.926 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.6 t -104.11 172.65 6.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 72.55 111.147 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.746 HG21 HD13 ' A' ' 124' ' ' LEU . 16.9 m -146.28 177.37 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.27 -0.423 . . . . 71.21 111.067 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.8 t -162.2 127.25 3.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 72.43 111.083 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.665 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -165.77 153.95 24.27 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.774 -0.727 . . . . 43.33 112.506 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 150' ' ' LYS . 13.1 p -102.64 137.18 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.818 0.342 . . . . 54.3 111.149 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.733 HG13 HG22 ' A' ' 122' ' ' VAL . 4.4 mp -54.09 106.43 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.252 -0.431 . . . . 73.4 111.067 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -96.02 -39.84 9.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 70.02 110.885 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -120.99 141.93 15.21 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.783 -0.722 . . . . 74.52 112.485 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.9 pttp -124.54 147.43 48.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.781 0.325 . . . . 75.2 110.918 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.2 m -118.1 177.25 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 71.4 111.142 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.09 95.8 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 72.03 110.893 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 90.16 -36.71 3.49 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.732 -0.747 . . . . 73.33 112.461 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -98.27 173.52 27.63 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.761 -0.733 . . . . 73.01 112.481 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.582 ' HB3' HD23 ' A' ' 131' ' ' LEU . 8.3 m-85 -132.42 164.22 27.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.976 0.417 . . . . 73.13 110.866 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.47 ' O ' HG23 ' A' ' 112' ' ' ILE . 0.3 OUTLIER -135.45 150.82 49.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.108 -0.496 . . . . 71.3 111.161 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.733 HG22 HG13 ' A' ' 112' ' ' ILE . 5.3 t -136.48 156.57 36.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.255 -0.43 . . . . 62.52 111.118 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -114.21 108.47 17.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 63.43 110.927 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.746 HD13 HG21 ' A' ' 108' ' ' VAL . 18.9 mt -109.24 84.87 1.99 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 74.2 110.859 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 51.45 56.39 7.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 75.4 110.911 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.37 -35.14 4.33 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.769 -0.729 . . . . 71.51 112.49 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.694 ' CG2' HG11 ' A' ' 166' ' ' VAL . 26.0 mm -70.82 150.42 9.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.866 0.365 . . . . 73.32 111.103 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.557 ' O ' HG13 ' A' ' 166' ' ' VAL . 1.9 mpt_? -117.25 114.29 23.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.477 . . . . 73.51 110.881 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.45 ' HB3' ' HB ' ' A' ' 122' ' ' VAL . . . -92.64 161.3 14.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.484 . . . . 63.52 111.129 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -136.11 113.0 10.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 74.44 110.885 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.677 HD21 HG23 ' A' ' 122' ' ' VAL . 1.2 mm? -86.64 129.98 50.75 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.578 0.704 . . . . 72.14 110.955 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 127.88 15.19 Favored 'Trans proline' 0 N--CA 1.465 -0.167 0 C-N-CA 122.681 2.254 . . . . 70.4 112.357 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -51.56 -28.29 21.16 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.753 -0.737 . . . . 72.2 112.479 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 72.9 m -56.41 -25.09 48.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.958 0.408 . . . . 71.14 110.852 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.5 mt -88.98 -33.52 17.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.127 -0.488 . . . . 71.02 110.941 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.401 HG13 HD22 ' A' ' 147' ' ' LEU . 87.9 t -53.99 -27.43 16.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 72.44 111.108 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.45 112.67 20.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.166 -0.47 . . . . 72.0 110.885 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.401 ' O ' HG13 ' A' ' 138' ' ' VAL . 7.0 p -173.62 123.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 53.41 111.097 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 62.95 160.6 0.12 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.556 0.693 . . . . 72.02 110.889 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 149.91 67.75 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.722 2.282 . . . . 72.14 112.354 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.9 m -150.19 159.47 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 61.41 111.16 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -110.16 -73.92 0.67 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 73.12 110.9 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -63.97 145.2 56.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.454 . . . . 65.31 110.885 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.798 HG22 HD12 ' A' ' 147' ' ' LEU . 0.2 OUTLIER -108.39 23.61 14.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 34.45 111.144 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.5 mp -87.34 -22.79 24.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 72.53 110.909 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 43.9 p-80 -66.68 -25.26 66.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.433 . . . . 72.35 110.816 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.798 HD12 HG22 ' A' ' 144' ' ' THR . 59.9 mt -63.79 -59.06 5.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 63.33 110.968 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -119.43 142.18 48.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 74.44 110.894 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 91.38 -14.55 63.5 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.76 -0.733 . . . . 65.23 112.472 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.585 ' O ' HD12 ' A' ' 112' ' ' ILE . 1.6 tmmm? -53.87 128.98 32.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.768 0.318 . . . . 70.04 110.95 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.51 105.06 14.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 74.3 110.914 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.574 HD12 ' HD3' ' A' ' 150' ' ' LYS . 4.6 mt -139.04 179.84 6.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 72.43 110.953 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -115.91 152.94 32.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 74.32 110.894 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.479 ' CZ ' HG21 ' A' ' 122' ' ' VAL . 11.9 m-85 -126.5 178.4 5.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 73.31 110.853 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 18.1 tttt -131.37 160.39 35.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 74.34 110.884 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 106' ' ' GLU . 7.6 p -76.72 127.63 37.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 74.32 111.146 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.2 tp -127.87 -38.3 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.187 -0.46 . . . . 71.04 111.095 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -174.66 132.81 0.35 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.484 . . . . 75.32 110.884 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.604 ' HB3' HG23 ' A' ' 166' ' ' VAL . 3.7 pp -158.06 135.7 10.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 65.04 110.902 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -117.12 125.86 51.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.465 . . . . 74.52 110.85 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -80.47 -26.15 38.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 71.33 110.922 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -73.29 -41.31 63.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 74.31 110.973 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -82.97 -15.41 51.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 65.14 110.897 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.74 42.36 10.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 72.53 110.894 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -141.71 140.51 33.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 75.13 110.856 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.694 HG11 ' CG2' ' A' ' 127' ' ' ILE . 5.9 p -146.03 141.09 21.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 71.02 111.136 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 20.1 m -134.87 167.52 25.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.161 -0.472 . . . . 72.33 111.095 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 8.5 m -120.45 148.97 23.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 74.3 111.118 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.652 ' OG ' ' HB2' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -84.73 155.23 21.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.15 -0.477 . . . . 62.55 110.829 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.621 ' O ' HG12 ' A' ' 173' ' ' VAL . 30.2 mtt85 -64.08 -38.53 91.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 71.21 110.946 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -80.1 -23.11 41.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 64.34 110.888 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.652 ' HB2' ' OG ' ' A' ' 169' ' ' SER . . . -53.72 -41.7 67.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 63.4 111.113 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.621 HG12 ' O ' ' A' ' 170' ' ' ARG . 13.0 p -66.02 -21.79 29.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 63.23 111.101 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 16.3 mm -70.07 -53.98 21.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.451 . . . . 73.44 111.146 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -55.46 -47.8 75.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 72.13 110.861 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 68.5 m -56.42 -42.23 77.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 74.04 110.827 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -64.69 -51.65 61.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.076 -0.511 . . . . 62.41 110.854 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -92.06 54.18 2.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.504 . . . . 61.14 110.879 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 4.0 p . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 74.5 110.908 -179.873 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.9 mptt . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.829 0.347 . . . . 73.43 110.92 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.04 -37.83 33.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.21 -0.45 . . . . 63.45 111.086 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.4 ttmm -60.1 -20.04 56.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 73.34 110.854 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 17.2 tpp180 -60.03 -20.12 56.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 73.43 110.829 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 -51.45 -31.77 24.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 73.45 110.921 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -80.3 -42.45 23.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.187 -0.46 . . . . 71.43 110.812 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.57 -19.95 66.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 71.42 111.092 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.445 ' CD1' HD21 ' A' ' 98' ' ' LEU . 41.7 m0 -57.3 -23.8 50.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 74.32 110.863 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 49.6 mt -52.43 -28.73 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 70.15 111.178 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 58.3 p -76.0 -60.75 2.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 60.33 111.153 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.445 HD21 ' CD1' ' A' ' 95' ' ' TRP . 4.5 pp -60.16 -20.39 58.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 75.55 110.992 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.43 ' N ' HD12 ' A' ' 98' ' ' LEU . 5.7 mm-40 -51.65 -47.81 63.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.103 -0.499 . . . . 35.4 110.888 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.5 mtpp -54.04 -27.5 32.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 74.54 110.95 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 98' ' ' LEU . . . -72.7 -43.86 62.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 73.43 111.092 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.569 ' CD2' HD13 ' A' ' 159' ' ' LEU . 12.5 m-85 -65.38 -31.84 73.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 64.12 110.924 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -60.31 -26.04 66.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 65.01 110.895 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -95.85 20.82 9.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.189 -0.459 . . . . 74.24 110.852 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 51.86 55.46 9.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 75.23 111.12 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -76.15 163.37 27.16 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.238 -0.437 . . . . 75.25 110.886 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.8 t -91.93 153.76 19.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.476 . . . . 72.55 111.131 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.2 m -144.53 178.62 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 71.21 111.179 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.1 t -157.23 123.47 4.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 72.43 111.171 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -155.87 153.2 24.57 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.73 -0.747 . . . . 43.33 112.497 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 150' ' ' LYS . 10.2 p -101.02 140.21 20.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.839 0.352 . . . . 54.3 111.14 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.685 HG13 HG22 ' A' ' 122' ' ' VAL . 4.4 mp -60.12 120.93 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 73.4 111.145 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -102.27 -43.02 5.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 70.02 110.875 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -118.45 142.99 17.36 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.682 -0.77 . . . . 74.52 112.468 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.6 pttt -124.06 123.71 40.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.837 0.351 . . . . 75.2 110.945 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 26.6 m -110.09 177.33 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 71.4 111.122 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -62.16 94.14 0.05 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 72.03 110.953 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.88 -36.14 3.61 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.765 -0.731 . . . . 73.33 112.499 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -90.02 173.8 39.94 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.728 -0.749 . . . . 73.01 112.503 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -151.15 127.48 10.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.992 0.425 . . . . 73.13 110.872 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 57.8 p -98.19 142.46 29.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 71.3 111.159 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.685 HG22 HG13 ' A' ' 112' ' ' ILE . 21.3 t -133.74 147.15 30.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 62.52 111.117 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -97.25 134.87 39.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.1 -0.5 . . . . 63.43 110.896 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 78.4 mt -139.41 74.55 1.47 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.119 -0.491 . . . . 74.2 110.972 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 62.98 42.15 7.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.113 -0.494 . . . . 75.4 110.902 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 103.03 -31.05 9.19 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.695 -0.764 . . . . 71.51 112.542 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.573 ' CG2' HG21 ' A' ' 166' ' ' VAL . 60.9 mt -78.04 144.07 11.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.869 0.366 . . . . 73.32 111.101 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.6 mtp180 -109.22 114.02 27.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 73.51 110.908 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -92.5 171.54 8.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 63.52 111.109 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.494 ' HB3' HG23 ' A' ' 167' ' ' VAL . 2.3 t80 -136.44 129.96 31.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.43 . . . . 74.44 110.842 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.414 HD22 ' CE2' ' A' ' 154' ' ' PHE . 1.0 OUTLIER -109.51 130.54 22.66 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.627 0.727 . . . . 72.14 110.914 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 140.77 43.51 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.707 2.271 . . . . 70.4 112.334 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.668 ' O ' HG23 ' A' ' 136' ' ' VAL . . . -66.02 -11.88 56.07 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.771 -0.728 . . . . 72.2 112.554 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.9 t -76.52 -22.52 54.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.906 0.384 . . . . 71.14 110.873 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.57 39.52 3.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.504 . . . . 71.02 110.901 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 133' ' ' GLY . 85.4 t -53.67 -63.09 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 72.44 111.103 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.544 ' HB3' ' HE2' ' A' ' 146' ' ' HIS . 1.0 OUTLIER -179.65 171.21 1.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 72.0 110.901 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.407 HG13 ' O ' ' A' ' 138' ' ' VAL . 5.9 p -106.06 121.08 58.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 53.41 111.108 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -177.33 160.79 1.44 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.642 0.734 . . . . 72.02 110.864 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 166.6 26.93 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.675 2.25 . . . . 72.14 112.38 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 31.6 m -51.67 -29.63 10.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.233 -0.44 . . . . 61.41 111.106 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 54.1 mtm180 -51.86 133.04 32.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 73.12 110.949 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -51.96 169.08 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 65.31 110.849 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.4 t -169.82 142.41 2.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 34.45 111.17 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.4 tt -87.9 -8.92 55.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.268 -0.423 . . . . 72.53 110.883 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . 0.544 ' HE2' ' HB3' ' A' ' 137' ' ' ASP . 0.9 OUTLIER -62.25 -15.72 48.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.443 . . . . 72.35 110.844 179.909 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 47.9 mt -68.85 -24.05 64.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 63.33 110.958 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -118.77 123.97 46.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.169 -0.469 . . . . 74.44 110.845 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 89.54 26.12 26.1 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.711 -0.757 . . . . 65.23 112.448 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.615 ' HD3' HD13 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -82.78 128.17 34.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.828 0.347 . . . . 70.04 110.865 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.657 ' O ' HD12 ' A' ' 152' ' ' LEU . 16.4 pt-20 -105.15 108.54 20.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.203 -0.453 . . . . 74.3 110.932 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.657 HD12 ' O ' ' A' ' 151' ' ' GLU . 2.6 mp -139.11 -179.51 5.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 72.43 110.914 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -114.31 150.89 33.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 74.32 110.891 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.414 ' CE2' HD22 ' A' ' 131' ' ' LEU . 19.3 m-85 -125.42 168.06 14.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 73.31 110.884 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -119.76 123.29 43.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 74.34 110.862 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 91.9 t -67.61 117.02 8.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.244 -0.434 . . . . 74.32 111.173 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.4 tp -120.79 -33.35 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 71.04 111.124 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -171.15 119.96 0.5 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 75.32 110.872 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.619 ' H ' HD23 ' A' ' 159' ' ' LEU . 2.6 pt? -125.33 139.14 53.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 65.04 110.881 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -118.5 88.95 3.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 74.52 110.908 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -67.7 -20.03 65.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 71.33 110.934 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.23 -37.73 67.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 74.31 110.84 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -93.25 16.39 13.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.444 . . . . 65.14 110.861 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.2 m120 51.74 30.11 6.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 72.53 110.938 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -143.1 164.18 30.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 75.13 110.853 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.573 HG21 ' CG2' ' A' ' 127' ' ' ILE . 20.2 t -143.43 144.61 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 71.02 111.13 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.494 HG23 ' HB3' ' A' ' 130' ' ' PHE . 14.3 p -129.07 152.2 36.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 72.33 111.13 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 130' ' ' PHE . 25.2 m -119.42 145.68 25.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 74.3 111.124 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.36 159.81 33.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 62.55 110.799 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.4 ' O ' HG12 ' A' ' 173' ' ' VAL . 11.0 ptm180 -93.45 -37.72 11.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.07 -0.513 . . . . 71.21 110.881 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 -79.59 -26.75 41.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 64.34 110.895 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.43 -13.94 62.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.124 -0.489 . . . . 63.4 111.124 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 170' ' ' ARG . 11.0 p -52.98 -30.7 16.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 63.23 111.045 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 23.5 pt -61.96 -30.15 47.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 73.44 111.145 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -71.71 -46.52 58.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.473 . . . . 72.13 111.027 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 52.6 p -52.01 -47.24 65.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.124 -0.489 . . . . 74.04 110.81 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -54.9 -52.98 61.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 62.41 110.945 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -109.1 55.82 0.63 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 61.14 110.906 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 72.2 p . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 74.5 110.929 -179.906 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt . . . . . 0 C--O 1.23 0.038 0 CA-C-O 120.746 0.307 . . . . 73.43 110.877 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.56 -40.03 43.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.455 . . . . 63.45 111.073 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.8 pptp? -60.14 -20.01 56.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 73.34 110.909 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -59.19 -20.87 57.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.434 . . . . 73.43 110.898 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -51.38 -31.22 21.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 73.45 110.838 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.501 ' O ' HG23 ' A' ' 96' ' ' ILE . 16.9 tt0 -80.43 -46.13 16.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 71.43 110.861 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.703 ' O ' HG22 ' A' ' 97' ' ' THR . . . -62.3 -17.18 57.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 71.42 111.133 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 35.5 m0 -57.85 -22.28 47.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.117 -0.492 . . . . 74.32 110.92 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.501 HG23 ' O ' ' A' ' 93' ' ' GLU . 31.0 pt -53.03 -31.24 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 70.15 111.117 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.703 HG22 ' O ' ' A' ' 94' ' ' ALA . 12.8 t -72.32 -30.05 64.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 60.33 111.17 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.611 ' CD1' HD11 ' A' ' 127' ' ' ILE . 18.4 mt -67.38 -21.0 65.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 75.55 110.865 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -76.23 -36.12 58.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 35.4 110.87 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -84.03 -22.45 31.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.118 -0.492 . . . . 74.54 110.823 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.14 -27.73 59.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.416 . . . . 73.43 111.067 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.621 ' CG ' HD21 ' A' ' 159' ' ' LEU . 50.9 t80 -55.53 -25.74 39.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.258 -0.428 . . . . 64.12 110.946 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.74 -27.77 30.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.094 -0.503 . . . . 65.01 110.906 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -97.1 -19.2 18.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 74.24 110.846 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 64.03 50.8 2.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 75.23 111.081 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -64.31 167.14 7.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 75.25 110.867 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.2 t -102.42 165.27 11.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 72.55 111.244 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.7 m -148.73 177.73 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 71.21 111.13 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 109' ' ' THR . 4.3 t -149.32 118.09 6.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.447 . . . . 72.43 111.148 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -134.5 164.77 24.59 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.735 -0.745 . . . . 43.33 112.491 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.707 HG23 ' C ' ' A' ' 150' ' ' LYS . 13.3 p -105.51 135.79 42.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.777 0.322 . . . . 54.3 111.174 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.539 HD12 ' O ' ' A' ' 150' ' ' LYS . 4.2 mp -54.35 101.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 73.4 111.159 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -74.21 -44.26 53.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 70.02 110.886 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -134.81 155.06 21.78 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.763 -0.732 . . . . 74.52 112.469 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -124.32 128.82 49.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.848 0.356 . . . . 75.2 110.881 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.3 m -114.61 176.79 2.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.201 -0.454 . . . . 71.4 111.085 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -66.73 98.46 0.53 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 72.03 110.922 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 91.5 -35.57 3.91 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.753 -0.737 . . . . 73.33 112.535 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -98.25 173.63 27.76 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.756 -0.735 . . . . 73.01 112.552 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -146.96 118.75 8.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.925 0.393 . . . . 73.13 110.882 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.13 150.81 26.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 71.3 111.145 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.418 ' HB ' ' HB3' ' A' ' 129' ' ' ALA . 18.7 t -140.64 149.98 21.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 62.52 111.097 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -105.94 114.64 28.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.451 . . . . 63.43 110.898 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 77.8 mt -114.53 77.2 1.04 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 74.2 110.894 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 63.34 52.22 2.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 75.4 110.933 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 93.96 -34.71 4.51 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.762 -0.732 . . . . 71.51 112.523 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.611 HD11 ' CD1' ' A' ' 98' ' ' LEU . 27.5 mt -75.18 150.85 6.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.802 0.334 . . . . 73.32 111.149 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -110.76 132.11 54.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 73.51 110.822 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.418 ' HB3' ' HB ' ' A' ' 122' ' ' VAL . . . -110.12 171.56 7.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 63.52 111.088 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -138.54 122.38 17.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.24 -0.436 . . . . 74.44 110.888 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.507 HD21 ' HE2' ' A' ' 154' ' ' PHE . 10.3 mp -95.07 130.11 33.61 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.648 0.737 . . . . 72.14 110.931 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.413 ' O ' HG23 ' A' ' 136' ' ' VAL . 54.1 Cg_endo -69.76 132.46 23.38 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.727 2.284 . . . . 70.4 112.398 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -74.48 -11.14 82.71 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.675 -0.774 . . . . 72.2 112.445 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 41.8 m -50.4 -32.74 18.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.948 0.404 . . . . 71.14 110.887 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.783 HD12 ' HB2' ' A' ' 170' ' ' ARG . 28.6 mt -123.12 38.62 4.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.11 -0.496 . . . . 71.02 110.939 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 132' ' ' PRO . 89.6 t -122.75 -34.98 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 72.44 111.113 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -99.2 113.52 25.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 72.0 110.865 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 55.7 t -144.21 108.71 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 53.41 111.175 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.53 160.94 0.12 Allowed Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.655 0.74 . . . . 72.02 110.866 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 129.18 17.09 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.725 2.284 . . . . 72.14 112.353 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 7.7 m -149.04 149.61 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 61.41 111.136 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 36.3 ptt85 -123.37 36.91 4.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.468 . . . . 73.12 110.845 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -122.56 104.5 9.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.206 -0.452 . . . . 65.31 110.876 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 41.3 p -126.47 25.21 6.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.173 -0.467 . . . . 34.45 111.175 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -86.36 -22.28 26.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.258 -0.428 . . . . 72.53 110.931 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 50.5 p-80 -90.43 -20.92 22.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 72.35 110.846 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 89.7 mt -87.89 50.78 2.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.268 -0.424 . . . . 63.33 110.92 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -165.23 124.07 1.71 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 74.44 110.873 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 63.46 32.26 83.54 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.693 -0.765 . . . . 65.23 112.488 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.707 ' C ' HG23 ' A' ' 111' ' ' VAL . 0.3 OUTLIER -101.85 129.25 48.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.747 0.308 . . . . 70.04 110.913 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -86.07 105.01 16.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 74.3 110.859 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.474 HD22 ' HE3' ' A' ' 150' ' ' LYS . 10.2 tp -114.62 155.35 26.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 72.43 110.905 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -97.07 129.99 44.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 74.32 110.9 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.507 ' HE2' HD21 ' A' ' 131' ' ' LEU . 46.3 m-85 -123.05 -179.4 4.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 73.31 110.861 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.1 tmmm? -141.45 146.17 36.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.087 -0.506 . . . . 74.34 110.915 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 47.5 t -94.63 78.96 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.248 -0.433 . . . . 74.32 111.142 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.5 tt -91.5 -25.33 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 71.04 111.092 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -152.38 114.53 4.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 75.32 110.884 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.621 HD21 ' CG ' ' A' ' 102' ' ' TYR . 0.9 OUTLIER -118.44 149.27 41.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.431 . . . . 65.04 110.908 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -116.06 57.57 0.75 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.213 -0.449 . . . . 74.52 110.89 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -58.95 -25.14 63.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.467 . . . . 71.33 110.906 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 33.0 tttt -55.73 -25.85 42.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 74.31 110.832 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.12 24.83 12.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.309 -0.405 . . . . 65.14 110.859 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 9.1 m120 53.66 28.31 7.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.483 . . . . 72.53 110.902 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -143.08 172.99 11.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 75.13 110.825 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.8 m -147.88 144.23 19.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 71.02 111.167 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 19.2 m -128.53 170.46 18.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 72.33 111.148 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.444 HG21 HD12 ' A' ' 131' ' ' LEU . 5.5 m -120.34 155.02 23.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 74.3 111.169 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.5 m -88.42 156.04 19.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 62.55 110.902 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.783 ' HB2' HD12 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -82.41 -29.0 31.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.134 -0.484 . . . . 71.21 110.899 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -70.82 -24.05 62.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.488 . . . . 64.34 110.915 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.57 -14.47 61.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.1 -0.5 . . . . 63.4 111.171 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 170' ' ' ARG . 14.4 p -53.26 -28.04 14.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 63.23 111.081 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 35.4 pt -58.9 -21.49 19.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.24 -0.436 . . . . 73.44 111.112 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -75.9 -51.46 12.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 72.13 110.879 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 68.5 p -51.85 -62.01 1.9 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 74.04 110.836 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -50.15 -53.68 25.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 62.41 110.928 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 38.9 t30 54.96 29.68 12.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 61.14 110.909 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 43.2 p . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 74.5 110.85 -179.81 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt . . . . . 0 CA--C 1.526 0.051 0 CA-C-O 120.773 0.321 . . . . 73.43 110.884 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.36 -41.96 81.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 63.45 111.084 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 20.6 mmmt -56.47 -25.98 52.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.283 -0.417 . . . . 73.34 110.917 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.9 tpp180 -74.31 -24.26 59.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.281 -0.418 . . . . 73.43 110.863 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -51.8 -45.5 63.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 73.45 110.849 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -76.85 -31.69 57.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 71.43 110.934 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.44 -17.54 63.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.494 . . . . 71.42 111.117 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.655 ' CD1' HD21 ' A' ' 98' ' ' LEU . 31.9 m0 -57.19 -23.46 47.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 74.32 110.882 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 68.1 mt -54.07 -27.59 16.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 70.15 111.134 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 70.9 p -76.95 -59.11 2.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 60.33 111.154 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.655 HD21 ' CD1' ' A' ' 95' ' ' TRP . 3.4 pp -61.66 -18.09 58.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 75.55 110.842 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -54.15 -61.73 2.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 35.4 110.93 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? -66.84 -23.97 66.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.091 -0.504 . . . . 74.54 110.941 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.524 ' HB1' ' HG3' ' A' ' 106' ' ' GLU . . . -53.17 -45.56 68.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 73.43 111.145 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.652 ' CE1' HG21 ' A' ' 156' ' ' VAL . 38.1 m-85 -53.34 -33.21 52.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 64.12 110.901 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -57.24 -26.26 60.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 65.01 110.894 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.28 20.82 11.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 74.24 110.833 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 53.71 64.14 1.95 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 75.23 111.075 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.524 ' HG3' ' HB1' ' A' ' 101' ' ' ALA . 16.2 mm-40 -79.25 178.63 7.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 75.25 110.959 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.1 p -120.03 170.71 9.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 72.55 111.107 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.705 HG11 HD13 ' A' ' 124' ' ' LEU . 5.2 m -135.34 -179.3 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 71.21 111.121 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.6 t -155.69 121.41 4.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 72.43 111.191 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 176.5 168.09 36.08 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.758 -0.734 . . . . 43.33 112.502 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 151' ' ' GLU . 12.5 m -116.01 150.26 18.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.874 0.369 . . . . 54.3 111.132 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.793 HD12 ' HB3' ' A' ' 150' ' ' LYS . 5.4 mt -60.4 99.2 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 73.4 111.16 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 64.2 t-20 -87.8 -41.23 13.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 70.02 110.917 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -114.03 141.08 16.78 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.724 -0.75 . . . . 74.52 112.446 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -124.4 123.01 39.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.846 0.355 . . . . 75.2 110.928 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.6 m -108.22 176.67 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.246 -0.434 . . . . 71.4 111.149 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -66.83 99.18 0.6 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 72.03 110.953 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 90.85 -35.79 3.79 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.732 -0.747 . . . . 73.33 112.485 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -98.2 173.49 27.68 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.77 -0.729 . . . . 73.01 112.472 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.574 ' HZ ' HD22 ' A' ' 147' ' ' LEU . 6.6 m-85 -144.09 118.85 9.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.905 0.383 . . . . 73.13 110.927 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.24 149.68 25.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 71.3 111.17 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.7 t -143.65 137.42 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 62.52 111.137 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -90.07 104.94 17.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 63.43 110.944 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.705 HD13 HG11 ' A' ' 108' ' ' VAL . 12.5 mt -97.44 84.82 3.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.088 -0.506 . . . . 74.2 110.924 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 51.79 44.18 29.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 75.4 110.879 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 103.87 -33.72 6.35 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.715 -0.755 . . . . 71.51 112.493 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 21.6 mm -73.53 153.07 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.825 0.345 . . . . 73.32 111.165 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -105.27 119.39 38.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 73.51 110.882 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.636 ' HB2' HD11 ' A' ' 124' ' ' LEU . . . -101.29 171.66 7.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 63.52 111.075 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.513 ' O ' HG22 ' A' ' 168' ' ' VAL . 6.4 t80 -145.89 120.67 9.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 74.44 110.927 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.518 HD12 HG21 ' A' ' 168' ' ' VAL . 9.3 mp -92.92 130.1 37.55 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.619 0.723 . . . . 72.14 110.946 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.591 ' O ' HG23 ' A' ' 136' ' ' VAL . 55.1 Cg_endo -69.64 135.65 31.28 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.718 2.278 . . . . 70.4 112.386 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -67.74 -11.44 60.3 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.732 -0.747 . . . . 72.2 112.476 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 38.2 m -53.49 -35.03 60.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.904 0.383 . . . . 71.14 110.879 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.489 HD12 ' HB2' ' A' ' 170' ' ' ARG . 0.6 OUTLIER -123.41 39.05 4.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 71.02 110.937 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 132' ' ' PRO . 83.4 t -118.45 -24.16 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 72.44 111.129 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -98.53 112.03 24.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 72.0 110.846 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.2 m -154.01 132.07 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 53.41 111.139 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 19.5 mtm-85 62.62 161.59 0.12 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.612 0.72 . . . . 72.02 110.867 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.8 164.17 35.56 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.722 2.281 . . . . 72.14 112.336 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 7.4 p -51.27 139.43 6.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.199 -0.455 . . . . 61.41 111.105 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -178.4 105.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 73.12 110.905 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 59.0 97.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 65.31 110.839 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.17 4.68 33.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.102 -0.499 . . . . 34.45 111.114 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -87.22 -9.86 54.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.255 -0.429 . . . . 72.53 110.933 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . 0.469 ' CE1' HD23 ' A' ' 147' ' ' LEU . 0.7 OUTLIER -75.4 -5.91 47.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 72.35 110.909 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.574 HD22 ' HZ ' ' A' ' 120' ' ' PHE . 2.7 pp -118.3 31.11 6.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 63.33 110.906 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.421 ' OE1' HD12 ' A' ' 147' ' ' LEU . 5.7 mm-40 -128.68 126.61 40.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 74.44 110.91 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 63.44 31.71 81.69 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.701 -0.762 . . . . 65.23 112.531 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.793 ' HB3' HD12 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -72.36 131.74 43.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.81 0.338 . . . . 70.04 110.85 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.568 ' HA ' HG12 ' A' ' 111' ' ' VAL . 0.2 OUTLIER -99.84 96.6 7.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.175 -0.466 . . . . 74.3 110.905 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.747 HD22 ' CB ' ' A' ' 176' ' ' SER . 6.9 mt -138.64 141.24 39.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 72.43 110.934 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -89.92 129.44 36.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 74.32 110.903 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.451 ' HE2' HD21 ' A' ' 131' ' ' LEU . 34.8 m-85 -110.73 -179.16 3.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 73.31 110.901 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.667 ' CE ' ' HB3' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -143.99 151.0 39.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 74.34 110.915 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.652 HG21 ' CE1' ' A' ' 102' ' ' TYR . 61.2 t -91.45 112.48 25.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 74.32 111.091 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 15.7 tt -87.57 -33.76 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 71.04 111.114 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -177.89 126.38 0.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 75.32 110.873 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.481 ' HB3' HG12 ' A' ' 166' ' ' VAL . 0.2 OUTLIER -102.05 119.63 39.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 65.04 110.949 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -73.5 126.48 30.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 74.52 110.884 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -78.03 -29.05 49.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 71.33 110.867 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 12.4 tptm -53.12 -32.17 46.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.248 -0.433 . . . . 74.31 110.93 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -113.52 -15.27 12.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.1 -0.5 . . . . 65.14 110.85 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.07 47.94 5.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 72.53 110.922 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -142.27 154.42 44.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.48 . . . . 75.13 110.849 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.481 HG12 ' HB3' ' A' ' 159' ' ' LEU . 16.9 m -102.92 144.33 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 71.02 111.1 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 29.5 m -132.34 171.25 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 72.33 111.157 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.518 HG21 HD12 ' A' ' 131' ' ' LEU . 26.5 m -119.97 155.25 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 74.3 111.143 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.77 150.23 30.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 62.55 110.872 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.558 ' O ' HG12 ' A' ' 173' ' ' VAL . 10.8 ptt180 -82.24 0.11 42.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 71.21 110.863 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.44 -58.81 2.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 64.34 110.867 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.667 ' HB3' ' CE ' ' A' ' 155' ' ' LYS . . . -83.37 -7.22 59.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 63.4 111.071 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.558 HG12 ' O ' ' A' ' 170' ' ' ARG . 7.9 p -50.92 -28.21 6.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 63.23 111.133 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 28.5 pt -50.32 -30.8 7.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 73.44 111.118 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -54.7 -45.74 74.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 72.13 110.925 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . 0.747 ' CB ' HD22 ' A' ' 152' ' ' LEU . 6.2 p -51.22 -44.13 61.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 74.04 110.913 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -64.42 -51.07 65.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.064 -0.516 . . . . 62.41 110.901 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -84.81 54.61 3.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 61.14 110.843 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 74.5 110.806 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.7 ttpp . . . . . 0 C--O 1.23 0.039 0 CA-C-O 120.84 0.353 . . . . 73.43 110.897 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.27 -28.55 42.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 63.45 111.137 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -60.03 -20.46 58.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 73.34 110.851 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -61.9 -19.82 63.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 73.43 110.875 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -51.76 -30.9 24.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.271 -0.422 . . . . 73.45 110.907 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -81.31 -45.6 15.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.225 -0.443 . . . . 71.43 110.854 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.8 -15.89 59.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 71.42 111.108 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.716 ' CD1' HD21 ' A' ' 98' ' ' LEU . 31.5 m0 -57.72 -22.86 48.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 74.32 110.866 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 52.1 mt -54.66 -26.33 16.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.304 -0.407 . . . . 70.15 111.135 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 70.3 p -80.26 -59.2 2.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 60.33 111.089 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.716 HD21 ' CD1' ' A' ' 95' ' ' TRP . 4.2 pp -61.49 -18.48 59.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.235 -0.439 . . . . 75.55 110.905 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -73.51 -25.7 60.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 35.4 110.842 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -79.44 -22.9 43.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 74.54 110.849 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.684 ' HB1' ' OE2' ' A' ' 106' ' ' GLU . . . -65.53 -38.95 91.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 73.43 111.076 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.451 ' CD1' HG11 ' A' ' 156' ' ' VAL . 37.9 m-85 -69.1 -23.85 64.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.304 -0.407 . . . . 64.12 110.942 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.27 -25.23 58.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 65.01 110.906 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -94.82 20.93 8.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 74.24 110.904 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 60.95 65.34 1.02 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 75.23 111.158 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.684 ' OE2' ' HB1' ' A' ' 101' ' ' ALA . 27.4 mt-10 -90.19 169.22 11.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 75.25 110.827 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.3 m -120.48 139.24 53.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 72.55 111.104 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.506 HG22 HG23 ' A' ' 156' ' ' VAL . 30.1 m -125.74 -177.22 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 71.21 111.072 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.6 t -161.06 123.46 3.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.116 -0.493 . . . . 72.43 111.184 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.497 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -149.24 148.48 19.89 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.731 -0.747 . . . . 43.33 112.448 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 150' ' ' LYS . 10.5 p -90.96 135.61 26.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.804 0.335 . . . . 54.3 111.115 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.736 HG13 HG22 ' A' ' 122' ' ' VAL . 4.8 mp -63.37 107.14 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.492 . . . . 73.4 111.101 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -91.51 -34.52 14.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.48 . . . . 70.02 110.915 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -128.21 143.78 14.69 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.773 -0.727 . . . . 74.52 112.497 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.5 pttp -123.94 134.77 53.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.822 0.344 . . . . 75.2 110.907 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.3 m -117.36 176.59 2.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 71.4 111.095 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -66.37 98.05 0.45 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 72.03 110.959 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 91.93 -35.26 4.05 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.753 -0.737 . . . . 73.33 112.485 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -98.17 173.51 27.75 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.761 -0.733 . . . . 73.01 112.611 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.578 ' HZ ' HD22 ' A' ' 147' ' ' LEU . 7.1 m-85 -145.37 118.93 9.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.919 0.39 . . . . 73.13 110.965 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.434 ' O ' HG23 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -85.79 147.01 26.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 71.3 111.109 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.765 ' HB ' ' HB3' ' A' ' 129' ' ' ALA . 32.8 t -138.52 147.68 25.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 62.52 111.134 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -102.55 105.7 16.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 63.43 110.828 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.499 HD13 HG21 ' A' ' 108' ' ' VAL . 81.8 mt -105.91 74.43 1.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 74.2 110.962 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 57.72 51.06 9.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 75.4 111.003 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 99.79 -33.5 6.2 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.757 -0.735 . . . . 71.51 112.5 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.55 ' CG2' HG21 ' A' ' 166' ' ' VAL . 25.0 mm -76.58 150.25 6.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.793 0.33 . . . . 73.32 111.157 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 57.9 mtm180 -109.66 117.12 33.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 73.51 110.859 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.765 ' HB3' ' HB ' ' A' ' 122' ' ' VAL . . . -94.55 171.56 8.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 63.52 111.171 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.405 ' HB3' HG12 ' A' ' 167' ' ' VAL . 3.0 t80 -146.74 122.03 10.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.28 -0.418 . . . . 74.44 110.853 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 9.4 mp -110.54 129.43 23.96 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.643 0.735 . . . . 72.14 110.923 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 152.11 69.01 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.695 2.263 . . . . 70.4 112.325 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.46 -18.57 61.27 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.724 -0.75 . . . . 72.2 112.523 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 44.2 t -73.65 -26.21 60.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.849 0.357 . . . . 71.14 110.8 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.771 HD12 ' HA ' ' A' ' 170' ' ' ARG . 10.1 tt -79.97 -26.92 39.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 71.02 110.875 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.537 HG21 ' CD2' ' A' ' 120' ' ' PHE . 81.8 t -78.94 -62.76 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 72.44 111.119 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -166.37 161.92 16.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 72.0 110.908 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 27.0 m -82.04 147.87 5.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 53.41 111.138 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.01 160.53 0.12 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.605 0.717 . . . . 72.02 110.884 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.69 145.54 57.89 Favored 'Trans proline' 0 C--O 1.23 0.123 0 C-N-CA 122.745 2.297 . . . . 72.14 112.289 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.6 p -116.29 149.96 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 61.41 111.141 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -66.21 -75.22 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 73.12 110.859 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -179.93 138.57 0.12 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 65.31 110.896 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.82 157.5 33.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 34.45 111.122 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.8 mp -87.57 -9.64 53.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 72.53 110.88 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -60.33 -18.79 52.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.161 -0.472 . . . . 72.35 110.81 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.578 HD22 ' HZ ' ' A' ' 120' ' ' PHE . 1.4 pp -109.35 36.41 2.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 63.33 110.931 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -129.66 124.68 34.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 74.44 110.832 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 66.64 23.51 72.25 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.727 -0.749 . . . . 65.23 112.489 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.666 ' HD3' HD12 ' A' ' 152' ' ' LEU . 1.6 ttmm -63.33 130.26 43.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.726 0.298 . . . . 70.04 110.878 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -104.16 89.71 3.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 74.3 110.843 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.666 HD12 ' HD3' ' A' ' 150' ' ' LYS . 5.8 mt -138.34 135.98 35.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.139 -0.482 . . . . 72.43 110.921 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -85.91 158.03 20.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 74.32 110.852 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.427 ' CE2' HG21 ' A' ' 122' ' ' VAL . 4.2 m-85 -126.06 -179.23 4.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 73.31 110.852 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.435 ' CB ' ' HB1' ' A' ' 172' ' ' ALA . 6.5 tttp -125.26 108.24 11.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.12 -0.491 . . . . 74.34 110.899 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.506 HG23 HG22 ' A' ' 108' ' ' VAL . 21.5 t -69.33 128.92 33.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.43 . . . . 74.32 111.127 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 7.8 tp -118.3 -29.35 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 71.04 111.164 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.614 ' C ' HD13 ' A' ' 159' ' ' LEU . 0.0 OUTLIER -170.99 166.42 7.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 75.32 110.918 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.614 HD13 ' C ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -155.84 165.48 36.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 65.04 110.917 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -119.18 96.58 5.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 74.52 110.878 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -77.12 -23.3 51.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.159 -0.473 . . . . 71.33 110.857 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 22.5 tptt -51.79 -45.75 63.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 74.31 110.967 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -104.6 16.88 25.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 65.14 110.893 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 51.51 48.57 22.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 72.53 110.939 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -121.88 153.81 37.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 75.13 110.947 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.55 HG21 ' CG2' ' A' ' 127' ' ' ILE . 97.3 t -142.98 128.51 16.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 71.02 111.151 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.405 HG12 ' HB3' ' A' ' 130' ' ' PHE . 34.1 m -134.81 171.18 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 72.33 111.184 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 6.3 m -120.27 145.75 26.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 74.3 111.084 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.85 157.47 37.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 62.55 110.871 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.771 ' HA ' HD12 ' A' ' 135' ' ' LEU . 0.3 OUTLIER -81.87 -42.13 20.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.121 -0.491 . . . . 71.21 110.82 -179.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 83.7 mtm-85 -59.7 -20.6 57.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.266 -0.424 . . . . 64.34 110.847 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.435 ' HB1' ' CB ' ' A' ' 155' ' ' LYS . . . -61.7 -17.45 55.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 63.4 111.084 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 10.2 p -50.71 -30.5 8.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 63.23 111.173 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 27.2 pt -51.48 -32.44 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.488 . . . . 73.44 111.12 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -88.03 -26.4 22.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.463 . . . . 72.13 110.853 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . 0.467 ' OG ' HD22 ' A' ' 152' ' ' LEU . 5.1 t -91.29 12.79 19.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 74.04 110.877 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -50.01 -53.43 26.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 62.41 110.91 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -128.14 -58.48 1.21 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 61.14 110.886 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 10.9 t . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 74.5 110.873 -179.848 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.5 tptm . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.798 0.332 . . . . 73.43 110.916 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.75 -30.16 59.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 63.45 111.079 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -64.67 -27.95 69.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 73.34 110.939 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -57.07 -27.16 61.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 73.43 110.866 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -52.04 -37.7 54.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 73.45 110.904 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -81.77 -29.91 32.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.447 . . . . 71.43 110.922 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.96 -24.47 61.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 71.42 111.159 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.561 ' HA ' HD23 ' A' ' 98' ' ' LEU . 53.9 m0 -58.77 -22.57 58.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.197 -0.456 . . . . 74.32 110.962 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 70.0 mt -51.53 -29.96 10.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.218 -0.446 . . . . 70.15 111.134 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 73.3 p -64.27 -52.13 60.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 60.33 111.104 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.629 HD21 HD11 ' A' ' 127' ' ' ILE . 0.6 OUTLIER -70.88 -21.73 62.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.435 . . . . 75.55 110.962 179.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -59.9 -52.29 66.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.164 -0.471 . . . . 35.4 110.867 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -57.65 -27.45 62.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.471 . . . . 74.54 110.953 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 98' ' ' LEU . . . -51.98 -48.4 64.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.166 -0.47 . . . . 73.43 111.111 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.426 ' OH ' HG11 ' A' ' 108' ' ' VAL . 92.8 m-85 -55.74 -33.26 64.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 64.12 110.924 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.57 -26.41 66.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 65.01 110.899 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -104.46 20.97 17.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 74.24 110.838 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 57.91 67.41 0.96 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 75.23 111.043 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -104.06 176.15 5.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 75.25 110.937 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.3 t -121.14 164.95 16.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.166 -0.47 . . . . 72.55 111.062 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.426 HG11 ' OH ' ' A' ' 102' ' ' TYR . 34.9 m -135.4 -178.09 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 71.21 111.096 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.438 ' O ' HD23 ' A' ' 124' ' ' LEU . 4.9 t -154.13 122.85 6.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.081 -0.508 . . . . 72.43 111.156 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -156.87 150.97 22.35 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.742 -0.742 . . . . 43.33 112.503 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.467 ' C ' HG13 ' A' ' 122' ' ' VAL . 7.3 p -109.45 141.2 25.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.829 0.347 . . . . 54.3 111.12 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.768 HG13 HG22 ' A' ' 122' ' ' VAL . 4.3 mp -67.36 101.88 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.132 -0.485 . . . . 73.4 111.066 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -91.26 -27.16 18.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 70.02 110.912 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -134.18 143.05 14.62 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.736 -0.745 . . . . 74.52 112.48 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.98 136.66 54.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.788 0.327 . . . . 75.2 110.937 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.3 m -118.39 176.44 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 71.4 111.183 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.94 97.73 0.37 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 72.03 110.928 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 92.24 -35.02 4.16 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.752 -0.737 . . . . 73.33 112.465 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -98.17 173.55 27.79 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.737 -0.744 . . . . 73.01 112.48 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.742 ' CE2' HG11 ' A' ' 136' ' ' VAL . 9.0 m-85 -146.03 119.09 8.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.86 0.362 . . . . 73.13 110.877 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.486 ' O ' HG23 ' A' ' 112' ' ' ILE . 1.4 m -86.5 150.6 24.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 71.3 111.155 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.768 HG22 HG13 ' A' ' 112' ' ' ILE . 21.6 t -138.89 131.93 38.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.287 -0.415 . . . . 62.52 111.165 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -84.01 99.27 10.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 63.43 110.897 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.719 HD12 ' HB2' ' A' ' 129' ' ' ALA . 25.4 mt -99.89 77.65 2.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 74.2 110.907 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 52.14 52.92 13.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 75.4 110.878 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 93.36 -22.31 35.78 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.764 -0.731 . . . . 71.51 112.532 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.629 HD11 HD21 ' A' ' 98' ' ' LEU . 57.1 mt -83.02 144.43 10.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.8 0.333 . . . . 73.32 111.141 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -100.52 109.25 21.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 73.51 110.848 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.765 ' HB3' ' HB ' ' A' ' 122' ' ' VAL . . . -92.99 171.59 8.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 63.52 111.019 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -146.76 129.73 16.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 74.44 110.856 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.591 ' CD2' HG23 ' A' ' 168' ' ' VAL . 5.5 mt -120.17 129.52 25.3 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.587 0.708 . . . . 72.14 110.943 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.615 ' O ' HG23 ' A' ' 136' ' ' VAL . 53.7 Cg_endo -69.88 136.78 33.55 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.677 2.252 . . . . 70.4 112.29 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -71.54 -16.74 75.95 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.759 -0.734 . . . . 72.2 112.424 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 2.9 t -55.4 -26.37 41.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.88 0.371 . . . . 71.14 110.858 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.503 HD13 ' HB2' ' A' ' 171' ' ' ARG . 28.7 mt -120.61 24.64 10.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.47 . . . . 71.02 110.932 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.742 HG11 ' CE2' ' A' ' 120' ' ' PHE . 88.6 t -113.46 -49.41 5.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 72.44 111.174 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -99.08 112.64 24.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 72.0 110.85 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.417 ' O ' HG23 ' A' ' 138' ' ' VAL . 5.8 m -152.89 107.07 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 53.41 111.14 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 18.7 mmt-85 51.94 69.13 2.63 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.557 0.694 . . . . 72.02 110.89 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 143.81 52.11 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.618 2.212 . . . . 72.14 112.362 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 4.1 m -139.77 85.89 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 61.41 111.196 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.1 ptt-85 39.42 41.74 0.74 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.472 . . . . 73.12 110.824 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -137.93 97.39 3.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 65.31 110.925 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.721 ' CG2' HD12 ' A' ' 147' ' ' LEU . 0.2 OUTLIER -118.77 -13.67 9.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 34.45 111.125 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 13.7 mt -62.88 -21.65 66.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 72.53 110.943 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -93.36 18.21 10.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 72.35 110.891 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.721 HD12 ' CG2' ' A' ' 144' ' ' THR . 61.5 mt -110.51 -33.11 6.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 63.33 110.949 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -128.32 129.5 46.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 74.44 110.879 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 90.42 -14.84 61.51 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.771 -0.728 . . . . 65.23 112.45 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.548 ' O ' HD12 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -59.89 129.97 44.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.804 0.335 . . . . 70.04 110.867 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -111.02 114.28 27.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 74.3 110.942 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.712 HD22 ' C ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -140.66 165.17 28.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 72.43 110.922 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.57 ' N ' HD22 ' A' ' 152' ' ' LEU . 1.3 tt0 -98.38 131.03 45.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.175 -0.466 . . . . 74.32 110.93 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.476 ' CZ ' HD11 ' A' ' 152' ' ' LEU . 16.2 m-85 -97.22 -179.41 4.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 73.31 110.879 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.45 ' H ' ' HB1' ' A' ' 172' ' ' ALA . 13.6 tttm -137.09 145.98 44.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 74.34 110.918 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.421 HG13 ' O ' ' A' ' 156' ' ' VAL . 5.5 p -56.62 120.18 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.434 . . . . 74.32 111.145 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.8 tp -130.21 -38.86 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.109 -0.496 . . . . 71.04 111.146 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -169.28 139.38 2.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 75.32 110.927 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -153.21 125.76 8.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 65.04 110.915 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -91.29 63.37 4.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 74.52 110.873 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -55.39 -26.44 41.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 71.33 110.923 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 18.5 ttpp -57.3 -43.16 82.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 74.31 110.915 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -102.94 24.85 10.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.448 . . . . 65.14 110.937 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 52.71 33.44 13.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.098 -0.501 . . . . 72.53 110.926 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -108.78 154.67 21.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 75.13 110.908 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 7.1 p -152.4 123.73 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 71.02 111.119 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 19.5 m -134.63 148.18 29.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 72.33 111.192 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.591 HG23 ' CD2' ' A' ' 131' ' ' LEU . 6.1 m -120.44 171.81 8.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 74.3 111.158 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.9 m -123.88 142.19 51.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 62.55 110.895 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.591 ' O ' HG23 ' A' ' 173' ' ' VAL . 0.2 OUTLIER -65.92 -34.35 77.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 71.21 110.899 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.503 ' HB2' HD13 ' A' ' 135' ' ' LEU . 29.5 ttm180 -61.93 -20.79 64.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 64.34 110.883 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.45 ' HB1' ' H ' ' A' ' 155' ' ' LYS . . . -55.89 -24.83 39.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 63.4 111.069 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 170' ' ' ARG . 95.6 t -51.88 -37.62 21.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 63.23 111.102 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 2.0 pp -54.05 -27.31 16.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.186 -0.461 . . . . 73.44 111.125 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -77.24 -63.63 1.32 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.466 . . . . 72.13 110.846 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 66.3 p -52.27 -49.24 64.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 74.04 110.857 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -53.72 -58.58 6.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.489 . . . . 62.41 110.871 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -59.59 -74.31 0.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 61.14 110.96 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 6.4 p . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.131 -0.486 . . . . 74.5 110.859 -179.912 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.5 mmtt . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.723 0.296 . . . . 73.43 110.829 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.95 -55.4 14.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 63.45 111.11 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.68 -27.28 69.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.27 -0.423 . . . . 73.34 110.88 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -66.58 -26.84 67.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.426 . . . . 73.43 110.9 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -51.95 -43.22 63.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 73.45 110.871 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -79.29 -24.94 42.54 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.198 -0.456 . . . . 71.43 110.914 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -77.75 -19.72 54.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 71.42 111.055 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.573 ' CD1' HD21 ' A' ' 98' ' ' LEU . 41.4 m0 -58.1 -22.68 51.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 74.32 110.897 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 35.7 pt -51.78 -29.35 10.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.285 -0.416 . . . . 70.15 111.14 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.1 p -75.27 -61.48 1.89 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.146 -0.479 . . . . 60.33 111.18 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.573 HD21 ' CD1' ' A' ' 95' ' ' TRP . 3.4 pp -59.05 -21.76 59.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.25 -0.432 . . . . 75.55 110.874 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -51.92 -47.22 64.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 35.4 110.85 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -62.65 -28.94 70.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.121 -0.49 . . . . 74.54 110.893 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 98' ' ' LEU . . . -58.05 -44.09 87.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 73.43 111.099 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.798 ' HB3' HD11 ' A' ' 159' ' ' LEU . 42.6 m-85 -56.41 -34.08 66.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.158 -0.474 . . . . 64.12 110.968 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.32 -26.06 60.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.1 -0.5 . . . . 65.01 110.881 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -94.79 20.7 8.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.143 -0.48 . . . . 74.24 110.828 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 59.35 36.59 23.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.439 . . . . 75.23 111.123 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -61.89 152.97 30.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 75.25 110.877 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.636 HG22 ' HG2' ' A' ' 155' ' ' LYS . 35.5 p -93.69 148.52 22.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.066 -0.516 . . . . 72.55 111.09 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.7 m -123.32 168.85 15.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 71.21 111.114 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.518 HG22 ' HG2' ' A' ' 153' ' ' GLU . 0.5 OUTLIER -146.41 118.49 8.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.477 . . . . 72.43 111.135 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -152.37 151.02 22.94 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.649 -0.786 . . . . 43.33 112.44 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 150' ' ' LYS . 12.3 p -101.28 139.6 22.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.722 0.296 . . . . 54.3 111.164 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.622 HD12 ' O ' ' A' ' 150' ' ' LYS . 4.0 mp -61.1 116.49 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 73.4 111.06 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -97.86 -45.2 6.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 70.02 110.861 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -124.89 153.54 17.9 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.778 -0.725 . . . . 74.52 112.539 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 9.2 ptmm? -124.05 125.2 44.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.843 0.354 . . . . 75.2 110.905 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.0 m -104.02 177.31 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 71.4 111.109 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 53.2 mttt -62.15 94.64 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 72.03 110.861 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 90.08 -36.25 3.6 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.75 -0.738 . . . . 73.33 112.534 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -92.59 173.51 35.43 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.713 -0.756 . . . . 73.01 112.509 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -142.94 118.28 10.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.934 0.397 . . . . 73.13 110.917 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 33.3 p -84.84 150.97 24.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 71.3 111.135 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.611 HG22 HG13 ' A' ' 112' ' ' ILE . 64.3 t -139.38 138.37 40.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 62.52 111.168 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -91.44 100.55 13.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 63.43 110.889 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 10.9 mt -90.72 81.85 5.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 74.2 110.945 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.3 p30 42.0 52.11 4.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 75.4 110.905 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 104.01 -34.02 6.11 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.762 -0.732 . . . . 71.51 112.49 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.662 ' CG2' HG11 ' A' ' 166' ' ' VAL . 25.2 mt -76.45 152.29 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.779 0.323 . . . . 73.32 111.136 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.555 ' O ' HG13 ' A' ' 166' ' ' VAL . 53.7 mtm180 -105.09 105.49 15.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 73.51 110.889 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.573 ' HB3' ' HB ' ' A' ' 122' ' ' VAL . . . -92.81 159.12 15.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 63.52 111.032 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -133.75 125.95 29.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 74.44 110.871 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.809 HD22 HD11 ' A' ' 135' ' ' LEU . 22.6 mt -115.05 131.65 23.42 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.634 0.73 . . . . 72.14 110.843 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.614 ' HD2' HD21 ' A' ' 135' ' ' LEU . 53.8 Cg_endo -69.74 164.65 33.73 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.665 2.243 . . . . 70.4 112.399 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.729 ' HA2' HG13 ' A' ' 136' ' ' VAL . . . -67.13 -11.0 58.02 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.719 -0.753 . . . . 72.2 112.513 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.5 t -60.24 -32.27 70.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.94 0.4 . . . . 71.14 110.881 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.809 HD11 HD22 ' A' ' 131' ' ' LEU . 0.8 OUTLIER -124.09 41.97 3.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 71.02 110.943 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.729 HG13 ' HA2' ' A' ' 133' ' ' GLY . 0.3 OUTLIER -50.72 -43.07 23.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 72.44 111.142 179.814 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -179.71 119.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 72.0 110.859 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 12.7 p -76.06 138.79 20.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 53.41 111.168 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 30.8 mtp180 61.24 75.62 0.44 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.626 0.727 . . . . 72.02 110.865 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.73 135.31 30.19 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.702 2.268 . . . . 72.14 112.336 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.412 HG12 ' N ' ' A' ' 142' ' ' ARG . 5.9 t -127.74 157.94 39.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 61.41 111.15 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.412 ' N ' HG12 ' A' ' 141' ' ' VAL . 0.0 OUTLIER -50.89 -30.81 15.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 73.12 110.827 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -84.34 129.57 34.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 65.31 110.847 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.615 HG22 HD11 ' A' ' 147' ' ' LEU . 18.1 p -98.6 27.92 4.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 34.45 111.131 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.5 tp -87.49 -21.36 25.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 72.53 110.88 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 33.7 p-80 -89.08 -21.86 23.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 72.35 110.86 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.615 HD11 HG22 ' A' ' 144' ' ' THR . 59.2 mt -51.84 -57.98 7.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 63.33 110.973 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -101.7 145.11 29.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 74.44 110.848 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 95.45 -12.15 68.06 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.756 -0.735 . . . . 65.23 112.573 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.622 ' O ' HD12 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -55.65 133.56 50.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.682 0.277 . . . . 70.04 110.95 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -110.26 111.92 23.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.269 -0.423 . . . . 74.3 110.897 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.514 HD12 ' HD3' ' A' ' 150' ' ' LYS . 5.4 mt -139.21 159.32 42.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 72.43 110.894 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.518 ' HG2' HG22 ' A' ' 109' ' ' THR . 12.9 mt-10 -95.0 148.18 22.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 74.32 110.867 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.724 ' HA ' HG23 ' A' ' 173' ' ' VAL . 3.6 m-85 -123.32 -179.47 4.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 73.31 110.832 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.636 ' HG2' HG22 ' A' ' 107' ' ' THR . 0.2 OUTLIER -135.14 108.19 7.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 74.34 110.902 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.602 HG21 ' CD1' ' A' ' 102' ' ' TYR . 89.1 t -60.47 105.98 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.217 -0.447 . . . . 74.32 111.129 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.6 tt -89.58 -30.29 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 71.04 111.144 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -176.41 169.67 2.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 75.32 110.894 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.798 HD11 ' HB3' ' A' ' 102' ' ' TYR . 0.4 OUTLIER -143.1 160.96 39.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 65.04 110.889 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.78 101.8 10.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.187 -0.461 . . . . 74.52 110.931 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -81.15 -36.08 30.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 71.33 110.929 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 29.9 tttp -69.45 -46.14 67.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 74.31 110.888 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -73.62 -15.31 61.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 65.14 110.922 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.4 m120 63.34 41.06 8.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 72.53 110.945 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -139.09 128.94 24.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 75.13 110.897 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.662 HG11 ' CG2' ' A' ' 127' ' ' ILE . 7.2 p -99.98 130.59 48.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 71.02 111.066 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 18.9 m -134.79 171.17 18.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 72.33 111.118 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.433 HG23 HD23 ' A' ' 131' ' ' LEU . 1.8 m -120.34 153.16 23.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.468 . . . . 74.3 111.112 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.28 160.64 31.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 62.55 110.875 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.701 ' O ' HG12 ' A' ' 173' ' ' VAL . 17.6 ptt180 -121.74 -33.94 3.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.167 -0.47 . . . . 71.21 110.893 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -81.75 -34.35 30.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 64.34 110.86 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -83.62 -26.4 29.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 63.4 111.12 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.724 HG23 ' HA ' ' A' ' 154' ' ' PHE . 5.7 p -58.07 -20.29 14.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 63.23 111.128 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 27.3 pt -53.11 -27.96 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.485 . . . . 73.44 111.117 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -87.21 -31.81 20.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 72.13 110.895 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 3.7 t -76.8 -25.03 52.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 74.04 110.827 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.481 ' HA ' HD22 ' A' ' 152' ' ' LEU . 36.6 mt-10 -60.81 -33.7 73.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.122 -0.49 . . . . 62.41 110.889 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -123.88 49.04 1.79 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.491 . . . . 61.14 110.886 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 41.8 t . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 74.5 110.825 -179.829 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.854 0.359 . . . . 73.43 110.957 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.41 -51.44 68.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 63.45 111.08 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.1 mtmm -55.87 -26.01 45.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 73.34 110.892 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.87 -26.46 36.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 73.43 110.865 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 14.7 t60 -51.61 -30.27 20.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.153 -0.476 . . . . 73.45 110.911 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -79.29 -34.98 41.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.165 -0.47 . . . . 71.43 110.872 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.32 -15.52 62.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 71.42 111.096 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -57.76 -22.48 47.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 74.32 110.951 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 27.2 pt -52.31 -32.7 16.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.288 -0.414 . . . . 70.15 111.154 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.6 p -86.07 -23.65 26.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 60.33 111.13 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.497 ' O ' HD12 ' A' ' 98' ' ' LEU . 7.6 tp -67.8 -28.55 67.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.21 -0.45 . . . . 75.55 110.889 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -60.35 -48.17 82.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 35.4 110.898 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -67.41 -24.65 65.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 74.54 110.888 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.1 -36.92 85.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 73.43 111.095 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.73 ' CG ' HD21 ' A' ' 159' ' ' LEU . 12.6 t80 -52.81 -28.96 25.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 64.12 110.977 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.49 -25.05 50.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.078 -0.51 . . . . 65.01 110.902 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -94.3 -22.21 18.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.139 -0.482 . . . . 74.24 110.874 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 62.16 44.49 7.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.443 . . . . 75.23 111.066 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.77 165.27 15.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 75.25 110.936 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.8 t -94.56 168.07 11.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 72.55 111.163 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.2 m -152.96 -178.62 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 71.21 111.128 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 109' ' ' THR . 4.1 t -141.43 116.67 10.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 72.43 111.215 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.403 ' CA ' HD23 ' A' ' 124' ' ' LEU . . . -134.46 151.98 20.5 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.721 -0.752 . . . . 43.33 112.449 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.689 HG22 ' HA ' ' A' ' 151' ' ' GLU . 85.5 t -115.56 134.2 59.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.751 0.31 . . . . 54.3 111.132 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.494 HD12 ' O ' ' A' ' 150' ' ' LYS . 3.5 mp -54.66 115.34 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 73.4 111.136 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -100.16 -41.64 7.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 70.02 110.926 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -120.87 145.84 17.37 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.799 -0.715 . . . . 74.52 112.512 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.2 pttt -124.03 128.42 49.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.788 0.328 . . . . 75.2 110.927 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.6 m -119.82 176.5 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 71.4 111.167 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -68.15 99.06 0.85 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 72.03 110.927 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 92.02 -35.13 4.1 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.763 -0.732 . . . . 73.33 112.452 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -98.26 173.6 27.71 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.774 -0.727 . . . . 73.01 112.494 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -152.56 119.06 5.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.989 0.423 . . . . 73.13 110.905 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.418 ' O ' HG23 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -86.29 150.89 24.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.159 -0.473 . . . . 71.3 111.116 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.653 ' HB ' ' HB3' ' A' ' 129' ' ' ALA . 19.9 t -140.69 139.83 34.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.494 . . . . 62.52 111.121 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -95.02 107.28 19.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 63.43 110.871 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.403 HD23 ' CA ' ' A' ' 110' ' ' GLY . 26.9 mt -103.18 72.67 1.18 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.157 -0.474 . . . . 74.2 110.955 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 54.38 50.89 15.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 75.4 110.927 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 103.9 -33.38 6.62 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.714 -0.755 . . . . 71.51 112.461 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.6 mm -80.06 156.18 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.842 0.354 . . . . 73.32 111.114 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 47.7 mtt180 -114.84 121.67 43.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 73.51 110.956 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.653 ' HB3' ' HB ' ' A' ' 122' ' ' VAL . . . -102.25 168.45 9.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.25 -0.432 . . . . 63.52 111.123 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -147.87 124.41 11.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 74.44 110.844 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.584 HD21 ' CG2' ' A' ' 122' ' ' VAL . 0.1 OUTLIER -122.89 130.16 24.72 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.68 0.753 . . . . 72.14 110.887 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 146.21 59.77 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.652 2.235 . . . . 70.4 112.373 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -67.63 -11.35 59.88 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.772 -0.727 . . . . 72.2 112.482 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.6 m -51.33 -30.63 19.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.89 0.376 . . . . 71.14 110.838 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.539 HD22 ' CA ' ' A' ' 170' ' ' ARG . 5.0 tp -116.16 29.09 8.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 71.02 110.886 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 94.4 t -120.01 -32.74 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.251 -0.431 . . . . 72.44 111.113 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -108.11 116.0 31.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 72.0 110.843 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.439 HG12 ' H ' ' A' ' 139' ' ' ARG . 1.4 t -129.18 166.95 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 53.41 111.092 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.484 ' N ' ' HD2' ' A' ' 140' ' ' PRO . 0.9 OUTLIER -50.86 -60.68 5.05 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.602 0.715 . . . . 72.02 110.893 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 139' ' ' ARG . 54.5 Cg_endo -69.74 133.36 25.42 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.746 2.297 . . . . 72.14 112.361 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.7 m -128.83 148.7 33.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 61.41 111.103 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 81.9 mtt180 -124.73 -60.72 1.36 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.48 . . . . 73.12 110.88 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -153.01 162.75 40.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 65.31 110.87 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.526 HG22 HD11 ' A' ' 147' ' ' LEU . 5.8 p -106.5 19.72 20.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.205 -0.452 . . . . 34.45 111.184 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 145' ' ' LEU . 4.2 mm? -87.36 -24.56 24.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.494 . . . . 72.53 110.968 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.4 -8.59 59.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.146 -0.479 . . . . 72.35 110.88 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.526 HD11 HG22 ' A' ' 144' ' ' THR . 78.7 mt -58.92 -49.42 77.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.171 -0.468 . . . . 63.33 110.918 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -130.26 137.44 50.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 74.44 110.855 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 92.11 -16.44 59.62 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.799 -0.715 . . . . 65.23 112.505 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.593 ' HD3' HD13 ' A' ' 152' ' ' LEU . 0.4 OUTLIER -51.62 127.17 19.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.717 0.294 . . . . 70.04 110.914 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.689 ' HA ' HG22 ' A' ' 111' ' ' VAL . 2.9 pm0 -89.29 111.1 21.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.252 -0.431 . . . . 74.3 110.852 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.593 HD13 ' HD3' ' A' ' 150' ' ' LYS . 1.5 tp -139.25 -175.46 4.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 72.43 110.941 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -133.78 135.7 44.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 74.32 110.884 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.578 ' CE1' HG11 ' A' ' 122' ' ' VAL . 13.4 m-85 -119.25 -179.34 3.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.477 . . . . 73.31 110.834 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.666 ' O ' HD12 ' A' ' 157' ' ' ILE . 4.2 mttm -128.47 160.77 31.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 74.34 110.948 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.422 HG12 ' CD1' ' A' ' 102' ' ' TYR . 21.6 t -84.07 82.06 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.276 -0.42 . . . . 74.32 111.096 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.666 HD12 ' O ' ' A' ' 155' ' ' LYS . 5.1 mp -77.99 -40.49 26.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 71.04 111.089 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.41 154.74 7.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 75.32 110.857 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.73 HD21 ' CG ' ' A' ' 102' ' ' TYR . 0.2 OUTLIER -140.03 112.73 7.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 65.04 110.869 179.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -67.61 91.45 0.29 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.172 -0.467 . . . . 74.52 110.885 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -60.58 -19.93 59.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 71.33 110.923 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -51.6 -37.79 51.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 74.31 110.905 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 24.2 ttt85 -123.06 19.79 9.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 65.14 110.894 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 51.82 29.89 6.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 72.53 110.874 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -112.85 157.98 20.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.202 -0.454 . . . . 75.13 110.928 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.623 HG23 ' HB3' ' A' ' 159' ' ' LEU . 10.2 p -125.96 144.23 36.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 71.02 111.137 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 19.7 m -127.81 169.54 19.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 72.33 111.171 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 15.5 m -120.28 162.01 19.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.451 . . . . 74.3 111.087 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.638 ' H ' HD13 ' A' ' 157' ' ' ILE . 28.4 t -103.36 161.17 14.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 62.55 110.852 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.539 ' CA ' HD22 ' A' ' 135' ' ' LEU . 25.8 mtm180 -79.93 -58.16 3.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 71.21 110.918 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -56.35 -26.02 51.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 64.34 110.871 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.26 -14.03 61.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 63.4 111.04 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 13.5 p -51.6 -29.59 10.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 63.23 111.168 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 32.7 pt -51.62 -30.32 11.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.135 -0.484 . . . . 73.44 111.106 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -69.7 -38.54 77.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 72.13 110.945 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 26.0 t -51.78 -58.57 6.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.07 -0.514 . . . . 74.04 110.916 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -72.72 -61.61 1.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 62.41 110.874 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 16.0 t30 57.19 47.58 16.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 61.14 110.833 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 74.5 110.889 -179.928 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.915 0.388 . . . . 75.23 110.868 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -89.06 -46.78 8.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 73.43 110.929 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.18 -29.95 65.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 63.45 111.112 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 32.6 mmtt -58.39 -26.29 63.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 73.34 110.876 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 6.1 mtt85 -65.44 -25.83 67.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 73.43 110.894 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 54.0 m170 -51.97 -47.93 64.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 73.45 110.848 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -80.2 -26.53 39.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 71.43 110.89 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.2 -21.17 62.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 71.42 111.089 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.435 ' CD1' HD11 ' A' ' 98' ' ' LEU . 42.1 m0 -58.01 -22.85 51.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.209 -0.451 . . . . 74.32 110.922 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 74.9 mt -54.59 -26.58 16.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.448 . . . . 70.15 111.122 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.5 m -77.93 -28.16 49.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 60.33 111.164 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.595 ' CD1' HD11 ' A' ' 127' ' ' ILE . 18.7 mt -64.1 -27.67 69.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 75.55 110.907 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -51.56 -49.94 61.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 35.4 110.9 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -25.07 68.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 74.54 110.901 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.74 -55.2 8.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 73.43 111.081 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.493 ' CB ' HD22 ' A' ' 159' ' ' LEU . 33.3 m-85 -57.58 -26.27 61.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 64.12 110.904 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.71 -40.85 63.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 65.01 110.869 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -98.48 20.77 12.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 74.24 110.842 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 61.53 56.4 2.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 75.23 111.112 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -64.64 143.18 58.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 75.25 110.906 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.3 t -86.72 143.75 27.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.147 -0.479 . . . . 72.55 111.154 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.418 HG21 HD13 ' A' ' 124' ' ' LEU . 23.6 m -122.07 -179.62 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 71.21 111.154 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 4.3 t -159.96 119.58 2.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 72.43 111.14 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.687 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -160.2 172.4 36.65 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.716 -0.754 . . . . 43.33 112.458 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.627 ' C ' HG13 ' A' ' 122' ' ' VAL . 11.7 p -116.1 145.35 21.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.775 0.321 . . . . 54.3 111.119 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.431 ' CG1' HG22 ' A' ' 122' ' ' VAL . 5.6 mt -66.74 117.87 8.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 73.4 111.109 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -97.65 -43.72 7.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 70.02 110.887 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -121.67 148.23 17.26 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.725 -0.75 . . . . 74.52 112.474 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 27.0 pttt -124.21 125.4 44.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.789 0.328 . . . . 75.2 110.928 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.5 m -114.08 176.96 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 71.4 111.166 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 28.9 mttp -62.47 94.38 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 72.03 110.87 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 90.61 -35.76 3.77 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.704 -0.76 . . . . 73.33 112.508 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -90.38 173.69 39.21 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.749 -0.739 . . . . 73.01 112.531 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.489 ' HE2' HG11 ' A' ' 136' ' ' VAL . 15.3 m-85 -152.04 118.92 5.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.994 0.426 . . . . 73.13 110.927 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.11 135.81 33.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.49 . . . . 71.3 111.152 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.725 HG11 ' CZ ' ' A' ' 154' ' ' PHE . 18.1 t -135.39 138.12 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 62.52 111.089 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -88.85 113.34 24.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.453 . . . . 63.43 110.881 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.687 HD23 ' HA3' ' A' ' 110' ' ' GLY . 11.1 mt -121.16 96.44 5.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.464 . . . . 74.2 110.907 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 63.32 25.24 14.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 75.4 110.919 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 103.96 -23.1 33.24 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.677 -0.773 . . . . 71.51 112.467 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.595 HD11 ' CD1' ' A' ' 98' ' ' LEU . 21.9 mt -83.05 151.87 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.808 0.337 . . . . 73.32 111.119 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -99.65 124.3 44.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 73.51 110.868 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.628 ' HB1' ' CG2' ' A' ' 168' ' ' VAL . . . -101.15 171.75 7.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 63.52 111.097 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -142.82 117.91 10.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 74.44 110.895 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.575 HD11 ' CE2' ' A' ' 154' ' ' PHE . 7.7 mp -100.28 129.56 27.81 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.653 0.74 . . . . 72.14 110.918 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.518 ' O ' HG23 ' A' ' 136' ' ' VAL . 53.7 Cg_endo -69.71 132.5 23.55 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.706 2.27 . . . . 70.4 112.352 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -74.91 -11.22 83.8 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 72.2 112.486 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 26.5 t -50.56 -33.94 23.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.934 0.397 . . . . 71.14 110.888 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.622 HD12 ' HG2' ' A' ' 170' ' ' ARG . 28.0 mt -123.42 39.28 4.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.081 -0.508 . . . . 71.02 110.906 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 132' ' ' PRO . 99.4 t -122.77 -59.04 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 72.44 111.103 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -116.34 117.52 30.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 72.0 110.822 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 7.3 p -173.81 123.9 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 53.41 111.134 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 53.04 72.61 1.11 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.55 0.69 . . . . 72.02 110.889 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 132.84 24.09 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.644 2.229 . . . . 72.14 112.325 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 6.8 p -126.03 -37.93 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.456 . . . . 61.41 111.102 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -126.92 -176.98 3.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 73.12 110.872 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -52.09 132.48 33.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.196 -0.456 . . . . 65.31 110.818 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 9.0 t -123.16 42.6 3.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 34.45 111.125 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -85.88 -11.46 53.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 72.53 110.861 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.57 -8.38 54.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 72.35 110.862 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 64.9 mt -59.51 -31.17 69.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 63.33 110.892 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -123.53 134.9 53.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 74.44 110.903 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 92.81 0.95 68.32 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.719 -0.753 . . . . 65.23 112.482 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.4 127.92 34.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.721 0.295 . . . . 70.04 110.89 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.479 ' O ' HD22 ' A' ' 152' ' ' LEU . 34.1 mt-10 -109.59 87.0 2.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 74.3 110.9 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.479 HD22 ' O ' ' A' ' 151' ' ' GLU . 0.4 OUTLIER -139.11 166.34 24.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 72.43 110.923 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -81.92 173.75 11.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.214 -0.448 . . . . 74.32 110.9 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.725 ' CZ ' HG11 ' A' ' 122' ' ' VAL . 37.3 m-85 -133.47 -179.38 5.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 73.31 110.852 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 12.1 ttpt -130.84 108.59 9.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 74.34 110.907 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.457 HG11 ' CD1' ' A' ' 102' ' ' TYR . 21.9 t -70.42 126.53 30.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 74.32 111.167 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.9 tp -119.0 -30.47 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 71.04 111.182 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 20.7 ttmt -171.87 133.21 0.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 75.32 110.903 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.494 ' H ' HD23 ' A' ' 159' ' ' LEU . 0.9 OUTLIER -109.47 148.17 31.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 65.04 110.902 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.19 89.37 3.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 74.52 110.869 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -67.71 -23.16 65.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 71.33 110.865 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.81 -43.26 63.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 74.31 110.895 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -99.66 24.74 7.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 65.14 110.885 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 9.7 p30 41.52 38.59 0.9 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 72.53 110.917 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -143.07 168.79 18.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 75.13 110.872 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.48 HG22 HG22 ' A' ' 127' ' ' ILE . 15.8 m -128.67 144.39 38.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 71.02 111.145 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 18.3 m -116.74 171.8 5.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 72.33 111.129 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.628 ' CG2' ' HB1' ' A' ' 129' ' ' ALA . 15.8 t -119.42 152.28 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 74.3 111.103 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 14.0 t -70.01 154.7 41.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 62.55 110.873 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.622 ' HG2' HD12 ' A' ' 135' ' ' LEU . 18.4 ttm180 -83.46 -54.56 4.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 71.21 110.906 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.417 ' O ' HG23 ' A' ' 174' ' ' ILE . 12.5 ptp180 -57.4 -27.01 61.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 64.34 110.878 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.2 -19.64 55.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 63.4 111.097 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.554 HG22 ' HG3' ' A' ' 177' ' ' GLU . 11.1 p -52.38 -28.96 12.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 63.23 111.115 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 171' ' ' ARG . 30.8 pt -51.26 -30.71 10.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 73.44 111.085 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -87.98 -46.81 9.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 72.13 110.89 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 4.2 p -56.51 -40.51 75.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 74.04 110.83 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.554 ' HG3' HG22 ' A' ' 173' ' ' VAL . 8.2 mt-10 -51.92 -49.16 63.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 62.41 110.911 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -176.94 86.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 61.14 110.875 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 4.7 p . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 74.5 110.872 -179.834 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.871 0.367 . . . . 75.23 110.873 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? -105.14 -34.25 8.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 73.43 110.906 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.2 -35.33 79.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 63.45 111.089 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.68 -27.49 64.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 73.34 110.963 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.9 tpp180 -60.41 -26.58 66.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 73.43 110.833 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -52.09 -30.09 24.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 73.45 110.854 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 -80.04 -34.5 38.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 71.43 110.872 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.75 -15.96 61.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 71.42 111.083 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -57.98 -22.68 50.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 74.32 110.929 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 43.1 mm -55.35 -25.41 17.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.287 -0.415 . . . . 70.15 111.131 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 71.0 p -85.69 -23.97 27.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.232 -0.44 . . . . 60.33 111.093 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.463 ' CD1' HD11 ' A' ' 127' ' ' ILE . 63.4 mt -67.54 -49.0 65.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 75.55 110.922 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -51.9 -43.49 63.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 35.4 110.876 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.87 -24.39 41.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 74.54 110.894 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.08 -26.47 56.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 73.43 111.114 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.454 ' HB2' HD21 ' A' ' 159' ' ' LEU . 16.1 t80 -56.04 -25.12 43.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 64.12 110.941 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -54.82 -26.84 37.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 65.01 110.891 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -92.75 -22.04 19.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.081 -0.509 . . . . 74.24 110.846 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 63.9 44.91 4.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 75.23 111.123 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -62.43 -179.81 0.27 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.22 -0.446 . . . . 75.25 110.832 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 32.7 p -106.61 178.82 4.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.1 -0.5 . . . . 72.55 111.089 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.9 m -152.35 -178.66 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 71.21 111.181 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 86.5 m -154.22 122.89 6.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 72.43 111.15 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.406 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -158.09 154.97 26.01 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.7 -0.762 . . . . 43.33 112.422 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 150' ' ' LYS . 10.8 p -105.16 137.62 33.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.743 0.306 . . . . 54.3 111.216 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.735 HG13 HG22 ' A' ' 122' ' ' VAL . 4.2 mp -57.98 112.02 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.218 -0.446 . . . . 73.4 111.134 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 20.4 m-20 -95.17 -30.3 14.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.098 -0.501 . . . . 70.02 110.892 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -134.14 144.4 16.34 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.708 -0.758 . . . . 74.52 112.502 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.93 136.84 54.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.861 0.362 . . . . 75.2 110.917 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.1 m -118.8 176.44 3.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 71.4 111.044 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.1 tptt -66.0 97.75 0.38 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 72.03 110.92 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 92.2 -35.02 4.16 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.717 -0.754 . . . . 73.33 112.46 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -98.18 173.62 27.84 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.747 . . . . 73.01 112.494 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.416 ' HE2' HG13 ' A' ' 136' ' ' VAL . 8.4 m-85 -146.2 118.91 8.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.911 0.386 . . . . 73.13 110.918 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.631 ' O ' HG23 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -86.26 149.5 25.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 71.3 111.14 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.735 HG22 HG13 ' A' ' 112' ' ' ILE . 21.3 t -140.75 142.35 30.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 62.52 111.103 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -99.61 99.52 10.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 63.43 110.873 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.606 HD21 ' HD2' ' A' ' 154' ' ' PHE . 16.2 mt -102.02 89.68 3.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 74.2 110.929 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 51.97 39.31 25.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 75.4 110.844 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 103.68 -27.15 20.92 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.768 -0.729 . . . . 71.51 112.464 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.463 HD11 ' CD1' ' A' ' 98' ' ' LEU . 24.4 mm -74.15 150.23 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.787 0.327 . . . . 73.32 111.154 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.7 ttt180 -110.7 111.87 23.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 73.51 110.863 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.711 ' HB1' ' CG2' ' A' ' 168' ' ' VAL . . . -92.91 171.54 8.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 63.52 111.147 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -145.58 107.85 4.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 74.44 110.873 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.653 HD11 ' CE1' ' A' ' 154' ' ' PHE . 6.6 mp -92.35 129.46 40.96 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.512 0.672 . . . . 72.14 110.959 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 155.18 66.58 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.64 2.226 . . . . 70.4 112.35 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.64 ' O ' HG23 ' A' ' 136' ' ' VAL . . . -67.19 -11.66 59.3 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.707 -0.759 . . . . 72.2 112.473 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.3 p -79.47 -20.86 46.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.922 0.391 . . . . 71.14 110.871 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.724 HD22 ' HA ' ' A' ' 170' ' ' ARG . 4.8 tp -120.34 39.23 3.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.123 -0.49 . . . . 71.02 110.908 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 133' ' ' GLY . 85.1 t -62.37 -62.46 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 72.44 111.106 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -173.76 146.05 1.22 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.095 -0.502 . . . . 72.0 110.873 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.8 m -85.74 151.79 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 53.41 111.093 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.17 73.47 0.93 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.599 0.714 . . . . 72.02 110.905 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 139.16 39.72 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.714 2.276 . . . . 72.14 112.358 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.514 HG12 ' HE1' ' A' ' 146' ' ' HIS . 10.6 p -120.49 151.98 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.301 -0.409 . . . . 61.41 111.086 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -51.99 -30.15 23.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 73.12 110.859 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.477 ' O ' HG13 ' A' ' 141' ' ' VAL . 2.7 m-20 -82.91 129.21 34.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 65.31 110.834 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 79.6 p -108.57 37.4 2.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 34.45 111.118 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.3 tp -87.16 -22.15 25.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 72.53 110.903 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.514 ' HE1' HG12 ' A' ' 141' ' ' VAL . 29.0 p-80 -96.13 18.44 13.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 72.35 110.823 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 48.4 mt -110.7 39.35 2.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 63.33 110.878 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -167.48 123.87 1.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 74.44 110.907 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.19 15.54 71.74 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.673 -0.775 . . . . 65.23 112.479 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.607 ' O ' HD12 ' A' ' 112' ' ' ILE . 2.0 tmmm? -71.2 138.23 49.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.769 0.319 . . . . 70.04 110.866 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -105.08 118.45 36.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 74.3 110.832 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.0 tp -139.05 146.92 41.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.108 -0.496 . . . . 72.43 110.899 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -90.94 129.71 36.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.439 . . . . 74.32 110.888 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.693 ' CE2' HG11 ' A' ' 122' ' ' VAL . 17.9 m-85 -114.91 -179.43 3.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 73.31 110.897 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.74 136.05 21.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 74.34 110.91 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.675 ' CG1' HD22 ' A' ' 159' ' ' LEU . 22.0 t -58.72 112.28 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 74.32 111.148 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.462 HD13 ' O ' ' A' ' 157' ' ' ILE . 0.0 OUTLIER -114.78 -26.14 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 71.04 111.183 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -169.17 115.79 0.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 75.32 110.892 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.675 HD22 ' CG1' ' A' ' 156' ' ' VAL . 2.2 pt? -150.17 132.95 15.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.225 -0.443 . . . . 65.04 110.919 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -117.82 109.73 16.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 74.52 110.804 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -64.71 -30.64 71.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 71.33 110.926 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 9.3 ttmt -70.29 -29.93 66.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 74.31 110.895 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 38.7 mtt180 -91.83 -15.37 28.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.427 . . . . 65.14 110.9 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 60.62 42.89 13.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 72.53 110.919 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -143.06 140.69 31.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 75.13 110.864 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.553 HG22 ' HB2' ' A' ' 159' ' ' LEU . 46.7 t -137.23 141.23 40.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 71.02 111.104 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.5 m -134.78 170.92 18.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 72.33 111.177 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.711 ' CG2' ' HB1' ' A' ' 129' ' ' ALA . 20.7 t -120.47 149.19 23.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 74.3 111.133 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.77 160.89 18.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 62.55 110.862 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.724 ' HA ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -94.36 -33.71 13.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 71.21 110.908 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -76.87 -25.04 52.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 64.34 110.879 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.8 -9.38 58.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 63.4 111.131 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 10.5 p -51.35 -30.15 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 63.23 111.129 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 31.5 pt -52.07 -29.55 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 73.44 111.081 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -54.73 -65.95 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 72.13 110.857 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.96 -43.93 63.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 74.04 110.895 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -55.72 -51.17 68.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.491 . . . . 62.41 110.863 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -123.15 71.8 1.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 61.14 110.852 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 63.3 p . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 74.5 110.867 -179.87 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.898 0.38 . . . . 75.23 110.889 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -89.49 93.64 9.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.465 . . . . 73.43 110.898 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.62 -26.16 50.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 63.45 111.112 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.8 pttt -53.88 -27.95 33.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 73.34 110.846 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -59.69 -25.52 64.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 73.43 110.793 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -51.99 -37.5 53.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.195 -0.457 . . . . 73.45 110.874 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.41 ' O ' HG23 ' A' ' 96' ' ' ILE . 41.9 tt0 -78.56 -37.04 43.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.113 -0.494 . . . . 71.43 110.911 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.0 -18.14 63.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 71.42 111.147 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.419 ' CD1' HD11 ' A' ' 98' ' ' LEU . 33.3 m0 -56.6 -24.53 48.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.459 . . . . 74.32 110.916 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 93' ' ' GLU . 29.2 pt -55.02 -26.11 17.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 70.15 111.097 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 57.1 m -78.38 -27.22 46.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 60.33 111.142 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.452 ' CD1' HD11 ' A' ' 127' ' ' ILE . 17.9 mt -66.61 -24.85 66.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 75.55 110.95 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -51.85 -34.87 42.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 35.4 110.881 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 36.5 mttp -83.83 -26.36 29.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.128 -0.487 . . . . 74.54 110.873 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.565 ' HB1' ' CB ' ' A' ' 106' ' ' GLU . . . -53.33 -58.38 7.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 73.43 111.089 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -52.32 -29.64 24.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 64.12 110.961 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.05 -36.19 78.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 65.01 110.96 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -108.58 20.74 18.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.171 -0.468 . . . . 74.24 110.896 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 51.59 62.25 2.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 75.23 111.097 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.565 ' CB ' ' HB1' ' A' ' 101' ' ' ALA . 0.6 OUTLIER -71.33 155.24 40.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 75.25 110.926 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.6 t -104.11 172.65 6.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 72.55 111.147 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.746 HG21 HD13 ' A' ' 124' ' ' LEU . 16.9 m -146.28 177.37 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.27 -0.423 . . . . 71.21 111.067 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.8 t -162.2 127.25 3.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 72.43 111.083 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.665 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -165.77 153.95 24.27 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.774 -0.727 . . . . 43.33 112.506 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 150' ' ' LYS . 13.1 p -102.64 137.18 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.818 0.342 . . . . 54.3 111.149 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.733 HG13 HG22 ' A' ' 122' ' ' VAL . 4.4 mp -54.09 106.43 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.252 -0.431 . . . . 73.4 111.067 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -96.02 -39.84 9.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 70.02 110.885 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -120.99 141.93 15.21 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.783 -0.722 . . . . 74.52 112.485 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.9 pttp -124.54 147.43 48.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.781 0.325 . . . . 75.2 110.918 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.2 m -118.1 177.25 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 71.4 111.142 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.09 95.8 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 72.03 110.893 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 90.16 -36.71 3.49 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.732 -0.747 . . . . 73.33 112.461 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -98.27 173.52 27.63 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.761 -0.733 . . . . 73.01 112.481 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.582 ' HB3' HD23 ' A' ' 131' ' ' LEU . 8.3 m-85 -132.42 164.22 27.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.976 0.417 . . . . 73.13 110.866 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.47 ' O ' HG23 ' A' ' 112' ' ' ILE . 0.3 OUTLIER -135.45 150.82 49.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.108 -0.496 . . . . 71.3 111.161 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.733 HG22 HG13 ' A' ' 112' ' ' ILE . 5.3 t -136.48 156.57 36.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.255 -0.43 . . . . 62.52 111.118 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -114.21 108.47 17.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 63.43 110.927 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.746 HD13 HG21 ' A' ' 108' ' ' VAL . 18.9 mt -109.24 84.87 1.99 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 74.2 110.859 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 51.45 56.39 7.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 75.4 110.911 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.37 -35.14 4.33 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.769 -0.729 . . . . 71.51 112.49 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.694 ' CG2' HG11 ' A' ' 166' ' ' VAL . 26.0 mm -70.82 150.42 9.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.866 0.365 . . . . 73.32 111.103 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.557 ' O ' HG13 ' A' ' 166' ' ' VAL . 1.9 mpt_? -117.25 114.29 23.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.477 . . . . 73.51 110.881 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.45 ' HB3' ' HB ' ' A' ' 122' ' ' VAL . . . -92.64 161.3 14.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.484 . . . . 63.52 111.129 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -136.11 113.0 10.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 74.44 110.885 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.677 HD21 HG23 ' A' ' 122' ' ' VAL . 1.2 mm? -86.64 129.98 50.75 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.578 0.704 . . . . 72.14 110.955 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 127.88 15.19 Favored 'Trans proline' 0 N--CA 1.465 -0.167 0 C-N-CA 122.681 2.254 . . . . 70.4 112.357 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -51.56 -28.29 21.16 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.753 -0.737 . . . . 72.2 112.479 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 72.9 m -56.41 -25.09 48.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.958 0.408 . . . . 71.14 110.852 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.5 mt -88.98 -33.52 17.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.127 -0.488 . . . . 71.02 110.941 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.401 HG13 HD22 ' A' ' 147' ' ' LEU . 87.9 t -53.99 -27.43 16.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 72.44 111.108 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.45 112.67 20.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.166 -0.47 . . . . 72.0 110.885 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.401 ' O ' HG13 ' A' ' 138' ' ' VAL . 7.0 p -173.62 123.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 53.41 111.097 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 62.95 160.6 0.12 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.556 0.693 . . . . 72.02 110.889 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 149.91 67.75 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.722 2.282 . . . . 72.14 112.354 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.9 m -150.19 159.47 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 61.41 111.16 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -110.16 -73.92 0.67 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 73.12 110.9 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -63.97 145.2 56.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.454 . . . . 65.31 110.885 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.798 HG22 HD12 ' A' ' 147' ' ' LEU . 0.2 OUTLIER -108.39 23.61 14.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 34.45 111.144 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.5 mp -87.34 -22.79 24.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 72.53 110.909 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 43.9 p-80 -66.68 -25.26 66.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.433 . . . . 72.35 110.816 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.798 HD12 HG22 ' A' ' 144' ' ' THR . 59.9 mt -63.79 -59.06 5.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 63.33 110.968 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -119.43 142.18 48.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 74.44 110.894 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 91.38 -14.55 63.5 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.76 -0.733 . . . . 65.23 112.472 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.585 ' O ' HD12 ' A' ' 112' ' ' ILE . 1.6 tmmm? -53.87 128.98 32.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.768 0.318 . . . . 70.04 110.95 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.51 105.06 14.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 74.3 110.914 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.574 HD12 ' HD3' ' A' ' 150' ' ' LYS . 4.6 mt -139.04 179.84 6.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 72.43 110.953 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -115.91 152.94 32.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 74.32 110.894 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.479 ' CZ ' HG21 ' A' ' 122' ' ' VAL . 11.9 m-85 -126.5 178.4 5.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 73.31 110.853 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 18.1 tttt -131.37 160.39 35.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 74.34 110.884 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 106' ' ' GLU . 7.6 p -76.72 127.63 37.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 74.32 111.146 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.2 tp -127.87 -38.3 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.187 -0.46 . . . . 71.04 111.095 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -174.66 132.81 0.35 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.484 . . . . 75.32 110.884 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.604 ' HB3' HG23 ' A' ' 166' ' ' VAL . 3.7 pp -158.06 135.7 10.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 65.04 110.902 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -117.12 125.86 51.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.465 . . . . 74.52 110.85 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -80.47 -26.15 38.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 71.33 110.922 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -73.29 -41.31 63.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 74.31 110.973 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -82.97 -15.41 51.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 65.14 110.897 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.74 42.36 10.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 72.53 110.894 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -141.71 140.51 33.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 75.13 110.856 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.694 HG11 ' CG2' ' A' ' 127' ' ' ILE . 5.9 p -146.03 141.09 21.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 71.02 111.136 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 20.1 m -134.87 167.52 25.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.161 -0.472 . . . . 72.33 111.095 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 8.5 m -120.45 148.97 23.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 74.3 111.118 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.652 ' OG ' ' HB2' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -84.73 155.23 21.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.15 -0.477 . . . . 62.55 110.829 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.621 ' O ' HG12 ' A' ' 173' ' ' VAL . 30.2 mtt85 -64.08 -38.53 91.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 71.21 110.946 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -80.1 -23.11 41.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 64.34 110.888 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.652 ' HB2' ' OG ' ' A' ' 169' ' ' SER . . . -53.72 -41.7 67.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 63.4 111.113 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.621 HG12 ' O ' ' A' ' 170' ' ' ARG . 13.0 p -66.02 -21.79 29.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 63.23 111.101 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 16.3 mm -70.07 -53.98 21.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.451 . . . . 73.44 111.146 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -55.46 -47.8 75.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 72.13 110.861 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 68.5 m -56.42 -42.23 77.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 74.04 110.827 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -64.69 -51.65 61.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.076 -0.511 . . . . 62.41 110.854 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -92.06 54.18 2.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.504 . . . . 61.14 110.879 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 4.0 p . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 74.5 110.908 -179.873 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.886 0.374 . . . . 75.23 110.88 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -120.24 140.33 51.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 73.43 110.92 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.04 -37.83 33.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.21 -0.45 . . . . 63.45 111.086 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.4 ttmm -60.1 -20.04 56.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 73.34 110.854 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 17.2 tpp180 -60.03 -20.12 56.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 73.43 110.829 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 -51.45 -31.77 24.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 73.45 110.921 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -80.3 -42.45 23.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.187 -0.46 . . . . 71.43 110.812 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.57 -19.95 66.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 71.42 111.092 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.445 ' CD1' HD21 ' A' ' 98' ' ' LEU . 41.7 m0 -57.3 -23.8 50.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 74.32 110.863 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 49.6 mt -52.43 -28.73 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 70.15 111.178 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 58.3 p -76.0 -60.75 2.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 60.33 111.153 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.445 HD21 ' CD1' ' A' ' 95' ' ' TRP . 4.5 pp -60.16 -20.39 58.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 75.55 110.992 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.43 ' N ' HD12 ' A' ' 98' ' ' LEU . 5.7 mm-40 -51.65 -47.81 63.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.103 -0.499 . . . . 35.4 110.888 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.5 mtpp -54.04 -27.5 32.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 74.54 110.95 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 98' ' ' LEU . . . -72.7 -43.86 62.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 73.43 111.092 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.569 ' CD2' HD13 ' A' ' 159' ' ' LEU . 12.5 m-85 -65.38 -31.84 73.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 64.12 110.924 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -60.31 -26.04 66.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 65.01 110.895 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -95.85 20.82 9.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.189 -0.459 . . . . 74.24 110.852 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 51.86 55.46 9.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 75.23 111.12 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -76.15 163.37 27.16 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.238 -0.437 . . . . 75.25 110.886 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.8 t -91.93 153.76 19.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.476 . . . . 72.55 111.131 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.2 m -144.53 178.62 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 71.21 111.179 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.1 t -157.23 123.47 4.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 72.43 111.171 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -155.87 153.2 24.57 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.73 -0.747 . . . . 43.33 112.497 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 150' ' ' LYS . 10.2 p -101.02 140.21 20.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.839 0.352 . . . . 54.3 111.14 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.685 HG13 HG22 ' A' ' 122' ' ' VAL . 4.4 mp -60.12 120.93 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 73.4 111.145 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -102.27 -43.02 5.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 70.02 110.875 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -118.45 142.99 17.36 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.682 -0.77 . . . . 74.52 112.468 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.6 pttt -124.06 123.71 40.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.837 0.351 . . . . 75.2 110.945 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 26.6 m -110.09 177.33 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 71.4 111.122 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -62.16 94.14 0.05 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 72.03 110.953 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.88 -36.14 3.61 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.765 -0.731 . . . . 73.33 112.499 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -90.02 173.8 39.94 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.728 -0.749 . . . . 73.01 112.503 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -151.15 127.48 10.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.992 0.425 . . . . 73.13 110.872 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 57.8 p -98.19 142.46 29.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 71.3 111.159 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.685 HG22 HG13 ' A' ' 112' ' ' ILE . 21.3 t -133.74 147.15 30.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 62.52 111.117 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -97.25 134.87 39.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.1 -0.5 . . . . 63.43 110.896 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 78.4 mt -139.41 74.55 1.47 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.119 -0.491 . . . . 74.2 110.972 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 62.98 42.15 7.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.113 -0.494 . . . . 75.4 110.902 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 103.03 -31.05 9.19 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.695 -0.764 . . . . 71.51 112.542 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.573 ' CG2' HG21 ' A' ' 166' ' ' VAL . 60.9 mt -78.04 144.07 11.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.869 0.366 . . . . 73.32 111.101 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.6 mtp180 -109.22 114.02 27.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 73.51 110.908 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -92.5 171.54 8.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 63.52 111.109 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.494 ' HB3' HG23 ' A' ' 167' ' ' VAL . 2.3 t80 -136.44 129.96 31.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.43 . . . . 74.44 110.842 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.414 HD22 ' CE2' ' A' ' 154' ' ' PHE . 1.0 OUTLIER -109.51 130.54 22.66 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.627 0.727 . . . . 72.14 110.914 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 140.77 43.51 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.707 2.271 . . . . 70.4 112.334 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.668 ' O ' HG23 ' A' ' 136' ' ' VAL . . . -66.02 -11.88 56.07 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.771 -0.728 . . . . 72.2 112.554 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.9 t -76.52 -22.52 54.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.906 0.384 . . . . 71.14 110.873 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.57 39.52 3.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.504 . . . . 71.02 110.901 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 133' ' ' GLY . 85.4 t -53.67 -63.09 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 72.44 111.103 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.544 ' HB3' ' HE2' ' A' ' 146' ' ' HIS . 1.0 OUTLIER -179.65 171.21 1.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 72.0 110.901 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.407 HG13 ' O ' ' A' ' 138' ' ' VAL . 5.9 p -106.06 121.08 58.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 53.41 111.108 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -177.33 160.79 1.44 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.642 0.734 . . . . 72.02 110.864 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 166.6 26.93 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.675 2.25 . . . . 72.14 112.38 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 31.6 m -51.67 -29.63 10.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.233 -0.44 . . . . 61.41 111.106 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 54.1 mtm180 -51.86 133.04 32.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 73.12 110.949 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -51.96 169.08 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 65.31 110.849 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.4 t -169.82 142.41 2.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 34.45 111.17 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.4 tt -87.9 -8.92 55.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.268 -0.423 . . . . 72.53 110.883 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.544 ' HE2' ' HB3' ' A' ' 137' ' ' ASP . 0.9 OUTLIER -62.25 -15.72 48.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.443 . . . . 72.35 110.844 179.909 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 47.9 mt -68.85 -24.05 64.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 63.33 110.958 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -118.77 123.97 46.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.169 -0.469 . . . . 74.44 110.845 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 89.54 26.12 26.1 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.711 -0.757 . . . . 65.23 112.448 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.615 ' HD3' HD13 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -82.78 128.17 34.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.828 0.347 . . . . 70.04 110.865 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.657 ' O ' HD12 ' A' ' 152' ' ' LEU . 16.4 pt-20 -105.15 108.54 20.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.203 -0.453 . . . . 74.3 110.932 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.657 HD12 ' O ' ' A' ' 151' ' ' GLU . 2.6 mp -139.11 -179.51 5.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 72.43 110.914 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -114.31 150.89 33.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 74.32 110.891 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.414 ' CE2' HD22 ' A' ' 131' ' ' LEU . 19.3 m-85 -125.42 168.06 14.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 73.31 110.884 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -119.76 123.29 43.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 74.34 110.862 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 91.9 t -67.61 117.02 8.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.244 -0.434 . . . . 74.32 111.173 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.4 tp -120.79 -33.35 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 71.04 111.124 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -171.15 119.96 0.5 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 75.32 110.872 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.619 ' H ' HD23 ' A' ' 159' ' ' LEU . 2.6 pt? -125.33 139.14 53.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 65.04 110.881 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -118.5 88.95 3.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 74.52 110.908 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -67.7 -20.03 65.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 71.33 110.934 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.23 -37.73 67.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 74.31 110.84 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -93.25 16.39 13.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.444 . . . . 65.14 110.861 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.2 m120 51.74 30.11 6.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 72.53 110.938 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -143.1 164.18 30.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 75.13 110.853 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.573 HG21 ' CG2' ' A' ' 127' ' ' ILE . 20.2 t -143.43 144.61 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 71.02 111.13 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.494 HG23 ' HB3' ' A' ' 130' ' ' PHE . 14.3 p -129.07 152.2 36.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 72.33 111.13 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 130' ' ' PHE . 25.2 m -119.42 145.68 25.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 74.3 111.124 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.36 159.81 33.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 62.55 110.799 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.4 ' O ' HG12 ' A' ' 173' ' ' VAL . 11.0 ptm180 -93.45 -37.72 11.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.07 -0.513 . . . . 71.21 110.881 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 -79.59 -26.75 41.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 64.34 110.895 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.43 -13.94 62.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.124 -0.489 . . . . 63.4 111.124 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 170' ' ' ARG . 11.0 p -52.98 -30.7 16.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 63.23 111.045 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 23.5 pt -61.96 -30.15 47.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 73.44 111.145 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -71.71 -46.52 58.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.473 . . . . 72.13 111.027 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 52.6 p -52.01 -47.24 65.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.124 -0.489 . . . . 74.04 110.81 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -54.9 -52.98 61.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 62.41 110.945 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -109.1 55.82 0.63 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 61.14 110.906 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 72.2 p . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 74.5 110.929 -179.906 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.926 0.393 . . . . 75.23 110.874 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -98.95 -178.24 3.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 73.43 110.877 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.56 -40.03 43.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.455 . . . . 63.45 111.073 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.8 pptp? -60.14 -20.01 56.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 73.34 110.909 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -59.19 -20.87 57.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.434 . . . . 73.43 110.898 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -51.38 -31.22 21.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 73.45 110.838 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.501 ' O ' HG23 ' A' ' 96' ' ' ILE . 16.9 tt0 -80.43 -46.13 16.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 71.43 110.861 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.703 ' O ' HG22 ' A' ' 97' ' ' THR . . . -62.3 -17.18 57.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 71.42 111.133 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 35.5 m0 -57.85 -22.28 47.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.117 -0.492 . . . . 74.32 110.92 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.501 HG23 ' O ' ' A' ' 93' ' ' GLU . 31.0 pt -53.03 -31.24 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 70.15 111.117 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.703 HG22 ' O ' ' A' ' 94' ' ' ALA . 12.8 t -72.32 -30.05 64.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 60.33 111.17 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.611 ' CD1' HD11 ' A' ' 127' ' ' ILE . 18.4 mt -67.38 -21.0 65.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 75.55 110.865 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -76.23 -36.12 58.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 35.4 110.87 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -84.03 -22.45 31.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.118 -0.492 . . . . 74.54 110.823 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.14 -27.73 59.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.416 . . . . 73.43 111.067 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.621 ' CG ' HD21 ' A' ' 159' ' ' LEU . 50.9 t80 -55.53 -25.74 39.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.258 -0.428 . . . . 64.12 110.946 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.74 -27.77 30.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.094 -0.503 . . . . 65.01 110.906 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -97.1 -19.2 18.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 74.24 110.846 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 64.03 50.8 2.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 75.23 111.081 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -64.31 167.14 7.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 75.25 110.867 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.2 t -102.42 165.27 11.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 72.55 111.244 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.7 m -148.73 177.73 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 71.21 111.13 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 109' ' ' THR . 4.3 t -149.32 118.09 6.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.447 . . . . 72.43 111.148 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -134.5 164.77 24.59 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.735 -0.745 . . . . 43.33 112.491 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.707 HG23 ' C ' ' A' ' 150' ' ' LYS . 13.3 p -105.51 135.79 42.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.777 0.322 . . . . 54.3 111.174 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.539 HD12 ' O ' ' A' ' 150' ' ' LYS . 4.2 mp -54.35 101.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 73.4 111.159 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -74.21 -44.26 53.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 70.02 110.886 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -134.81 155.06 21.78 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.763 -0.732 . . . . 74.52 112.469 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -124.32 128.82 49.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.848 0.356 . . . . 75.2 110.881 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.3 m -114.61 176.79 2.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.201 -0.454 . . . . 71.4 111.085 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -66.73 98.46 0.53 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 72.03 110.922 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 91.5 -35.57 3.91 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.753 -0.737 . . . . 73.33 112.535 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -98.25 173.63 27.76 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.756 -0.735 . . . . 73.01 112.552 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -146.96 118.75 8.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.925 0.393 . . . . 73.13 110.882 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.13 150.81 26.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 71.3 111.145 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.418 ' HB ' ' HB3' ' A' ' 129' ' ' ALA . 18.7 t -140.64 149.98 21.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 62.52 111.097 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -105.94 114.64 28.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.451 . . . . 63.43 110.898 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 77.8 mt -114.53 77.2 1.04 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 74.2 110.894 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 63.34 52.22 2.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 75.4 110.933 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 93.96 -34.71 4.51 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.762 -0.732 . . . . 71.51 112.523 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.611 HD11 ' CD1' ' A' ' 98' ' ' LEU . 27.5 mt -75.18 150.85 6.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.802 0.334 . . . . 73.32 111.149 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -110.76 132.11 54.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 73.51 110.822 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.418 ' HB3' ' HB ' ' A' ' 122' ' ' VAL . . . -110.12 171.56 7.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 63.52 111.088 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -138.54 122.38 17.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.24 -0.436 . . . . 74.44 110.888 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.507 HD21 ' HE2' ' A' ' 154' ' ' PHE . 10.3 mp -95.07 130.11 33.61 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.648 0.737 . . . . 72.14 110.931 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.413 ' O ' HG23 ' A' ' 136' ' ' VAL . 54.1 Cg_endo -69.76 132.46 23.38 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.727 2.284 . . . . 70.4 112.398 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -74.48 -11.14 82.71 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.675 -0.774 . . . . 72.2 112.445 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 41.8 m -50.4 -32.74 18.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.948 0.404 . . . . 71.14 110.887 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.783 HD12 ' HB2' ' A' ' 170' ' ' ARG . 28.6 mt -123.12 38.62 4.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.11 -0.496 . . . . 71.02 110.939 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 132' ' ' PRO . 89.6 t -122.75 -34.98 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 72.44 111.113 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -99.2 113.52 25.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 72.0 110.865 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 55.7 t -144.21 108.71 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 53.41 111.175 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.53 160.94 0.12 Allowed Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.655 0.74 . . . . 72.02 110.866 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 129.18 17.09 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.725 2.284 . . . . 72.14 112.353 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 7.7 m -149.04 149.61 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 61.41 111.136 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 36.3 ptt85 -123.37 36.91 4.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.468 . . . . 73.12 110.845 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -122.56 104.5 9.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.206 -0.452 . . . . 65.31 110.876 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 41.3 p -126.47 25.21 6.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.173 -0.467 . . . . 34.45 111.175 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -86.36 -22.28 26.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.258 -0.428 . . . . 72.53 110.931 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 50.5 p-80 -90.43 -20.92 22.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 72.35 110.846 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 89.7 mt -87.89 50.78 2.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.268 -0.424 . . . . 63.33 110.92 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -165.23 124.07 1.71 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 74.44 110.873 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 63.46 32.26 83.54 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.693 -0.765 . . . . 65.23 112.488 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.707 ' C ' HG23 ' A' ' 111' ' ' VAL . 0.3 OUTLIER -101.85 129.25 48.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.747 0.308 . . . . 70.04 110.913 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -86.07 105.01 16.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 74.3 110.859 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.474 HD22 ' HE3' ' A' ' 150' ' ' LYS . 10.2 tp -114.62 155.35 26.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 72.43 110.905 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -97.07 129.99 44.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 74.32 110.9 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.507 ' HE2' HD21 ' A' ' 131' ' ' LEU . 46.3 m-85 -123.05 -179.4 4.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 73.31 110.861 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.1 tmmm? -141.45 146.17 36.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.087 -0.506 . . . . 74.34 110.915 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 47.5 t -94.63 78.96 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.248 -0.433 . . . . 74.32 111.142 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.5 tt -91.5 -25.33 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 71.04 111.092 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -152.38 114.53 4.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 75.32 110.884 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.621 HD21 ' CG ' ' A' ' 102' ' ' TYR . 0.9 OUTLIER -118.44 149.27 41.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.431 . . . . 65.04 110.908 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -116.06 57.57 0.75 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.213 -0.449 . . . . 74.52 110.89 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -58.95 -25.14 63.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.467 . . . . 71.33 110.906 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 33.0 tttt -55.73 -25.85 42.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 74.31 110.832 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.12 24.83 12.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.309 -0.405 . . . . 65.14 110.859 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 9.1 m120 53.66 28.31 7.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.483 . . . . 72.53 110.902 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -143.08 172.99 11.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 75.13 110.825 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.8 m -147.88 144.23 19.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 71.02 111.167 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 19.2 m -128.53 170.46 18.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 72.33 111.148 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.444 HG21 HD12 ' A' ' 131' ' ' LEU . 5.5 m -120.34 155.02 23.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 74.3 111.169 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.5 m -88.42 156.04 19.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 62.55 110.902 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.783 ' HB2' HD12 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -82.41 -29.0 31.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.134 -0.484 . . . . 71.21 110.899 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -70.82 -24.05 62.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.488 . . . . 64.34 110.915 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.57 -14.47 61.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.1 -0.5 . . . . 63.4 111.171 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 170' ' ' ARG . 14.4 p -53.26 -28.04 14.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 63.23 111.081 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 35.4 pt -58.9 -21.49 19.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.24 -0.436 . . . . 73.44 111.112 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -75.9 -51.46 12.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 72.13 110.879 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 68.5 p -51.85 -62.01 1.9 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 74.04 110.836 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -50.15 -53.68 25.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 62.41 110.928 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 38.9 t30 54.96 29.68 12.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 61.14 110.909 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 43.2 p . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 74.5 110.85 -179.81 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.939 0.399 . . . . 75.23 110.836 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -126.84 -70.09 0.73 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.1 -0.5 . . . . 73.43 110.884 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.36 -41.96 81.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 63.45 111.084 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 20.6 mmmt -56.47 -25.98 52.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.283 -0.417 . . . . 73.34 110.917 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.9 tpp180 -74.31 -24.26 59.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.281 -0.418 . . . . 73.43 110.863 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -51.8 -45.5 63.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 73.45 110.849 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -76.85 -31.69 57.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 71.43 110.934 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.44 -17.54 63.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.494 . . . . 71.42 111.117 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.655 ' CD1' HD21 ' A' ' 98' ' ' LEU . 31.9 m0 -57.19 -23.46 47.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 74.32 110.882 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 68.1 mt -54.07 -27.59 16.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 70.15 111.134 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 70.9 p -76.95 -59.11 2.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 60.33 111.154 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.655 HD21 ' CD1' ' A' ' 95' ' ' TRP . 3.4 pp -61.66 -18.09 58.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 75.55 110.842 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -54.15 -61.73 2.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 35.4 110.93 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? -66.84 -23.97 66.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.091 -0.504 . . . . 74.54 110.941 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.524 ' HB1' ' HG3' ' A' ' 106' ' ' GLU . . . -53.17 -45.56 68.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 73.43 111.145 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.652 ' CE1' HG21 ' A' ' 156' ' ' VAL . 38.1 m-85 -53.34 -33.21 52.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 64.12 110.901 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -57.24 -26.26 60.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 65.01 110.894 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.28 20.82 11.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 74.24 110.833 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 53.71 64.14 1.95 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 75.23 111.075 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.524 ' HG3' ' HB1' ' A' ' 101' ' ' ALA . 16.2 mm-40 -79.25 178.63 7.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 75.25 110.959 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.1 p -120.03 170.71 9.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 72.55 111.107 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.705 HG11 HD13 ' A' ' 124' ' ' LEU . 5.2 m -135.34 -179.3 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 71.21 111.121 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.6 t -155.69 121.41 4.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 72.43 111.191 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 176.5 168.09 36.08 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.758 -0.734 . . . . 43.33 112.502 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 151' ' ' GLU . 12.5 m -116.01 150.26 18.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.874 0.369 . . . . 54.3 111.132 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.793 HD12 ' HB3' ' A' ' 150' ' ' LYS . 5.4 mt -60.4 99.2 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 73.4 111.16 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 64.2 t-20 -87.8 -41.23 13.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 70.02 110.917 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -114.03 141.08 16.78 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.724 -0.75 . . . . 74.52 112.446 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -124.4 123.01 39.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.846 0.355 . . . . 75.2 110.928 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.6 m -108.22 176.67 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.246 -0.434 . . . . 71.4 111.149 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -66.83 99.18 0.6 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 72.03 110.953 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 90.85 -35.79 3.79 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.732 -0.747 . . . . 73.33 112.485 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -98.2 173.49 27.68 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.77 -0.729 . . . . 73.01 112.472 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.574 ' HZ ' HD22 ' A' ' 147' ' ' LEU . 6.6 m-85 -144.09 118.85 9.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.905 0.383 . . . . 73.13 110.927 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.24 149.68 25.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 71.3 111.17 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.7 t -143.65 137.42 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 62.52 111.137 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -90.07 104.94 17.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 63.43 110.944 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.705 HD13 HG11 ' A' ' 108' ' ' VAL . 12.5 mt -97.44 84.82 3.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.088 -0.506 . . . . 74.2 110.924 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 51.79 44.18 29.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 75.4 110.879 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 103.87 -33.72 6.35 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.715 -0.755 . . . . 71.51 112.493 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 21.6 mm -73.53 153.07 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.825 0.345 . . . . 73.32 111.165 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -105.27 119.39 38.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 73.51 110.882 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.636 ' HB2' HD11 ' A' ' 124' ' ' LEU . . . -101.29 171.66 7.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 63.52 111.075 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.513 ' O ' HG22 ' A' ' 168' ' ' VAL . 6.4 t80 -145.89 120.67 9.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 74.44 110.927 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.518 HD12 HG21 ' A' ' 168' ' ' VAL . 9.3 mp -92.92 130.1 37.55 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.619 0.723 . . . . 72.14 110.946 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.591 ' O ' HG23 ' A' ' 136' ' ' VAL . 55.1 Cg_endo -69.64 135.65 31.28 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.718 2.278 . . . . 70.4 112.386 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -67.74 -11.44 60.3 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.732 -0.747 . . . . 72.2 112.476 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 38.2 m -53.49 -35.03 60.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.904 0.383 . . . . 71.14 110.879 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.489 HD12 ' HB2' ' A' ' 170' ' ' ARG . 0.6 OUTLIER -123.41 39.05 4.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 71.02 110.937 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 132' ' ' PRO . 83.4 t -118.45 -24.16 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 72.44 111.129 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -98.53 112.03 24.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 72.0 110.846 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.2 m -154.01 132.07 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 53.41 111.139 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 19.5 mtm-85 62.62 161.59 0.12 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.612 0.72 . . . . 72.02 110.867 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.8 164.17 35.56 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.722 2.281 . . . . 72.14 112.336 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 7.4 p -51.27 139.43 6.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.199 -0.455 . . . . 61.41 111.105 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -178.4 105.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 73.12 110.905 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 59.0 97.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 65.31 110.839 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.17 4.68 33.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.102 -0.499 . . . . 34.45 111.114 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -87.22 -9.86 54.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.255 -0.429 . . . . 72.53 110.933 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.469 ' CE1' HD23 ' A' ' 147' ' ' LEU . 0.7 OUTLIER -75.4 -5.91 47.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 72.35 110.909 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.574 HD22 ' HZ ' ' A' ' 120' ' ' PHE . 2.7 pp -118.3 31.11 6.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 63.33 110.906 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.421 ' OE1' HD12 ' A' ' 147' ' ' LEU . 5.7 mm-40 -128.68 126.61 40.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 74.44 110.91 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 63.44 31.71 81.69 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.701 -0.762 . . . . 65.23 112.531 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.793 ' HB3' HD12 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -72.36 131.74 43.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.81 0.338 . . . . 70.04 110.85 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.568 ' HA ' HG12 ' A' ' 111' ' ' VAL . 0.2 OUTLIER -99.84 96.6 7.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.175 -0.466 . . . . 74.3 110.905 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.747 HD22 ' CB ' ' A' ' 176' ' ' SER . 6.9 mt -138.64 141.24 39.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 72.43 110.934 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -89.92 129.44 36.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 74.32 110.903 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.451 ' HE2' HD21 ' A' ' 131' ' ' LEU . 34.8 m-85 -110.73 -179.16 3.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 73.31 110.901 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.667 ' CE ' ' HB3' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -143.99 151.0 39.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 74.34 110.915 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.652 HG21 ' CE1' ' A' ' 102' ' ' TYR . 61.2 t -91.45 112.48 25.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 74.32 111.091 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 15.7 tt -87.57 -33.76 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 71.04 111.114 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -177.89 126.38 0.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 75.32 110.873 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.481 ' HB3' HG12 ' A' ' 166' ' ' VAL . 0.2 OUTLIER -102.05 119.63 39.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 65.04 110.949 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -73.5 126.48 30.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 74.52 110.884 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -78.03 -29.05 49.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 71.33 110.867 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 12.4 tptm -53.12 -32.17 46.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.248 -0.433 . . . . 74.31 110.93 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -113.52 -15.27 12.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.1 -0.5 . . . . 65.14 110.85 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.07 47.94 5.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 72.53 110.922 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -142.27 154.42 44.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.48 . . . . 75.13 110.849 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.481 HG12 ' HB3' ' A' ' 159' ' ' LEU . 16.9 m -102.92 144.33 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 71.02 111.1 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 29.5 m -132.34 171.25 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 72.33 111.157 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.518 HG21 HD12 ' A' ' 131' ' ' LEU . 26.5 m -119.97 155.25 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 74.3 111.143 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.77 150.23 30.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 62.55 110.872 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.558 ' O ' HG12 ' A' ' 173' ' ' VAL . 10.8 ptt180 -82.24 0.11 42.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 71.21 110.863 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.44 -58.81 2.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 64.34 110.867 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.667 ' HB3' ' CE ' ' A' ' 155' ' ' LYS . . . -83.37 -7.22 59.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 63.4 111.071 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.558 HG12 ' O ' ' A' ' 170' ' ' ARG . 7.9 p -50.92 -28.21 6.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 63.23 111.133 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 28.5 pt -50.32 -30.8 7.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 73.44 111.118 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -54.7 -45.74 74.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 72.13 110.925 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.747 ' CB ' HD22 ' A' ' 152' ' ' LEU . 6.2 p -51.22 -44.13 61.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 74.04 110.913 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -64.42 -51.07 65.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.064 -0.516 . . . . 62.41 110.901 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -84.81 54.61 3.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 61.14 110.843 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 74.5 110.806 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.949 0.404 . . . . 75.23 110.832 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.7 ttpp -144.96 163.44 34.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 73.43 110.897 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.27 -28.55 42.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 63.45 111.137 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -60.03 -20.46 58.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 73.34 110.851 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -61.9 -19.82 63.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 73.43 110.875 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -51.76 -30.9 24.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.271 -0.422 . . . . 73.45 110.907 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -81.31 -45.6 15.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.225 -0.443 . . . . 71.43 110.854 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.8 -15.89 59.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 71.42 111.108 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.716 ' CD1' HD21 ' A' ' 98' ' ' LEU . 31.5 m0 -57.72 -22.86 48.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 74.32 110.866 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 52.1 mt -54.66 -26.33 16.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.304 -0.407 . . . . 70.15 111.135 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 70.3 p -80.26 -59.2 2.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 60.33 111.089 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.716 HD21 ' CD1' ' A' ' 95' ' ' TRP . 4.2 pp -61.49 -18.48 59.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.235 -0.439 . . . . 75.55 110.905 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -73.51 -25.7 60.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 35.4 110.842 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -79.44 -22.9 43.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 74.54 110.849 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.684 ' HB1' ' OE2' ' A' ' 106' ' ' GLU . . . -65.53 -38.95 91.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 73.43 111.076 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.451 ' CD1' HG11 ' A' ' 156' ' ' VAL . 37.9 m-85 -69.1 -23.85 64.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.304 -0.407 . . . . 64.12 110.942 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.27 -25.23 58.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 65.01 110.906 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -94.82 20.93 8.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 74.24 110.904 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 60.95 65.34 1.02 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 75.23 111.158 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.684 ' OE2' ' HB1' ' A' ' 101' ' ' ALA . 27.4 mt-10 -90.19 169.22 11.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 75.25 110.827 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.3 m -120.48 139.24 53.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 72.55 111.104 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.506 HG22 HG23 ' A' ' 156' ' ' VAL . 30.1 m -125.74 -177.22 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 71.21 111.072 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.6 t -161.06 123.46 3.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.116 -0.493 . . . . 72.43 111.184 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.497 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -149.24 148.48 19.89 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.731 -0.747 . . . . 43.33 112.448 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 150' ' ' LYS . 10.5 p -90.96 135.61 26.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.804 0.335 . . . . 54.3 111.115 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.736 HG13 HG22 ' A' ' 122' ' ' VAL . 4.8 mp -63.37 107.14 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.492 . . . . 73.4 111.101 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -91.51 -34.52 14.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.48 . . . . 70.02 110.915 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -128.21 143.78 14.69 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.773 -0.727 . . . . 74.52 112.497 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.5 pttp -123.94 134.77 53.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.822 0.344 . . . . 75.2 110.907 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.3 m -117.36 176.59 2.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 71.4 111.095 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -66.37 98.05 0.45 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 72.03 110.959 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 91.93 -35.26 4.05 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.753 -0.737 . . . . 73.33 112.485 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -98.17 173.51 27.75 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.761 -0.733 . . . . 73.01 112.611 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.578 ' HZ ' HD22 ' A' ' 147' ' ' LEU . 7.1 m-85 -145.37 118.93 9.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.919 0.39 . . . . 73.13 110.965 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.434 ' O ' HG23 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -85.79 147.01 26.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 71.3 111.109 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.765 ' HB ' ' HB3' ' A' ' 129' ' ' ALA . 32.8 t -138.52 147.68 25.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 62.52 111.134 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -102.55 105.7 16.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 63.43 110.828 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.499 HD13 HG21 ' A' ' 108' ' ' VAL . 81.8 mt -105.91 74.43 1.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 74.2 110.962 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 57.72 51.06 9.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 75.4 111.003 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 99.79 -33.5 6.2 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.757 -0.735 . . . . 71.51 112.5 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.55 ' CG2' HG21 ' A' ' 166' ' ' VAL . 25.0 mm -76.58 150.25 6.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.793 0.33 . . . . 73.32 111.157 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 57.9 mtm180 -109.66 117.12 33.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 73.51 110.859 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.765 ' HB3' ' HB ' ' A' ' 122' ' ' VAL . . . -94.55 171.56 8.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 63.52 111.171 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.405 ' HB3' HG12 ' A' ' 167' ' ' VAL . 3.0 t80 -146.74 122.03 10.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.28 -0.418 . . . . 74.44 110.853 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 9.4 mp -110.54 129.43 23.96 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.643 0.735 . . . . 72.14 110.923 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 152.11 69.01 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.695 2.263 . . . . 70.4 112.325 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.46 -18.57 61.27 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.724 -0.75 . . . . 72.2 112.523 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 44.2 t -73.65 -26.21 60.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.849 0.357 . . . . 71.14 110.8 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.771 HD12 ' HA ' ' A' ' 170' ' ' ARG . 10.1 tt -79.97 -26.92 39.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 71.02 110.875 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.537 HG21 ' CD2' ' A' ' 120' ' ' PHE . 81.8 t -78.94 -62.76 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 72.44 111.119 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -166.37 161.92 16.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 72.0 110.908 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 27.0 m -82.04 147.87 5.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 53.41 111.138 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.01 160.53 0.12 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.605 0.717 . . . . 72.02 110.884 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.69 145.54 57.89 Favored 'Trans proline' 0 C--O 1.23 0.123 0 C-N-CA 122.745 2.297 . . . . 72.14 112.289 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.6 p -116.29 149.96 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 61.41 111.141 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -66.21 -75.22 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 73.12 110.859 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -179.93 138.57 0.12 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 65.31 110.896 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.82 157.5 33.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 34.45 111.122 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.8 mp -87.57 -9.64 53.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 72.53 110.88 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -60.33 -18.79 52.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.161 -0.472 . . . . 72.35 110.81 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.578 HD22 ' HZ ' ' A' ' 120' ' ' PHE . 1.4 pp -109.35 36.41 2.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 63.33 110.931 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -129.66 124.68 34.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 74.44 110.832 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 66.64 23.51 72.25 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.727 -0.749 . . . . 65.23 112.489 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.666 ' HD3' HD12 ' A' ' 152' ' ' LEU . 1.6 ttmm -63.33 130.26 43.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.726 0.298 . . . . 70.04 110.878 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -104.16 89.71 3.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 74.3 110.843 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.666 HD12 ' HD3' ' A' ' 150' ' ' LYS . 5.8 mt -138.34 135.98 35.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.139 -0.482 . . . . 72.43 110.921 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -85.91 158.03 20.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 74.32 110.852 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.427 ' CE2' HG21 ' A' ' 122' ' ' VAL . 4.2 m-85 -126.06 -179.23 4.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 73.31 110.852 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.435 ' CB ' ' HB1' ' A' ' 172' ' ' ALA . 6.5 tttp -125.26 108.24 11.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.12 -0.491 . . . . 74.34 110.899 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.506 HG23 HG22 ' A' ' 108' ' ' VAL . 21.5 t -69.33 128.92 33.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.43 . . . . 74.32 111.127 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 7.8 tp -118.3 -29.35 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 71.04 111.164 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.614 ' C ' HD13 ' A' ' 159' ' ' LEU . 0.0 OUTLIER -170.99 166.42 7.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 75.32 110.918 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.614 HD13 ' C ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -155.84 165.48 36.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 65.04 110.917 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -119.18 96.58 5.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 74.52 110.878 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -77.12 -23.3 51.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.159 -0.473 . . . . 71.33 110.857 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 22.5 tptt -51.79 -45.75 63.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 74.31 110.967 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -104.6 16.88 25.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 65.14 110.893 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 51.51 48.57 22.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 72.53 110.939 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -121.88 153.81 37.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 75.13 110.947 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.55 HG21 ' CG2' ' A' ' 127' ' ' ILE . 97.3 t -142.98 128.51 16.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 71.02 111.151 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.405 HG12 ' HB3' ' A' ' 130' ' ' PHE . 34.1 m -134.81 171.18 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 72.33 111.184 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 6.3 m -120.27 145.75 26.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 74.3 111.084 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.85 157.47 37.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 62.55 110.871 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.771 ' HA ' HD12 ' A' ' 135' ' ' LEU . 0.3 OUTLIER -81.87 -42.13 20.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.121 -0.491 . . . . 71.21 110.82 -179.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 83.7 mtm-85 -59.7 -20.6 57.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.266 -0.424 . . . . 64.34 110.847 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.435 ' HB1' ' CB ' ' A' ' 155' ' ' LYS . . . -61.7 -17.45 55.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 63.4 111.084 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 10.2 p -50.71 -30.5 8.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 63.23 111.173 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 27.2 pt -51.48 -32.44 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.488 . . . . 73.44 111.12 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -88.03 -26.4 22.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.463 . . . . 72.13 110.853 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.467 ' OG ' HD22 ' A' ' 152' ' ' LEU . 5.1 t -91.29 12.79 19.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 74.04 110.877 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -50.01 -53.43 26.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 62.41 110.91 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -128.14 -58.48 1.21 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 61.14 110.886 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 10.9 t . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 74.5 110.873 -179.848 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.3 mp0 . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.966 0.412 . . . . 75.23 110.867 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -114.93 117.66 31.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 73.43 110.916 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.75 -30.16 59.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 63.45 111.079 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -64.67 -27.95 69.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 73.34 110.939 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -57.07 -27.16 61.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 73.43 110.866 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -52.04 -37.7 54.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 73.45 110.904 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -81.77 -29.91 32.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.447 . . . . 71.43 110.922 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.96 -24.47 61.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 71.42 111.159 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.561 ' HA ' HD23 ' A' ' 98' ' ' LEU . 53.9 m0 -58.77 -22.57 58.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.197 -0.456 . . . . 74.32 110.962 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 70.0 mt -51.53 -29.96 10.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.218 -0.446 . . . . 70.15 111.134 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 73.3 p -64.27 -52.13 60.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 60.33 111.104 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.629 HD21 HD11 ' A' ' 127' ' ' ILE . 0.6 OUTLIER -70.88 -21.73 62.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.435 . . . . 75.55 110.962 179.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -59.9 -52.29 66.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.164 -0.471 . . . . 35.4 110.867 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -57.65 -27.45 62.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.471 . . . . 74.54 110.953 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 98' ' ' LEU . . . -51.98 -48.4 64.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.166 -0.47 . . . . 73.43 111.111 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.426 ' OH ' HG11 ' A' ' 108' ' ' VAL . 92.8 m-85 -55.74 -33.26 64.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 64.12 110.924 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.57 -26.41 66.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 65.01 110.899 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -104.46 20.97 17.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 74.24 110.838 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 57.91 67.41 0.96 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 75.23 111.043 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -104.06 176.15 5.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 75.25 110.937 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.3 t -121.14 164.95 16.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.166 -0.47 . . . . 72.55 111.062 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.426 HG11 ' OH ' ' A' ' 102' ' ' TYR . 34.9 m -135.4 -178.09 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 71.21 111.096 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.438 ' O ' HD23 ' A' ' 124' ' ' LEU . 4.9 t -154.13 122.85 6.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.081 -0.508 . . . . 72.43 111.156 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -156.87 150.97 22.35 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.742 -0.742 . . . . 43.33 112.503 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.467 ' C ' HG13 ' A' ' 122' ' ' VAL . 7.3 p -109.45 141.2 25.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.829 0.347 . . . . 54.3 111.12 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.768 HG13 HG22 ' A' ' 122' ' ' VAL . 4.3 mp -67.36 101.88 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.132 -0.485 . . . . 73.4 111.066 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -91.26 -27.16 18.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 70.02 110.912 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -134.18 143.05 14.62 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.736 -0.745 . . . . 74.52 112.48 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.98 136.66 54.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.788 0.327 . . . . 75.2 110.937 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.3 m -118.39 176.44 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 71.4 111.183 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.94 97.73 0.37 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 72.03 110.928 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 92.24 -35.02 4.16 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.752 -0.737 . . . . 73.33 112.465 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -98.17 173.55 27.79 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.737 -0.744 . . . . 73.01 112.48 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.742 ' CE2' HG11 ' A' ' 136' ' ' VAL . 9.0 m-85 -146.03 119.09 8.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.86 0.362 . . . . 73.13 110.877 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.486 ' O ' HG23 ' A' ' 112' ' ' ILE . 1.4 m -86.5 150.6 24.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 71.3 111.155 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.768 HG22 HG13 ' A' ' 112' ' ' ILE . 21.6 t -138.89 131.93 38.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.287 -0.415 . . . . 62.52 111.165 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -84.01 99.27 10.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 63.43 110.897 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.719 HD12 ' HB2' ' A' ' 129' ' ' ALA . 25.4 mt -99.89 77.65 2.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 74.2 110.907 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 52.14 52.92 13.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 75.4 110.878 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 93.36 -22.31 35.78 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.764 -0.731 . . . . 71.51 112.532 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.629 HD11 HD21 ' A' ' 98' ' ' LEU . 57.1 mt -83.02 144.43 10.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.8 0.333 . . . . 73.32 111.141 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -100.52 109.25 21.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 73.51 110.848 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.765 ' HB3' ' HB ' ' A' ' 122' ' ' VAL . . . -92.99 171.59 8.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 63.52 111.019 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -146.76 129.73 16.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 74.44 110.856 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.591 ' CD2' HG23 ' A' ' 168' ' ' VAL . 5.5 mt -120.17 129.52 25.3 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.587 0.708 . . . . 72.14 110.943 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.615 ' O ' HG23 ' A' ' 136' ' ' VAL . 53.7 Cg_endo -69.88 136.78 33.55 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.677 2.252 . . . . 70.4 112.29 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -71.54 -16.74 75.95 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.759 -0.734 . . . . 72.2 112.424 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 2.9 t -55.4 -26.37 41.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.88 0.371 . . . . 71.14 110.858 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.503 HD13 ' HB2' ' A' ' 171' ' ' ARG . 28.7 mt -120.61 24.64 10.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.47 . . . . 71.02 110.932 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.742 HG11 ' CE2' ' A' ' 120' ' ' PHE . 88.6 t -113.46 -49.41 5.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 72.44 111.174 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -99.08 112.64 24.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 72.0 110.85 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.417 ' O ' HG23 ' A' ' 138' ' ' VAL . 5.8 m -152.89 107.07 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 53.41 111.14 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 18.7 mmt-85 51.94 69.13 2.63 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.557 0.694 . . . . 72.02 110.89 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 143.81 52.11 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.618 2.212 . . . . 72.14 112.362 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 4.1 m -139.77 85.89 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 61.41 111.196 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.1 ptt-85 39.42 41.74 0.74 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.472 . . . . 73.12 110.824 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -137.93 97.39 3.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 65.31 110.925 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.721 ' CG2' HD12 ' A' ' 147' ' ' LEU . 0.2 OUTLIER -118.77 -13.67 9.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 34.45 111.125 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 13.7 mt -62.88 -21.65 66.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 72.53 110.943 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -93.36 18.21 10.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 72.35 110.891 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.721 HD12 ' CG2' ' A' ' 144' ' ' THR . 61.5 mt -110.51 -33.11 6.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 63.33 110.949 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -128.32 129.5 46.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 74.44 110.879 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 90.42 -14.84 61.51 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.771 -0.728 . . . . 65.23 112.45 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.548 ' O ' HD12 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -59.89 129.97 44.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.804 0.335 . . . . 70.04 110.867 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -111.02 114.28 27.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 74.3 110.942 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.712 HD22 ' C ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -140.66 165.17 28.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 72.43 110.922 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.57 ' N ' HD22 ' A' ' 152' ' ' LEU . 1.3 tt0 -98.38 131.03 45.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.175 -0.466 . . . . 74.32 110.93 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.476 ' CZ ' HD11 ' A' ' 152' ' ' LEU . 16.2 m-85 -97.22 -179.41 4.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 73.31 110.879 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.45 ' H ' ' HB1' ' A' ' 172' ' ' ALA . 13.6 tttm -137.09 145.98 44.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 74.34 110.918 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.421 HG13 ' O ' ' A' ' 156' ' ' VAL . 5.5 p -56.62 120.18 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.434 . . . . 74.32 111.145 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.8 tp -130.21 -38.86 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.109 -0.496 . . . . 71.04 111.146 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -169.28 139.38 2.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 75.32 110.927 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -153.21 125.76 8.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 65.04 110.915 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -91.29 63.37 4.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 74.52 110.873 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -55.39 -26.44 41.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 71.33 110.923 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 18.5 ttpp -57.3 -43.16 82.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 74.31 110.915 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -102.94 24.85 10.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.448 . . . . 65.14 110.937 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 52.71 33.44 13.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.098 -0.501 . . . . 72.53 110.926 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -108.78 154.67 21.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 75.13 110.908 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 7.1 p -152.4 123.73 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 71.02 111.119 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 19.5 m -134.63 148.18 29.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 72.33 111.192 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.591 HG23 ' CD2' ' A' ' 131' ' ' LEU . 6.1 m -120.44 171.81 8.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 74.3 111.158 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.9 m -123.88 142.19 51.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 62.55 110.895 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.591 ' O ' HG23 ' A' ' 173' ' ' VAL . 0.2 OUTLIER -65.92 -34.35 77.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 71.21 110.899 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.503 ' HB2' HD13 ' A' ' 135' ' ' LEU . 29.5 ttm180 -61.93 -20.79 64.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 64.34 110.883 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.45 ' HB1' ' H ' ' A' ' 155' ' ' LYS . . . -55.89 -24.83 39.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 63.4 111.069 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 170' ' ' ARG . 95.6 t -51.88 -37.62 21.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 63.23 111.102 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 2.0 pp -54.05 -27.31 16.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.186 -0.461 . . . . 73.44 111.125 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -77.24 -63.63 1.32 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.466 . . . . 72.13 110.846 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 66.3 p -52.27 -49.24 64.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 74.04 110.857 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -53.72 -58.58 6.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.489 . . . . 62.41 110.871 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -59.59 -74.31 0.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 61.14 110.96 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 6.4 p . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.131 -0.486 . . . . 74.5 110.859 -179.912 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.943 0.401 . . . . 75.23 110.895 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.5 mmtt 59.6 40.11 20.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.145 -0.479 . . . . 73.43 110.829 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.95 -55.4 14.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 63.45 111.11 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.68 -27.28 69.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.27 -0.423 . . . . 73.34 110.88 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -66.58 -26.84 67.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.426 . . . . 73.43 110.9 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -51.95 -43.22 63.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 73.45 110.871 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -79.29 -24.94 42.54 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.198 -0.456 . . . . 71.43 110.914 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -77.75 -19.72 54.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 71.42 111.055 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.573 ' CD1' HD21 ' A' ' 98' ' ' LEU . 41.4 m0 -58.1 -22.68 51.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 74.32 110.897 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 35.7 pt -51.78 -29.35 10.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.285 -0.416 . . . . 70.15 111.14 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.1 p -75.27 -61.48 1.89 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.146 -0.479 . . . . 60.33 111.18 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.573 HD21 ' CD1' ' A' ' 95' ' ' TRP . 3.4 pp -59.05 -21.76 59.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.25 -0.432 . . . . 75.55 110.874 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -51.92 -47.22 64.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 35.4 110.85 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -62.65 -28.94 70.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.121 -0.49 . . . . 74.54 110.893 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 98' ' ' LEU . . . -58.05 -44.09 87.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 73.43 111.099 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.798 ' HB3' HD11 ' A' ' 159' ' ' LEU . 42.6 m-85 -56.41 -34.08 66.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.158 -0.474 . . . . 64.12 110.968 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.32 -26.06 60.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.1 -0.5 . . . . 65.01 110.881 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -94.79 20.7 8.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.143 -0.48 . . . . 74.24 110.828 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 59.35 36.59 23.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.439 . . . . 75.23 111.123 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -61.89 152.97 30.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 75.25 110.877 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.636 HG22 ' HG2' ' A' ' 155' ' ' LYS . 35.5 p -93.69 148.52 22.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.066 -0.516 . . . . 72.55 111.09 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.7 m -123.32 168.85 15.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 71.21 111.114 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.518 HG22 ' HG2' ' A' ' 153' ' ' GLU . 0.5 OUTLIER -146.41 118.49 8.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.477 . . . . 72.43 111.135 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -152.37 151.02 22.94 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.649 -0.786 . . . . 43.33 112.44 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 150' ' ' LYS . 12.3 p -101.28 139.6 22.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.722 0.296 . . . . 54.3 111.164 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.622 HD12 ' O ' ' A' ' 150' ' ' LYS . 4.0 mp -61.1 116.49 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 73.4 111.06 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -97.86 -45.2 6.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 70.02 110.861 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -124.89 153.54 17.9 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.778 -0.725 . . . . 74.52 112.539 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 9.2 ptmm? -124.05 125.2 44.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.843 0.354 . . . . 75.2 110.905 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.0 m -104.02 177.31 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 71.4 111.109 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 53.2 mttt -62.15 94.64 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 72.03 110.861 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 90.08 -36.25 3.6 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.75 -0.738 . . . . 73.33 112.534 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -92.59 173.51 35.43 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.713 -0.756 . . . . 73.01 112.509 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -142.94 118.28 10.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.934 0.397 . . . . 73.13 110.917 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 33.3 p -84.84 150.97 24.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 71.3 111.135 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.611 HG22 HG13 ' A' ' 112' ' ' ILE . 64.3 t -139.38 138.37 40.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 62.52 111.168 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -91.44 100.55 13.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 63.43 110.889 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 10.9 mt -90.72 81.85 5.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 74.2 110.945 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.3 p30 42.0 52.11 4.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 75.4 110.905 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 104.01 -34.02 6.11 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.762 -0.732 . . . . 71.51 112.49 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.662 ' CG2' HG11 ' A' ' 166' ' ' VAL . 25.2 mt -76.45 152.29 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.779 0.323 . . . . 73.32 111.136 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.555 ' O ' HG13 ' A' ' 166' ' ' VAL . 53.7 mtm180 -105.09 105.49 15.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 73.51 110.889 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.573 ' HB3' ' HB ' ' A' ' 122' ' ' VAL . . . -92.81 159.12 15.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 63.52 111.032 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -133.75 125.95 29.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 74.44 110.871 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.809 HD22 HD11 ' A' ' 135' ' ' LEU . 22.6 mt -115.05 131.65 23.42 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.634 0.73 . . . . 72.14 110.843 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.614 ' HD2' HD21 ' A' ' 135' ' ' LEU . 53.8 Cg_endo -69.74 164.65 33.73 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.665 2.243 . . . . 70.4 112.399 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.729 ' HA2' HG13 ' A' ' 136' ' ' VAL . . . -67.13 -11.0 58.02 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.719 -0.753 . . . . 72.2 112.513 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.5 t -60.24 -32.27 70.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.94 0.4 . . . . 71.14 110.881 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.809 HD11 HD22 ' A' ' 131' ' ' LEU . 0.8 OUTLIER -124.09 41.97 3.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 71.02 110.943 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.729 HG13 ' HA2' ' A' ' 133' ' ' GLY . 0.3 OUTLIER -50.72 -43.07 23.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 72.44 111.142 179.814 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -179.71 119.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 72.0 110.859 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 12.7 p -76.06 138.79 20.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 53.41 111.168 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 30.8 mtp180 61.24 75.62 0.44 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.626 0.727 . . . . 72.02 110.865 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.73 135.31 30.19 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.702 2.268 . . . . 72.14 112.336 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.412 HG12 ' N ' ' A' ' 142' ' ' ARG . 5.9 t -127.74 157.94 39.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 61.41 111.15 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.412 ' N ' HG12 ' A' ' 141' ' ' VAL . 0.0 OUTLIER -50.89 -30.81 15.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 73.12 110.827 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -84.34 129.57 34.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 65.31 110.847 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.615 HG22 HD11 ' A' ' 147' ' ' LEU . 18.1 p -98.6 27.92 4.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 34.45 111.131 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.5 tp -87.49 -21.36 25.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 72.53 110.88 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 33.7 p-80 -89.08 -21.86 23.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 72.35 110.86 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.615 HD11 HG22 ' A' ' 144' ' ' THR . 59.2 mt -51.84 -57.98 7.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 63.33 110.973 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -101.7 145.11 29.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 74.44 110.848 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 95.45 -12.15 68.06 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.756 -0.735 . . . . 65.23 112.573 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.622 ' O ' HD12 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -55.65 133.56 50.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.682 0.277 . . . . 70.04 110.95 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -110.26 111.92 23.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.269 -0.423 . . . . 74.3 110.897 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.514 HD12 ' HD3' ' A' ' 150' ' ' LYS . 5.4 mt -139.21 159.32 42.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 72.43 110.894 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.518 ' HG2' HG22 ' A' ' 109' ' ' THR . 12.9 mt-10 -95.0 148.18 22.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 74.32 110.867 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.724 ' HA ' HG23 ' A' ' 173' ' ' VAL . 3.6 m-85 -123.32 -179.47 4.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 73.31 110.832 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.636 ' HG2' HG22 ' A' ' 107' ' ' THR . 0.2 OUTLIER -135.14 108.19 7.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 74.34 110.902 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.602 HG21 ' CD1' ' A' ' 102' ' ' TYR . 89.1 t -60.47 105.98 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.217 -0.447 . . . . 74.32 111.129 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.6 tt -89.58 -30.29 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 71.04 111.144 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -176.41 169.67 2.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 75.32 110.894 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.798 HD11 ' HB3' ' A' ' 102' ' ' TYR . 0.4 OUTLIER -143.1 160.96 39.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 65.04 110.889 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.78 101.8 10.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.187 -0.461 . . . . 74.52 110.931 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -81.15 -36.08 30.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 71.33 110.929 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 29.9 tttp -69.45 -46.14 67.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 74.31 110.888 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -73.62 -15.31 61.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 65.14 110.922 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.4 m120 63.34 41.06 8.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 72.53 110.945 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -139.09 128.94 24.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 75.13 110.897 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.662 HG11 ' CG2' ' A' ' 127' ' ' ILE . 7.2 p -99.98 130.59 48.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 71.02 111.066 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 18.9 m -134.79 171.17 18.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 72.33 111.118 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.433 HG23 HD23 ' A' ' 131' ' ' LEU . 1.8 m -120.34 153.16 23.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.468 . . . . 74.3 111.112 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.28 160.64 31.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 62.55 110.875 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.701 ' O ' HG12 ' A' ' 173' ' ' VAL . 17.6 ptt180 -121.74 -33.94 3.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.167 -0.47 . . . . 71.21 110.893 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -81.75 -34.35 30.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 64.34 110.86 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -83.62 -26.4 29.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 63.4 111.12 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.724 HG23 ' HA ' ' A' ' 154' ' ' PHE . 5.7 p -58.07 -20.29 14.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 63.23 111.128 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 27.3 pt -53.11 -27.96 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.485 . . . . 73.44 111.117 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -87.21 -31.81 20.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 72.13 110.895 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 3.7 t -76.8 -25.03 52.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 74.04 110.827 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.481 ' HA ' HD22 ' A' ' 152' ' ' LEU . 36.6 mt-10 -60.81 -33.7 73.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.122 -0.49 . . . . 62.41 110.889 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -123.88 49.04 1.79 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.491 . . . . 61.14 110.886 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 41.8 t . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 74.5 110.825 -179.829 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.903 0.382 . . . . 75.23 110.892 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -81.71 -27.78 33.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.11 -0.495 . . . . 73.43 110.957 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.41 -51.44 68.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 63.45 111.08 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.1 mtmm -55.87 -26.01 45.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 73.34 110.892 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.87 -26.46 36.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 73.43 110.865 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 14.7 t60 -51.61 -30.27 20.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.153 -0.476 . . . . 73.45 110.911 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -79.29 -34.98 41.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.165 -0.47 . . . . 71.43 110.872 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.32 -15.52 62.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 71.42 111.096 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -57.76 -22.48 47.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 74.32 110.951 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 27.2 pt -52.31 -32.7 16.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.288 -0.414 . . . . 70.15 111.154 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.6 p -86.07 -23.65 26.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 60.33 111.13 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.497 ' O ' HD12 ' A' ' 98' ' ' LEU . 7.6 tp -67.8 -28.55 67.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.21 -0.45 . . . . 75.55 110.889 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -60.35 -48.17 82.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 35.4 110.898 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -67.41 -24.65 65.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 74.54 110.888 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.1 -36.92 85.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 73.43 111.095 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.73 ' CG ' HD21 ' A' ' 159' ' ' LEU . 12.6 t80 -52.81 -28.96 25.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 64.12 110.977 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.49 -25.05 50.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.078 -0.51 . . . . 65.01 110.902 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -94.3 -22.21 18.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.139 -0.482 . . . . 74.24 110.874 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 62.16 44.49 7.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.443 . . . . 75.23 111.066 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.77 165.27 15.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 75.25 110.936 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.8 t -94.56 168.07 11.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 72.55 111.163 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.2 m -152.96 -178.62 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 71.21 111.128 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 109' ' ' THR . 4.1 t -141.43 116.67 10.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 72.43 111.215 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.403 ' CA ' HD23 ' A' ' 124' ' ' LEU . . . -134.46 151.98 20.5 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.721 -0.752 . . . . 43.33 112.449 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.689 HG22 ' HA ' ' A' ' 151' ' ' GLU . 85.5 t -115.56 134.2 59.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.751 0.31 . . . . 54.3 111.132 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.494 HD12 ' O ' ' A' ' 150' ' ' LYS . 3.5 mp -54.66 115.34 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 73.4 111.136 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -100.16 -41.64 7.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 70.02 110.926 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -120.87 145.84 17.37 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.799 -0.715 . . . . 74.52 112.512 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.2 pttt -124.03 128.42 49.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.788 0.328 . . . . 75.2 110.927 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.6 m -119.82 176.5 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 71.4 111.167 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -68.15 99.06 0.85 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 72.03 110.927 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 92.02 -35.13 4.1 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.763 -0.732 . . . . 73.33 112.452 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -98.26 173.6 27.71 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.774 -0.727 . . . . 73.01 112.494 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -152.56 119.06 5.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.989 0.423 . . . . 73.13 110.905 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.418 ' O ' HG23 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -86.29 150.89 24.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.159 -0.473 . . . . 71.3 111.116 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.653 ' HB ' ' HB3' ' A' ' 129' ' ' ALA . 19.9 t -140.69 139.83 34.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.494 . . . . 62.52 111.121 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -95.02 107.28 19.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 63.43 110.871 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.403 HD23 ' CA ' ' A' ' 110' ' ' GLY . 26.9 mt -103.18 72.67 1.18 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.157 -0.474 . . . . 74.2 110.955 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 54.38 50.89 15.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 75.4 110.927 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 103.9 -33.38 6.62 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.714 -0.755 . . . . 71.51 112.461 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.6 mm -80.06 156.18 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.842 0.354 . . . . 73.32 111.114 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 47.7 mtt180 -114.84 121.67 43.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 73.51 110.956 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.653 ' HB3' ' HB ' ' A' ' 122' ' ' VAL . . . -102.25 168.45 9.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.25 -0.432 . . . . 63.52 111.123 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -147.87 124.41 11.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 74.44 110.844 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.584 HD21 ' CG2' ' A' ' 122' ' ' VAL . 0.1 OUTLIER -122.89 130.16 24.72 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.68 0.753 . . . . 72.14 110.887 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 146.21 59.77 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.652 2.235 . . . . 70.4 112.373 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -67.63 -11.35 59.88 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.772 -0.727 . . . . 72.2 112.482 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.6 m -51.33 -30.63 19.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.89 0.376 . . . . 71.14 110.838 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.539 HD22 ' CA ' ' A' ' 170' ' ' ARG . 5.0 tp -116.16 29.09 8.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 71.02 110.886 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 94.4 t -120.01 -32.74 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.251 -0.431 . . . . 72.44 111.113 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -108.11 116.0 31.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 72.0 110.843 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.439 HG12 ' H ' ' A' ' 139' ' ' ARG . 1.4 t -129.18 166.95 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 53.41 111.092 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.484 ' N ' ' HD2' ' A' ' 140' ' ' PRO . 0.9 OUTLIER -50.86 -60.68 5.05 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.602 0.715 . . . . 72.02 110.893 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 139' ' ' ARG . 54.5 Cg_endo -69.74 133.36 25.42 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.746 2.297 . . . . 72.14 112.361 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.7 m -128.83 148.7 33.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 61.41 111.103 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 81.9 mtt180 -124.73 -60.72 1.36 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.48 . . . . 73.12 110.88 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -153.01 162.75 40.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 65.31 110.87 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.526 HG22 HD11 ' A' ' 147' ' ' LEU . 5.8 p -106.5 19.72 20.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.205 -0.452 . . . . 34.45 111.184 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 145' ' ' LEU . 4.2 mm? -87.36 -24.56 24.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.494 . . . . 72.53 110.968 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.4 -8.59 59.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.146 -0.479 . . . . 72.35 110.88 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.526 HD11 HG22 ' A' ' 144' ' ' THR . 78.7 mt -58.92 -49.42 77.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.171 -0.468 . . . . 63.33 110.918 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -130.26 137.44 50.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 74.44 110.855 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 92.11 -16.44 59.62 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.799 -0.715 . . . . 65.23 112.505 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.593 ' HD3' HD13 ' A' ' 152' ' ' LEU . 0.4 OUTLIER -51.62 127.17 19.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.717 0.294 . . . . 70.04 110.914 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.689 ' HA ' HG22 ' A' ' 111' ' ' VAL . 2.9 pm0 -89.29 111.1 21.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.252 -0.431 . . . . 74.3 110.852 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.593 HD13 ' HD3' ' A' ' 150' ' ' LYS . 1.5 tp -139.25 -175.46 4.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 72.43 110.941 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -133.78 135.7 44.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 74.32 110.884 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.578 ' CE1' HG11 ' A' ' 122' ' ' VAL . 13.4 m-85 -119.25 -179.34 3.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.477 . . . . 73.31 110.834 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.666 ' O ' HD12 ' A' ' 157' ' ' ILE . 4.2 mttm -128.47 160.77 31.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 74.34 110.948 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.422 HG12 ' CD1' ' A' ' 102' ' ' TYR . 21.6 t -84.07 82.06 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.276 -0.42 . . . . 74.32 111.096 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.666 HD12 ' O ' ' A' ' 155' ' ' LYS . 5.1 mp -77.99 -40.49 26.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 71.04 111.089 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.41 154.74 7.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 75.32 110.857 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.73 HD21 ' CG ' ' A' ' 102' ' ' TYR . 0.2 OUTLIER -140.03 112.73 7.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 65.04 110.869 179.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -67.61 91.45 0.29 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.172 -0.467 . . . . 74.52 110.885 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -60.58 -19.93 59.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 71.33 110.923 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -51.6 -37.79 51.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 74.31 110.905 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 24.2 ttt85 -123.06 19.79 9.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 65.14 110.894 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 51.82 29.89 6.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 72.53 110.874 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -112.85 157.98 20.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.202 -0.454 . . . . 75.13 110.928 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.623 HG23 ' HB3' ' A' ' 159' ' ' LEU . 10.2 p -125.96 144.23 36.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 71.02 111.137 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 19.7 m -127.81 169.54 19.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 72.33 111.171 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 15.5 m -120.28 162.01 19.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.451 . . . . 74.3 111.087 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.638 ' H ' HD13 ' A' ' 157' ' ' ILE . 28.4 t -103.36 161.17 14.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 62.55 110.852 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.539 ' CA ' HD22 ' A' ' 135' ' ' LEU . 25.8 mtm180 -79.93 -58.16 3.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 71.21 110.918 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -56.35 -26.02 51.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 64.34 110.871 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.26 -14.03 61.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 63.4 111.04 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 13.5 p -51.6 -29.59 10.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 63.23 111.168 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 32.7 pt -51.62 -30.32 11.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.135 -0.484 . . . . 73.44 111.106 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -69.7 -38.54 77.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 72.13 110.945 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 26.0 t -51.78 -58.57 6.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.07 -0.514 . . . . 74.04 110.916 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -72.72 -61.61 1.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 62.41 110.874 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 16.0 t30 57.19 47.58 16.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 61.14 110.833 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 74.5 110.889 -179.928 . . . . . . . . 0 0 . 1 stop_ save_